| ,Unnamed: 0.6,Unnamed: 0.5,Unnamed: 0.4,Unnamed: 0.3,Unnamed: 0.2,Unnamed: 0.1,Unnamed: 0,id,name,source,type,Inter_ID |
| 0,0,0,0,0,0,0,0,R-HSA-3781865,Diseases of glycosylation,REACTOME,pathway,PATHWAY_0 |
| 1,1,1,1,1,1,1,1,R-HSA-211976,Endogenous sterols,REACTOME,pathway,PATHWAY_1 |
| 2,2,2,2,2,2,2,2,R-HSA-9670621,Defective Inhibition of DNA Recombination at Telomere,REACTOME,pathway,PATHWAY_2 |
| 3,3,3,3,3,3,3,3,R-HSA-975577,N-Glycan antennae elongation,REACTOME,pathway,PATHWAY_3 |
| 4,4,4,4,4,4,4,4,R-HSA-1482922,Acyl chain remodelling of PI,REACTOME,pathway,PATHWAY_4 |
| 5,5,5,5,5,5,5,5,R-HSA-434313,Intracellular metabolism of fatty acids regulates insulin secretion,REACTOME,pathway,PATHWAY_5 |
| 6,6,6,6,6,6,6,6,R-HSA-9018681,Biosynthesis of protectins,REACTOME,pathway,PATHWAY_6 |
| 7,7,7,7,7,7,7,7,R-HSA-5099900,WNT5A-dependent internalization of FZD4,REACTOME,pathway,PATHWAY_7 |
| 8,8,8,8,8,8,8,8,R-HSA-156842,Eukaryotic Translation Elongation,REACTOME,pathway,PATHWAY_8 |
| 9,9,9,9,9,9,9,9,R-HSA-9793380,Formation of paraxial mesoderm,REACTOME,pathway,PATHWAY_9 |
| 10,10,10,10,10,10,10,10,R-HSA-2142688,Synthesis of 5-eicosatetraenoic acids,REACTOME,pathway,PATHWAY_10 |
| 11,11,11,11,11,11,11,11,R-HSA-2559584,Formation of Senescence-Associated Heterochromatin Foci (SAHF),REACTOME,pathway,PATHWAY_11 |
| 12,12,12,12,12,12,12,12,R-HSA-5625886,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,REACTOME,pathway,PATHWAY_12 |
| 13,13,13,13,13,13,13,13,R-HSA-9026395,Biosynthesis of DHA-derived sulfido conjugates,REACTOME,pathway,PATHWAY_13 |
| 14,14,14,14,14,14,14,14,R-HSA-168333,NEP/NS2 Interacts with the Cellular Export Machinery,REACTOME,pathway,PATHWAY_14 |
| 15,15,15,15,15,15,15,15,R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,REACTOME,pathway,PATHWAY_15 |
| 16,16,16,16,16,16,16,16,R-HSA-111452,Activation and oligomerization of BAK protein,REACTOME,pathway,PATHWAY_16 |
| 17,17,17,17,17,17,17,17,R-HSA-9845323,Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs),REACTOME,pathway,PATHWAY_17 |
| 18,18,18,18,18,18,18,18,R-HSA-209931,Serotonin and melatonin biosynthesis,REACTOME,pathway,PATHWAY_18 |
| 19,19,19,19,19,19,19,19,R-HSA-8949664,Processing of SMDT1,REACTOME,pathway,PATHWAY_19 |
| 20,20,20,20,20,20,20,20,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,REACTOME,pathway,PATHWAY_20 |
| 21,21,21,21,21,21,21,21,R-HSA-2995383,Initiation of Nuclear Envelope (NE) Reformation,REACTOME,pathway,PATHWAY_21 |
| 22,22,22,22,22,22,22,22,R-HSA-8964038,LDL clearance,REACTOME,pathway,PATHWAY_22 |
| 23,23,23,23,23,23,23,23,R-HSA-159740,Gamma-carboxylation of protein precursors,REACTOME,pathway,PATHWAY_23 |
| 24,24,24,24,24,24,24,24,R-HSA-428359,Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,REACTOME,pathway,PATHWAY_24 |
| 25,25,25,25,25,25,25,25,R-HSA-5660883,Defective SLC7A9 causes cystinuria (CSNU),REACTOME,pathway,PATHWAY_25 |
| 26,26,26,26,26,26,26,26,R-HSA-9028335,Activated NTRK2 signals through PI3K,REACTOME,pathway,PATHWAY_26 |
| 27,27,27,27,27,27,27,27,R-HSA-3359463,Defective CUBN causes MGA1,REACTOME,pathway,PATHWAY_27 |
| 28,28,28,28,28,28,28,28,R-HSA-5638303,Inhibition of Signaling by Overexpressed EGFR,REACTOME,pathway,PATHWAY_28 |
| 29,29,29,29,29,29,29,29,R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,REACTOME,pathway,PATHWAY_29 |
| 30,30,30,30,30,30,30,30,R-HSA-437239,Recycling pathway of L1,REACTOME,pathway,PATHWAY_30 |
| 31,31,31,31,31,31,31,31,R-HSA-5668599,RHO GTPases Activate NADPH Oxidases,REACTOME,pathway,PATHWAY_31 |
| 32,32,32,32,32,32,32,32,R-HSA-9926550,"Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition",REACTOME,pathway,PATHWAY_32 |
| 33,33,33,33,33,33,33,33,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,REACTOME,pathway,PATHWAY_33 |
| 34,34,34,34,34,34,34,34,R-HSA-5083625,Defective GALNT3 causes HFTC,REACTOME,pathway,PATHWAY_34 |
| 35,35,35,35,35,35,35,35,R-HSA-9632693,Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects,REACTOME,pathway,PATHWAY_35 |
| 36,36,36,36,36,36,36,36,R-HSA-5668914,Diseases of metabolism,REACTOME,pathway,PATHWAY_36 |
| 37,37,37,37,37,37,37,37,R-HSA-5358747,CTNNB1 S33 mutants aren't phosphorylated,REACTOME,pathway,PATHWAY_37 |
| 38,38,38,38,38,38,38,38,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,REACTOME,pathway,PATHWAY_38 |
| 39,39,39,39,39,39,39,39,R-HSA-9022537,Loss of MECP2 binding ability to the NCoR/SMRT complex,REACTOME,pathway,PATHWAY_39 |
| 40,40,40,40,40,40,40,40,R-HSA-9694682,SARS-CoV-2 Genome Replication and Transcription,REACTOME,pathway,PATHWAY_40 |
| 41,41,41,41,41,41,41,41,R-HSA-8964043,Plasma lipoprotein clearance,REACTOME,pathway,PATHWAY_41 |
| 42,42,42,42,42,42,42,42,R-HSA-9860931,Response of endothelial cells to shear stress,REACTOME,pathway,PATHWAY_42 |
| 43,43,43,43,43,43,43,43,R-HSA-162594,Early Phase of HIV Life Cycle,REACTOME,pathway,PATHWAY_43 |
| 44,44,44,44,44,44,44,44,R-HSA-4719377,Defective DPM2 causes DPM2-CDG,REACTOME,pathway,PATHWAY_44 |
| 45,45,45,45,45,45,45,45,R-HSA-4043911,Defective PMM2 causes PMM2-CDG,REACTOME,pathway,PATHWAY_45 |
| 46,46,46,46,46,46,46,46,R-HSA-2691230,Signaling by NOTCH1 HD Domain Mutants in Cancer,REACTOME,pathway,PATHWAY_46 |
| 47,47,47,47,47,47,47,47,R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs,REACTOME,pathway,PATHWAY_47 |
| 48,48,48,48,48,48,48,48,R-HSA-109582,Hemostasis,REACTOME,pathway,PATHWAY_48 |
| 49,49,49,49,49,49,49,49,R-HSA-8949613,Cristae formation,REACTOME,pathway,PATHWAY_49 |
| 50,50,50,50,50,50,50,50,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),REACTOME,pathway,PATHWAY_50 |
| 51,51,51,51,51,51,51,51,R-HSA-9706369,Negative regulation of FLT3,REACTOME,pathway,PATHWAY_51 |
| 52,52,52,52,52,52,52,52,R-HSA-9619483,Activation of AMPK downstream of NMDARs,REACTOME,pathway,PATHWAY_52 |
| 53,53,53,53,53,53,53,53,R-HSA-73728,RNA Polymerase I Promoter Opening,REACTOME,pathway,PATHWAY_53 |
| 54,54,54,54,54,54,54,54,R-HSA-9762293,Regulation of CDH11 gene transcription,REACTOME,pathway,PATHWAY_54 |
| 55,55,55,55,55,55,55,55,R-HSA-2161522,Abacavir ADME,REACTOME,pathway,PATHWAY_55 |
| 56,56,56,56,56,56,56,56,R-HSA-9865125,Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD,REACTOME,pathway,PATHWAY_56 |
| 57,57,57,57,57,57,57,57,R-HSA-72766,Translation,REACTOME,pathway,PATHWAY_57 |
| 58,58,58,58,58,58,58,58,R-HSA-5173214,O-glycosylation of TSR domain-containing proteins,REACTOME,pathway,PATHWAY_58 |
| 59,59,59,59,59,59,59,59,R-HSA-9034015,Signaling by NTRK3 (TRKC),REACTOME,pathway,PATHWAY_59 |
| 60,60,60,60,60,60,60,60,R-HSA-1839128,FGFR4 mutant receptor activation,REACTOME,pathway,PATHWAY_60 |
| 61,61,61,61,61,61,61,61,R-HSA-375280,Amine ligand-binding receptors,REACTOME,pathway,PATHWAY_61 |
| 62,62,62,62,62,62,62,62,R-HSA-9027307,Biosynthesis of maresin-like SPMs,REACTOME,pathway,PATHWAY_62 |
| 63,63,63,63,63,63,63,63,R-HSA-937072,TRAF6-mediated induction of TAK1 complex within TLR4 complex,REACTOME,pathway,PATHWAY_63 |
| 64,64,64,64,64,64,64,64,R-HSA-1660524,PIPs transport between plasma and early endosome membranes,REACTOME,pathway,PATHWAY_64 |
| 65,65,65,65,65,65,65,65,R-HSA-445989,TAK1-dependent IKK and NF-kappa-B activation ,REACTOME,pathway,PATHWAY_65 |
| 66,66,66,66,66,66,66,66,R-HSA-5250955,Toxicity of botulinum toxin type D (botD),REACTOME,pathway,PATHWAY_66 |
| 67,67,67,67,67,67,67,67,R-HSA-110314,Recognition of DNA damage by PCNA-containing replication complex,REACTOME,pathway,PATHWAY_67 |
| 68,68,68,68,68,68,68,68,R-HSA-9013422,RHOBTB1 GTPase cycle,REACTOME,pathway,PATHWAY_68 |
| 69,69,69,69,69,69,69,69,R-HSA-9637687,Suppression of phagosomal maturation,REACTOME,pathway,PATHWAY_69 |
| 70,70,70,70,70,70,70,70,R-HSA-4720454,Defective ALG9 causes CDG-1l,REACTOME,pathway,PATHWAY_70 |
| 71,71,71,71,71,71,71,71,R-HSA-9692914,SARS-CoV-1-host interactions,REACTOME,pathway,PATHWAY_71 |
| 72,72,72,72,72,72,72,72,R-HSA-445355,Smooth Muscle Contraction,REACTOME,pathway,PATHWAY_72 |
| 73,73,73,73,73,73,73,73,R-HSA-193368,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,REACTOME,pathway,PATHWAY_73 |
| 74,74,74,74,74,74,74,74,R-HSA-9634597,GPER1 signaling,REACTOME,pathway,PATHWAY_74 |
| 75,75,75,75,75,75,75,75,R-HSA-163358,PKA-mediated phosphorylation of key metabolic factors,REACTOME,pathway,PATHWAY_75 |
| 76,76,76,76,76,76,76,76,R-HSA-5083632,Defective C1GALT1C1 causes TNPS,REACTOME,pathway,PATHWAY_76 |
| 77,77,77,77,77,77,77,77,R-HSA-9657688,Defective factor XII causes hereditary angioedema,REACTOME,pathway,PATHWAY_77 |
| 78,78,78,78,78,78,78,78,R-HSA-933543,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,REACTOME,pathway,PATHWAY_78 |
| 79,79,79,79,79,79,79,79,R-HSA-9759785,Diseases of propionyl-CoA catabolism,REACTOME,pathway,PATHWAY_79 |
| 80,80,80,80,80,80,80,80,R-HSA-5656121,Translesion synthesis by POLI,REACTOME,pathway,PATHWAY_80 |
| 81,81,81,81,81,81,81,81,R-HSA-167243,Tat-mediated HIV elongation arrest and recovery,REACTOME,pathway,PATHWAY_81 |
| 82,82,82,82,82,82,82,82,R-HSA-73894,DNA Repair,REACTOME,pathway,PATHWAY_82 |
| 83,83,83,83,83,83,83,83,R-HSA-69202,Cyclin E associated events during G1/S transition ,REACTOME,pathway,PATHWAY_83 |
| 84,84,84,84,84,84,84,84,R-HSA-210745,Regulation of gene expression in beta cells,REACTOME,pathway,PATHWAY_84 |
| 85,85,85,85,85,85,85,85,R-HSA-9748784,Drug ADME,REACTOME,pathway,PATHWAY_85 |
| 86,86,86,86,86,86,86,86,R-HSA-9637690,Response of Mtb to phagocytosis,REACTOME,pathway,PATHWAY_86 |
| 87,87,87,87,87,87,87,87,R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,REACTOME,pathway,PATHWAY_87 |
| 88,88,88,88,88,88,88,88,R-HSA-9018679,Biosynthesis of EPA-derived SPMs,REACTOME,pathway,PATHWAY_88 |
| 89,89,89,89,89,89,89,89,R-HSA-73621,Pyrimidine catabolism,REACTOME,pathway,PATHWAY_89 |
| 90,90,90,90,90,90,90,90,R-HSA-72649,Translation initiation complex formation,REACTOME,pathway,PATHWAY_90 |
| 91,91,91,91,91,91,91,91,R-HSA-5250924,B-WICH complex positively regulates rRNA expression,REACTOME,pathway,PATHWAY_91 |
| 92,92,92,92,92,92,92,92,R-HSA-9675151,Disorders of Developmental Biology,REACTOME,pathway,PATHWAY_92 |
| 93,93,93,93,93,93,93,93,R-HSA-4724325,Defective ALG8 causes CDG-1h,REACTOME,pathway,PATHWAY_93 |
| 94,94,94,94,94,94,94,94,R-HSA-2871796,FCERI mediated MAPK activation,REACTOME,pathway,PATHWAY_94 |
| 95,95,95,95,95,95,95,95,R-HSA-6803211,TP53 Regulates Transcription of Death Receptors and Ligands,REACTOME,pathway,PATHWAY_95 |
| 96,96,96,96,96,96,96,96,R-HSA-163754,Insulin effects increased synthesis of Xylulose-5-Phosphate,REACTOME,pathway,PATHWAY_96 |
| 97,97,97,97,97,97,97,97,R-HSA-9703648,Signaling by FLT3 ITD and TKD mutants,REACTOME,pathway,PATHWAY_97 |
| 98,98,98,98,98,98,98,98,R-HSA-9020933,Interleukin-23 signaling,REACTOME,pathway,PATHWAY_98 |
| 99,99,99,99,99,99,99,99,R-HSA-1280215,Cytokine Signaling in Immune system,REACTOME,pathway,PATHWAY_99 |
| 100,100,100,100,100,100,100,100,R-HSA-1474228,Degradation of the extracellular matrix,REACTOME,pathway,PATHWAY_100 |
| 101,101,101,101,101,101,101,101,R-HSA-111933,Calmodulin induced events,REACTOME,pathway,PATHWAY_101 |
| 102,102,102,102,102,102,102,102,R-HSA-5632684,Hedgehog 'on' state,REACTOME,pathway,PATHWAY_102 |
| 103,103,103,103,103,103,103,103,R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,REACTOME,pathway,PATHWAY_103 |
| 104,104,104,104,104,104,104,104,R-HSA-1482839,Acyl chain remodelling of PE,REACTOME,pathway,PATHWAY_104 |
| 105,105,105,105,105,105,105,105,R-HSA-2660825,Signaling by NOTCH1 t(7 |
| 106,106,106,106,106,106,106,106,R-HSA-8982491,Glycogen metabolism,REACTOME,pathway,PATHWAY_106 |
| 107,107,107,107,107,107,107,107,R-HSA-8949275,RUNX3 Regulates Immune Response and Cell Migration,REACTOME,pathway,PATHWAY_107 |
| 108,108,108,108,108,108,108,108,R-HSA-975574,Reactions specific to the hybrid N-glycan synthesis pathway,REACTOME,pathway,PATHWAY_108 |
| 109,109,109,109,109,109,109,109,R-HSA-9702605,pexidartinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_109 |
| 110,110,110,110,110,110,110,110,R-HSA-456926,Thrombin signalling through proteinase activated receptors (PARs),REACTOME,pathway,PATHWAY_110 |
| 111,111,111,111,111,111,111,111,R-HSA-2022928,HS-GAG biosynthesis,REACTOME,pathway,PATHWAY_111 |
| 112,112,112,112,112,112,112,112,R-HSA-8983711,OAS antiviral response,REACTOME,pathway,PATHWAY_112 |
| 113,113,113,113,113,113,113,113,R-HSA-350054,Notch-HLH transcription pathway,REACTOME,pathway,PATHWAY_113 |
| 114,114,114,114,114,114,114,114,R-HSA-9820960,Respiratory syncytial virus (RSV) attachment and entry,REACTOME,pathway,PATHWAY_114 |
| 115,115,115,115,115,115,115,115,R-HSA-5660489,MTF1 activates gene expression,REACTOME,pathway,PATHWAY_115 |
| 116,116,116,116,116,116,116,116,R-HSA-8853333,Signaling by FGFR2 fusions,REACTOME,pathway,PATHWAY_116 |
| 117,117,117,117,117,117,117,117,R-HSA-427589,Type II Na+/Pi cotransporters,REACTOME,pathway,PATHWAY_117 |
| 118,118,118,118,118,118,118,118,R-HSA-444821,Relaxin receptors,REACTOME,pathway,PATHWAY_118 |
| 119,119,119,119,119,119,119,119,R-HSA-1643713,Signaling by EGFR in Cancer,REACTOME,pathway,PATHWAY_119 |
| 120,120,120,120,120,120,120,120,R-HSA-141424,Amplification of signal from the kinetochores,REACTOME,pathway,PATHWAY_120 |
| 121,121,121,121,121,121,121,121,R-HSA-372790,Signaling by GPCR,REACTOME,pathway,PATHWAY_121 |
| 122,122,122,122,122,122,122,122,R-HSA-9614085,FOXO-mediated transcription,REACTOME,pathway,PATHWAY_122 |
| 123,123,123,123,123,123,123,123,R-HSA-9717329,lorlatinib-resistant ALK mutants,REACTOME,pathway,PATHWAY_123 |
| 124,124,124,124,124,124,124,124,R-HSA-73864,RNA Polymerase I Transcription,REACTOME,pathway,PATHWAY_124 |
| 125,125,125,125,125,125,125,125,R-HSA-1236974,ER-Phagosome pathway,REACTOME,pathway,PATHWAY_125 |
| 126,126,126,126,126,126,126,126,R-HSA-69615,G1/S DNA Damage Checkpoints,REACTOME,pathway,PATHWAY_126 |
| 127,127,127,127,127,127,127,127,R-HSA-74713,IRS activation,REACTOME,pathway,PATHWAY_127 |
| 128,128,128,128,128,128,128,128,R-HSA-446199,Synthesis of Dolichyl-phosphate,REACTOME,pathway,PATHWAY_128 |
| 129,129,129,129,129,129,129,129,R-HSA-212718,EGFR interacts with phospholipase C-gamma,REACTOME,pathway,PATHWAY_129 |
| 130,130,130,130,130,130,130,130,R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,REACTOME,pathway,PATHWAY_130 |
| 131,131,131,131,131,131,131,131,R-HSA-5663205,Infectious disease,REACTOME,pathway,PATHWAY_131 |
| 132,132,132,132,132,132,132,132,R-HSA-3642278,Loss of Function of TGFBR2 in Cancer,REACTOME,pathway,PATHWAY_132 |
| 133,133,133,133,133,133,133,133,R-HSA-556833,Metabolism of lipids,REACTOME,pathway,PATHWAY_133 |
| 134,134,134,134,134,134,134,134,R-HSA-9613354,Lipophagy,REACTOME,pathway,PATHWAY_134 |
| 135,135,135,135,135,135,135,135,R-HSA-9759194,Nuclear events mediated by NFE2L2,REACTOME,pathway,PATHWAY_135 |
| 136,136,136,136,136,136,136,136,R-HSA-9842640,Signaling by LTK in cancer,REACTOME,pathway,PATHWAY_136 |
| 137,137,137,137,137,137,137,137,R-HSA-9702632,sunitinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_137 |
| 138,138,138,138,138,138,138,138,R-HSA-5669034,TNFs bind their physiological receptors,REACTOME,pathway,PATHWAY_138 |
| 139,139,139,139,139,139,139,139,R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,REACTOME,pathway,PATHWAY_139 |
| 140,140,140,140,140,140,140,140,R-HSA-9637628,Modulation by Mtb of host immune system,REACTOME,pathway,PATHWAY_140 |
| 141,141,141,141,141,141,141,141,R-HSA-390650,Histamine receptors,REACTOME,pathway,PATHWAY_141 |
| 142,142,142,142,142,142,142,142,R-HSA-1169091,Activation of NF-kappaB in B cells,REACTOME,pathway,PATHWAY_142 |
| 143,143,143,143,143,143,143,143,R-HSA-1358803,Downregulation of ERBB2:ERBB3 signaling,REACTOME,pathway,PATHWAY_143 |
| 144,144,144,144,144,144,144,144,R-HSA-9013408,RHOG GTPase cycle,REACTOME,pathway,PATHWAY_144 |
| 145,145,145,145,145,145,145,145,R-HSA-2453864,Retinoid cycle disease events,REACTOME,pathway,PATHWAY_145 |
| 146,146,146,146,146,146,146,146,R-HSA-400451,Free fatty acids regulate insulin secretion,REACTOME,pathway,PATHWAY_146 |
| 147,147,147,147,147,147,147,147,R-HSA-1566948,Elastic fibre formation,REACTOME,pathway,PATHWAY_147 |
| 148,148,148,148,148,148,148,148,R-HSA-3656237,Defective EXT2 causes exostoses 2,REACTOME,pathway,PATHWAY_148 |
| 149,149,149,149,149,149,149,149,R-HSA-936964,"Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)",REACTOME,pathway,PATHWAY_149 |
| 150,150,150,150,150,150,150,150,R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,REACTOME,pathway,PATHWAY_150 |
| 151,151,151,151,151,151,151,151,R-HSA-389887,Beta-oxidation of pristanoyl-CoA,REACTOME,pathway,PATHWAY_151 |
| 152,152,152,152,152,152,152,152,R-HSA-162710,Synthesis of glycosylphosphatidylinositol (GPI),REACTOME,pathway,PATHWAY_152 |
| 153,153,153,153,153,153,153,153,R-HSA-1538133,G0 and Early G1,REACTOME,pathway,PATHWAY_153 |
| 154,154,154,154,154,154,154,154,R-HSA-977606,Regulation of Complement cascade,REACTOME,pathway,PATHWAY_154 |
| 155,155,155,155,155,155,155,155,R-HSA-5689603,UCH proteinases,REACTOME,pathway,PATHWAY_155 |
| 156,156,156,156,156,156,156,156,R-HSA-159236,Transport of Mature mRNA derived from an Intron-Containing Transcript,REACTOME,pathway,PATHWAY_156 |
| 157,157,157,157,157,157,157,157,R-HSA-3858494,Beta-catenin independent WNT signaling,REACTOME,pathway,PATHWAY_157 |
| 158,158,158,158,158,158,158,158,R-HSA-5365859,RA biosynthesis pathway,REACTOME,pathway,PATHWAY_158 |
| 159,159,159,159,159,159,159,159,R-HSA-1912420,Pre-NOTCH Processing in Golgi,REACTOME,pathway,PATHWAY_159 |
| 160,160,160,160,160,160,160,160,R-HSA-5357769,Caspase activation via extrinsic apoptotic signalling pathway,REACTOME,pathway,PATHWAY_160 |
| 161,161,161,161,161,161,161,161,R-HSA-8980692,RHOA GTPase cycle,REACTOME,pathway,PATHWAY_161 |
| 162,162,162,162,162,162,162,162,R-HSA-9630750,Evasion of Oncogene Induced Senescence Due to p16INK4A Defects,REACTOME,pathway,PATHWAY_162 |
| 163,163,163,163,163,163,163,163,R-HSA-174577,Activation of C3 and C5,REACTOME,pathway,PATHWAY_163 |
| 164,164,164,164,164,164,164,164,R-HSA-4549356,"Defective DPAGT1 causes CDG-1j, CMSTA2",REACTOME,pathway,PATHWAY_164 |
| 165,165,165,165,165,165,165,165,R-HSA-9825892,Regulation of MITF-M-dependent genes involved in cell cycle and proliferation,REACTOME,pathway,PATHWAY_165 |
| 166,166,166,166,166,166,166,166,R-HSA-9927353,Co-inhibition by BTLA,REACTOME,pathway,PATHWAY_166 |
| 167,167,167,167,167,167,167,167,R-HSA-73863,RNA Polymerase I Transcription Termination,REACTOME,pathway,PATHWAY_167 |
| 168,168,168,168,168,168,168,168,R-HSA-1169092,Activation of RAS in B cells,REACTOME,pathway,PATHWAY_168 |
| 169,169,169,169,169,169,169,169,R-HSA-8849469,PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,REACTOME,pathway,PATHWAY_169 |
| 170,170,170,170,170,170,170,170,R-HSA-9694516,SARS-CoV-2 Infection,REACTOME,pathway,PATHWAY_170 |
| 171,171,171,171,171,171,171,171,R-HSA-8849932,Synaptic adhesion-like molecules,REACTOME,pathway,PATHWAY_171 |
| 172,172,172,172,172,172,172,172,R-HSA-8878171,Transcriptional regulation by RUNX1,REACTOME,pathway,PATHWAY_172 |
| 173,173,173,173,173,173,173,173,R-HSA-3645790,TGFBR2 Kinase Domain Mutants in Cancer,REACTOME,pathway,PATHWAY_173 |
| 174,174,174,174,174,174,174,174,R-HSA-4086400,PCP/CE pathway,REACTOME,pathway,PATHWAY_174 |
| 175,175,175,175,175,175,175,175,R-HSA-3359454,Defective TCN2 causes TCN2 deficiency,REACTOME,pathway,PATHWAY_175 |
| 176,176,176,176,176,176,176,176,R-HSA-68949,Orc1 removal from chromatin,REACTOME,pathway,PATHWAY_176 |
| 177,177,177,177,177,177,177,177,R-HSA-6794361,Neurexins and neuroligins,REACTOME,pathway,PATHWAY_177 |
| 178,178,178,178,178,178,178,178,R-HSA-5655799,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum),REACTOME,pathway,PATHWAY_178 |
| 179,179,179,179,179,179,179,179,R-HSA-5696400,Dual Incision in GG-NER,REACTOME,pathway,PATHWAY_179 |
| 180,180,180,180,180,180,180,180,R-HSA-69478,G2/M DNA replication checkpoint,REACTOME,pathway,PATHWAY_180 |
| 181,181,181,181,181,181,181,181,R-HSA-166663,Initial triggering of complement,REACTOME,pathway,PATHWAY_181 |
| 182,182,182,182,182,182,182,182,R-HSA-1368082,RORA activates gene expression,REACTOME,pathway,PATHWAY_182 |
| 183,183,183,183,183,183,183,183,R-HSA-977225,Amyloid fiber formation,REACTOME,pathway,PATHWAY_183 |
| 184,184,184,184,184,184,184,184,R-HSA-193648,NRAGE signals death through JNK,REACTOME,pathway,PATHWAY_184 |
| 185,185,185,185,185,185,185,185,R-HSA-186712,Regulation of beta-cell development,REACTOME,pathway,PATHWAY_185 |
| 186,186,186,186,186,186,186,186,R-HSA-947581,Molybdenum cofactor biosynthesis,REACTOME,pathway,PATHWAY_186 |
| 187,187,187,187,187,187,187,187,R-HSA-5683177,Defective ABCC8 can cause hypo- and hyper-glycemias,REACTOME,pathway,PATHWAY_187 |
| 188,188,188,188,188,188,188,188,R-HSA-9669917,Imatinib-resistant KIT mutants,REACTOME,pathway,PATHWAY_188 |
| 189,189,189,189,189,189,189,189,R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,REACTOME,pathway,PATHWAY_189 |
| 190,190,190,190,190,190,190,190,R-HSA-8853383,Lysosomal oligosaccharide catabolism,REACTOME,pathway,PATHWAY_190 |
| 191,191,191,191,191,191,191,191,R-HSA-6803157,Antimicrobial peptides,REACTOME,pathway,PATHWAY_191 |
| 192,192,192,192,192,192,192,192,R-HSA-71032,Propionyl-CoA catabolism,REACTOME,pathway,PATHWAY_192 |
| 193,193,193,193,193,193,193,193,R-HSA-163765,ChREBP activates metabolic gene expression,REACTOME,pathway,PATHWAY_193 |
| 194,194,194,194,194,194,194,194,R-HSA-9828721,Translation of respiratory syncytial virus mRNAs,REACTOME,pathway,PATHWAY_194 |
| 195,195,195,195,195,195,195,195,R-HSA-5619047,Defective SLC2A9 causes hypouricemia renal 2 (RHUC2),REACTOME,pathway,PATHWAY_195 |
| 196,196,196,196,196,196,196,196,R-HSA-879518,Transport of organic anions,REACTOME,pathway,PATHWAY_196 |
| 197,197,197,197,197,197,197,197,R-HSA-72187,mRNA 3'-end processing,REACTOME,pathway,PATHWAY_197 |
| 198,198,198,198,198,198,198,198,R-HSA-182971,EGFR downregulation,REACTOME,pathway,PATHWAY_198 |
| 199,199,199,199,199,199,199,199,R-HSA-68881,Mitotic Metaphase/Anaphase Transition,REACTOME,pathway,PATHWAY_199 |
| 200,200,200,200,200,200,200,200,R-HSA-9692912,SARS-CoV-1 targets PDZ proteins in cell-cell junction,REACTOME,pathway,PATHWAY_200 |
| 201,201,201,201,201,201,201,201,R-HSA-6806834,Signaling by MET,REACTOME,pathway,PATHWAY_201 |
| 202,202,202,202,202,202,202,202,R-HSA-5358751,CTNNB1 S45 mutants aren't phosphorylated,REACTOME,pathway,PATHWAY_202 |
| 203,203,203,203,203,203,203,203,R-HSA-9759811,Regulation of CDH11 mRNA translation by microRNAs,REACTOME,pathway,PATHWAY_203 |
| 204,204,204,204,204,204,204,204,R-HSA-6782861,Synthesis of wybutosine at G37 of tRNA(Phe),REACTOME,pathway,PATHWAY_204 |
| 205,205,205,205,205,205,205,205,R-HSA-1368071,NR1D1 (REV-ERBA) represses gene expression,REACTOME,pathway,PATHWAY_205 |
| 206,206,206,206,206,206,206,206,R-HSA-72086,mRNA Capping,REACTOME,pathway,PATHWAY_206 |
| 207,207,207,207,207,207,207,207,R-HSA-176407,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,REACTOME,pathway,PATHWAY_207 |
| 208,208,208,208,208,208,208,208,R-HSA-5654743,Signaling by FGFR4,REACTOME,pathway,PATHWAY_208 |
| 209,209,209,209,209,209,209,209,R-HSA-2206291,MPS IIIC - Sanfilippo syndrome C,REACTOME,pathway,PATHWAY_209 |
| 210,210,210,210,210,210,210,210,R-HSA-5675482,Regulation of necroptotic cell death,REACTOME,pathway,PATHWAY_210 |
| 211,211,211,211,211,211,211,211,R-HSA-2029485,Role of phospholipids in phagocytosis,REACTOME,pathway,PATHWAY_211 |
| 212,212,212,212,212,212,212,212,R-HSA-174490,Membrane binding and targetting of GAG proteins,REACTOME,pathway,PATHWAY_212 |
| 213,213,213,213,213,213,213,213,R-HSA-9709570,Impaired BRCA2 binding to RAD51,REACTOME,pathway,PATHWAY_213 |
| 214,214,214,214,214,214,214,214,R-HSA-73929,"Base-Excision Repair, AP Site Formation",REACTOME,pathway,PATHWAY_214 |
| 215,215,215,215,215,215,215,215,R-HSA-1483226,Synthesis of PI,REACTOME,pathway,PATHWAY_215 |
| 216,216,216,216,216,216,216,216,R-HSA-8963743,Digestion and absorption,REACTOME,pathway,PATHWAY_216 |
| 217,217,217,217,217,217,217,217,R-HSA-9605308,Diseases of Base Excision Repair,REACTOME,pathway,PATHWAY_217 |
| 218,218,218,218,218,218,218,218,R-HSA-9702509,FLT3 mutants bind TKIs,REACTOME,pathway,PATHWAY_218 |
| 219,219,219,219,219,219,219,219,R-HSA-139910,Activation of BMF and translocation to mitochondria,REACTOME,pathway,PATHWAY_219 |
| 220,220,220,220,220,220,220,220,R-HSA-425561,Sodium/Calcium exchangers,REACTOME,pathway,PATHWAY_220 |
| 221,221,221,221,221,221,221,221,R-HSA-9857492,Protein lipoylation,REACTOME,pathway,PATHWAY_221 |
| 222,222,222,222,222,222,222,222,R-HSA-9840310,Glycosphingolipid catabolism,REACTOME,pathway,PATHWAY_222 |
| 223,223,223,223,223,223,223,223,R-HSA-1483115,Hydrolysis of LPC,REACTOME,pathway,PATHWAY_223 |
| 224,224,224,224,224,224,224,224,R-HSA-5693606,DNA Double Strand Break Response,REACTOME,pathway,PATHWAY_224 |
| 225,225,225,225,225,225,225,225,R-HSA-9672396,Defective cofactor function of FVIIIa variant,REACTOME,pathway,PATHWAY_225 |
| 226,226,226,226,226,226,226,226,R-HSA-8866376,Reelin signalling pathway,REACTOME,pathway,PATHWAY_226 |
| 227,227,227,227,227,227,227,227,R-HSA-9026519,Activated NTRK2 signals through RAS,REACTOME,pathway,PATHWAY_227 |
| 228,228,228,228,228,228,228,228,R-HSA-9013406,RHOQ GTPase cycle,REACTOME,pathway,PATHWAY_228 |
| 229,229,229,229,229,229,229,229,R-HSA-351906,Apoptotic cleavage of cell adhesion proteins,REACTOME,pathway,PATHWAY_229 |
| 230,230,230,230,230,230,230,230,R-HSA-9013507,NOTCH3 Activation and Transmission of Signal to the Nucleus,REACTOME,pathway,PATHWAY_230 |
| 231,231,231,231,231,231,231,231,R-HSA-844455,The NLRP1 inflammasome,REACTOME,pathway,PATHWAY_231 |
| 232,232,232,232,232,232,232,232,R-HSA-9854311,Maturation of TCA enzymes and regulation of TCA cycle,REACTOME,pathway,PATHWAY_232 |
| 233,233,233,233,233,233,233,233,R-HSA-9013973,TICAM1-dependent activation of IRF3/IRF7,REACTOME,pathway,PATHWAY_233 |
| 234,234,234,234,234,234,234,234,R-HSA-9682706,Replication of the SARS-CoV-1 genome,REACTOME,pathway,PATHWAY_234 |
| 235,235,235,235,235,235,235,235,R-HSA-3359473,Defective MMADHC causes MMAHCD,REACTOME,pathway,PATHWAY_235 |
| 236,236,236,236,236,236,236,236,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,REACTOME,pathway,PATHWAY_236 |
| 237,237,237,237,237,237,237,237,R-HSA-8853334,Signaling by FGFR3 fusions in cancer,REACTOME,pathway,PATHWAY_237 |
| 238,238,238,238,238,238,238,238,R-HSA-9665233,Resistance of ERBB2 KD mutants to trastuzumab,REACTOME,pathway,PATHWAY_238 |
| 239,239,239,239,239,239,239,239,R-HSA-2142691,Synthesis of Leukotrienes (LT) and Eoxins (EX),REACTOME,pathway,PATHWAY_239 |
| 240,240,240,240,240,240,240,240,R-HSA-9629232,Defective Base Excision Repair Associated with NEIL3,REACTOME,pathway,PATHWAY_240 |
| 241,241,241,241,241,241,241,241,R-HSA-5083630,Defective LFNG causes SCDO3,REACTOME,pathway,PATHWAY_241 |
| 242,242,242,242,242,242,242,242,R-HSA-936837,Ion transport by P-type ATPases,REACTOME,pathway,PATHWAY_242 |
| 243,243,243,243,243,243,243,243,R-HSA-69239,Synthesis of DNA,REACTOME,pathway,PATHWAY_243 |
| 244,244,244,244,244,244,244,244,R-HSA-5658208,Defective SLC5A2 causes renal glucosuria (GLYS1),REACTOME,pathway,PATHWAY_244 |
| 245,245,245,245,245,245,245,245,R-HSA-446205,Synthesis of GDP-mannose,REACTOME,pathway,PATHWAY_245 |
| 246,246,246,246,246,246,246,246,R-HSA-1500620,Meiosis,REACTOME,pathway,PATHWAY_246 |
| 247,247,247,247,247,247,247,247,R-HSA-391903,Eicosanoid ligand-binding receptors,REACTOME,pathway,PATHWAY_247 |
| 248,248,248,248,248,248,248,248,R-HSA-390651,Dopamine receptors,REACTOME,pathway,PATHWAY_248 |
| 249,249,249,249,249,249,249,249,R-HSA-5223345,Miscellaneous transport and binding events,REACTOME,pathway,PATHWAY_249 |
| 250,250,250,250,250,250,250,250,R-HSA-5619066,Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1),REACTOME,pathway,PATHWAY_250 |
| 251,251,251,251,251,251,251,251,R-HSA-5250982,Toxicity of tetanus toxin (tetX),REACTOME,pathway,PATHWAY_251 |
| 252,252,252,252,252,252,252,252,R-HSA-9918443,Defective visual phototransduction due to OPN1SW loss of function,REACTOME,pathway,PATHWAY_252 |
| 253,253,253,253,253,253,253,253,R-HSA-2129379,Molecules associated with elastic fibres,REACTOME,pathway,PATHWAY_253 |
| 254,254,254,254,254,254,254,254,R-HSA-417973,Adenosine P1 receptors,REACTOME,pathway,PATHWAY_254 |
| 255,255,255,255,255,255,255,255,R-HSA-196071,Metabolism of steroid hormones,REACTOME,pathway,PATHWAY_255 |
| 256,256,256,256,256,256,256,256,R-HSA-9723905,Loss of function of TP53 in cancer due to loss of tetramerization ability,REACTOME,pathway,PATHWAY_256 |
| 257,257,257,257,257,257,257,257,R-HSA-2466712,"Biosynthesis of A2E, implicated in retinal degradation",REACTOME,pathway,PATHWAY_257 |
| 258,258,258,258,258,258,258,258,R-HSA-9754189,Germ layer formation at gastrulation,REACTOME,pathway,PATHWAY_258 |
| 259,259,259,259,259,259,259,259,R-HSA-203641,NOSTRIN mediated eNOS trafficking,REACTOME,pathway,PATHWAY_259 |
| 260,260,260,260,260,260,260,260,R-HSA-5660862,Defective SLC7A7 causes lysinuric protein intolerance (LPI),REACTOME,pathway,PATHWAY_260 |
| 261,261,261,261,261,261,261,261,R-HSA-5602358,Diseases associated with the TLR signaling cascade,REACTOME,pathway,PATHWAY_261 |
| 262,262,262,262,262,262,262,262,R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,REACTOME,pathway,PATHWAY_262 |
| 263,263,263,263,263,263,263,263,R-HSA-5657562,Essential fructosuria,REACTOME,pathway,PATHWAY_263 |
| 264,264,264,264,264,264,264,264,R-HSA-162587,HIV Life Cycle,REACTOME,pathway,PATHWAY_264 |
| 265,265,265,265,265,265,265,265,R-HSA-83936,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,REACTOME,pathway,PATHWAY_265 |
| 266,266,266,266,266,266,266,266,R-HSA-73886,Chromosome Maintenance,REACTOME,pathway,PATHWAY_266 |
| 267,267,267,267,267,267,267,267,R-HSA-1170546,Prolactin receptor signaling,REACTOME,pathway,PATHWAY_267 |
| 268,268,268,268,268,268,268,268,R-HSA-196843,Vitamin B2 (riboflavin) metabolism,REACTOME,pathway,PATHWAY_268 |
| 269,269,269,269,269,269,269,269,R-HSA-211897,Cytochrome P450 - arranged by substrate type,REACTOME,pathway,PATHWAY_269 |
| 270,270,270,270,270,270,270,270,R-HSA-5619048,"Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)",REACTOME,pathway,PATHWAY_270 |
| 271,271,271,271,271,271,271,271,R-HSA-211916,Vitamins,REACTOME,pathway,PATHWAY_271 |
| 272,272,272,272,272,272,272,272,R-HSA-2025928,Calcineurin activates NFAT,REACTOME,pathway,PATHWAY_272 |
| 273,273,273,273,273,273,273,273,R-HSA-2022854,Keratan sulfate biosynthesis,REACTOME,pathway,PATHWAY_273 |
| 274,274,274,274,274,274,274,274,R-HSA-191650,Regulation of gap junction activity,REACTOME,pathway,PATHWAY_274 |
| 275,275,275,275,275,275,275,275,R-HSA-2160916,Hyaluronan uptake and degradation,REACTOME,pathway,PATHWAY_275 |
| 276,276,276,276,276,276,276,276,R-HSA-426496,Post-transcriptional silencing by small RNAs,REACTOME,pathway,PATHWAY_276 |
| 277,277,277,277,277,277,277,277,R-HSA-5578996,Defective CYP27A1 causes CTX,REACTOME,pathway,PATHWAY_277 |
| 278,278,278,278,278,278,278,278,R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,REACTOME,pathway,PATHWAY_278 |
| 279,279,279,279,279,279,279,279,R-HSA-389948,Co-inhibition by PD-1,REACTOME,pathway,PATHWAY_279 |
| 280,280,280,280,280,280,280,280,R-HSA-5659729,Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,REACTOME,pathway,PATHWAY_280 |
| 281,281,281,281,281,281,281,281,R-HSA-1839130,Signaling by activated point mutants of FGFR3,REACTOME,pathway,PATHWAY_281 |
| 282,282,282,282,282,282,282,282,R-HSA-6785470,tRNA processing in the mitochondrion,REACTOME,pathway,PATHWAY_282 |
| 283,283,283,283,283,283,283,283,R-HSA-380320,Recruitment of NuMA to mitotic centrosomes,REACTOME,pathway,PATHWAY_283 |
| 284,284,284,284,284,284,284,284,R-HSA-432047,Passive transport by Aquaporins,REACTOME,pathway,PATHWAY_284 |
| 285,285,285,285,285,285,285,285,R-HSA-9694631,Maturation of nucleoprotein,REACTOME,pathway,PATHWAY_285 |
| 286,286,286,286,286,286,286,286,R-HSA-9673766,Signaling by cytosolic PDGFRA and PDGFRB fusion proteins,REACTOME,pathway,PATHWAY_286 |
| 287,287,287,287,287,287,287,287,R-HSA-5619055,Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI),REACTOME,pathway,PATHWAY_287 |
| 288,288,288,288,288,288,288,288,R-HSA-9734195,Defective APRT disrupts adenine salvage,REACTOME,pathway,PATHWAY_288 |
| 289,289,289,289,289,289,289,289,R-HSA-140180,COX reactions,REACTOME,pathway,PATHWAY_289 |
| 290,290,290,290,290,290,290,290,R-HSA-392154,Nitric oxide stimulates guanylate cyclase,REACTOME,pathway,PATHWAY_290 |
| 291,291,291,291,291,291,291,291,R-HSA-400685,Sema4D in semaphorin signaling,REACTOME,pathway,PATHWAY_291 |
| 292,292,292,292,292,292,292,292,R-HSA-9018676,Biosynthesis of D-series resolvins,REACTOME,pathway,PATHWAY_292 |
| 293,293,293,293,293,293,293,293,R-HSA-2206296,MPS II - Hunter syndrome,REACTOME,pathway,PATHWAY_293 |
| 294,294,294,294,294,294,294,294,R-HSA-5662853,Essential pentosuria,REACTOME,pathway,PATHWAY_294 |
| 295,295,295,295,295,295,295,295,R-HSA-211994,Sterols are 12-hydroxylated by CYP8B1,REACTOME,pathway,PATHWAY_295 |
| 296,296,296,296,296,296,296,296,R-HSA-2046105,Linoleic acid (LA) metabolism,REACTOME,pathway,PATHWAY_296 |
| 297,297,297,297,297,297,297,297,R-HSA-75064,mRNA Editing: A to I Conversion,REACTOME,pathway,PATHWAY_297 |
| 298,298,298,298,298,298,298,298,R-HSA-2214320,Anchoring fibril formation,REACTOME,pathway,PATHWAY_298 |
| 299,299,299,299,299,299,299,299,R-HSA-5619052,Defective SLC9A9 causes autism 16 (AUTS16),REACTOME,pathway,PATHWAY_299 |
| 300,300,300,300,300,300,300,300,R-HSA-9861559,PDH complex synthesizes acetyl-CoA from PYR,REACTOME,pathway,PATHWAY_300 |
| 301,301,301,301,301,301,301,301,R-HSA-428542,Regulation of commissural axon pathfinding by SLIT and ROBO,REACTOME,pathway,PATHWAY_301 |
| 302,302,302,302,302,302,302,302,R-HSA-167826,The fatty acid cycling model,REACTOME,pathway,PATHWAY_302 |
| 303,303,303,303,303,303,303,303,R-HSA-350562,Regulation of ornithine decarboxylase (ODC),REACTOME,pathway,PATHWAY_303 |
| 304,304,304,304,304,304,304,304,R-HSA-9614399,Regulation of localization of FOXO transcription factors,REACTOME,pathway,PATHWAY_304 |
| 305,305,305,305,305,305,305,305,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,REACTOME,pathway,PATHWAY_305 |
| 306,306,306,306,306,306,306,306,R-HSA-9010642,ROBO receptors bind AKAP5,REACTOME,pathway,PATHWAY_306 |
| 307,307,307,307,307,307,307,307,R-HSA-1482883,Acyl chain remodeling of DAG and TAG,REACTOME,pathway,PATHWAY_307 |
| 308,308,308,308,308,308,308,308,R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,REACTOME,pathway,PATHWAY_308 |
| 309,309,309,309,309,309,309,309,R-HSA-2428924,IGF1R signaling cascade,REACTOME,pathway,PATHWAY_309 |
| 310,310,310,310,310,310,310,310,R-HSA-912526,Interleukin receptor SHC signaling,REACTOME,pathway,PATHWAY_310 |
| 311,311,311,311,311,311,311,311,R-HSA-170660,Adenylate cyclase activating pathway,REACTOME,pathway,PATHWAY_311 |
| 312,312,312,312,312,312,312,312,R-HSA-177243,Interactions of Rev with host cellular proteins,REACTOME,pathway,PATHWAY_312 |
| 313,313,313,313,313,313,313,313,R-HSA-156582,Acetylation,REACTOME,pathway,PATHWAY_313 |
| 314,314,314,314,314,314,314,314,R-HSA-8941855,RUNX3 regulates CDKN1A transcription,REACTOME,pathway,PATHWAY_314 |
| 315,315,315,315,315,315,315,315,R-HSA-933541,TRAF6 mediated IRF7 activation,REACTOME,pathway,PATHWAY_315 |
| 316,316,316,316,316,316,316,316,R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,REACTOME,pathway,PATHWAY_316 |
| 317,317,317,317,317,317,317,317,R-HSA-75944,Transcription from mitochondrial promoters,REACTOME,pathway,PATHWAY_317 |
| 318,318,318,318,318,318,318,318,R-HSA-5625900,RHO GTPases activate CIT,REACTOME,pathway,PATHWAY_318 |
| 319,319,319,319,319,319,319,319,R-HSA-163560,Triglyceride catabolism,REACTOME,pathway,PATHWAY_319 |
| 320,320,320,320,320,320,320,320,R-HSA-210455,Astrocytic Glutamate-Glutamine Uptake And Metabolism,REACTOME,pathway,PATHWAY_320 |
| 321,321,321,321,321,321,321,321,R-HSA-8874211,CREB3 factors activate genes,REACTOME,pathway,PATHWAY_321 |
| 322,322,322,322,322,322,322,322,R-HSA-114452,Activation of BH3-only proteins,REACTOME,pathway,PATHWAY_322 |
| 323,323,323,323,323,323,323,323,R-HSA-5339716,Signaling by GSK3beta mutants,REACTOME,pathway,PATHWAY_323 |
| 324,324,324,324,324,324,324,324,R-HSA-3065676,SUMO is conjugated to E1 (UBA2:SAE1),REACTOME,pathway,PATHWAY_324 |
| 325,325,325,325,325,325,325,325,R-HSA-3315487,SMAD2/3 MH2 Domain Mutants in Cancer,REACTOME,pathway,PATHWAY_325 |
| 326,326,326,326,326,326,326,326,R-HSA-9717301,NVP-TAE684-resistant ALK mutants,REACTOME,pathway,PATHWAY_326 |
| 327,327,327,327,327,327,327,327,R-HSA-9614657,FOXO-mediated transcription of cell death genes,REACTOME,pathway,PATHWAY_327 |
| 328,328,328,328,328,328,328,328,R-HSA-5619110,"Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",REACTOME,pathway,PATHWAY_328 |
| 329,329,329,329,329,329,329,329,R-HSA-5688354,Defective pro-SFTPC causes SMDP2 and RDS,REACTOME,pathway,PATHWAY_329 |
| 330,330,330,330,330,330,330,330,R-HSA-1592389,Activation of Matrix Metalloproteinases,REACTOME,pathway,PATHWAY_330 |
| 331,331,331,331,331,331,331,331,R-HSA-8949215,Mitochondrial calcium ion transport,REACTOME,pathway,PATHWAY_331 |
| 332,332,332,332,332,332,332,332,R-HSA-2022923,Dermatan sulfate biosynthesis,REACTOME,pathway,PATHWAY_332 |
| 333,333,333,333,333,333,333,333,R-HSA-3295583,TRP channels,REACTOME,pathway,PATHWAY_333 |
| 334,334,334,334,334,334,334,334,R-HSA-5362768,Hh mutants are degraded by ERAD,REACTOME,pathway,PATHWAY_334 |
| 335,335,335,335,335,335,335,335,R-HSA-9035034,RHOF GTPase cycle,REACTOME,pathway,PATHWAY_335 |
| 336,336,336,336,336,336,336,336,R-HSA-8981607,Intracellular oxygen transport,REACTOME,pathway,PATHWAY_336 |
| 337,337,337,337,337,337,337,337,R-HSA-176187,Activation of ATR in response to replication stress,REACTOME,pathway,PATHWAY_337 |
| 338,338,338,338,338,338,338,338,R-HSA-9856530,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,REACTOME,pathway,PATHWAY_338 |
| 339,339,339,339,339,339,339,339,R-HSA-164938,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,REACTOME,pathway,PATHWAY_339 |
| 340,340,340,340,340,340,340,340,R-HSA-9652169,Signaling by MAP2K mutants,REACTOME,pathway,PATHWAY_340 |
| 341,341,341,341,341,341,341,341,R-HSA-196791,Vitamin D (calciferol) metabolism,REACTOME,pathway,PATHWAY_341 |
| 342,342,342,342,342,342,342,342,R-HSA-3928665,EPH-ephrin mediated repulsion of cells,REACTOME,pathway,PATHWAY_342 |
| 343,343,343,343,343,343,343,343,R-HSA-1306955,GRB7 events in ERBB2 signaling,REACTOME,pathway,PATHWAY_343 |
| 344,344,344,344,344,344,344,344,R-HSA-9675143,Diseases of the neuronal system,REACTOME,pathway,PATHWAY_344 |
| 345,345,345,345,345,345,345,345,R-HSA-983695,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,REACTOME,pathway,PATHWAY_345 |
| 346,346,346,346,346,346,346,346,R-HSA-380259,Loss of Nlp from mitotic centrosomes,REACTOME,pathway,PATHWAY_346 |
| 347,347,347,347,347,347,347,347,R-HSA-380284,Loss of proteins required for interphase microtubule organization from the centrosome,REACTOME,pathway,PATHWAY_347 |
| 348,348,348,348,348,348,348,348,R-HSA-177929,Signaling by EGFR,REACTOME,pathway,PATHWAY_348 |
| 349,349,349,349,349,349,349,349,R-HSA-5679090,Defective ABCG8 causes GBD4 and sitosterolemia,REACTOME,pathway,PATHWAY_349 |
| 350,350,350,350,350,350,350,350,R-HSA-9031628,NGF-stimulated transcription,REACTOME,pathway,PATHWAY_350 |
| 351,351,351,351,351,351,351,351,R-HSA-9918450,Defective visual phototransduction due to OPN1LW loss of function,REACTOME,pathway,PATHWAY_351 |
| 352,352,352,352,352,352,352,352,R-HSA-427601,Multifunctional anion exchangers,REACTOME,pathway,PATHWAY_352 |
| 353,353,353,353,353,353,353,353,R-HSA-111463,SMAC (DIABLO) binds to IAPs ,REACTOME,pathway,PATHWAY_353 |
| 354,354,354,354,354,354,354,354,R-HSA-211957,Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,REACTOME,pathway,PATHWAY_354 |
| 355,355,355,355,355,355,355,355,R-HSA-3359469,Defective MTR causes HMAG,REACTOME,pathway,PATHWAY_355 |
| 356,356,356,356,356,356,356,356,R-HSA-9860276,SLC15A4:TASL-dependent IRF5 activation,REACTOME,pathway,PATHWAY_356 |
| 357,357,357,357,357,357,357,357,R-HSA-389397,Orexin and neuropeptides FF and QRFP bind to their respective receptors,REACTOME,pathway,PATHWAY_357 |
| 358,358,358,358,358,358,358,358,R-HSA-1059683,Interleukin-6 signaling,REACTOME,pathway,PATHWAY_358 |
| 359,359,359,359,359,359,359,359,R-HSA-73772,RNA Polymerase I Promoter Escape,REACTOME,pathway,PATHWAY_359 |
| 360,360,360,360,360,360,360,360,R-HSA-500792,GPCR ligand binding,REACTOME,pathway,PATHWAY_360 |
| 361,361,361,361,361,361,361,361,R-HSA-525793,Myogenesis,REACTOME,pathway,PATHWAY_361 |
| 362,362,362,362,362,362,362,362,R-HSA-167169,HIV Transcription Elongation,REACTOME,pathway,PATHWAY_362 |
| 363,363,363,363,363,363,363,363,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,REACTOME,pathway,PATHWAY_363 |
| 364,364,364,364,364,364,364,364,R-HSA-9013405,RHOD GTPase cycle,REACTOME,pathway,PATHWAY_364 |
| 365,365,365,365,365,365,365,365,R-HSA-927802,Nonsense-Mediated Decay (NMD),REACTOME,pathway,PATHWAY_365 |
| 366,366,366,366,366,366,366,366,R-HSA-5633007,Regulation of TP53 Activity,REACTOME,pathway,PATHWAY_366 |
| 367,367,367,367,367,367,367,367,R-HSA-9018683,Biosynthesis of DPA-derived SPMs,REACTOME,pathway,PATHWAY_367 |
| 368,368,368,368,368,368,368,368,R-HSA-1296052,Ca2+ activated K+ channels,REACTOME,pathway,PATHWAY_368 |
| 369,369,369,369,369,369,369,369,R-HSA-2473224,Antagonism of Activin by Follistatin,REACTOME,pathway,PATHWAY_369 |
| 370,370,370,370,370,370,370,370,R-HSA-9639288,Amino acids regulate mTORC1,REACTOME,pathway,PATHWAY_370 |
| 371,371,371,371,371,371,371,371,R-HSA-416476,G alpha (q) signalling events,REACTOME,pathway,PATHWAY_371 |
| 372,372,372,372,372,372,372,372,R-HSA-201688,WNT mediated activation of DVL,REACTOME,pathway,PATHWAY_372 |
| 373,373,373,373,373,373,373,373,R-HSA-1226099,Signaling by FGFR in disease,REACTOME,pathway,PATHWAY_373 |
| 374,374,374,374,374,374,374,374,R-HSA-189085,Digestion of dietary carbohydrate,REACTOME,pathway,PATHWAY_374 |
| 375,375,375,375,375,375,375,375,R-HSA-9839397,TGFBR3 regulates FGF2 signaling,REACTOME,pathway,PATHWAY_375 |
| 376,376,376,376,376,376,376,376,R-HSA-1489509,DAG and IP3 signaling,REACTOME,pathway,PATHWAY_376 |
| 377,377,377,377,377,377,377,377,R-HSA-5688890,Defective CSF2RA causes SMDP4,REACTOME,pathway,PATHWAY_377 |
| 378,378,378,378,378,378,378,378,R-HSA-9757110,Prednisone ADME,REACTOME,pathway,PATHWAY_378 |
| 379,379,379,379,379,379,379,379,R-HSA-1614558,Degradation of cysteine and homocysteine,REACTOME,pathway,PATHWAY_379 |
| 380,380,380,380,380,380,380,380,R-HSA-400206,Regulation of lipid metabolism by PPARalpha,REACTOME,pathway,PATHWAY_380 |
| 381,381,381,381,381,381,381,381,R-HSA-1855191,Synthesis of IPs in the nucleus,REACTOME,pathway,PATHWAY_381 |
| 382,382,382,382,382,382,382,382,R-HSA-6783589,Interleukin-6 family signaling,REACTOME,pathway,PATHWAY_382 |
| 383,383,383,383,383,383,383,383,R-HSA-3247509,Chromatin modifying enzymes,REACTOME,pathway,PATHWAY_383 |
| 384,384,384,384,384,384,384,384,R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,REACTOME,pathway,PATHWAY_384 |
| 385,385,385,385,385,385,385,385,R-HSA-209560,NF-kB is activated and signals survival,REACTOME,pathway,PATHWAY_385 |
| 386,386,386,386,386,386,386,386,R-HSA-4724289,Defective ALG6 causes CDG-1c,REACTOME,pathway,PATHWAY_386 |
| 387,387,387,387,387,387,387,387,R-HSA-264642,Acetylcholine Neurotransmitter Release Cycle,REACTOME,pathway,PATHWAY_387 |
| 388,388,388,388,388,388,388,388,R-HSA-1221632,Meiotic synapsis,REACTOME,pathway,PATHWAY_388 |
| 389,389,389,389,389,389,389,389,R-HSA-8985801,Regulation of cortical dendrite branching,REACTOME,pathway,PATHWAY_389 |
| 390,390,390,390,390,390,390,390,R-HSA-5655332,Signaling by FGFR3 in disease,REACTOME,pathway,PATHWAY_390 |
| 391,391,391,391,391,391,391,391,R-HSA-1362300,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,REACTOME,pathway,PATHWAY_391 |
| 392,392,392,392,392,392,392,392,R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,REACTOME,pathway,PATHWAY_392 |
| 393,393,393,393,393,393,393,393,R-HSA-4719360,Defective DPM3 causes DPM3-CDG,REACTOME,pathway,PATHWAY_393 |
| 394,394,394,394,394,394,394,394,R-HSA-1295596,Spry regulation of FGF signaling,REACTOME,pathway,PATHWAY_394 |
| 395,395,395,395,395,395,395,395,R-HSA-9694719,Maturation of protein 3a,REACTOME,pathway,PATHWAY_395 |
| 396,396,396,396,396,396,396,396,R-HSA-9851151,MDK and PTN in ALK signaling,REACTOME,pathway,PATHWAY_396 |
| 397,397,397,397,397,397,397,397,R-HSA-159230,Transport of the SLBP Dependant Mature mRNA,REACTOME,pathway,PATHWAY_397 |
| 398,398,398,398,398,398,398,398,R-HSA-5579019,Defective FMO3 causes TMAU,REACTOME,pathway,PATHWAY_398 |
| 399,399,399,399,399,399,399,399,R-HSA-168256,Immune System,REACTOME,pathway,PATHWAY_399 |
| 400,400,400,400,400,400,400,400,R-HSA-177128,Conjugation of salicylate with glycine,REACTOME,pathway,PATHWAY_400 |
| 401,401,401,401,401,401,401,401,R-HSA-9675126,Diseases of mitotic cell cycle,REACTOME,pathway,PATHWAY_401 |
| 402,402,402,402,402,402,402,402,R-HSA-426486,Small interfering RNA (siRNA) biogenesis,REACTOME,pathway,PATHWAY_402 |
| 403,403,403,403,403,403,403,403,R-HSA-194313,VEGF ligand-receptor interactions,REACTOME,pathway,PATHWAY_403 |
| 404,404,404,404,404,404,404,404,R-HSA-5610780,Degradation of GLI1 by the proteasome,REACTOME,pathway,PATHWAY_404 |
| 405,405,405,405,405,405,405,405,R-HSA-9604323,Negative regulation of NOTCH4 signaling,REACTOME,pathway,PATHWAY_405 |
| 406,406,406,406,406,406,406,406,R-HSA-9008059,Interleukin-37 signaling,REACTOME,pathway,PATHWAY_406 |
| 407,407,407,407,407,407,407,407,R-HSA-9793242,SUMOylation of nuclear envelope proteins,REACTOME,pathway,PATHWAY_407 |
| 408,408,408,408,408,408,408,408,R-HSA-69560,Transcriptional activation of p53 responsive genes ,REACTOME,pathway,PATHWAY_408 |
| 409,409,409,409,409,409,409,409,R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),REACTOME,pathway,PATHWAY_409 |
| 410,410,410,410,410,410,410,410,R-HSA-429958,mRNA decay by 3' to 5' exoribonuclease,REACTOME,pathway,PATHWAY_410 |
| 411,411,411,411,411,411,411,411,R-HSA-430039,mRNA decay by 5' to 3' exoribonuclease,REACTOME,pathway,PATHWAY_411 |
| 412,412,412,412,412,412,412,412,R-HSA-5660526,Response to metal ions,REACTOME,pathway,PATHWAY_412 |
| 413,413,413,413,413,413,413,413,R-HSA-113510,E2F mediated regulation of DNA replication,REACTOME,pathway,PATHWAY_413 |
| 414,414,414,414,414,414,414,414,R-HSA-77352,Beta oxidation of butanoyl-CoA to acetyl-CoA,REACTOME,pathway,PATHWAY_414 |
| 415,415,415,415,415,415,415,415,R-HSA-9820865,Z-decay: degradation of maternal mRNAs by zygotically expressed factors,REACTOME,pathway,PATHWAY_415 |
| 416,416,416,416,416,416,416,416,R-HSA-418889,Caspase activation via Dependence Receptors in the absence of ligand,REACTOME,pathway,PATHWAY_416 |
| 417,417,417,417,417,417,417,417,R-HSA-381070,IRE1alpha activates chaperones,REACTOME,pathway,PATHWAY_417 |
| 418,418,418,418,418,418,418,418,R-HSA-421270,Cell-cell junction organization,REACTOME,pathway,PATHWAY_418 |
| 419,419,419,419,419,419,419,419,R-HSA-9022927,MECP2 regulates transcription of genes involved in GABA signaling,REACTOME,pathway,PATHWAY_419 |
| 420,420,420,420,420,420,420,420,R-HSA-9909505,Modulation of host responses by IFN-stimulated genes,REACTOME,pathway,PATHWAY_420 |
| 421,421,421,421,421,421,421,421,R-HSA-432720,Lysosome Vesicle Biogenesis,REACTOME,pathway,PATHWAY_421 |
| 422,422,422,422,422,422,422,422,R-HSA-8935964,RUNX1 regulates expression of components of tight junctions,REACTOME,pathway,PATHWAY_422 |
| 423,423,423,423,423,423,423,423,R-HSA-8951430,RUNX3 regulates WNT signaling,REACTOME,pathway,PATHWAY_423 |
| 424,424,424,424,424,424,424,424,R-HSA-1266738,Developmental Biology,REACTOME,pathway,PATHWAY_424 |
| 425,425,425,425,425,425,425,425,R-HSA-389661,Glyoxylate metabolism and glycine degradation,REACTOME,pathway,PATHWAY_425 |
| 426,426,426,426,426,426,426,426,R-HSA-170670,Adenylate cyclase inhibitory pathway,REACTOME,pathway,PATHWAY_426 |
| 427,427,427,427,427,427,427,427,R-HSA-166658,Complement cascade,REACTOME,pathway,PATHWAY_427 |
| 428,428,428,428,428,428,428,428,R-HSA-1483248,Synthesis of PIPs at the ER membrane,REACTOME,pathway,PATHWAY_428 |
| 429,429,429,429,429,429,429,429,R-HSA-8931987,RUNX1 regulates estrogen receptor mediated transcription,REACTOME,pathway,PATHWAY_429 |
| 430,430,430,430,430,430,430,430,R-HSA-5619044,Defective SLC6A19 causes Hartnup disorder (HND),REACTOME,pathway,PATHWAY_430 |
| 431,431,431,431,431,431,431,431,R-HSA-187042,TRKA activation by NGF,REACTOME,pathway,PATHWAY_431 |
| 432,432,432,432,432,432,432,432,R-HSA-422475,Axon guidance,REACTOME,pathway,PATHWAY_432 |
| 433,433,433,433,433,433,433,433,R-HSA-392451,G beta:gamma signalling through PI3Kgamma,REACTOME,pathway,PATHWAY_433 |
| 434,434,434,434,434,434,434,434,R-HSA-196807,Nicotinate metabolism,REACTOME,pathway,PATHWAY_434 |
| 435,435,435,435,435,435,435,435,R-HSA-380270,Recruitment of mitotic centrosome proteins and complexes,REACTOME,pathway,PATHWAY_435 |
| 436,436,436,436,436,436,436,436,R-HSA-4420332,Defective B3GALT6 causes EDSP2 and SEMDJL1,REACTOME,pathway,PATHWAY_436 |
| 437,437,437,437,437,437,437,437,R-HSA-9664433,Leishmania parasite growth and survival,REACTOME,pathway,PATHWAY_437 |
| 438,438,438,438,438,438,438,438,R-HSA-163841,"Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation",REACTOME,pathway,PATHWAY_438 |
| 439,439,439,439,439,439,439,439,R-HSA-1257604,PIP3 activates AKT signaling,REACTOME,pathway,PATHWAY_439 |
| 440,440,440,440,440,440,440,440,R-HSA-5579021,Defective CYP21A2 causes AH3,REACTOME,pathway,PATHWAY_440 |
| 441,441,441,441,441,441,441,441,R-HSA-5250968,Toxicity of botulinum toxin type A (botA),REACTOME,pathway,PATHWAY_441 |
| 442,442,442,442,442,442,442,442,R-HSA-1483076,Synthesis of CL,REACTOME,pathway,PATHWAY_442 |
| 443,443,443,443,443,443,443,443,R-HSA-194441,Metabolism of non-coding RNA,REACTOME,pathway,PATHWAY_443 |
| 444,444,444,444,444,444,444,444,R-HSA-8878166,Transcriptional regulation by RUNX2,REACTOME,pathway,PATHWAY_444 |
| 445,445,445,445,445,445,445,445,R-HSA-5210891,Uptake and function of anthrax toxins,REACTOME,pathway,PATHWAY_445 |
| 446,446,446,446,446,446,446,446,R-HSA-9759774,Diseases of mitochondrial beta oxidation,REACTOME,pathway,PATHWAY_446 |
| 447,447,447,447,447,447,447,447,R-HSA-9692913,SARS-CoV-1-mediated effects on programmed cell death,REACTOME,pathway,PATHWAY_447 |
| 448,448,448,448,448,448,448,448,R-HSA-1500931,Cell-Cell communication,REACTOME,pathway,PATHWAY_448 |
| 449,449,449,449,449,449,449,449,R-HSA-9694301,Maturation of replicase proteins,REACTOME,pathway,PATHWAY_449 |
| 450,450,450,450,450,450,450,450,R-HSA-9820841,M-decay: degradation of maternal mRNAs by maternally stored factors,REACTOME,pathway,PATHWAY_450 |
| 451,451,451,451,451,451,451,451,R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,REACTOME,pathway,PATHWAY_451 |
| 452,452,452,452,452,452,452,452,R-HSA-202430,Translocation of ZAP-70 to Immunological synapse,REACTOME,pathway,PATHWAY_452 |
| 453,453,453,453,453,453,453,453,R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,REACTOME,pathway,PATHWAY_453 |
| 454,454,454,454,454,454,454,454,R-HSA-140179,Amine Oxidase reactions,REACTOME,pathway,PATHWAY_454 |
| 455,455,455,455,455,455,455,455,R-HSA-113418,Formation of the Early Elongation Complex,REACTOME,pathway,PATHWAY_455 |
| 456,456,456,456,456,456,456,456,R-HSA-199418,Negative regulation of the PI3K/AKT network,REACTOME,pathway,PATHWAY_456 |
| 457,457,457,457,457,457,457,457,R-HSA-9865118,Diseases of branched-chain amino acid catabolism,REACTOME,pathway,PATHWAY_457 |
| 458,458,458,458,458,458,458,458,R-HSA-75158,TRAIL signaling,REACTOME,pathway,PATHWAY_458 |
| 459,459,459,459,459,459,459,459,R-HSA-5659735,Defective SLC6A19 causes Hartnup disorder (HND),REACTOME,pathway,PATHWAY_459 |
| 460,460,460,460,460,460,460,460,R-HSA-9636569,Suppression of autophagy,REACTOME,pathway,PATHWAY_460 |
| 461,461,461,461,461,461,461,461,R-HSA-427413,NoRC negatively regulates rRNA expression,REACTOME,pathway,PATHWAY_461 |
| 462,462,462,462,462,462,462,462,R-HSA-159782,Removal of aminoterminal propeptides from gamma-carboxylated proteins,REACTOME,pathway,PATHWAY_462 |
| 463,463,463,463,463,463,463,463,R-HSA-162585,Uncoating of the HIV Virion,REACTOME,pathway,PATHWAY_463 |
| 464,464,464,464,464,464,464,464,R-HSA-5654693,FRS-mediated FGFR1 signaling,REACTOME,pathway,PATHWAY_464 |
| 465,465,465,465,465,465,465,465,R-HSA-195721,Signaling by WNT,REACTOME,pathway,PATHWAY_465 |
| 466,466,466,466,466,466,466,466,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,REACTOME,pathway,PATHWAY_466 |
| 467,467,467,467,467,467,467,467,R-HSA-5684996,MAPK1/MAPK3 signaling,REACTOME,pathway,PATHWAY_467 |
| 468,468,468,468,468,468,468,468,R-HSA-8984722,Interleukin-35 Signalling,REACTOME,pathway,PATHWAY_468 |
| 469,469,469,469,469,469,469,469,R-HSA-417957,P2Y receptors,REACTOME,pathway,PATHWAY_469 |
| 470,470,470,470,470,470,470,470,R-HSA-5619099,"Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)",REACTOME,pathway,PATHWAY_470 |
| 471,471,471,471,471,471,471,471,R-HSA-209776,Metabolism of amine-derived hormones,REACTOME,pathway,PATHWAY_471 |
| 472,472,472,472,472,472,472,472,R-HSA-373760,L1CAM interactions,REACTOME,pathway,PATHWAY_472 |
| 473,473,473,473,473,473,473,473,R-HSA-429593,Inositol transporters,REACTOME,pathway,PATHWAY_473 |
| 474,474,474,474,474,474,474,474,R-HSA-70688,Proline catabolism,REACTOME,pathway,PATHWAY_474 |
| 475,475,475,475,475,475,475,475,R-HSA-9702614,ponatinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_475 |
| 476,476,476,476,476,476,476,476,R-HSA-5683678,Defective ABCA3 causes SMDP3,REACTOME,pathway,PATHWAY_476 |
| 477,477,477,477,477,477,477,477,R-HSA-73762,RNA Polymerase I Transcription Initiation,REACTOME,pathway,PATHWAY_477 |
| 478,478,478,478,478,478,478,478,R-HSA-9918440,Defective visual phototransduction due to RDH12 loss of function,REACTOME,pathway,PATHWAY_478 |
| 479,479,479,479,479,479,479,479,R-HSA-9853506,OGDH complex synthesizes succinyl-CoA from 2-OG,REACTOME,pathway,PATHWAY_479 |
| 480,480,480,480,480,480,480,480,R-HSA-75109,Triglyceride biosynthesis,REACTOME,pathway,PATHWAY_480 |
| 481,481,481,481,481,481,481,481,R-HSA-5576891,Cardiac conduction,REACTOME,pathway,PATHWAY_481 |
| 482,482,482,482,482,482,482,482,R-HSA-5620971,Pyroptosis,REACTOME,pathway,PATHWAY_482 |
| 483,483,483,483,483,483,483,483,R-HSA-140834,Extrinsic Pathway of Fibrin Clot Formation,REACTOME,pathway,PATHWAY_483 |
| 484,484,484,484,484,484,484,484,R-HSA-6804759,Regulation of TP53 Activity through Association with Co-factors,REACTOME,pathway,PATHWAY_484 |
| 485,485,485,485,485,485,485,485,R-HSA-1482925,Acyl chain remodelling of PG,REACTOME,pathway,PATHWAY_485 |
| 486,486,486,486,486,486,486,486,R-HSA-5679001,Defective ABCC2 causes DJS,REACTOME,pathway,PATHWAY_486 |
| 487,487,487,487,487,487,487,487,R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),REACTOME,pathway,PATHWAY_487 |
| 488,488,488,488,488,488,488,488,R-HSA-3000484,Scavenging by Class F Receptors,REACTOME,pathway,PATHWAY_488 |
| 489,489,489,489,489,489,489,489,R-HSA-165054,Rev-mediated nuclear export of HIV RNA,REACTOME,pathway,PATHWAY_489 |
| 490,490,490,490,490,490,490,490,R-HSA-3000480,Scavenging by Class A Receptors,REACTOME,pathway,PATHWAY_490 |
| 491,491,491,491,491,491,491,491,R-HSA-9824439,Bacterial Infection Pathways,REACTOME,pathway,PATHWAY_491 |
| 492,492,492,492,492,492,492,492,R-HSA-450341,Activation of the AP-1 family of transcription factors,REACTOME,pathway,PATHWAY_492 |
| 493,493,493,493,493,493,493,493,R-HSA-379398,Enzymatic degradation of Dopamine by monoamine oxidase,REACTOME,pathway,PATHWAY_493 |
| 494,494,494,494,494,494,494,494,R-HSA-9701898,STAT3 nuclear events downstream of ALK signaling,REACTOME,pathway,PATHWAY_494 |
| 495,495,495,495,495,495,495,495,R-HSA-72731,Recycling of eIF2:GDP,REACTOME,pathway,PATHWAY_495 |
| 496,496,496,496,496,496,496,496,R-HSA-447043,Neurofascin interactions,REACTOME,pathway,PATHWAY_496 |
| 497,497,497,497,497,497,497,497,R-HSA-70268,Pyruvate metabolism,REACTOME,pathway,PATHWAY_497 |
| 498,498,498,498,498,498,498,498,R-HSA-162582,Signal Transduction,REACTOME,pathway,PATHWAY_498 |
| 499,499,499,499,499,499,499,499,R-HSA-5423646,Aflatoxin activation and detoxification,REACTOME,pathway,PATHWAY_499 |
| 500,500,500,500,500,500,500,500,R-HSA-157579,Telomere Maintenance,REACTOME,pathway,PATHWAY_500 |
| 501,501,501,501,501,501,501,501,R-HSA-201556,Signaling by ALK,REACTOME,pathway,PATHWAY_501 |
| 502,502,502,502,502,502,502,502,R-HSA-9820962,Assembly and release of respiratory syncytial virus (RSV) virions,REACTOME,pathway,PATHWAY_502 |
| 503,503,503,503,503,503,503,503,R-HSA-9729555,Sensory perception of sour taste,REACTOME,pathway,PATHWAY_503 |
| 504,504,504,504,504,504,504,504,R-HSA-444411,Rhesus glycoproteins mediate ammonium transport,REACTOME,pathway,PATHWAY_504 |
| 505,505,505,505,505,505,505,505,R-HSA-5576893,Phase 2 - plateau phase,REACTOME,pathway,PATHWAY_505 |
| 506,506,506,506,506,506,506,506,R-HSA-9702624,sorafenib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_506 |
| 507,507,507,507,507,507,507,507,R-HSA-192456,Digestion of dietary lipid,REACTOME,pathway,PATHWAY_507 |
| 508,508,508,508,508,508,508,508,R-HSA-169911,Regulation of Apoptosis,REACTOME,pathway,PATHWAY_508 |
| 509,509,509,509,509,509,509,509,R-HSA-77111,Synthesis of Ketone Bodies,REACTOME,pathway,PATHWAY_509 |
| 510,510,510,510,510,510,510,510,R-HSA-168315,Inhibition of Host mRNA Processing and RNA Silencing,REACTOME,pathway,PATHWAY_510 |
| 511,511,511,511,511,511,511,511,R-HSA-352238,Breakdown of the nuclear lamina,REACTOME,pathway,PATHWAY_511 |
| 512,512,512,512,512,512,512,512,R-HSA-168305,Inhibition of Interferon Synthesis,REACTOME,pathway,PATHWAY_512 |
| 513,513,513,513,513,513,513,513,R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,REACTOME,pathway,PATHWAY_513 |
| 514,514,514,514,514,514,514,514,R-HSA-2142845,Hyaluronan metabolism,REACTOME,pathway,PATHWAY_514 |
| 515,515,515,515,515,515,515,515,R-HSA-2187338,Visual phototransduction,REACTOME,pathway,PATHWAY_515 |
| 516,516,516,516,516,516,516,516,R-HSA-9845622,Defective VWF binding to collagen type I ,REACTOME,pathway,PATHWAY_516 |
| 517,517,517,517,517,517,517,517,R-HSA-2206282,MPS IIIB - Sanfilippo syndrome B,REACTOME,pathway,PATHWAY_517 |
| 518,518,518,518,518,518,518,518,R-HSA-204626,Hypusine synthesis from eIF5A-lysine,REACTOME,pathway,PATHWAY_518 |
| 519,519,519,519,519,519,519,519,R-HSA-5621480,Dectin-2 family,REACTOME,pathway,PATHWAY_519 |
| 520,520,520,520,520,520,520,520,R-HSA-9670615,Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations,REACTOME,pathway,PATHWAY_520 |
| 521,521,521,521,521,521,521,521,R-HSA-9022534,Loss of MECP2 binding ability to 5hmC-DNA,REACTOME,pathway,PATHWAY_521 |
| 522,522,522,522,522,522,522,522,R-HSA-9675108,Nervous system development,REACTOME,pathway,PATHWAY_522 |
| 523,523,523,523,523,523,523,523,R-HSA-8851805,MET activates RAS signaling,REACTOME,pathway,PATHWAY_523 |
| 524,524,524,524,524,524,524,524,R-HSA-8875878,MET promotes cell motility,REACTOME,pathway,PATHWAY_524 |
| 525,525,525,525,525,525,525,525,R-HSA-9009391,Extra-nuclear estrogen signaling,REACTOME,pathway,PATHWAY_525 |
| 526,526,526,526,526,526,526,526,R-HSA-8866907,Activation of the TFAP2 (AP-2) family of transcription factors,REACTOME,pathway,PATHWAY_526 |
| 527,527,527,527,527,527,527,527,R-HSA-2132295,MHC class II antigen presentation,REACTOME,pathway,PATHWAY_527 |
| 528,528,528,528,528,528,528,528,R-HSA-5423599,Diseases of Mismatch Repair (MMR),REACTOME,pathway,PATHWAY_528 |
| 529,529,529,529,529,529,529,529,R-HSA-5693616,Presynaptic phase of homologous DNA pairing and strand exchange,REACTOME,pathway,PATHWAY_529 |
| 530,530,530,530,530,530,530,530,R-HSA-5601884,PIWI-interacting RNA (piRNA) biogenesis,REACTOME,pathway,PATHWAY_530 |
| 531,531,531,531,531,531,531,531,R-HSA-3322077,Glycogen synthesis,REACTOME,pathway,PATHWAY_531 |
| 532,532,532,532,532,532,532,532,R-HSA-174437,Removal of the Flap Intermediate from the C-strand,REACTOME,pathway,PATHWAY_532 |
| 533,533,533,533,533,533,533,533,R-HSA-2644605,FBXW7 Mutants and NOTCH1 in Cancer,REACTOME,pathway,PATHWAY_533 |
| 534,534,534,534,534,534,534,534,R-HSA-5619098,Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS),REACTOME,pathway,PATHWAY_534 |
| 535,535,535,535,535,535,535,535,R-HSA-9851695,Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes,REACTOME,pathway,PATHWAY_535 |
| 536,536,536,536,536,536,536,536,R-HSA-3000497,Scavenging by Class H Receptors,REACTOME,pathway,PATHWAY_536 |
| 537,537,537,537,537,537,537,537,R-HSA-446388,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,REACTOME,pathway,PATHWAY_537 |
| 538,538,538,538,538,538,538,538,R-HSA-8951664,Neddylation,REACTOME,pathway,PATHWAY_538 |
| 539,539,539,539,539,539,539,539,R-HSA-419771,Opsins,REACTOME,pathway,PATHWAY_539 |
| 540,540,540,540,540,540,540,540,R-HSA-2562578,TRIF-mediated programmed cell death,REACTOME,pathway,PATHWAY_540 |
| 541,541,541,541,541,541,541,541,R-HSA-4641265,Repression of WNT target genes,REACTOME,pathway,PATHWAY_541 |
| 542,542,542,542,542,542,542,542,R-HSA-9034793,Activated NTRK3 signals through PLCG1,REACTOME,pathway,PATHWAY_542 |
| 543,543,543,543,543,543,543,543,R-HSA-8934903,Receptor Mediated Mitophagy,REACTOME,pathway,PATHWAY_543 |
| 544,544,544,544,544,544,544,544,R-HSA-9761174,Formation of intermediate mesoderm,REACTOME,pathway,PATHWAY_544 |
| 545,545,545,545,545,545,545,545,R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,REACTOME,pathway,PATHWAY_545 |
| 546,546,546,546,546,546,546,546,R-HSA-1592230,Mitochondrial biogenesis,REACTOME,pathway,PATHWAY_546 |
| 547,547,547,547,547,547,547,547,R-HSA-1299287,Tandem pore domain halothane-inhibited K+ channel (THIK),REACTOME,pathway,PATHWAY_547 |
| 548,548,548,548,548,548,548,548,R-HSA-5619071,Defective SLC22A12 causes renal hypouricemia 1 (RHUC1),REACTOME,pathway,PATHWAY_548 |
| 549,549,549,549,549,549,549,549,R-HSA-9616222,Transcriptional regulation of granulopoiesis,REACTOME,pathway,PATHWAY_549 |
| 550,550,550,550,550,550,550,550,R-HSA-390696,Adrenoceptors,REACTOME,pathway,PATHWAY_550 |
| 551,551,551,551,551,551,551,551,R-HSA-5579005,Defective CYP4F22 causes ARCI5,REACTOME,pathway,PATHWAY_551 |
| 552,552,552,552,552,552,552,552,R-HSA-8875656,MET receptor recycling,REACTOME,pathway,PATHWAY_552 |
| 553,553,553,553,553,553,553,553,R-HSA-8874177,ATF6B (ATF6-beta) activates chaperones,REACTOME,pathway,PATHWAY_553 |
| 554,554,554,554,554,554,554,554,R-HSA-629594,Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,REACTOME,pathway,PATHWAY_554 |
| 555,555,555,555,555,555,555,555,R-HSA-9864848,Complex IV assembly,REACTOME,pathway,PATHWAY_555 |
| 556,556,556,556,556,556,556,556,R-HSA-9616333,Defective Base Excision Repair Associated with NTHL1,REACTOME,pathway,PATHWAY_556 |
| 557,557,557,557,557,557,557,557,R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,REACTOME,pathway,PATHWAY_557 |
| 558,558,558,558,558,558,558,558,R-HSA-445717,Aquaporin-mediated transport,REACTOME,pathway,PATHWAY_558 |
| 559,559,559,559,559,559,559,559,R-HSA-5637810,Constitutive Signaling by EGFRvIII,REACTOME,pathway,PATHWAY_559 |
| 560,560,560,560,560,560,560,560,R-HSA-168249,Innate Immune System,REACTOME,pathway,PATHWAY_560 |
| 561,561,561,561,561,561,561,561,R-HSA-2197563,NOTCH2 intracellular domain regulates transcription,REACTOME,pathway,PATHWAY_561 |
| 562,562,562,562,562,562,562,562,R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,REACTOME,pathway,PATHWAY_562 |
| 563,563,563,563,563,563,563,563,R-HSA-3214858,RMTs methylate histone arginines,REACTOME,pathway,PATHWAY_563 |
| 564,564,564,564,564,564,564,564,R-HSA-9830674,Formation of the ureteric bud,REACTOME,pathway,PATHWAY_564 |
| 565,565,565,565,565,565,565,565,R-HSA-1187000,Fertilization,REACTOME,pathway,PATHWAY_565 |
| 566,566,566,566,566,566,566,566,R-HSA-156587,Amino Acid conjugation,REACTOME,pathway,PATHWAY_566 |
| 567,567,567,567,567,567,567,567,R-HSA-1660537,PIPs transport between early endosome and Golgi membranes,REACTOME,pathway,PATHWAY_567 |
| 568,568,568,568,568,568,568,568,R-HSA-9659379,Sensory processing of sound,REACTOME,pathway,PATHWAY_568 |
| 569,569,569,569,569,569,569,569,R-HSA-8854518,AURKA Activation by TPX2,REACTOME,pathway,PATHWAY_569 |
| 570,570,570,570,570,570,570,570,R-HSA-9734735,Defective ADA disrupts (deoxy)adenosine deamination,REACTOME,pathway,PATHWAY_570 |
| 571,571,571,571,571,571,571,571,R-HSA-168270,Fusion and Uncoating of the Influenza Virion,REACTOME,pathway,PATHWAY_571 |
| 572,572,572,572,572,572,572,572,R-HSA-1483171,Synthesis of BMP,REACTOME,pathway,PATHWAY_572 |
| 573,573,573,573,573,573,573,573,R-HSA-163767,PP2A-mediated dephosphorylation of key metabolic factors,REACTOME,pathway,PATHWAY_573 |
| 574,574,574,574,574,574,574,574,R-HSA-70635,Urea cycle,REACTOME,pathway,PATHWAY_574 |
| 575,575,575,575,575,575,575,575,R-HSA-1362409,Mitochondrial iron-sulfur cluster biogenesis,REACTOME,pathway,PATHWAY_575 |
| 576,576,576,576,576,576,576,576,R-HSA-376176,Signaling by ROBO receptors,REACTOME,pathway,PATHWAY_576 |
| 577,577,577,577,577,577,577,577,R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,REACTOME,pathway,PATHWAY_577 |
| 578,578,578,578,578,578,578,578,R-HSA-9702620,quizartinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_578 |
| 579,579,579,579,579,579,579,579,R-HSA-1483101,Synthesis of PS,REACTOME,pathway,PATHWAY_579 |
| 580,580,580,580,580,580,580,580,R-HSA-9609507,Protein localization,REACTOME,pathway,PATHWAY_580 |
| 581,581,581,581,581,581,581,581,R-HSA-170822,Regulation of Glucokinase by Glucokinase Regulatory Protein,REACTOME,pathway,PATHWAY_581 |
| 582,582,582,582,582,582,582,582,R-HSA-8940973,RUNX2 regulates osteoblast differentiation,REACTOME,pathway,PATHWAY_582 |
| 583,583,583,583,583,583,583,583,R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",REACTOME,pathway,PATHWAY_583 |
| 584,584,584,584,584,584,584,584,R-HSA-9836573,Mitochondrial RNA degradation,REACTOME,pathway,PATHWAY_584 |
| 585,585,585,585,585,585,585,585,R-HSA-9636003,NEIL3-mediated resolution of ICLs,REACTOME,pathway,PATHWAY_585 |
| 586,586,586,586,586,586,586,586,R-HSA-5609976,Defective GALK1 causes GALCT2,REACTOME,pathway,PATHWAY_586 |
| 587,587,587,587,587,587,587,587,R-HSA-1855192,IPs transport between nucleus and ER lumen,REACTOME,pathway,PATHWAY_587 |
| 588,588,588,588,588,588,588,588,R-HSA-9674555,Signaling by CSF3 (G-CSF),REACTOME,pathway,PATHWAY_588 |
| 589,589,589,589,589,589,589,589,R-HSA-9842663,Signaling by LTK,REACTOME,pathway,PATHWAY_589 |
| 590,590,590,590,590,590,590,590,R-HSA-5654719,SHC-mediated cascade:FGFR4,REACTOME,pathway,PATHWAY_590 |
| 591,591,591,591,591,591,591,591,R-HSA-8941284,RUNX2 regulates chondrocyte maturation,REACTOME,pathway,PATHWAY_591 |
| 592,592,592,592,592,592,592,592,R-HSA-198753,ERK/MAPK targets,REACTOME,pathway,PATHWAY_592 |
| 593,593,593,593,593,593,593,593,R-HSA-193681,Ceramide signalling,REACTOME,pathway,PATHWAY_593 |
| 594,594,594,594,594,594,594,594,R-HSA-9665250,Resistance of ERBB2 KD mutants to AEE788,REACTOME,pathway,PATHWAY_594 |
| 595,595,595,595,595,595,595,595,R-HSA-880009,Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,REACTOME,pathway,PATHWAY_595 |
| 596,596,596,596,596,596,596,596,R-HSA-264870,Caspase-mediated cleavage of cytoskeletal proteins,REACTOME,pathway,PATHWAY_596 |
| 597,597,597,597,597,597,597,597,R-HSA-9026403,Biosynthesis of DPAn-3-derived 13-series resolvins,REACTOME,pathway,PATHWAY_597 |
| 598,598,598,598,598,598,598,598,R-HSA-9013418,RHOBTB2 GTPase cycle,REACTOME,pathway,PATHWAY_598 |
| 599,599,599,599,599,599,599,599,R-HSA-8941413,Events associated with phagocytolytic activity of PMN cells,REACTOME,pathway,PATHWAY_599 |
| 600,600,600,600,600,600,600,600,R-HSA-111469,"SMAC, XIAP-regulated apoptotic response",REACTOME,pathway,PATHWAY_600 |
| 601,601,601,601,601,601,601,601,R-HSA-5658623,FGFRL1 modulation of FGFR1 signaling,REACTOME,pathway,PATHWAY_601 |
| 602,602,602,602,602,602,602,602,R-HSA-9914355,Isovaleric acidemia,REACTOME,pathway,PATHWAY_602 |
| 603,603,603,603,603,603,603,603,R-HSA-373080,Class B/2 (Secretin family receptors),REACTOME,pathway,PATHWAY_603 |
| 604,604,604,604,604,604,604,604,R-HSA-9753510,Signaling by RAS GAP mutants,REACTOME,pathway,PATHWAY_604 |
| 605,605,605,605,605,605,605,605,R-HSA-8878159,Transcriptional regulation by RUNX3,REACTOME,pathway,PATHWAY_605 |
| 606,606,606,606,606,606,606,606,R-HSA-9717323,ceritinib-resistant ALK mutants,REACTOME,pathway,PATHWAY_606 |
| 607,607,607,607,607,607,607,607,R-HSA-1852241,Organelle biogenesis and maintenance,REACTOME,pathway,PATHWAY_607 |
| 608,608,608,608,608,608,608,608,R-HSA-352230,Amino acid transport across the plasma membrane,REACTOME,pathway,PATHWAY_608 |
| 609,609,609,609,609,609,609,609,R-HSA-500657,Presynaptic function of Kainate receptors,REACTOME,pathway,PATHWAY_609 |
| 610,610,610,610,610,610,610,610,R-HSA-975163,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,REACTOME,pathway,PATHWAY_610 |
| 611,611,611,611,611,611,611,611,R-HSA-3304356,SMAD2/3 Phosphorylation Motif Mutants in Cancer,REACTOME,pathway,PATHWAY_611 |
| 612,612,612,612,612,612,612,612,R-HSA-111459,Activation of caspases through apoptosome-mediated cleavage,REACTOME,pathway,PATHWAY_612 |
| 613,613,613,613,613,613,613,613,R-HSA-9033807,ABO blood group biosynthesis,REACTOME,pathway,PATHWAY_613 |
| 614,614,614,614,614,614,614,614,R-HSA-111885,Opioid Signalling,REACTOME,pathway,PATHWAY_614 |
| 615,615,615,615,615,615,615,615,R-HSA-390648,Muscarinic acetylcholine receptors,REACTOME,pathway,PATHWAY_615 |
| 616,616,616,616,616,616,616,616,R-HSA-190322,FGFR4 ligand binding and activation,REACTOME,pathway,PATHWAY_616 |
| 617,617,617,617,617,617,617,617,R-HSA-4551295,Defective ALG11 causes CDG-1p,REACTOME,pathway,PATHWAY_617 |
| 618,618,618,618,618,618,618,618,R-HSA-9925561,Developmental Lineage of Pancreatic Acinar Cells,REACTOME,pathway,PATHWAY_618 |
| 619,619,619,619,619,619,619,619,R-HSA-2206305,MPS IIID - Sanfilippo syndrome D,REACTOME,pathway,PATHWAY_619 |
| 620,620,620,620,620,620,620,620,R-HSA-5626978,TNFR1-mediated ceramide production,REACTOME,pathway,PATHWAY_620 |
| 621,621,621,621,621,621,621,621,R-HSA-72312,rRNA processing,REACTOME,pathway,PATHWAY_621 |
| 622,622,622,622,622,622,622,622,R-HSA-75105,Fatty acyl-CoA biosynthesis,REACTOME,pathway,PATHWAY_622 |
| 623,623,623,623,623,623,623,623,R-HSA-5619056,Defective HK1 causes hexokinase deficiency (HK deficiency),REACTOME,pathway,PATHWAY_623 |
| 624,624,624,624,624,624,624,624,R-HSA-8939243,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,REACTOME,pathway,PATHWAY_624 |
| 625,625,625,625,625,625,625,625,R-HSA-9735871,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,REACTOME,pathway,PATHWAY_625 |
| 626,626,626,626,626,626,626,626,R-HSA-69273,Cyclin A/B1/B2 associated events during G2/M transition,REACTOME,pathway,PATHWAY_626 |
| 627,627,627,627,627,627,627,627,R-HSA-1963640,GRB2 events in ERBB2 signaling,REACTOME,pathway,PATHWAY_627 |
| 628,628,628,628,628,628,628,628,R-HSA-382551,Transport of small molecules,REACTOME,pathway,PATHWAY_628 |
| 629,629,629,629,629,629,629,629,R-HSA-190861,Gap junction assembly,REACTOME,pathway,PATHWAY_629 |
| 630,630,630,630,630,630,630,630,R-HSA-9686347,Microbial modulation of RIPK1-mediated regulated necrosis,REACTOME,pathway,PATHWAY_630 |
| 631,631,631,631,631,631,631,631,R-HSA-9706574,RHOBTB GTPase Cycle,REACTOME,pathway,PATHWAY_631 |
| 632,632,632,632,632,632,632,632,R-HSA-9735869,SARS-CoV-1 modulates host translation machinery,REACTOME,pathway,PATHWAY_632 |
| 633,633,633,633,633,633,633,633,R-HSA-170984,ARMS-mediated activation,REACTOME,pathway,PATHWAY_633 |
| 634,634,634,634,634,634,634,634,R-HSA-112308,Presynaptic depolarization and calcium channel opening,REACTOME,pathway,PATHWAY_634 |
| 635,635,635,635,635,635,635,635,R-HSA-1483206,Glycerophospholipid biosynthesis,REACTOME,pathway,PATHWAY_635 |
| 636,636,636,636,636,636,636,636,R-HSA-9702577,semaxanib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_636 |
| 637,637,637,637,637,637,637,637,R-HSA-451308,Activation of Ca-permeable Kainate Receptor,REACTOME,pathway,PATHWAY_637 |
| 638,638,638,638,638,638,638,638,R-HSA-190372,FGFR3c ligand binding and activation,REACTOME,pathway,PATHWAY_638 |
| 639,639,639,639,639,639,639,639,R-HSA-9701192,Defective homologous recombination repair (HRR) due to BRCA1 loss of function,REACTOME,pathway,PATHWAY_639 |
| 640,640,640,640,640,640,640,640,R-HSA-844456,The NLRP3 inflammasome,REACTOME,pathway,PATHWAY_640 |
| 641,641,641,641,641,641,641,641,R-HSA-168273,Influenza Viral RNA Transcription and Replication,REACTOME,pathway,PATHWAY_641 |
| 642,642,642,642,642,642,642,642,R-HSA-8847453,Synthesis of PIPs in the nucleus,REACTOME,pathway,PATHWAY_642 |
| 643,643,643,643,643,643,643,643,R-HSA-446343,Localization of the PINCH-ILK-PARVIN complex to focal adhesions,REACTOME,pathway,PATHWAY_643 |
| 644,644,644,644,644,644,644,644,R-HSA-9669924,Masitinib-resistant KIT mutants,REACTOME,pathway,PATHWAY_644 |
| 645,645,645,645,645,645,645,645,R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,REACTOME,pathway,PATHWAY_645 |
| 646,646,646,646,646,646,646,646,R-HSA-194315,Signaling by Rho GTPases,REACTOME,pathway,PATHWAY_646 |
| 647,647,647,647,647,647,647,647,R-HSA-8866427,VLDLR internalisation and degradation,REACTOME,pathway,PATHWAY_647 |
| 648,648,648,648,648,648,648,648,R-HSA-453276,Regulation of mitotic cell cycle,REACTOME,pathway,PATHWAY_648 |
| 649,649,649,649,649,649,649,649,R-HSA-174414,Processive synthesis on the C-strand of the telomere,REACTOME,pathway,PATHWAY_649 |
| 650,650,650,650,650,650,650,650,R-HSA-2428928,IRS-related events triggered by IGF1R,REACTOME,pathway,PATHWAY_650 |
| 651,651,651,651,651,651,651,651,R-HSA-114294,"Activation, translocation and oligomerization of BAX",REACTOME,pathway,PATHWAY_651 |
| 652,652,652,652,652,652,652,652,R-HSA-4839743,Signaling by CTNNB1 phospho-site mutants,REACTOME,pathway,PATHWAY_652 |
| 653,653,653,653,653,653,653,653,R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,REACTOME,pathway,PATHWAY_653 |
| 654,654,654,654,654,654,654,654,R-HSA-1433559,Regulation of KIT signaling,REACTOME,pathway,PATHWAY_654 |
| 655,655,655,655,655,655,655,655,R-HSA-9768777,Regulation of NPAS4 gene transcription,REACTOME,pathway,PATHWAY_655 |
| 656,656,656,656,656,656,656,656,R-HSA-1660510,PIPs transport between Golgi and plasma membranes,REACTOME,pathway,PATHWAY_656 |
| 657,657,657,657,657,657,657,657,R-HSA-9702569,KW2449-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_657 |
| 658,658,658,658,658,658,658,658,R-HSA-428540,Activation of RAC1,REACTOME,pathway,PATHWAY_658 |
| 659,659,659,659,659,659,659,659,R-HSA-9017802,Noncanonical activation of NOTCH3,REACTOME,pathway,PATHWAY_659 |
| 660,660,660,660,660,660,660,660,R-HSA-1236394,Signaling by ERBB4,REACTOME,pathway,PATHWAY_660 |
| 661,661,661,661,661,661,661,661,R-HSA-196836,Vitamin C (ascorbate) metabolism,REACTOME,pathway,PATHWAY_661 |
| 662,662,662,662,662,662,662,662,R-HSA-3299685,Detoxification of Reactive Oxygen Species,REACTOME,pathway,PATHWAY_662 |
| 663,663,663,663,663,663,663,663,R-HSA-8852135,Protein ubiquitination,REACTOME,pathway,PATHWAY_663 |
| 664,664,664,664,664,664,664,664,R-HSA-1834941,STING mediated induction of host immune responses,REACTOME,pathway,PATHWAY_664 |
| 665,665,665,665,665,665,665,665,R-HSA-9758919,Epithelial-Mesenchymal Transition (EMT) during gastrulation,REACTOME,pathway,PATHWAY_665 |
| 666,666,666,666,666,666,666,666,R-HSA-1236973,Cross-presentation of particulate exogenous antigens (phagosomes),REACTOME,pathway,PATHWAY_666 |
| 667,667,667,667,667,667,667,667,R-HSA-5083633,"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",REACTOME,pathway,PATHWAY_667 |
| 668,668,668,668,668,668,668,668,R-HSA-9024909,BDNF activates NTRK2 (TRKB) signaling,REACTOME,pathway,PATHWAY_668 |
| 669,669,669,669,669,669,669,669,R-HSA-74259,Purine catabolism,REACTOME,pathway,PATHWAY_669 |
| 670,670,670,670,670,670,670,670,R-HSA-5654228,Phospholipase C-mediated cascade |
| 671,671,671,671,671,671,671,671,R-HSA-9013419,RHOT2 GTPase cycle,REACTOME,pathway,PATHWAY_671 |
| 672,672,672,672,672,672,672,672,R-HSA-190375,FGFR2c ligand binding and activation,REACTOME,pathway,PATHWAY_672 |
| 673,673,673,673,673,673,673,673,R-HSA-6798695,Neutrophil degranulation,REACTOME,pathway,PATHWAY_673 |
| 674,674,674,674,674,674,674,674,R-HSA-9754706,Atorvastatin ADME,REACTOME,pathway,PATHWAY_674 |
| 675,675,675,675,675,675,675,675,R-HSA-9759476,Regulation of Homotypic Cell-Cell Adhesion,REACTOME,pathway,PATHWAY_675 |
| 676,676,676,676,676,676,676,676,R-HSA-5693554,Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),REACTOME,pathway,PATHWAY_676 |
| 677,677,677,677,677,677,677,677,R-HSA-69416,Dimerization of procaspase-8,REACTOME,pathway,PATHWAY_677 |
| 678,678,678,678,678,678,678,678,R-HSA-5619081,Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),REACTOME,pathway,PATHWAY_678 |
| 679,679,679,679,679,679,679,679,R-HSA-77288,mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,REACTOME,pathway,PATHWAY_679 |
| 680,680,680,680,680,680,680,680,R-HSA-174411,Polymerase switching on the C-strand of the telomere,REACTOME,pathway,PATHWAY_680 |
| 681,681,681,681,681,681,681,681,R-HSA-1250342,PI3K events in ERBB4 signaling,REACTOME,pathway,PATHWAY_681 |
| 682,682,682,682,682,682,682,682,R-HSA-9014826,Interleukin-36 pathway,REACTOME,pathway,PATHWAY_682 |
| 683,683,683,683,683,683,683,683,R-HSA-418038,Nucleotide-like (purinergic) receptors,REACTOME,pathway,PATHWAY_683 |
| 684,684,684,684,684,684,684,684,R-HSA-5674404,PTEN Loss of Function in Cancer,REACTOME,pathway,PATHWAY_684 |
| 685,685,685,685,685,685,685,685,R-HSA-375276,Peptide ligand-binding receptors,REACTOME,pathway,PATHWAY_685 |
| 686,686,686,686,686,686,686,686,R-HSA-2514856,The phototransduction cascade,REACTOME,pathway,PATHWAY_686 |
| 687,687,687,687,687,687,687,687,R-HSA-1236975,Antigen processing-Cross presentation,REACTOME,pathway,PATHWAY_687 |
| 688,688,688,688,688,688,688,688,R-HSA-6807878,COPI-mediated anterograde transport,REACTOME,pathway,PATHWAY_688 |
| 689,689,689,689,689,689,689,689,R-HSA-168303,Packaging of Eight RNA Segments,REACTOME,pathway,PATHWAY_689 |
| 690,690,690,690,690,690,690,690,R-HSA-194002,Glucocorticoid biosynthesis,REACTOME,pathway,PATHWAY_690 |
| 691,691,691,691,691,691,691,691,R-HSA-168276,NS1 Mediated Effects on Host Pathways,REACTOME,pathway,PATHWAY_691 |
| 692,692,692,692,692,692,692,692,R-HSA-351143,Agmatine biosynthesis,REACTOME,pathway,PATHWAY_692 |
| 693,693,693,693,693,693,693,693,R-HSA-389599,Alpha-oxidation of phytanate,REACTOME,pathway,PATHWAY_693 |
| 694,694,694,694,694,694,694,694,R-HSA-110362,POLB-Dependent Long Patch Base Excision Repair,REACTOME,pathway,PATHWAY_694 |
| 695,695,695,695,695,695,695,695,R-HSA-9909438,3-Methylcrotonyl-CoA carboxylase deficiency,REACTOME,pathway,PATHWAY_695 |
| 696,696,696,696,696,696,696,696,R-HSA-8853884,Transcriptional Regulation by VENTX,REACTOME,pathway,PATHWAY_696 |
| 697,697,697,697,697,697,697,697,R-HSA-180024,DARPP-32 events,REACTOME,pathway,PATHWAY_697 |
| 698,698,698,698,698,698,698,698,R-HSA-1679131,Trafficking and processing of endosomal TLR,REACTOME,pathway,PATHWAY_698 |
| 699,699,699,699,699,699,699,699,R-HSA-170968,Frs2-mediated activation,REACTOME,pathway,PATHWAY_699 |
| 700,700,700,700,700,700,700,700,R-HSA-9669921,KIT mutants bind TKIs,REACTOME,pathway,PATHWAY_700 |
| 701,701,701,701,701,701,701,701,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,REACTOME,pathway,PATHWAY_701 |
| 702,702,702,702,702,702,702,702,R-HSA-3274531,Glycogen storage disease type Ia (G6PC),REACTOME,pathway,PATHWAY_702 |
| 703,703,703,703,703,703,703,703,R-HSA-5619035,Defective SLC17A5 causes Salla disease (SD) and ISSD,REACTOME,pathway,PATHWAY_703 |
| 704,704,704,704,704,704,704,704,R-HSA-9665244,Resistance of ERBB2 KD mutants to sapitinib,REACTOME,pathway,PATHWAY_704 |
| 705,705,705,705,705,705,705,705,R-HSA-9012999,RHO GTPase cycle,REACTOME,pathway,PATHWAY_705 |
| 706,706,706,706,706,706,706,706,R-HSA-9671555,Signaling by PDGFR in disease,REACTOME,pathway,PATHWAY_706 |
| 707,707,707,707,707,707,707,707,R-HSA-9018677,Biosynthesis of DHA-derived SPMs,REACTOME,pathway,PATHWAY_707 |
| 708,708,708,708,708,708,708,708,R-HSA-392518,Signal amplification,REACTOME,pathway,PATHWAY_708 |
| 709,709,709,709,709,709,709,709,R-HSA-6804757,Regulation of TP53 Degradation,REACTOME,pathway,PATHWAY_709 |
| 710,710,710,710,710,710,710,710,R-HSA-5619036,Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6),REACTOME,pathway,PATHWAY_710 |
| 711,711,711,711,711,711,711,711,R-HSA-5654696,Downstream signaling of activated FGFR2,REACTOME,pathway,PATHWAY_711 |
| 712,712,712,712,712,712,712,712,R-HSA-9701190,Defective homologous recombination repair (HRR) due to BRCA2 loss of function,REACTOME,pathway,PATHWAY_712 |
| 713,713,713,713,713,713,713,713,R-HSA-2990846,SUMOylation,REACTOME,pathway,PATHWAY_713 |
| 714,714,714,714,714,714,714,714,R-HSA-9665251,Resistance of ERBB2 KD mutants to lapatinib,REACTOME,pathway,PATHWAY_714 |
| 715,715,715,715,715,715,715,715,R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,REACTOME,pathway,PATHWAY_715 |
| 716,716,716,716,716,716,716,716,R-HSA-174048,APC/C:Cdc20 mediated degradation of Cyclin B,REACTOME,pathway,PATHWAY_716 |
| 717,717,717,717,717,717,717,717,R-HSA-5621481,C-type lectin receptors (CLRs),REACTOME,pathway,PATHWAY_717 |
| 718,718,718,718,718,718,718,718,R-HSA-549127,Organic cation transport,REACTOME,pathway,PATHWAY_718 |
| 719,719,719,719,719,719,719,719,R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,REACTOME,pathway,PATHWAY_719 |
| 720,720,720,720,720,720,720,720,R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,REACTOME,pathway,PATHWAY_720 |
| 721,721,721,721,721,721,721,721,R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",REACTOME,pathway,PATHWAY_721 |
| 722,722,722,722,722,722,722,722,R-HSA-2453902,The canonical retinoid cycle in rods (twilight vision),REACTOME,pathway,PATHWAY_722 |
| 723,723,723,723,723,723,723,723,R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,REACTOME,pathway,PATHWAY_723 |
| 724,724,724,724,724,724,724,724,R-HSA-9828642,Respiratory syncytial virus genome transcription,REACTOME,pathway,PATHWAY_724 |
| 725,725,725,725,725,725,725,725,R-HSA-5688031,Defective pro-SFTPB causes SMDP1 and RDS,REACTOME,pathway,PATHWAY_725 |
| 726,726,726,726,726,726,726,726,R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,REACTOME,pathway,PATHWAY_726 |
| 727,727,727,727,727,727,727,727,R-HSA-9609736,Assembly and cell surface presentation of NMDA receptors,REACTOME,pathway,PATHWAY_727 |
| 728,728,728,728,728,728,728,728,R-HSA-9735804,Diseases of nucleotide metabolism,REACTOME,pathway,PATHWAY_728 |
| 729,729,729,729,729,729,729,729,R-HSA-5467348,Truncations of AMER1 destabilize the destruction complex,REACTOME,pathway,PATHWAY_729 |
| 730,730,730,730,730,730,730,730,R-HSA-442720,CREB1 phosphorylation through the activation of Adenylate Cyclase,REACTOME,pathway,PATHWAY_730 |
| 731,731,731,731,731,731,731,731,R-HSA-5579020,Defective SLC35D1 causes SCHBCKD,REACTOME,pathway,PATHWAY_731 |
| 732,732,732,732,732,732,732,732,R-HSA-9664422,FCGR3A-mediated phagocytosis,REACTOME,pathway,PATHWAY_732 |
| 733,733,733,733,733,733,733,733,R-HSA-1640170,Cell Cycle,REACTOME,pathway,PATHWAY_733 |
| 734,734,734,734,734,734,734,734,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,REACTOME,pathway,PATHWAY_734 |
| 735,735,735,735,735,735,735,735,R-HSA-205017,NFG and proNGF binds to p75NTR,REACTOME,pathway,PATHWAY_735 |
| 736,736,736,736,736,736,736,736,R-HSA-5602636,IKBKB deficiency causes SCID,REACTOME,pathway,PATHWAY_736 |
| 737,737,737,737,737,737,737,737,R-HSA-5579016,Defective UGT1A4 causes hyperbilirubinemia,REACTOME,pathway,PATHWAY_737 |
| 738,738,738,738,738,738,738,738,R-HSA-198323,AKT phosphorylates targets in the cytosol,REACTOME,pathway,PATHWAY_738 |
| 739,739,739,739,739,739,739,739,R-HSA-389357,CD28 dependent PI3K/Akt signaling,REACTOME,pathway,PATHWAY_739 |
| 740,740,740,740,740,740,740,740,R-HSA-5651801,PCNA-Dependent Long Patch Base Excision Repair,REACTOME,pathway,PATHWAY_740 |
| 741,741,741,741,741,741,741,741,R-HSA-1296053,Classical Kir channels,REACTOME,pathway,PATHWAY_741 |
| 742,742,742,742,742,742,742,742,R-HSA-449836,Other interleukin signaling,REACTOME,pathway,PATHWAY_742 |
| 743,743,743,743,743,743,743,743,R-HSA-5467340,AXIN missense mutants destabilize the destruction complex,REACTOME,pathway,PATHWAY_743 |
| 744,744,744,744,744,744,744,744,R-HSA-4570464,SUMOylation of RNA binding proteins,REACTOME,pathway,PATHWAY_744 |
| 745,745,745,745,745,745,745,745,R-HSA-390450,Folding of actin by CCT/TriC,REACTOME,pathway,PATHWAY_745 |
| 746,746,746,746,746,746,746,746,R-HSA-2122948,Activated NOTCH1 Transmits Signal to the Nucleus,REACTOME,pathway,PATHWAY_746 |
| 747,747,747,747,747,747,747,747,R-HSA-3229121,Glycogen storage diseases,REACTOME,pathway,PATHWAY_747 |
| 748,748,748,748,748,748,748,748,R-HSA-190827,Transport of connexins along the secretory pathway,REACTOME,pathway,PATHWAY_748 |
| 749,749,749,749,749,749,749,749,R-HSA-9013404,RAC2 GTPase cycle,REACTOME,pathway,PATHWAY_749 |
| 750,750,750,750,750,750,750,750,R-HSA-9858328,OADH complex synthesizes glutaryl-CoA from 2-OA,REACTOME,pathway,PATHWAY_750 |
| 751,751,751,751,751,751,751,751,R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),REACTOME,pathway,PATHWAY_751 |
| 752,752,752,752,752,752,752,752,R-HSA-9652817,Signaling by MAPK mutants,REACTOME,pathway,PATHWAY_752 |
| 753,753,753,753,753,753,753,753,R-HSA-2559585,Oncogene Induced Senescence,REACTOME,pathway,PATHWAY_753 |
| 754,754,754,754,754,754,754,754,R-HSA-109704,PI3K Cascade,REACTOME,pathway,PATHWAY_754 |
| 755,755,755,755,755,755,755,755,R-HSA-2219528,PI3K/AKT Signaling in Cancer,REACTOME,pathway,PATHWAY_755 |
| 756,756,756,756,756,756,756,756,R-HSA-428643,Organic anion transporters,REACTOME,pathway,PATHWAY_756 |
| 757,757,757,757,757,757,757,757,R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,REACTOME,pathway,PATHWAY_757 |
| 758,758,758,758,758,758,758,758,R-HSA-8875791,MET activates STAT3,REACTOME,pathway,PATHWAY_758 |
| 759,759,759,759,759,759,759,759,R-HSA-77348,Beta oxidation of octanoyl-CoA to hexanoyl-CoA,REACTOME,pathway,PATHWAY_759 |
| 760,760,760,760,760,760,760,760,R-HSA-9694548,Maturation of spike protein,REACTOME,pathway,PATHWAY_760 |
| 761,761,761,761,761,761,761,761,R-HSA-159234,Transport of Mature mRNAs Derived from Intronless Transcripts,REACTOME,pathway,PATHWAY_761 |
| 762,762,762,762,762,762,762,762,R-HSA-68689,CDC6 association with the ORC:origin complex,REACTOME,pathway,PATHWAY_762 |
| 763,763,763,763,763,763,763,763,R-HSA-9729902,Reversible DNA damage induced by alkylating chemotherapeutic drugs,REACTOME,pathway,PATHWAY_763 |
| 764,764,764,764,764,764,764,764,R-HSA-112126,ALKBH3 mediated reversal of alkylation damage,REACTOME,pathway,PATHWAY_764 |
| 765,765,765,765,765,765,765,765,R-HSA-159227,Transport of the SLBP independent Mature mRNA,REACTOME,pathway,PATHWAY_765 |
| 766,766,766,766,766,766,766,766,R-HSA-9856872,Malate-aspartate shuttle,REACTOME,pathway,PATHWAY_766 |
| 767,767,767,767,767,767,767,767,R-HSA-1912422,Pre-NOTCH Expression and Processing,REACTOME,pathway,PATHWAY_767 |
| 768,768,768,768,768,768,768,768,R-HSA-373752,Netrin-1 signaling,REACTOME,pathway,PATHWAY_768 |
| 769,769,769,769,769,769,769,769,R-HSA-5678771,"Defective ABCB4 causes PFIC3, ICP3 and GBD1",REACTOME,pathway,PATHWAY_769 |
| 770,770,770,770,770,770,770,770,R-HSA-15869,Metabolism of nucleotides,REACTOME,pathway,PATHWAY_770 |
| 771,771,771,771,771,771,771,771,R-HSA-975634,Retinoid metabolism and transport,REACTOME,pathway,PATHWAY_771 |
| 772,772,772,772,772,772,772,772,R-HSA-9717316,alectinib-resistant ALK mutants,REACTOME,pathway,PATHWAY_772 |
| 773,773,773,773,773,773,773,773,R-HSA-9824272,Somitogenesis,REACTOME,pathway,PATHWAY_773 |
| 774,774,774,774,774,774,774,774,R-HSA-6785631,ERBB2 Regulates Cell Motility,REACTOME,pathway,PATHWAY_774 |
| 775,775,775,775,775,775,775,775,R-HSA-8848021,Signaling by PTK6,REACTOME,pathway,PATHWAY_775 |
| 776,776,776,776,776,776,776,776,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,REACTOME,pathway,PATHWAY_776 |
| 777,777,777,777,777,777,777,777,R-HSA-1296059,G protein gated Potassium channels,REACTOME,pathway,PATHWAY_777 |
| 778,778,778,778,778,778,778,778,R-HSA-173599,"Formation of the active cofactor, UDP-glucuronate",REACTOME,pathway,PATHWAY_778 |
| 779,779,779,779,779,779,779,779,R-HSA-2408557,Selenocysteine synthesis,REACTOME,pathway,PATHWAY_779 |
| 780,780,780,780,780,780,780,780,R-HSA-9025046,NTF3 activates NTRK2 (TRKB) signaling,REACTOME,pathway,PATHWAY_780 |
| 781,781,781,781,781,781,781,781,R-HSA-9013420,RHOU GTPase cycle,REACTOME,pathway,PATHWAY_781 |
| 782,782,782,782,782,782,782,782,R-HSA-804914,Transport of fatty acids,REACTOME,pathway,PATHWAY_782 |
| 783,783,783,783,783,783,783,783,R-HSA-2046106,alpha-linolenic acid (ALA) metabolism,REACTOME,pathway,PATHWAY_783 |
| 784,784,784,784,784,784,784,784,R-HSA-9818027,NFE2L2 regulating anti-oxidant/detoxification enzymes,REACTOME,pathway,PATHWAY_784 |
| 785,785,785,785,785,785,785,785,R-HSA-6791461,RPIA deficiency: failed conversion of RU5P to R5P,REACTOME,pathway,PATHWAY_785 |
| 786,786,786,786,786,786,786,786,R-HSA-5576886,Phase 4 - resting membrane potential,REACTOME,pathway,PATHWAY_786 |
| 787,787,787,787,787,787,787,787,R-HSA-75108,"Activation, myristolyation of BID and translocation to mitochondria",REACTOME,pathway,PATHWAY_787 |
| 788,788,788,788,788,788,788,788,R-HSA-3229133,Glycogen storage disease type Ib (SLC37A4),REACTOME,pathway,PATHWAY_788 |
| 789,789,789,789,789,789,789,789,R-HSA-5579002,Defective UGT1A1 causes hyperbilirubinemia,REACTOME,pathway,PATHWAY_789 |
| 790,790,790,790,790,790,790,790,R-HSA-69052,Switching of origins to a post-replicative state,REACTOME,pathway,PATHWAY_790 |
| 791,791,791,791,791,791,791,791,R-HSA-9860927,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",REACTOME,pathway,PATHWAY_791 |
| 792,792,792,792,792,792,792,792,R-HSA-162791,Attachment of GPI anchor to uPAR,REACTOME,pathway,PATHWAY_792 |
| 793,793,793,793,793,793,793,793,R-HSA-879415,Advanced glycosylation endproduct receptor signaling,REACTOME,pathway,PATHWAY_793 |
| 794,794,794,794,794,794,794,794,R-HSA-2428933,SHC-related events triggered by IGF1R,REACTOME,pathway,PATHWAY_794 |
| 795,795,795,795,795,795,795,795,R-HSA-5685938,HDR through Single Strand Annealing (SSA),REACTOME,pathway,PATHWAY_795 |
| 796,796,796,796,796,796,796,796,R-HSA-9715370,Miro GTPase Cycle,REACTOME,pathway,PATHWAY_796 |
| 797,797,797,797,797,797,797,797,R-HSA-8964539,Glutamate and glutamine metabolism,REACTOME,pathway,PATHWAY_797 |
| 798,798,798,798,798,798,798,798,R-HSA-9845619,Enhanced cleavage of VWF variant by ADAMTS13,REACTOME,pathway,PATHWAY_798 |
| 799,799,799,799,799,799,799,799,R-HSA-167287,HIV elongation arrest and recovery,REACTOME,pathway,PATHWAY_799 |
| 800,800,800,800,800,800,800,800,R-HSA-5687868,Defective SFTPA2 causes IPF,REACTOME,pathway,PATHWAY_800 |
| 801,801,801,801,801,801,801,801,R-HSA-937042,IRAK2 mediated activation of TAK1 complex,REACTOME,pathway,PATHWAY_801 |
| 802,802,802,802,802,802,802,802,R-HSA-2408522,Selenoamino acid metabolism,REACTOME,pathway,PATHWAY_802 |
| 803,803,803,803,803,803,803,803,R-HSA-2142696,Synthesis of Hepoxilins (HX) and Trioxilins (TrX),REACTOME,pathway,PATHWAY_803 |
| 804,804,804,804,804,804,804,804,R-HSA-9754560,SARS-CoV-2 modulates autophagy,REACTOME,pathway,PATHWAY_804 |
| 805,805,805,805,805,805,805,805,R-HSA-209905,Catecholamine biosynthesis,REACTOME,pathway,PATHWAY_805 |
| 806,806,806,806,806,806,806,806,R-HSA-211979,Eicosanoids,REACTOME,pathway,PATHWAY_806 |
| 807,807,807,807,807,807,807,807,R-HSA-8964046,VLDL clearance,REACTOME,pathway,PATHWAY_807 |
| 808,808,808,808,808,808,808,808,R-HSA-3371511,HSF1 activation,REACTOME,pathway,PATHWAY_808 |
| 809,809,809,809,809,809,809,809,R-HSA-5358351,Signaling by Hedgehog,REACTOME,pathway,PATHWAY_809 |
| 810,810,810,810,810,810,810,810,R-HSA-73942,DNA Damage Reversal,REACTOME,pathway,PATHWAY_810 |
| 811,811,811,811,811,811,811,811,R-HSA-69236,G1 Phase,REACTOME,pathway,PATHWAY_811 |
| 812,812,812,812,812,812,812,812,R-HSA-4570571,Defective RFT1 causes CDG-1n,REACTOME,pathway,PATHWAY_812 |
| 813,813,813,813,813,813,813,813,R-HSA-629597,Highly calcium permeable nicotinic acetylcholine receptors,REACTOME,pathway,PATHWAY_813 |
| 814,814,814,814,814,814,814,814,R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum stress,REACTOME,pathway,PATHWAY_814 |
| 815,815,815,815,815,815,815,815,R-HSA-164378,PKA activation in glucagon signalling,REACTOME,pathway,PATHWAY_815 |
| 816,816,816,816,816,816,816,816,R-HSA-379397,Enzymatic degradation of dopamine by COMT,REACTOME,pathway,PATHWAY_816 |
| 817,817,817,817,817,817,817,817,R-HSA-9818032,NFE2L2 regulating MDR associated enzymes,REACTOME,pathway,PATHWAY_817 |
| 818,818,818,818,818,818,818,818,R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,REACTOME,pathway,PATHWAY_818 |
| 819,819,819,819,819,819,819,819,R-HSA-442660,Na+/Cl- dependent neurotransmitter transporters,REACTOME,pathway,PATHWAY_819 |
| 820,820,820,820,820,820,820,820,R-HSA-3304347,Loss of Function of SMAD4 in Cancer,REACTOME,pathway,PATHWAY_820 |
| 821,821,821,821,821,821,821,821,R-HSA-68882,Mitotic Anaphase,REACTOME,pathway,PATHWAY_821 |
| 822,822,822,822,822,822,822,822,R-HSA-5250913,Positive epigenetic regulation of rRNA expression,REACTOME,pathway,PATHWAY_822 |
| 823,823,823,823,823,823,823,823,R-HSA-74158,RNA Polymerase III Transcription,REACTOME,pathway,PATHWAY_823 |
| 824,824,824,824,824,824,824,824,R-HSA-8849474,PTK6 Activates STAT3,REACTOME,pathway,PATHWAY_824 |
| 825,825,825,825,825,825,825,825,R-HSA-74752,Signaling by Insulin receptor,REACTOME,pathway,PATHWAY_825 |
| 826,826,826,826,826,826,826,826,R-HSA-4755609,Defective DHDDS causes RP59,REACTOME,pathway,PATHWAY_826 |
| 827,827,827,827,827,827,827,827,R-HSA-5659898,Intestinal saccharidase deficiencies,REACTOME,pathway,PATHWAY_827 |
| 828,828,828,828,828,828,828,828,R-HSA-9006821,Alternative Lengthening of Telomeres (ALT),REACTOME,pathway,PATHWAY_828 |
| 829,829,829,829,829,829,829,829,R-HSA-9607240,FLT3 Signaling,REACTOME,pathway,PATHWAY_829 |
| 830,830,830,830,830,830,830,830,R-HSA-418597,G alpha (z) signalling events,REACTOME,pathway,PATHWAY_830 |
| 831,831,831,831,831,831,831,831,R-HSA-8981373,Intestinal hexose absorption,REACTOME,pathway,PATHWAY_831 |
| 832,832,832,832,832,832,832,832,R-HSA-2514853,Condensation of Prometaphase Chromosomes,REACTOME,pathway,PATHWAY_832 |
| 833,833,833,833,833,833,833,833,R-HSA-8948216,Collagen chain trimerization,REACTOME,pathway,PATHWAY_833 |
| 834,834,834,834,834,834,834,834,R-HSA-192823,Viral mRNA Translation,REACTOME,pathway,PATHWAY_834 |
| 835,835,835,835,835,835,835,835,R-HSA-8952158,RUNX3 regulates BCL2L11 (BIM) transcription,REACTOME,pathway,PATHWAY_835 |
| 836,836,836,836,836,836,836,836,R-HSA-9696264,RND3 GTPase cycle,REACTOME,pathway,PATHWAY_836 |
| 837,837,837,837,837,837,837,837,R-HSA-2514859,"Inactivation, recovery and regulation of the phototransduction cascade",REACTOME,pathway,PATHWAY_837 |
| 838,838,838,838,838,838,838,838,R-HSA-5652227,Fructose biosynthesis,REACTOME,pathway,PATHWAY_838 |
| 839,839,839,839,839,839,839,839,R-HSA-167162,RNA Polymerase II HIV Promoter Escape,REACTOME,pathway,PATHWAY_839 |
| 840,840,840,840,840,840,840,840,R-HSA-190239,FGFR3 ligand binding and activation,REACTOME,pathway,PATHWAY_840 |
| 841,841,841,841,841,841,841,841,R-HSA-1368108,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",REACTOME,pathway,PATHWAY_841 |
| 842,842,842,842,842,842,842,842,R-HSA-8953897,Cellular responses to stimuli,REACTOME,pathway,PATHWAY_842 |
| 843,843,843,843,843,843,843,843,R-HSA-5619076,Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25),REACTOME,pathway,PATHWAY_843 |
| 844,844,844,844,844,844,844,844,R-HSA-9665247,Resistance of ERBB2 KD mutants to osimertinib,REACTOME,pathway,PATHWAY_844 |
| 845,845,845,845,845,845,845,845,R-HSA-180585,Vif-mediated degradation of APOBEC3G,REACTOME,pathway,PATHWAY_845 |
| 846,846,846,846,846,846,846,846,R-HSA-202040,G-protein activation,REACTOME,pathway,PATHWAY_846 |
| 847,847,847,847,847,847,847,847,R-HSA-435368,Zinc efflux and compartmentalization by the SLC30 family,REACTOME,pathway,PATHWAY_847 |
| 848,848,848,848,848,848,848,848,R-HSA-9678108,SARS-CoV-1 Infection,REACTOME,pathway,PATHWAY_848 |
| 849,849,849,849,849,849,849,849,R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA ,REACTOME,pathway,PATHWAY_849 |
| 850,850,850,850,850,850,850,850,R-HSA-500753,Pyrimidine biosynthesis,REACTOME,pathway,PATHWAY_850 |
| 851,851,851,851,851,851,851,851,R-HSA-9818030,NFE2L2 regulating tumorigenic genes,REACTOME,pathway,PATHWAY_851 |
| 852,852,852,852,852,852,852,852,R-HSA-9664407,Parasite infection,REACTOME,pathway,PATHWAY_852 |
| 853,853,853,853,853,853,853,853,R-HSA-111367,SLBP independent Processing of Histone Pre-mRNAs,REACTOME,pathway,PATHWAY_853 |
| 854,854,854,854,854,854,854,854,R-HSA-901032,ER Quality Control Compartment (ERQC),REACTOME,pathway,PATHWAY_854 |
| 855,855,855,855,855,855,855,855,R-HSA-69275,G2/M Transition,REACTOME,pathway,PATHWAY_855 |
| 856,856,856,856,856,856,856,856,R-HSA-5609975,Diseases associated with glycosylation precursor biosynthesis,REACTOME,pathway,PATHWAY_856 |
| 857,857,857,857,857,857,857,857,R-HSA-140534,Caspase activation via Death Receptors in the presence of ligand,REACTOME,pathway,PATHWAY_857 |
| 858,858,858,858,858,858,858,858,R-HSA-442729,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,REACTOME,pathway,PATHWAY_858 |
| 859,859,859,859,859,859,859,859,R-HSA-9683612,Maturation of protein M,REACTOME,pathway,PATHWAY_859 |
| 860,860,860,860,860,860,860,860,R-HSA-5250989,Toxicity of botulinum toxin type G (botG),REACTOME,pathway,PATHWAY_860 |
| 861,861,861,861,861,861,861,861,R-HSA-428890,Role of ABL in ROBO-SLIT signaling,REACTOME,pathway,PATHWAY_861 |
| 862,862,862,862,862,862,862,862,R-HSA-5620922,BBSome-mediated cargo-targeting to cilium,REACTOME,pathway,PATHWAY_862 |
| 863,863,863,863,863,863,863,863,R-HSA-888593,Reuptake of GABA,REACTOME,pathway,PATHWAY_863 |
| 864,864,864,864,864,864,864,864,R-HSA-9603505,NTRK3 as a dependence receptor,REACTOME,pathway,PATHWAY_864 |
| 865,865,865,865,865,865,865,865,R-HSA-9672393,Defective F8 binding to von Willebrand factor,REACTOME,pathway,PATHWAY_865 |
| 866,866,866,866,866,866,866,866,R-HSA-9859138,"BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV",REACTOME,pathway,PATHWAY_866 |
| 867,867,867,867,867,867,867,867,R-HSA-5602410,TLR3 deficiency - HSE,REACTOME,pathway,PATHWAY_867 |
| 868,868,868,868,868,868,868,868,R-HSA-9615710,Late endosomal microautophagy,REACTOME,pathway,PATHWAY_868 |
| 869,869,869,869,869,869,869,869,R-HSA-3371571,HSF1-dependent transactivation,REACTOME,pathway,PATHWAY_869 |
| 870,870,870,870,870,870,870,870,R-HSA-2467813,Separation of Sister Chromatids,REACTOME,pathway,PATHWAY_870 |
| 871,871,871,871,871,871,871,871,R-HSA-9843743,Transcriptional regulation of brown and beige adipocyte differentiation,REACTOME,pathway,PATHWAY_871 |
| 872,872,872,872,872,872,872,872,R-HSA-5625970,RHO GTPases activate KTN1,REACTOME,pathway,PATHWAY_872 |
| 873,873,873,873,873,873,873,873,R-HSA-5610787,Hedgehog 'off' state,REACTOME,pathway,PATHWAY_873 |
| 874,874,874,874,874,874,874,874,R-HSA-9035968,Defective GGT1 in aflatoxin detoxification causes GLUTH,REACTOME,pathway,PATHWAY_874 |
| 875,875,875,875,875,875,875,875,R-HSA-190873,Gap junction degradation,REACTOME,pathway,PATHWAY_875 |
| 876,876,876,876,876,876,876,876,R-HSA-9664535,LTC4-CYSLTR mediated IL4 production,REACTOME,pathway,PATHWAY_876 |
| 877,877,877,877,877,877,877,877,R-HSA-174495,"Synthesis And Processing Of GAG, GAGPOL Polyproteins",REACTOME,pathway,PATHWAY_877 |
| 878,878,878,878,878,878,878,878,R-HSA-1227990,Signaling by ERBB2 in Cancer,REACTOME,pathway,PATHWAY_878 |
| 879,879,879,879,879,879,879,879,R-HSA-5673001,RAF/MAP kinase cascade,REACTOME,pathway,PATHWAY_879 |
| 880,880,880,880,880,880,880,880,R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,REACTOME,pathway,PATHWAY_880 |
| 881,881,881,881,881,881,881,881,R-HSA-175567,Integration of viral DNA into host genomic DNA,REACTOME,pathway,PATHWAY_881 |
| 882,882,882,882,882,882,882,882,R-HSA-3304349,Loss of Function of SMAD2/3 in Cancer,REACTOME,pathway,PATHWAY_882 |
| 883,883,883,883,883,883,883,883,R-HSA-2691232,Constitutive Signaling by NOTCH1 HD Domain Mutants,REACTOME,pathway,PATHWAY_883 |
| 884,884,884,884,884,884,884,884,R-HSA-428157,Sphingolipid metabolism,REACTOME,pathway,PATHWAY_884 |
| 885,885,885,885,885,885,885,885,R-HSA-438066,"Unblocking of NMDA receptors, glutamate binding and activation",REACTOME,pathway,PATHWAY_885 |
| 886,886,886,886,886,886,886,886,R-HSA-9702600,midostaurin-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_886 |
| 887,887,887,887,887,887,887,887,R-HSA-68877,Mitotic Prometaphase,REACTOME,pathway,PATHWAY_887 |
| 888,888,888,888,888,888,888,888,R-HSA-1483166,Synthesis of PA,REACTOME,pathway,PATHWAY_888 |
| 889,889,889,889,889,889,889,889,R-HSA-165160,PDE3B signalling,REACTOME,pathway,PATHWAY_889 |
| 890,890,890,890,890,890,890,890,R-HSA-9830369,Kidney development,REACTOME,pathway,PATHWAY_890 |
| 891,891,891,891,891,891,891,891,R-HSA-166662,Lectin pathway of complement activation,REACTOME,pathway,PATHWAY_891 |
| 892,892,892,892,892,892,892,892,R-HSA-9717189,Sensory perception of taste,REACTOME,pathway,PATHWAY_892 |
| 893,893,893,893,893,893,893,893,R-HSA-73928,Depyrimidination,REACTOME,pathway,PATHWAY_893 |
| 894,894,894,894,894,894,894,894,R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),REACTOME,pathway,PATHWAY_894 |
| 895,895,895,895,895,895,895,895,R-HSA-9734009,Defective Intrinsic Pathway for Apoptosis,REACTOME,pathway,PATHWAY_895 |
| 896,896,896,896,896,896,896,896,R-HSA-9656256,Defective OGG1 Substrate Processing,REACTOME,pathway,PATHWAY_896 |
| 897,897,897,897,897,897,897,897,R-HSA-5357609,Glycogen storage disease type II (GAA),REACTOME,pathway,PATHWAY_897 |
| 898,898,898,898,898,898,898,898,R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,REACTOME,pathway,PATHWAY_898 |
| 899,899,899,899,899,899,899,899,R-HSA-9022699,MECP2 regulates neuronal receptors and channels,REACTOME,pathway,PATHWAY_899 |
| 900,900,900,900,900,900,900,900,R-HSA-9673218,Defective F9 secretion,REACTOME,pathway,PATHWAY_900 |
| 901,901,901,901,901,901,901,901,R-HSA-171286,Synthesis and processing of ENV and VPU,REACTOME,pathway,PATHWAY_901 |
| 902,902,902,902,902,902,902,902,R-HSA-180534,Vpu mediated degradation of CD4,REACTOME,pathway,PATHWAY_902 |
| 903,903,903,903,903,903,903,903,R-HSA-5654712,FRS-mediated FGFR4 signaling,REACTOME,pathway,PATHWAY_903 |
| 904,904,904,904,904,904,904,904,R-HSA-111931,PKA-mediated phosphorylation of CREB,REACTOME,pathway,PATHWAY_904 |
| 905,905,905,905,905,905,905,905,R-HSA-1474244,Extracellular matrix organization,REACTOME,pathway,PATHWAY_905 |
| 906,906,906,906,906,906,906,906,R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,REACTOME,pathway,PATHWAY_906 |
| 907,907,907,907,907,907,907,907,R-HSA-9694614,Attachment and Entry,REACTOME,pathway,PATHWAY_907 |
| 908,908,908,908,908,908,908,908,R-HSA-419812,Calcitonin-like ligand receptors,REACTOME,pathway,PATHWAY_908 |
| 909,909,909,909,909,909,909,909,R-HSA-8957322,Metabolism of steroids,REACTOME,pathway,PATHWAY_909 |
| 910,910,910,910,910,910,910,910,R-HSA-8868773,rRNA processing in the nucleus and cytosol,REACTOME,pathway,PATHWAY_910 |
| 911,911,911,911,911,911,911,911,R-HSA-9818035,NFE2L2 regulating ER-stress associated genes,REACTOME,pathway,PATHWAY_911 |
| 912,912,912,912,912,912,912,912,R-HSA-5579013,Defective CYP7B1 causes SPG5A and CBAS3,REACTOME,pathway,PATHWAY_912 |
| 913,913,913,913,913,913,913,913,R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,REACTOME,pathway,PATHWAY_913 |
| 914,914,914,914,914,914,914,914,R-HSA-4086398,Ca2+ pathway,REACTOME,pathway,PATHWAY_914 |
| 915,915,915,915,915,915,915,915,R-HSA-1433557,Signaling by SCF-KIT,REACTOME,pathway,PATHWAY_915 |
| 916,916,916,916,916,916,916,916,R-HSA-5218921,VEGFR2 mediated cell proliferation,REACTOME,pathway,PATHWAY_916 |
| 917,917,917,917,917,917,917,917,R-HSA-110056,MAPK3 (ERK1) activation,REACTOME,pathway,PATHWAY_917 |
| 918,918,918,918,918,918,918,918,R-HSA-174403,Glutathione synthesis and recycling,REACTOME,pathway,PATHWAY_918 |
| 919,919,919,919,919,919,919,919,R-HSA-6793080,rRNA modification in the mitochondrion,REACTOME,pathway,PATHWAY_919 |
| 920,920,920,920,920,920,920,920,R-HSA-196741,"Cobalamin (Cbl, vitamin B12) transport and metabolism",REACTOME,pathway,PATHWAY_920 |
| 921,921,921,921,921,921,921,921,R-HSA-9033500,TYSND1 cleaves peroxisomal proteins,REACTOME,pathway,PATHWAY_921 |
| 922,922,922,922,922,922,922,922,R-HSA-159424,Conjugation of carboxylic acids,REACTOME,pathway,PATHWAY_922 |
| 923,923,923,923,923,923,923,923,R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,REACTOME,pathway,PATHWAY_923 |
| 924,924,924,924,924,924,924,924,R-HSA-9662001,Defective factor VIII causes hemophilia A,REACTOME,pathway,PATHWAY_924 |
| 925,925,925,925,925,925,925,925,R-HSA-5678895,Defective CFTR causes cystic fibrosis,REACTOME,pathway,PATHWAY_925 |
| 926,926,926,926,926,926,926,926,R-HSA-9707616,Heme signaling,REACTOME,pathway,PATHWAY_926 |
| 927,927,927,927,927,927,927,927,R-HSA-1483152,Hydrolysis of LPE,REACTOME,pathway,PATHWAY_927 |
| 928,928,928,928,928,928,928,928,R-HSA-111457,Release of apoptotic factors from the mitochondria,REACTOME,pathway,PATHWAY_928 |
| 929,929,929,929,929,929,929,929,R-HSA-1266695,Interleukin-7 signaling,REACTOME,pathway,PATHWAY_929 |
| 930,930,930,930,930,930,930,930,R-HSA-1855196,IP3 and IP4 transport between cytosol and nucleus,REACTOME,pathway,PATHWAY_930 |
| 931,931,931,931,931,931,931,931,R-HSA-112412,SOS-mediated signalling,REACTOME,pathway,PATHWAY_931 |
| 932,932,932,932,932,932,932,932,R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,REACTOME,pathway,PATHWAY_932 |
| 933,933,933,933,933,933,933,933,R-HSA-168927,"TICAM1, RIP1-mediated IKK complex recruitment",REACTOME,pathway,PATHWAY_933 |
| 934,934,934,934,934,934,934,934,R-HSA-448424,Interleukin-17 signaling,REACTOME,pathway,PATHWAY_934 |
| 935,935,935,935,935,935,935,935,R-HSA-77289,Mitochondrial Fatty Acid Beta-Oxidation,REACTOME,pathway,PATHWAY_935 |
| 936,936,936,936,936,936,936,936,R-HSA-9702581,crenolanib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_936 |
| 937,937,937,937,937,937,937,937,R-HSA-1855231,Synthesis of IPs in the ER lumen,REACTOME,pathway,PATHWAY_937 |
| 938,938,938,938,938,938,938,938,R-HSA-193692,Regulated proteolysis of p75NTR,REACTOME,pathway,PATHWAY_938 |
| 939,939,939,939,939,939,939,939,R-HSA-9856532,Mechanical load activates signaling by PIEZO1 and integrins in osteocytes,REACTOME,pathway,PATHWAY_939 |
| 940,940,940,940,940,940,940,940,R-HSA-175474,Assembly Of The HIV Virion,REACTOME,pathway,PATHWAY_940 |
| 941,941,941,941,941,941,941,941,R-HSA-8941856,RUNX3 regulates NOTCH signaling,REACTOME,pathway,PATHWAY_941 |
| 942,942,942,942,942,942,942,942,R-HSA-3371599,Defective HLCS causes multiple carboxylase deficiency,REACTOME,pathway,PATHWAY_942 |
| 943,943,943,943,943,943,943,943,R-HSA-8856688,Golgi-to-ER retrograde transport,REACTOME,pathway,PATHWAY_943 |
| 944,944,944,944,944,944,944,944,R-HSA-8941237,Invadopodia formation,REACTOME,pathway,PATHWAY_944 |
| 945,945,945,945,945,945,945,945,R-HSA-674695,RNA Polymerase II Pre-transcription Events,REACTOME,pathway,PATHWAY_945 |
| 946,946,946,946,946,946,946,946,R-HSA-69618,Mitotic Spindle Checkpoint,REACTOME,pathway,PATHWAY_946 |
| 947,947,947,947,947,947,947,947,R-HSA-420499,Class C/3 (Metabotropic glutamate/pheromone receptors),REACTOME,pathway,PATHWAY_947 |
| 948,948,948,948,948,948,948,948,R-HSA-1307965,betaKlotho-mediated ligand binding,REACTOME,pathway,PATHWAY_948 |
| 949,949,949,949,949,949,949,949,R-HSA-1222449,Mtb iron assimilation by chelation,REACTOME,pathway,PATHWAY_949 |
| 950,950,950,950,950,950,950,950,R-HSA-9013106,RHOC GTPase cycle,REACTOME,pathway,PATHWAY_950 |
| 951,951,951,951,951,951,951,951,R-HSA-1660516,Synthesis of PIPs at the early endosome membrane,REACTOME,pathway,PATHWAY_951 |
| 952,952,952,952,952,952,952,952,R-HSA-69206,G1/S Transition,REACTOME,pathway,PATHWAY_952 |
| 953,953,953,953,953,953,953,953,R-HSA-597592,Post-translational protein modification,REACTOME,pathway,PATHWAY_953 |
| 954,954,954,954,954,954,954,954,R-HSA-204998,"Cell death signalling via NRAGE, NRIF and NADE",REACTOME,pathway,PATHWAY_954 |
| 955,955,955,955,955,955,955,955,R-HSA-5690338,Defective ABCC6 causes PXE,REACTOME,pathway,PATHWAY_955 |
| 956,956,956,956,956,956,956,956,R-HSA-189445,Metabolism of porphyrins,REACTOME,pathway,PATHWAY_956 |
| 957,957,957,957,957,957,957,957,R-HSA-176417,Phosphorylation of Emi1,REACTOME,pathway,PATHWAY_957 |
| 958,958,958,958,958,958,958,958,R-HSA-5358565,Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),REACTOME,pathway,PATHWAY_958 |
| 959,959,959,959,959,959,959,959,R-HSA-168275,Entry of Influenza Virion into Host Cell via Endocytosis,REACTOME,pathway,PATHWAY_959 |
| 960,960,960,960,960,960,960,960,R-HSA-71288,Creatine metabolism,REACTOME,pathway,PATHWAY_960 |
| 961,961,961,961,961,961,961,961,R-HSA-9824594,Regulation of MITF-M-dependent genes involved in apoptosis,REACTOME,pathway,PATHWAY_961 |
| 962,962,962,962,962,962,962,962,R-HSA-8956319,Nucleotide catabolism,REACTOME,pathway,PATHWAY_962 |
| 963,963,963,963,963,963,963,963,R-HSA-193670,p75NTR negatively regulates cell cycle via SC1,REACTOME,pathway,PATHWAY_963 |
| 964,964,964,964,964,964,964,964,R-HSA-425397,"Transport of vitamins, nucleosides, and related molecules",REACTOME,pathway,PATHWAY_964 |
| 965,965,965,965,965,965,965,965,R-HSA-5619095,"Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)",REACTOME,pathway,PATHWAY_965 |
| 966,966,966,966,966,966,966,966,R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),REACTOME,pathway,PATHWAY_966 |
| 967,967,967,967,967,967,967,967,R-HSA-202131,Metabolism of nitric oxide: NOS3 activation and regulation,REACTOME,pathway,PATHWAY_967 |
| 968,968,968,968,968,968,968,968,R-HSA-165159,MTOR signalling,REACTOME,pathway,PATHWAY_968 |
| 969,969,969,969,969,969,969,969,R-HSA-8957275,Post-translational protein phosphorylation,REACTOME,pathway,PATHWAY_969 |
| 970,970,970,970,970,970,970,970,R-HSA-9033658,Blood group systems biosynthesis,REACTOME,pathway,PATHWAY_970 |
| 971,971,971,971,971,971,971,971,R-HSA-382556,ABC-family proteins mediated transport,REACTOME,pathway,PATHWAY_971 |
| 972,972,972,972,972,972,972,972,R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,REACTOME,pathway,PATHWAY_972 |
| 973,973,973,973,973,973,973,973,R-HSA-2142816,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),REACTOME,pathway,PATHWAY_973 |
| 974,974,974,974,974,974,974,974,R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),REACTOME,pathway,PATHWAY_974 |
| 975,975,975,975,975,975,975,975,R-HSA-71737,Pyrophosphate hydrolysis,REACTOME,pathway,PATHWAY_975 |
| 976,976,976,976,976,976,976,976,R-HSA-5339562,Uptake and actions of bacterial toxins,REACTOME,pathway,PATHWAY_976 |
| 977,977,977,977,977,977,977,977,R-HSA-168888,Inhibition of IFN-beta,REACTOME,pathway,PATHWAY_977 |
| 978,978,978,978,978,978,978,978,R-HSA-418359,Reduction of cytosolic Ca++ levels,REACTOME,pathway,PATHWAY_978 |
| 979,979,979,979,979,979,979,979,R-HSA-8876384,Listeria monocytogenes entry into host cells,REACTOME,pathway,PATHWAY_979 |
| 980,980,980,980,980,980,980,980,R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,REACTOME,pathway,PATHWAY_980 |
| 981,981,981,981,981,981,981,981,R-HSA-8939247,RUNX1 regulates transcription of genes involved in interleukin signaling,REACTOME,pathway,PATHWAY_981 |
| 982,982,982,982,982,982,982,982,R-HSA-8935690,Digestion,REACTOME,pathway,PATHWAY_982 |
| 983,983,983,983,983,983,983,983,R-HSA-9696273,RND1 GTPase cycle,REACTOME,pathway,PATHWAY_983 |
| 984,984,984,984,984,984,984,984,R-HSA-5654733,Negative regulation of FGFR4 signaling,REACTOME,pathway,PATHWAY_984 |
| 985,985,985,985,985,985,985,985,R-HSA-9759475,Regulation of CDH11 Expression and Function,REACTOME,pathway,PATHWAY_985 |
| 986,986,986,986,986,986,986,986,R-HSA-1236977,Endosomal/Vacuolar pathway,REACTOME,pathway,PATHWAY_986 |
| 987,987,987,987,987,987,987,987,R-HSA-450513,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",REACTOME,pathway,PATHWAY_987 |
| 988,988,988,988,988,988,988,988,R-HSA-168799,Neurotoxicity of clostridium toxins,REACTOME,pathway,PATHWAY_988 |
| 989,989,989,989,989,989,989,989,R-HSA-9673767,"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",REACTOME,pathway,PATHWAY_989 |
| 990,990,990,990,990,990,990,990,R-HSA-9669933,Signaling by kinase domain mutants of KIT,REACTOME,pathway,PATHWAY_990 |
| 991,991,991,991,991,991,991,991,R-HSA-606279,Deposition of new CENPA-containing nucleosomes at the centromere,REACTOME,pathway,PATHWAY_991 |
| 992,992,992,992,992,992,992,992,R-HSA-73943,Reversal of alkylation damage by DNA dioxygenases,REACTOME,pathway,PATHWAY_992 |
| 993,993,993,993,993,993,993,993,R-HSA-9733458,Induction of Cell-Cell Fusion,REACTOME,pathway,PATHWAY_993 |
| 994,994,994,994,994,994,994,994,R-HSA-8853336,Signaling by plasma membrane FGFR1 fusions,REACTOME,pathway,PATHWAY_994 |
| 995,995,995,995,995,995,995,995,R-HSA-418457,cGMP effects,REACTOME,pathway,PATHWAY_995 |
| 996,996,996,996,996,996,996,996,R-HSA-982772,Growth hormone receptor signaling,REACTOME,pathway,PATHWAY_996 |
| 997,997,997,997,997,997,997,997,R-HSA-8866906,TFAP2 (AP-2) family regulates transcription of other transcription factors,REACTOME,pathway,PATHWAY_997 |
| 998,998,998,998,998,998,998,998,R-HSA-9640463,Wax biosynthesis,REACTOME,pathway,PATHWAY_998 |
| 999,999,999,999,999,999,999,999,R-HSA-9032845,Activated NTRK2 signals through CDK5,REACTOME,pathway,PATHWAY_999 |
| 1000,1000,1000,1000,1000,1000,1000,1000,R-HSA-6787450,tRNA modification in the mitochondrion,REACTOME,pathway,PATHWAY_1000 |
| 1001,1001,1001,1001,1001,1001,1001,1001,R-HSA-977443,GABA receptor activation,REACTOME,pathway,PATHWAY_1001 |
| 1002,1002,1002,1002,1002,1002,1002,1002,R-HSA-9026290,Biosynthesis of DPAn-3-derived maresins,REACTOME,pathway,PATHWAY_1002 |
| 1003,1003,1003,1003,1003,1003,1003,1003,R-HSA-8849473,PTK6 Expression,REACTOME,pathway,PATHWAY_1003 |
| 1004,1004,1004,1004,1004,1004,1004,1004,R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,REACTOME,pathway,PATHWAY_1004 |
| 1005,1005,1005,1005,1005,1005,1005,1005,R-HSA-4755510,SUMOylation of immune response proteins,REACTOME,pathway,PATHWAY_1005 |
| 1006,1006,1006,1006,1006,1006,1006,1006,R-HSA-8857538,PTK6 promotes HIF1A stabilization,REACTOME,pathway,PATHWAY_1006 |
| 1007,1007,1007,1007,1007,1007,1007,1007,R-HSA-69091,Polymerase switching,REACTOME,pathway,PATHWAY_1007 |
| 1008,1008,1008,1008,1008,1008,1008,1008,R-HSA-373076,Class A/1 (Rhodopsin-like receptors),REACTOME,pathway,PATHWAY_1008 |
| 1009,1009,1009,1009,1009,1009,1009,1009,R-HSA-3560801,Defective B3GAT3 causes JDSSDHD,REACTOME,pathway,PATHWAY_1009 |
| 1010,1010,1010,1010,1010,1010,1010,1010,R-HSA-6802952,Signaling by BRAF and RAF1 fusions,REACTOME,pathway,PATHWAY_1010 |
| 1011,1011,1011,1011,1011,1011,1011,1011,R-HSA-9793528,Ciprofloxacin ADME,REACTOME,pathway,PATHWAY_1011 |
| 1012,1012,1012,1012,1012,1012,1012,1012,R-HSA-111957,Cam-PDE 1 activation,REACTOME,pathway,PATHWAY_1012 |
| 1013,1013,1013,1013,1013,1013,1013,1013,R-HSA-179812,GRB2 events in EGFR signaling,REACTOME,pathway,PATHWAY_1013 |
| 1014,1014,1014,1014,1014,1014,1014,1014,R-HSA-199220,Vitamin B5 (pantothenate) metabolism,REACTOME,pathway,PATHWAY_1014 |
| 1015,1015,1015,1015,1015,1015,1015,1015,R-HSA-2500257,Resolution of Sister Chromatid Cohesion,REACTOME,pathway,PATHWAY_1015 |
| 1016,1016,1016,1016,1016,1016,1016,1016,R-HSA-449147,Signaling by Interleukins,REACTOME,pathway,PATHWAY_1016 |
| 1017,1017,1017,1017,1017,1017,1017,1017,R-HSA-8866911,TFAP2 (AP-2) family regulates transcription of cell cycle factors,REACTOME,pathway,PATHWAY_1017 |
| 1018,1018,1018,1018,1018,1018,1018,1018,R-HSA-9032500,Activated NTRK2 signals through FYN,REACTOME,pathway,PATHWAY_1018 |
| 1019,1019,1019,1019,1019,1019,1019,1019,R-HSA-9014843,Interleukin-33 signaling,REACTOME,pathway,PATHWAY_1019 |
| 1020,1020,1020,1020,1020,1020,1020,1020,R-HSA-9841922,MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis,REACTOME,pathway,PATHWAY_1020 |
| 1021,1021,1021,1021,1021,1021,1021,1021,R-HSA-1227986,Signaling by ERBB2,REACTOME,pathway,PATHWAY_1021 |
| 1022,1022,1022,1022,1022,1022,1022,1022,R-HSA-5655862,Translesion synthesis by POLK,REACTOME,pathway,PATHWAY_1022 |
| 1023,1023,1023,1023,1023,1023,1023,1023,R-HSA-9013700,NOTCH4 Activation and Transmission of Signal to the Nucleus,REACTOME,pathway,PATHWAY_1023 |
| 1024,1024,1024,1024,1024,1024,1024,1024,R-HSA-5696398,Nucleotide Excision Repair,REACTOME,pathway,PATHWAY_1024 |
| 1025,1025,1025,1025,1025,1025,1025,1025,R-HSA-73893,DNA Damage Bypass,REACTOME,pathway,PATHWAY_1025 |
| 1026,1026,1026,1026,1026,1026,1026,1026,R-HSA-181431,Acetylcholine binding and downstream events,REACTOME,pathway,PATHWAY_1026 |
| 1027,1027,1027,1027,1027,1027,1027,1027,R-HSA-622323,Presynaptic nicotinic acetylcholine receptors,REACTOME,pathway,PATHWAY_1027 |
| 1028,1028,1028,1028,1028,1028,1028,1028,R-HSA-3656535,TGFBR1 LBD Mutants in Cancer,REACTOME,pathway,PATHWAY_1028 |
| 1029,1029,1029,1029,1029,1029,1029,1029,R-HSA-114608,Platelet degranulation ,REACTOME,pathway,PATHWAY_1029 |
| 1030,1030,1030,1030,1030,1030,1030,1030,R-HSA-4839726,Chromatin organization,REACTOME,pathway,PATHWAY_1030 |
| 1031,1031,1031,1031,1031,1031,1031,1031,R-HSA-5679096,Defective ABCG5 causes sitosterolemia,REACTOME,pathway,PATHWAY_1031 |
| 1032,1032,1032,1032,1032,1032,1032,1032,R-HSA-9620244,Long-term potentiation,REACTOME,pathway,PATHWAY_1032 |
| 1033,1033,1033,1033,1033,1033,1033,1033,R-HSA-9755511,KEAP1-NFE2L2 pathway,REACTOME,pathway,PATHWAY_1033 |
| 1034,1034,1034,1034,1034,1034,1034,1034,R-HSA-5687613,Diseases associated with surfactant metabolism,REACTOME,pathway,PATHWAY_1034 |
| 1035,1035,1035,1035,1035,1035,1035,1035,R-HSA-163680,AMPK inhibits chREBP transcriptional activation activity,REACTOME,pathway,PATHWAY_1035 |
| 1036,1036,1036,1036,1036,1036,1036,1036,R-HSA-2046104,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,REACTOME,pathway,PATHWAY_1036 |
| 1037,1037,1037,1037,1037,1037,1037,1037,R-HSA-9675135,Diseases of DNA repair,REACTOME,pathway,PATHWAY_1037 |
| 1038,1038,1038,1038,1038,1038,1038,1038,R-HSA-5654720,PI-3K cascade:FGFR4,REACTOME,pathway,PATHWAY_1038 |
| 1039,1039,1039,1039,1039,1039,1039,1039,R-HSA-4641258,Degradation of DVL,REACTOME,pathway,PATHWAY_1039 |
| 1040,1040,1040,1040,1040,1040,1040,1040,R-HSA-379401,Dopamine clearance from the synaptic cleft,REACTOME,pathway,PATHWAY_1040 |
| 1041,1041,1041,1041,1041,1041,1041,1041,R-HSA-549132,Organic cation/anion/zwitterion transport,REACTOME,pathway,PATHWAY_1041 |
| 1042,1042,1042,1042,1042,1042,1042,1042,R-HSA-418885,DCC mediated attractive signaling,REACTOME,pathway,PATHWAY_1042 |
| 1043,1043,1043,1043,1043,1043,1043,1043,R-HSA-3359467,Defective MTRR causes HMAE,REACTOME,pathway,PATHWAY_1043 |
| 1044,1044,1044,1044,1044,1044,1044,1044,R-HSA-9669929,Regorafenib-resistant KIT mutants,REACTOME,pathway,PATHWAY_1044 |
| 1045,1045,1045,1045,1045,1045,1045,1045,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,REACTOME,pathway,PATHWAY_1045 |
| 1046,1046,1046,1046,1046,1046,1046,1046,R-HSA-168255,Influenza Infection,REACTOME,pathway,PATHWAY_1046 |
| 1047,1047,1047,1047,1047,1047,1047,1047,R-HSA-9683439,Assembly of the SARS-CoV-1 Replication-Transcription Complex (RTC),REACTOME,pathway,PATHWAY_1047 |
| 1048,1048,1048,1048,1048,1048,1048,1048,R-HSA-6803204,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,REACTOME,pathway,PATHWAY_1048 |
| 1049,1049,1049,1049,1049,1049,1049,1049,R-HSA-5619041,Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG),REACTOME,pathway,PATHWAY_1049 |
| 1050,1050,1050,1050,1050,1050,1050,1050,R-HSA-6811440,Retrograde transport at the Trans-Golgi-Network,REACTOME,pathway,PATHWAY_1050 |
| 1051,1051,1051,1051,1051,1051,1051,1051,R-HSA-9013148,CDC42 GTPase cycle,REACTOME,pathway,PATHWAY_1051 |
| 1052,1052,1052,1052,1052,1052,1052,1052,R-HSA-162699,Synthesis of dolichyl-phosphate mannose,REACTOME,pathway,PATHWAY_1052 |
| 1053,1053,1053,1053,1053,1053,1053,1053,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,REACTOME,pathway,PATHWAY_1053 |
| 1054,1054,1054,1054,1054,1054,1054,1054,R-HSA-9704331,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,REACTOME,pathway,PATHWAY_1054 |
| 1055,1055,1055,1055,1055,1055,1055,1055,R-HSA-111996,Ca-dependent events,REACTOME,pathway,PATHWAY_1055 |
| 1056,1056,1056,1056,1056,1056,1056,1056,R-HSA-69186,Lagging Strand Synthesis,REACTOME,pathway,PATHWAY_1056 |
| 1057,1057,1057,1057,1057,1057,1057,1057,R-HSA-1300642,Sperm Motility And Taxes,REACTOME,pathway,PATHWAY_1057 |
| 1058,1058,1058,1058,1058,1058,1058,1058,R-HSA-6807047,Cholesterol biosynthesis via desmosterol,REACTOME,pathway,PATHWAY_1058 |
| 1059,1059,1059,1059,1059,1059,1059,1059,R-HSA-9707564,Cytoprotection by HMOX1,REACTOME,pathway,PATHWAY_1059 |
| 1060,1060,1060,1060,1060,1060,1060,1060,R-HSA-5579014,Defective CYP27B1 causes VDDR1A,REACTOME,pathway,PATHWAY_1060 |
| 1061,1061,1061,1061,1061,1061,1061,1061,R-HSA-69473,G2/M DNA damage checkpoint,REACTOME,pathway,PATHWAY_1061 |
| 1062,1062,1062,1062,1062,1062,1062,1062,R-HSA-426048,Arachidonate production from DAG,REACTOME,pathway,PATHWAY_1062 |
| 1063,1063,1063,1063,1063,1063,1063,1063,R-HSA-3359462,Defective AMN causes MGA1,REACTOME,pathway,PATHWAY_1063 |
| 1064,1064,1064,1064,1064,1064,1064,1064,R-HSA-2995410,Nuclear Envelope (NE) Reassembly,REACTOME,pathway,PATHWAY_1064 |
| 1065,1065,1065,1065,1065,1065,1065,1065,R-HSA-844623,The IPAF inflammasome,REACTOME,pathway,PATHWAY_1065 |
| 1066,1066,1066,1066,1066,1066,1066,1066,R-HSA-77346,Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,REACTOME,pathway,PATHWAY_1066 |
| 1067,1067,1067,1067,1067,1067,1067,1067,R-HSA-72689,Formation of a pool of free 40S subunits,REACTOME,pathway,PATHWAY_1067 |
| 1068,1068,1068,1068,1068,1068,1068,1068,R-HSA-1237112,Methionine salvage pathway,REACTOME,pathway,PATHWAY_1068 |
| 1069,1069,1069,1069,1069,1069,1069,1069,R-HSA-192105,Synthesis of bile acids and bile salts,REACTOME,pathway,PATHWAY_1069 |
| 1070,1070,1070,1070,1070,1070,1070,1070,R-HSA-6806664,Metabolism of vitamin K,REACTOME,pathway,PATHWAY_1070 |
| 1071,1071,1071,1071,1071,1071,1071,1071,R-HSA-1614517,Sulfide oxidation to sulfate,REACTOME,pathway,PATHWAY_1071 |
| 1072,1072,1072,1072,1072,1072,1072,1072,R-HSA-70350,Fructose catabolism,REACTOME,pathway,PATHWAY_1072 |
| 1073,1073,1073,1073,1073,1073,1073,1073,R-HSA-6794362,Protein-protein interactions at synapses,REACTOME,pathway,PATHWAY_1073 |
| 1074,1074,1074,1074,1074,1074,1074,1074,R-HSA-3595177,Defective CHSY1 causes TPBS,REACTOME,pathway,PATHWAY_1074 |
| 1075,1075,1075,1075,1075,1075,1075,1075,R-HSA-165181,Inhibition of TSC complex formation by PKB,REACTOME,pathway,PATHWAY_1075 |
| 1076,1076,1076,1076,1076,1076,1076,1076,R-HSA-5654708,Downstream signaling of activated FGFR3,REACTOME,pathway,PATHWAY_1076 |
| 1077,1077,1077,1077,1077,1077,1077,1077,R-HSA-110330,Recognition and association of DNA glycosylase with site containing an affected purine,REACTOME,pathway,PATHWAY_1077 |
| 1078,1078,1078,1078,1078,1078,1078,1078,R-HSA-9843745,Adipogenesis,REACTOME,pathway,PATHWAY_1078 |
| 1079,1079,1079,1079,1079,1079,1079,1079,R-HSA-5340588,Signaling by RNF43 mutants,REACTOME,pathway,PATHWAY_1079 |
| 1080,1080,1080,1080,1080,1080,1080,1080,R-HSA-9854909,Regulation of MITF-M dependent genes involved in invasion,REACTOME,pathway,PATHWAY_1080 |
| 1081,1081,1081,1081,1081,1081,1081,1081,R-HSA-5357801,Programmed Cell Death,REACTOME,pathway,PATHWAY_1081 |
| 1082,1082,1082,1082,1082,1082,1082,1082,R-HSA-75072,mRNA Editing,REACTOME,pathway,PATHWAY_1082 |
| 1083,1083,1083,1083,1083,1083,1083,1083,R-HSA-168898,Toll-like Receptor Cascades,REACTOME,pathway,PATHWAY_1083 |
| 1084,1084,1084,1084,1084,1084,1084,1084,R-HSA-5693571,Nonhomologous End-Joining (NHEJ),REACTOME,pathway,PATHWAY_1084 |
| 1085,1085,1085,1085,1085,1085,1085,1085,R-HSA-5579004,Defective CYP26C1 causes FFDD4,REACTOME,pathway,PATHWAY_1085 |
| 1086,1086,1086,1086,1086,1086,1086,1086,R-HSA-6803207,TP53 Regulates Transcription of Caspase Activators and Caspases,REACTOME,pathway,PATHWAY_1086 |
| 1087,1087,1087,1087,1087,1087,1087,1087,R-HSA-69231,Cyclin D associated events in G1,REACTOME,pathway,PATHWAY_1087 |
| 1088,1088,1088,1088,1088,1088,1088,1088,R-HSA-114508,Effects of PIP2 hydrolysis,REACTOME,pathway,PATHWAY_1088 |
| 1089,1089,1089,1089,1089,1089,1089,1089,R-HSA-1855204,Synthesis of IP3 and IP4 in the cytosol,REACTOME,pathway,PATHWAY_1089 |
| 1090,1090,1090,1090,1090,1090,1090,1090,R-HSA-5683057,MAPK family signaling cascades,REACTOME,pathway,PATHWAY_1090 |
| 1091,1091,1091,1091,1091,1091,1091,1091,R-HSA-8875555,MET activates RAP1 and RAC1,REACTOME,pathway,PATHWAY_1091 |
| 1092,1092,1092,1092,1092,1092,1092,1092,R-HSA-9694676,Translation of Replicase and Assembly of the Replication Transcription Complex,REACTOME,pathway,PATHWAY_1092 |
| 1093,1093,1093,1093,1093,1093,1093,1093,R-HSA-1461957,Beta defensins,REACTOME,pathway,PATHWAY_1093 |
| 1094,1094,1094,1094,1094,1094,1094,1094,R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,REACTOME,pathway,PATHWAY_1094 |
| 1095,1095,1095,1095,1095,1095,1095,1095,R-HSA-844615,The AIM2 inflammasome,REACTOME,pathway,PATHWAY_1095 |
| 1096,1096,1096,1096,1096,1096,1096,1096,R-HSA-68884,Mitotic Telophase/Cytokinesis,REACTOME,pathway,PATHWAY_1096 |
| 1097,1097,1097,1097,1097,1097,1097,1097,R-HSA-1251932,PLCG1 events in ERBB2 signaling,REACTOME,pathway,PATHWAY_1097 |
| 1098,1098,1098,1098,1098,1098,1098,1098,R-HSA-186763,Downstream signal transduction,REACTOME,pathway,PATHWAY_1098 |
| 1099,1099,1099,1099,1099,1099,1099,1099,R-HSA-5682113,Defective ABCA1 causes TGD,REACTOME,pathway,PATHWAY_1099 |
| 1100,1100,1100,1100,1100,1100,1100,1100,R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,REACTOME,pathway,PATHWAY_1100 |
| 1101,1101,1101,1101,1101,1101,1101,1101,R-HSA-8849175,Threonine catabolism,REACTOME,pathway,PATHWAY_1101 |
| 1102,1102,1102,1102,1102,1102,1102,1102,R-HSA-948021,Transport to the Golgi and subsequent modification,REACTOME,pathway,PATHWAY_1102 |
| 1103,1103,1103,1103,1103,1103,1103,1103,R-HSA-110312,Translesion synthesis by REV1,REACTOME,pathway,PATHWAY_1103 |
| 1104,1104,1104,1104,1104,1104,1104,1104,R-HSA-163282,Mitochondrial transcription initiation,REACTOME,pathway,PATHWAY_1104 |
| 1105,1105,1105,1105,1105,1105,1105,1105,R-HSA-9694686,Replication of the SARS-CoV-2 genome,REACTOME,pathway,PATHWAY_1105 |
| 1106,1106,1106,1106,1106,1106,1106,1106,R-HSA-159418,Recycling of bile acids and salts,REACTOME,pathway,PATHWAY_1106 |
| 1107,1107,1107,1107,1107,1107,1107,1107,R-HSA-451306,Ionotropic activity of kainate receptors,REACTOME,pathway,PATHWAY_1107 |
| 1108,1108,1108,1108,1108,1108,1108,1108,R-HSA-9672391,Defective F8 cleavage by thrombin,REACTOME,pathway,PATHWAY_1108 |
| 1109,1109,1109,1109,1109,1109,1109,1109,R-HSA-1475029,Reversible hydration of carbon dioxide,REACTOME,pathway,PATHWAY_1109 |
| 1110,1110,1110,1110,1110,1110,1110,1110,R-HSA-9636249,Inhibition of nitric oxide production,REACTOME,pathway,PATHWAY_1110 |
| 1111,1111,1111,1111,1111,1111,1111,1111,R-HSA-192869,cRNA Synthesis,REACTOME,pathway,PATHWAY_1111 |
| 1112,1112,1112,1112,1112,1112,1112,1112,R-HSA-5693568,Resolution of D-loop Structures through Holliday Junction Intermediates,REACTOME,pathway,PATHWAY_1112 |
| 1113,1113,1113,1113,1113,1113,1113,1113,R-HSA-2644607,Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,REACTOME,pathway,PATHWAY_1113 |
| 1114,1114,1114,1114,1114,1114,1114,1114,R-HSA-9912481,Branched-chain ketoacid dehydrogenase kinase deficiency,REACTOME,pathway,PATHWAY_1114 |
| 1115,1115,1115,1115,1115,1115,1115,1115,R-HSA-5619062,Defective SLC1A3 causes episodic ataxia 6 (EA6),REACTOME,pathway,PATHWAY_1115 |
| 1116,1116,1116,1116,1116,1116,1116,1116,R-HSA-5688849,Defective CSF2RB causes SMDP5,REACTOME,pathway,PATHWAY_1116 |
| 1117,1117,1117,1117,1117,1117,1117,1117,R-HSA-6804115,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,REACTOME,pathway,PATHWAY_1117 |
| 1118,1118,1118,1118,1118,1118,1118,1118,R-HSA-9708530,Regulation of BACH1 activity,REACTOME,pathway,PATHWAY_1118 |
| 1119,1119,1119,1119,1119,1119,1119,1119,R-HSA-193634,Axonal growth inhibition (RHOA activation),REACTOME,pathway,PATHWAY_1119 |
| 1120,1120,1120,1120,1120,1120,1120,1120,R-HSA-9841251,Mitochondrial unfolded protein response (UPRmt),REACTOME,pathway,PATHWAY_1120 |
| 1121,1121,1121,1121,1121,1121,1121,1121,R-HSA-9911233,Expression of NOTCH2NL genes,REACTOME,pathway,PATHWAY_1121 |
| 1122,1122,1122,1122,1122,1122,1122,1122,R-HSA-9646304,Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects,REACTOME,pathway,PATHWAY_1122 |
| 1123,1123,1123,1123,1123,1123,1123,1123,R-HSA-4641257,Degradation of AXIN,REACTOME,pathway,PATHWAY_1123 |
| 1124,1124,1124,1124,1124,1124,1124,1124,R-HSA-4085023,Defective GFPT1 causes CMSTA1,REACTOME,pathway,PATHWAY_1124 |
| 1125,1125,1125,1125,1125,1125,1125,1125,R-HSA-1660508,PIPs transport between late endosome and Golgi membranes,REACTOME,pathway,PATHWAY_1125 |
| 1126,1126,1126,1126,1126,1126,1126,1126,R-HSA-110373,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,REACTOME,pathway,PATHWAY_1126 |
| 1127,1127,1127,1127,1127,1127,1127,1127,R-HSA-6804114,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,REACTOME,pathway,PATHWAY_1127 |
| 1128,1128,1128,1128,1128,1128,1128,1128,R-HSA-9006925,Intracellular signaling by second messengers,REACTOME,pathway,PATHWAY_1128 |
| 1129,1129,1129,1129,1129,1129,1129,1129,R-HSA-933542,TRAF6 mediated NF-kB activation,REACTOME,pathway,PATHWAY_1129 |
| 1130,1130,1130,1130,1130,1130,1130,1130,R-HSA-6791465,Pentose phosphate pathway disease,REACTOME,pathway,PATHWAY_1130 |
| 1131,1131,1131,1131,1131,1131,1131,1131,R-HSA-9709603,Impaired BRCA2 binding to PALB2,REACTOME,pathway,PATHWAY_1131 |
| 1132,1132,1132,1132,1132,1132,1132,1132,R-HSA-9673324,WNT5:FZD7-mediated leishmania damping,REACTOME,pathway,PATHWAY_1132 |
| 1133,1133,1133,1133,1133,1133,1133,1133,R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,REACTOME,pathway,PATHWAY_1133 |
| 1134,1134,1134,1134,1134,1134,1134,1134,R-HSA-9843940,Regulation of endogenous retroelements by KRAB-ZFP proteins,REACTOME,pathway,PATHWAY_1134 |
| 1135,1135,1135,1135,1135,1135,1135,1135,R-HSA-198765,Signalling to ERK5,REACTOME,pathway,PATHWAY_1135 |
| 1136,1136,1136,1136,1136,1136,1136,1136,R-HSA-77075,RNA Pol II CTD phosphorylation and interaction with CE,REACTOME,pathway,PATHWAY_1136 |
| 1137,1137,1137,1137,1137,1137,1137,1137,R-HSA-73780,RNA Polymerase III Chain Elongation,REACTOME,pathway,PATHWAY_1137 |
| 1138,1138,1138,1138,1138,1138,1138,1138,R-HSA-8963678,Intestinal lipid absorption,REACTOME,pathway,PATHWAY_1138 |
| 1139,1139,1139,1139,1139,1139,1139,1139,R-HSA-3656225,Defective CHST6 causes MCDC1,REACTOME,pathway,PATHWAY_1139 |
| 1140,1140,1140,1140,1140,1140,1140,1140,R-HSA-9750126,Drug-induced formation of DNA interstrand crosslinks,REACTOME,pathway,PATHWAY_1140 |
| 1141,1141,1141,1141,1141,1141,1141,1141,R-HSA-5340573,LGK974 inhibits PORCN,REACTOME,pathway,PATHWAY_1141 |
| 1142,1142,1142,1142,1142,1142,1142,1142,R-HSA-9670095,Inhibition of DNA recombination at telomere,REACTOME,pathway,PATHWAY_1142 |
| 1143,1143,1143,1143,1143,1143,1143,1143,R-HSA-5579026,Defective CYP11A1 causes AICSR,REACTOME,pathway,PATHWAY_1143 |
| 1144,1144,1144,1144,1144,1144,1144,1144,R-HSA-5576894,Phase 1 - inactivation of fast Na+ channels,REACTOME,pathway,PATHWAY_1144 |
| 1145,1145,1145,1145,1145,1145,1145,1145,R-HSA-190377,FGFR2b ligand binding and activation,REACTOME,pathway,PATHWAY_1145 |
| 1146,1146,1146,1146,1146,1146,1146,1146,R-HSA-180746,Nuclear import of Rev protein,REACTOME,pathway,PATHWAY_1146 |
| 1147,1147,1147,1147,1147,1147,1147,1147,R-HSA-2206292,MPS VII - Sly syndrome,REACTOME,pathway,PATHWAY_1147 |
| 1148,1148,1148,1148,1148,1148,1148,1148,R-HSA-1483148,Synthesis of PG,REACTOME,pathway,PATHWAY_1148 |
| 1149,1149,1149,1149,1149,1149,1149,1149,R-HSA-5578995,Defective TPMT causes TPMT deficiency,REACTOME,pathway,PATHWAY_1149 |
| 1150,1150,1150,1150,1150,1150,1150,1150,R-HSA-9727281,Translation of Accessory Proteins,REACTOME,pathway,PATHWAY_1150 |
| 1151,1151,1151,1151,1151,1151,1151,1151,R-HSA-167158,Formation of the HIV-1 Early Elongation Complex,REACTOME,pathway,PATHWAY_1151 |
| 1152,1152,1152,1152,1152,1152,1152,1152,R-HSA-163359,Glucagon signaling in metabolic regulation,REACTOME,pathway,PATHWAY_1152 |
| 1153,1153,1153,1153,1153,1153,1153,1153,R-HSA-1963642,PI3K events in ERBB2 signaling,REACTOME,pathway,PATHWAY_1153 |
| 1154,1154,1154,1154,1154,1154,1154,1154,R-HSA-9818749,Regulation of NFE2L2 gene expression,REACTOME,pathway,PATHWAY_1154 |
| 1155,1155,1155,1155,1155,1155,1155,1155,R-HSA-110329,Cleavage of the damaged pyrimidine ,REACTOME,pathway,PATHWAY_1155 |
| 1156,1156,1156,1156,1156,1156,1156,1156,R-HSA-9635644,Inhibition of membrane repair,REACTOME,pathway,PATHWAY_1156 |
| 1157,1157,1157,1157,1157,1157,1157,1157,R-HSA-9694493,Maturation of protein E,REACTOME,pathway,PATHWAY_1157 |
| 1158,1158,1158,1158,1158,1158,1158,1158,R-HSA-9029569,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,REACTOME,pathway,PATHWAY_1158 |
| 1159,1159,1159,1159,1159,1159,1159,1159,R-HSA-8963889,Assembly of active LPL and LIPC lipase complexes,REACTOME,pathway,PATHWAY_1159 |
| 1160,1160,1160,1160,1160,1160,1160,1160,R-HSA-9748787,Azathioprine ADME,REACTOME,pathway,PATHWAY_1160 |
| 1161,1161,1161,1161,1161,1161,1161,1161,R-HSA-9680350,Signaling by CSF1 (M-CSF) in myeloid cells,REACTOME,pathway,PATHWAY_1161 |
| 1162,1162,1162,1162,1162,1162,1162,1162,R-HSA-209563,Axonal growth stimulation,REACTOME,pathway,PATHWAY_1162 |
| 1163,1163,1163,1163,1163,1163,1163,1163,R-HSA-428543,Inactivation of CDC42 and RAC1,REACTOME,pathway,PATHWAY_1163 |
| 1164,1164,1164,1164,1164,1164,1164,1164,R-HSA-75205,Dissolution of Fibrin Clot,REACTOME,pathway,PATHWAY_1164 |
| 1165,1165,1165,1165,1165,1165,1165,1165,R-HSA-399956,CRMPs in Sema3A signaling,REACTOME,pathway,PATHWAY_1165 |
| 1166,1166,1166,1166,1166,1166,1166,1166,R-HSA-9027283,Erythropoietin activates STAT5,REACTOME,pathway,PATHWAY_1166 |
| 1167,1167,1167,1167,1167,1167,1167,1167,R-HSA-9665230,Drug resistance in ERBB2 KD mutants,REACTOME,pathway,PATHWAY_1167 |
| 1168,1168,1168,1168,1168,1168,1168,1168,R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,REACTOME,pathway,PATHWAY_1168 |
| 1169,1169,1169,1169,1169,1169,1169,1169,R-HSA-5661231,Metallothioneins bind metals,REACTOME,pathway,PATHWAY_1169 |
| 1170,1170,1170,1170,1170,1170,1170,1170,R-HSA-264876,Insulin processing,REACTOME,pathway,PATHWAY_1170 |
| 1171,1171,1171,1171,1171,1171,1171,1171,R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,REACTOME,pathway,PATHWAY_1171 |
| 1172,1172,1172,1172,1172,1172,1172,1172,R-HSA-8941858,Regulation of RUNX3 expression and activity,REACTOME,pathway,PATHWAY_1172 |
| 1173,1173,1173,1173,1173,1173,1173,1173,R-HSA-9700206,Signaling by ALK in cancer,REACTOME,pathway,PATHWAY_1173 |
| 1174,1174,1174,1174,1174,1174,1174,1174,R-HSA-2564830,Cytosolic iron-sulfur cluster assembly,REACTOME,pathway,PATHWAY_1174 |
| 1175,1175,1175,1175,1175,1175,1175,1175,R-HSA-173623,Classical antibody-mediated complement activation,REACTOME,pathway,PATHWAY_1175 |
| 1176,1176,1176,1176,1176,1176,1176,1176,R-HSA-167290,Pausing and recovery of HIV elongation,REACTOME,pathway,PATHWAY_1176 |
| 1177,1177,1177,1177,1177,1177,1177,1177,R-HSA-2033519,Activated point mutants of FGFR2,REACTOME,pathway,PATHWAY_1177 |
| 1178,1178,1178,1178,1178,1178,1178,1178,R-HSA-444209,Free fatty acid receptors,REACTOME,pathway,PATHWAY_1178 |
| 1179,1179,1179,1179,1179,1179,1179,1179,R-HSA-76009,Platelet Aggregation (Plug Formation),REACTOME,pathway,PATHWAY_1179 |
| 1180,1180,1180,1180,1180,1180,1180,1180,R-HSA-9824856,Defective regulation of TLR7 by endogenous ligand,REACTOME,pathway,PATHWAY_1180 |
| 1181,1181,1181,1181,1181,1181,1181,1181,R-HSA-75892,Platelet Adhesion to exposed collagen,REACTOME,pathway,PATHWAY_1181 |
| 1182,1182,1182,1182,1182,1182,1182,1182,R-HSA-187015,Activation of TRKA receptors,REACTOME,pathway,PATHWAY_1182 |
| 1183,1183,1183,1183,1183,1183,1183,1183,R-HSA-9022538,Loss of MECP2 binding ability to 5mC-DNA,REACTOME,pathway,PATHWAY_1183 |
| 1184,1184,1184,1184,1184,1184,1184,1184,R-HSA-202424,Downstream TCR signaling,REACTOME,pathway,PATHWAY_1184 |
| 1185,1185,1185,1185,1185,1185,1185,1185,R-HSA-4793954,Defective MOGS causes CDG-2b,REACTOME,pathway,PATHWAY_1185 |
| 1186,1186,1186,1186,1186,1186,1186,1186,R-HSA-1839126,FGFR2 mutant receptor activation,REACTOME,pathway,PATHWAY_1186 |
| 1187,1187,1187,1187,1187,1187,1187,1187,R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,REACTOME,pathway,PATHWAY_1187 |
| 1188,1188,1188,1188,1188,1188,1188,1188,R-HSA-9916720,Mitochondrial short-chain enoyl-CoA hydratase deficiency 1,REACTOME,pathway,PATHWAY_1188 |
| 1189,1189,1189,1189,1189,1189,1189,1189,R-HSA-9682708,Transcription of SARS-CoV-1 sgRNAs,REACTOME,pathway,PATHWAY_1189 |
| 1190,1190,1190,1190,1190,1190,1190,1190,R-HSA-139915,Activation of PUMA and translocation to mitochondria,REACTOME,pathway,PATHWAY_1190 |
| 1191,1191,1191,1191,1191,1191,1191,1191,R-HSA-9753281,Paracetamol ADME,REACTOME,pathway,PATHWAY_1191 |
| 1192,1192,1192,1192,1192,1192,1192,1192,R-HSA-5579017,Defective CYP11B1 causes AH4,REACTOME,pathway,PATHWAY_1192 |
| 1193,1193,1193,1193,1193,1193,1193,1193,R-HSA-9772755,Formation of WDR5-containing histone-modifying complexes,REACTOME,pathway,PATHWAY_1193 |
| 1194,1194,1194,1194,1194,1194,1194,1194,R-HSA-5368286,Mitochondrial translation initiation,REACTOME,pathway,PATHWAY_1194 |
| 1195,1195,1195,1195,1195,1195,1195,1195,R-HSA-3134973,LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,REACTOME,pathway,PATHWAY_1195 |
| 1196,1196,1196,1196,1196,1196,1196,1196,R-HSA-177504,Retrograde neurotrophin signalling,REACTOME,pathway,PATHWAY_1196 |
| 1197,1197,1197,1197,1197,1197,1197,1197,R-HSA-427975,Proton/oligopeptide cotransporters,REACTOME,pathway,PATHWAY_1197 |
| 1198,1198,1198,1198,1198,1198,1198,1198,R-HSA-450385,Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,REACTOME,pathway,PATHWAY_1198 |
| 1199,1199,1199,1199,1199,1199,1199,1199,R-HSA-5467343,Deletions in the AMER1 gene destabilize the destruction complex,REACTOME,pathway,PATHWAY_1199 |
| 1200,1200,1200,1200,1200,1200,1200,1200,R-HSA-193775,Synthesis of bile acids and bile salts via 24-hydroxycholesterol,REACTOME,pathway,PATHWAY_1200 |
| 1201,1201,1201,1201,1201,1201,1201,1201,R-HSA-5250981,Toxicity of botulinum toxin type F (botF),REACTOME,pathway,PATHWAY_1201 |
| 1202,1202,1202,1202,1202,1202,1202,1202,R-HSA-2168880,Scavenging of heme from plasma,REACTOME,pathway,PATHWAY_1202 |
| 1203,1203,1203,1203,1203,1203,1203,1203,R-HSA-6804756,Regulation of TP53 Activity through Phosphorylation,REACTOME,pathway,PATHWAY_1203 |
| 1204,1204,1204,1204,1204,1204,1204,1204,R-HSA-8964026,Chylomicron clearance,REACTOME,pathway,PATHWAY_1204 |
| 1205,1205,1205,1205,1205,1205,1205,1205,R-HSA-390471,Association of TriC/CCT with target proteins during biosynthesis,REACTOME,pathway,PATHWAY_1205 |
| 1206,1206,1206,1206,1206,1206,1206,1206,R-HSA-3304351,Signaling by TGF-beta Receptor Complex in Cancer,REACTOME,pathway,PATHWAY_1206 |
| 1207,1207,1207,1207,1207,1207,1207,1207,R-HSA-452723,Transcriptional regulation of pluripotent stem cells,REACTOME,pathway,PATHWAY_1207 |
| 1208,1208,1208,1208,1208,1208,1208,1208,R-HSA-429914,Deadenylation-dependent mRNA decay,REACTOME,pathway,PATHWAY_1208 |
| 1209,1209,1209,1209,1209,1209,1209,1209,R-HSA-202403,TCR signaling,REACTOME,pathway,PATHWAY_1209 |
| 1210,1210,1210,1210,1210,1210,1210,1210,R-HSA-350864,Regulation of thyroid hormone activity,REACTOME,pathway,PATHWAY_1210 |
| 1211,1211,1211,1211,1211,1211,1211,1211,R-HSA-5603037,IRAK4 deficiency (TLR5),REACTOME,pathway,PATHWAY_1211 |
| 1212,1212,1212,1212,1212,1212,1212,1212,R-HSA-5663020,Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),REACTOME,pathway,PATHWAY_1212 |
| 1213,1213,1213,1213,1213,1213,1213,1213,R-HSA-9818028,NFE2L2 regulates pentose phosphate pathway genes,REACTOME,pathway,PATHWAY_1213 |
| 1214,1214,1214,1214,1214,1214,1214,1214,R-HSA-1638074,Keratan sulfate/keratin metabolism,REACTOME,pathway,PATHWAY_1214 |
| 1215,1215,1215,1215,1215,1215,1215,1215,R-HSA-5140745,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",REACTOME,pathway,PATHWAY_1215 |
| 1216,1216,1216,1216,1216,1216,1216,1216,R-HSA-9013508,NOTCH3 Intracellular Domain Regulates Transcription,REACTOME,pathway,PATHWAY_1216 |
| 1217,1217,1217,1217,1217,1217,1217,1217,R-HSA-399997,Acetylcholine regulates insulin secretion,REACTOME,pathway,PATHWAY_1217 |
| 1218,1218,1218,1218,1218,1218,1218,1218,R-HSA-4411364,Binding of TCF/LEF:CTNNB1 to target gene promoters,REACTOME,pathway,PATHWAY_1218 |
| 1219,1219,1219,1219,1219,1219,1219,1219,R-HSA-392517,Rap1 signalling,REACTOME,pathway,PATHWAY_1219 |
| 1220,1220,1220,1220,1220,1220,1220,1220,R-HSA-5389840,Mitochondrial translation elongation,REACTOME,pathway,PATHWAY_1220 |
| 1221,1221,1221,1221,1221,1221,1221,1221,R-HSA-71336,Pentose phosphate pathway,REACTOME,pathway,PATHWAY_1221 |
| 1222,1222,1222,1222,1222,1222,1222,1222,R-HSA-200425,Carnitine shuttle,REACTOME,pathway,PATHWAY_1222 |
| 1223,1223,1223,1223,1223,1223,1223,1223,R-HSA-9674404,Sorafenib-resistant PDGFR mutants,REACTOME,pathway,PATHWAY_1223 |
| 1224,1224,1224,1224,1224,1224,1224,1224,R-HSA-3249367,STAT6-mediated induction of chemokines,REACTOME,pathway,PATHWAY_1224 |
| 1225,1225,1225,1225,1225,1225,1225,1225,R-HSA-9674403,Regorafenib-resistant PDGFR mutants,REACTOME,pathway,PATHWAY_1225 |
| 1226,1226,1226,1226,1226,1226,1226,1226,R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,REACTOME,pathway,PATHWAY_1226 |
| 1227,1227,1227,1227,1227,1227,1227,1227,R-HSA-198693,AKT phosphorylates targets in the nucleus,REACTOME,pathway,PATHWAY_1227 |
| 1228,1228,1228,1228,1228,1228,1228,1228,R-HSA-5696394,DNA Damage Recognition in GG-NER,REACTOME,pathway,PATHWAY_1228 |
| 1229,1229,1229,1229,1229,1229,1229,1229,R-HSA-917729,Endosomal Sorting Complex Required For Transport (ESCRT),REACTOME,pathway,PATHWAY_1229 |
| 1230,1230,1230,1230,1230,1230,1230,1230,R-HSA-5689896,Ovarian tumor domain proteases,REACTOME,pathway,PATHWAY_1230 |
| 1231,1231,1231,1231,1231,1231,1231,1231,R-HSA-9768919,NPAS4 regulates expression of target genes,REACTOME,pathway,PATHWAY_1231 |
| 1232,1232,1232,1232,1232,1232,1232,1232,R-HSA-9617324,Negative regulation of NMDA receptor-mediated neuronal transmission,REACTOME,pathway,PATHWAY_1232 |
| 1233,1233,1233,1233,1233,1233,1233,1233,R-HSA-913531,Interferon Signaling,REACTOME,pathway,PATHWAY_1233 |
| 1234,1234,1234,1234,1234,1234,1234,1234,R-HSA-167238,Pausing and recovery of Tat-mediated HIV elongation,REACTOME,pathway,PATHWAY_1234 |
| 1235,1235,1235,1235,1235,1235,1235,1235,R-HSA-5619046,Defective SLC26A4 causes Pendred syndrome (PDS),REACTOME,pathway,PATHWAY_1235 |
| 1236,1236,1236,1236,1236,1236,1236,1236,R-HSA-194068,Bile acid and bile salt metabolism,REACTOME,pathway,PATHWAY_1236 |
| 1237,1237,1237,1237,1237,1237,1237,1237,R-HSA-390466,Chaperonin-mediated protein folding,REACTOME,pathway,PATHWAY_1237 |
| 1238,1238,1238,1238,1238,1238,1238,1238,R-HSA-937061,TRIF (TICAM1)-mediated TLR4 signaling ,REACTOME,pathway,PATHWAY_1238 |
| 1239,1239,1239,1239,1239,1239,1239,1239,R-HSA-8986944,Transcriptional Regulation by MECP2,REACTOME,pathway,PATHWAY_1239 |
| 1240,1240,1240,1240,1240,1240,1240,1240,R-HSA-9616334,Defective Base Excision Repair Associated with NEIL1,REACTOME,pathway,PATHWAY_1240 |
| 1241,1241,1241,1241,1241,1241,1241,1241,R-HSA-5578999,Defective GCLC causes HAGGSD,REACTOME,pathway,PATHWAY_1241 |
| 1242,1242,1242,1242,1242,1242,1242,1242,R-HSA-211000,Gene Silencing by RNA,REACTOME,pathway,PATHWAY_1242 |
| 1243,1243,1243,1243,1243,1243,1243,1243,R-HSA-2173789,TGF-beta receptor signaling activates SMADs,REACTOME,pathway,PATHWAY_1243 |
| 1244,1244,1244,1244,1244,1244,1244,1244,R-HSA-9702596,lestaurtinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_1244 |
| 1245,1245,1245,1245,1245,1245,1245,1245,R-HSA-5654687,Downstream signaling of activated FGFR1,REACTOME,pathway,PATHWAY_1245 |
| 1246,1246,1246,1246,1246,1246,1246,1246,R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,REACTOME,pathway,PATHWAY_1246 |
| 1247,1247,1247,1247,1247,1247,1247,1247,R-HSA-983712,Ion channel transport,REACTOME,pathway,PATHWAY_1247 |
| 1248,1248,1248,1248,1248,1248,1248,1248,R-HSA-72737,Cap-dependent Translation Initiation,REACTOME,pathway,PATHWAY_1248 |
| 1249,1249,1249,1249,1249,1249,1249,1249,R-HSA-9705677,SARS-CoV-2 targets PDZ proteins in cell-cell junction,REACTOME,pathway,PATHWAY_1249 |
| 1250,1250,1250,1250,1250,1250,1250,1250,R-HSA-9861718,Regulation of pyruvate metabolism,REACTOME,pathway,PATHWAY_1250 |
| 1251,1251,1251,1251,1251,1251,1251,1251,R-HSA-5339717,Signaling by LRP5 mutants ,REACTOME,pathway,PATHWAY_1251 |
| 1252,1252,1252,1252,1252,1252,1252,1252,R-HSA-9022702,MECP2 regulates transcription of neuronal ligands,REACTOME,pathway,PATHWAY_1252 |
| 1253,1253,1253,1253,1253,1253,1253,1253,R-HSA-379716,Cytosolic tRNA aminoacylation,REACTOME,pathway,PATHWAY_1253 |
| 1254,1254,1254,1254,1254,1254,1254,1254,R-HSA-426117,Cation-coupled Chloride cotransporters,REACTOME,pathway,PATHWAY_1254 |
| 1255,1255,1255,1255,1255,1255,1255,1255,R-HSA-6811438,Intra-Golgi traffic,REACTOME,pathway,PATHWAY_1255 |
| 1256,1256,1256,1256,1256,1256,1256,1256,R-HSA-6802957,Oncogenic MAPK signaling,REACTOME,pathway,PATHWAY_1256 |
| 1257,1257,1257,1257,1257,1257,1257,1257,R-HSA-446353,Cell-extracellular matrix interactions,REACTOME,pathway,PATHWAY_1257 |
| 1258,1258,1258,1258,1258,1258,1258,1258,R-HSA-167044,Signalling to RAS,REACTOME,pathway,PATHWAY_1258 |
| 1259,1259,1259,1259,1259,1259,1259,1259,R-HSA-69109,Leading Strand Synthesis,REACTOME,pathway,PATHWAY_1259 |
| 1260,1260,1260,1260,1260,1260,1260,1260,R-HSA-166786,Creation of C4 and C2 activators,REACTOME,pathway,PATHWAY_1260 |
| 1261,1261,1261,1261,1261,1261,1261,1261,R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,REACTOME,pathway,PATHWAY_1261 |
| 1262,1262,1262,1262,1262,1262,1262,1262,R-HSA-9816359,Maternal to zygotic transition (MZT),REACTOME,pathway,PATHWAY_1262 |
| 1263,1263,1263,1263,1263,1263,1263,1263,R-HSA-3928663,EPHA-mediated growth cone collapse,REACTOME,pathway,PATHWAY_1263 |
| 1264,1264,1264,1264,1264,1264,1264,1264,R-HSA-9664424,Cell recruitment (pro-inflammatory response),REACTOME,pathway,PATHWAY_1264 |
| 1265,1265,1265,1265,1265,1265,1265,1265,R-HSA-211736,Stimulation of the cell death response by PAK-2p34,REACTOME,pathway,PATHWAY_1265 |
| 1266,1266,1266,1266,1266,1266,1266,1266,R-HSA-202433,Generation of second messenger molecules,REACTOME,pathway,PATHWAY_1266 |
| 1267,1267,1267,1267,1267,1267,1267,1267,R-HSA-5368287,Mitochondrial translation,REACTOME,pathway,PATHWAY_1267 |
| 1268,1268,1268,1268,1268,1268,1268,1268,R-HSA-9026527,Activated NTRK2 signals through PLCG1,REACTOME,pathway,PATHWAY_1268 |
| 1269,1269,1269,1269,1269,1269,1269,1269,R-HSA-9027276,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),REACTOME,pathway,PATHWAY_1269 |
| 1270,1270,1270,1270,1270,1270,1270,1270,R-HSA-5619050,"Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)",REACTOME,pathway,PATHWAY_1270 |
| 1271,1271,1271,1271,1271,1271,1271,1271,R-HSA-9022535,Loss of phosphorylation of MECP2 at T308,REACTOME,pathway,PATHWAY_1271 |
| 1272,1272,1272,1272,1272,1272,1272,1272,R-HSA-5336415,Uptake and function of diphtheria toxin,REACTOME,pathway,PATHWAY_1272 |
| 1273,1273,1273,1273,1273,1273,1273,1273,R-HSA-418990,Adherens junctions interactions,REACTOME,pathway,PATHWAY_1273 |
| 1274,1274,1274,1274,1274,1274,1274,1274,R-HSA-1250347,SHC1 events in ERBB4 signaling,REACTOME,pathway,PATHWAY_1274 |
| 1275,1275,1275,1275,1275,1275,1275,1275,R-HSA-6802953,RAS signaling downstream of NF1 loss-of-function variants,REACTOME,pathway,PATHWAY_1275 |
| 1276,1276,1276,1276,1276,1276,1276,1276,R-HSA-9667769,Acetylcholine inhibits contraction of outer hair cells,REACTOME,pathway,PATHWAY_1276 |
| 1277,1277,1277,1277,1277,1277,1277,1277,R-HSA-198725,Nuclear Events (kinase and transcription factor activation),REACTOME,pathway,PATHWAY_1277 |
| 1278,1278,1278,1278,1278,1278,1278,1278,R-HSA-9612973,Autophagy,REACTOME,pathway,PATHWAY_1278 |
| 1279,1279,1279,1279,1279,1279,1279,1279,R-HSA-5625740,RHO GTPases activate PKNs,REACTOME,pathway,PATHWAY_1279 |
| 1280,1280,1280,1280,1280,1280,1280,1280,R-HSA-1299316,TWIK-releated acid-sensitive K+ channel (TASK),REACTOME,pathway,PATHWAY_1280 |
| 1281,1281,1281,1281,1281,1281,1281,1281,R-HSA-4090294,SUMOylation of intracellular receptors,REACTOME,pathway,PATHWAY_1281 |
| 1282,1282,1282,1282,1282,1282,1282,1282,R-HSA-212676,Dopamine Neurotransmitter Release Cycle,REACTOME,pathway,PATHWAY_1282 |
| 1283,1283,1283,1283,1283,1283,1283,1283,R-HSA-2559583,Cellular Senescence,REACTOME,pathway,PATHWAY_1283 |
| 1284,1284,1284,1284,1284,1284,1284,1284,R-HSA-71403,Citric acid cycle (TCA cycle),REACTOME,pathway,PATHWAY_1284 |
| 1285,1285,1285,1285,1285,1285,1285,1285,R-HSA-5467337,APC truncation mutants have impaired AXIN binding,REACTOME,pathway,PATHWAY_1285 |
| 1286,1286,1286,1286,1286,1286,1286,1286,R-HSA-8876493,InlA-mediated entry of Listeria monocytogenes into host cells,REACTOME,pathway,PATHWAY_1286 |
| 1287,1287,1287,1287,1287,1287,1287,1287,R-HSA-983189,Kinesins,REACTOME,pathway,PATHWAY_1287 |
| 1288,1288,1288,1288,1288,1288,1288,1288,R-HSA-3134963,DEx/H-box helicases activate type I IFN and inflammatory cytokines production ,REACTOME,pathway,PATHWAY_1288 |
| 1289,1289,1289,1289,1289,1289,1289,1289,R-HSA-9020558,Interleukin-2 signaling,REACTOME,pathway,PATHWAY_1289 |
| 1290,1290,1290,1290,1290,1290,1290,1290,R-HSA-9656255,Defective OGG1 Substrate Binding,REACTOME,pathway,PATHWAY_1290 |
| 1291,1291,1291,1291,1291,1291,1291,1291,R-HSA-1442490,Collagen degradation,REACTOME,pathway,PATHWAY_1291 |
| 1292,1292,1292,1292,1292,1292,1292,1292,R-HSA-1247673,Erythrocytes take up oxygen and release carbon dioxide,REACTOME,pathway,PATHWAY_1292 |
| 1293,1293,1293,1293,1293,1293,1293,1293,R-HSA-2980766,Nuclear Envelope Breakdown,REACTOME,pathway,PATHWAY_1293 |
| 1294,1294,1294,1294,1294,1294,1294,1294,R-HSA-73817,Purine ribonucleoside monophosphate biosynthesis,REACTOME,pathway,PATHWAY_1294 |
| 1295,1295,1295,1295,1295,1295,1295,1295,R-HSA-2206307,MPS IIIA - Sanfilippo syndrome A,REACTOME,pathway,PATHWAY_1295 |
| 1296,1296,1296,1296,1296,1296,1296,1296,R-HSA-73779,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,REACTOME,pathway,PATHWAY_1296 |
| 1297,1297,1297,1297,1297,1297,1297,1297,R-HSA-5357905,Regulation of TNFR1 signaling,REACTOME,pathway,PATHWAY_1297 |
| 1298,1298,1298,1298,1298,1298,1298,1298,R-HSA-112043,PLC beta mediated events,REACTOME,pathway,PATHWAY_1298 |
| 1299,1299,1299,1299,1299,1299,1299,1299,R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,REACTOME,pathway,PATHWAY_1299 |
| 1300,1300,1300,1300,1300,1300,1300,1300,R-HSA-111447,Activation of BAD and translocation to mitochondria ,REACTOME,pathway,PATHWAY_1300 |
| 1301,1301,1301,1301,1301,1301,1301,1301,R-HSA-446652,Interleukin-1 family signaling,REACTOME,pathway,PATHWAY_1301 |
| 1302,1302,1302,1302,1302,1302,1302,1302,R-HSA-72306,tRNA processing,REACTOME,pathway,PATHWAY_1302 |
| 1303,1303,1303,1303,1303,1303,1303,1303,R-HSA-9632700,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,REACTOME,pathway,PATHWAY_1303 |
| 1304,1304,1304,1304,1304,1304,1304,1304,R-HSA-399721,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",REACTOME,pathway,PATHWAY_1304 |
| 1305,1305,1305,1305,1305,1305,1305,1305,R-HSA-2029481,FCGR activation,REACTOME,pathway,PATHWAY_1305 |
| 1306,1306,1306,1306,1306,1306,1306,1306,R-HSA-379724,tRNA Aminoacylation,REACTOME,pathway,PATHWAY_1306 |
| 1307,1307,1307,1307,1307,1307,1307,1307,R-HSA-73856,RNA Polymerase II Transcription Termination,REACTOME,pathway,PATHWAY_1307 |
| 1308,1308,1308,1308,1308,1308,1308,1308,R-HSA-205043,NRIF signals cell death from the nucleus,REACTOME,pathway,PATHWAY_1308 |
| 1309,1309,1309,1309,1309,1309,1309,1309,R-HSA-389513,Co-inhibition by CTLA4,REACTOME,pathway,PATHWAY_1309 |
| 1310,1310,1310,1310,1310,1310,1310,1310,R-HSA-112313,Neurotransmitter uptake and metabolism In glial cells,REACTOME,pathway,PATHWAY_1310 |
| 1311,1311,1311,1311,1311,1311,1311,1311,R-HSA-8951911,RUNX3 regulates RUNX1-mediated transcription,REACTOME,pathway,PATHWAY_1311 |
| 1312,1312,1312,1312,1312,1312,1312,1312,R-HSA-5609978,Defective GALT can cause GALCT,REACTOME,pathway,PATHWAY_1312 |
| 1313,1313,1313,1313,1313,1313,1313,1313,R-HSA-1855183,"Synthesis of IP2, IP, and Ins in the cytosol",REACTOME,pathway,PATHWAY_1313 |
| 1314,1314,1314,1314,1314,1314,1314,1314,R-HSA-6782135,Dual incision in TC-NER,REACTOME,pathway,PATHWAY_1314 |
| 1315,1315,1315,1315,1315,1315,1315,1315,R-HSA-5607764,CLEC7A (Dectin-1) signaling,REACTOME,pathway,PATHWAY_1315 |
| 1316,1316,1316,1316,1316,1316,1316,1316,R-HSA-1989781,PPARA activates gene expression,REACTOME,pathway,PATHWAY_1316 |
| 1317,1317,1317,1317,1317,1317,1317,1317,R-HSA-5649702,APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,REACTOME,pathway,PATHWAY_1317 |
| 1318,1318,1318,1318,1318,1318,1318,1318,R-HSA-5678520,Defective ABCB11 causes PFIC2 and BRIC2,REACTOME,pathway,PATHWAY_1318 |
| 1319,1319,1319,1319,1319,1319,1319,1319,R-HSA-9630222,Defective NTHL1 substrate binding,REACTOME,pathway,PATHWAY_1319 |
| 1320,1320,1320,1320,1320,1320,1320,1320,R-HSA-8964616,G beta:gamma signalling through CDC42,REACTOME,pathway,PATHWAY_1320 |
| 1321,1321,1321,1321,1321,1321,1321,1321,R-HSA-3656534,Loss of Function of TGFBR1 in Cancer,REACTOME,pathway,PATHWAY_1321 |
| 1322,1322,1322,1322,1322,1322,1322,1322,R-HSA-1660499,Synthesis of PIPs at the plasma membrane,REACTOME,pathway,PATHWAY_1322 |
| 1323,1323,1323,1323,1323,1323,1323,1323,R-HSA-3311021,SMAD4 MH2 Domain Mutants in Cancer,REACTOME,pathway,PATHWAY_1323 |
| 1324,1324,1324,1324,1324,1324,1324,1324,R-HSA-9827857,Specification of primordial germ cells,REACTOME,pathway,PATHWAY_1324 |
| 1325,1325,1325,1325,1325,1325,1325,1325,R-HSA-1502540,Signaling by Activin,REACTOME,pathway,PATHWAY_1325 |
| 1326,1326,1326,1326,1326,1326,1326,1326,R-HSA-1234158,Regulation of gene expression by Hypoxia-inducible Factor,REACTOME,pathway,PATHWAY_1326 |
| 1327,1327,1327,1327,1327,1327,1327,1327,R-HSA-5619079,Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,REACTOME,pathway,PATHWAY_1327 |
| 1328,1328,1328,1328,1328,1328,1328,1328,R-HSA-74182,Ketone body metabolism,REACTOME,pathway,PATHWAY_1328 |
| 1329,1329,1329,1329,1329,1329,1329,1329,R-HSA-8849472,PTK6 Down-Regulation,REACTOME,pathway,PATHWAY_1329 |
| 1330,1330,1330,1330,1330,1330,1330,1330,R-HSA-425410,Metal ion SLC transporters,REACTOME,pathway,PATHWAY_1330 |
| 1331,1331,1331,1331,1331,1331,1331,1331,R-HSA-9646303,Evasion of Oncogene Induced Senescence Due to p14ARF Defects,REACTOME,pathway,PATHWAY_1331 |
| 1332,1332,1332,1332,1332,1332,1332,1332,R-HSA-3828062,Glycogen storage disease type 0 (muscle GYS1),REACTOME,pathway,PATHWAY_1332 |
| 1333,1333,1333,1333,1333,1333,1333,1333,R-HSA-9645722,Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function,REACTOME,pathway,PATHWAY_1333 |
| 1334,1334,1334,1334,1334,1334,1334,1334,R-HSA-9839394,TGFBR3 expression,REACTOME,pathway,PATHWAY_1334 |
| 1335,1335,1335,1335,1335,1335,1335,1335,R-HSA-9635465,Suppression of apoptosis,REACTOME,pathway,PATHWAY_1335 |
| 1336,1336,1336,1336,1336,1336,1336,1336,R-HSA-6799990,Metal sequestration by antimicrobial proteins,REACTOME,pathway,PATHWAY_1336 |
| 1337,1337,1337,1337,1337,1337,1337,1337,R-HSA-9694786,Transcription of SARS-CoV-2 sgRNAs,REACTOME,pathway,PATHWAY_1337 |
| 1338,1338,1338,1338,1338,1338,1338,1338,R-HSA-2871837,FCERI mediated NF-kB activation,REACTOME,pathway,PATHWAY_1338 |
| 1339,1339,1339,1339,1339,1339,1339,1339,R-HSA-3700989,Transcriptional Regulation by TP53,REACTOME,pathway,PATHWAY_1339 |
| 1340,1340,1340,1340,1340,1340,1340,1340,R-HSA-9749641,Aspirin ADME,REACTOME,pathway,PATHWAY_1340 |
| 1341,1341,1341,1341,1341,1341,1341,1341,R-HSA-622312,Inflammasomes,REACTOME,pathway,PATHWAY_1341 |
| 1342,1342,1342,1342,1342,1342,1342,1342,R-HSA-75157,FasL/ CD95L signaling,REACTOME,pathway,PATHWAY_1342 |
| 1343,1343,1343,1343,1343,1343,1343,1343,R-HSA-9833482,PKR-mediated signaling,REACTOME,pathway,PATHWAY_1343 |
| 1344,1344,1344,1344,1344,1344,1344,1344,R-HSA-9833109,Evasion by RSV of host interferon responses,REACTOME,pathway,PATHWAY_1344 |
| 1345,1345,1345,1345,1345,1345,1345,1345,R-HSA-3781860,Diseases associated with N-glycosylation of proteins,REACTOME,pathway,PATHWAY_1345 |
| 1346,1346,1346,1346,1346,1346,1346,1346,R-HSA-5358752,CTNNB1 T41 mutants aren't phosphorylated,REACTOME,pathway,PATHWAY_1346 |
| 1347,1347,1347,1347,1347,1347,1347,1347,R-HSA-9839406,TGFBR3 regulates activin signaling,REACTOME,pathway,PATHWAY_1347 |
| 1348,1348,1348,1348,1348,1348,1348,1348,R-HSA-1971475,A tetrasaccharide linker sequence is required for GAG synthesis,REACTOME,pathway,PATHWAY_1348 |
| 1349,1349,1349,1349,1349,1349,1349,1349,R-HSA-9669914,Dasatinib-resistant KIT mutants,REACTOME,pathway,PATHWAY_1349 |
| 1350,1350,1350,1350,1350,1350,1350,1350,R-HSA-168277,Influenza Virus Induced Apoptosis,REACTOME,pathway,PATHWAY_1350 |
| 1351,1351,1351,1351,1351,1351,1351,1351,R-HSA-162658,Golgi Cisternae Pericentriolar Stack Reorganization,REACTOME,pathway,PATHWAY_1351 |
| 1352,1352,1352,1352,1352,1352,1352,1352,R-HSA-75955,RNA Polymerase II Transcription Elongation,REACTOME,pathway,PATHWAY_1352 |
| 1353,1353,1353,1353,1353,1353,1353,1353,R-HSA-5358493,Synthesis of diphthamide-EEF2,REACTOME,pathway,PATHWAY_1353 |
| 1354,1354,1354,1354,1354,1354,1354,1354,R-HSA-399955,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,REACTOME,pathway,PATHWAY_1354 |
| 1355,1355,1355,1355,1355,1355,1355,1355,R-HSA-2408499,Formation of selenosugars for excretion,REACTOME,pathway,PATHWAY_1355 |
| 1356,1356,1356,1356,1356,1356,1356,1356,R-HSA-2179392,EGFR Transactivation by Gastrin,REACTOME,pathway,PATHWAY_1356 |
| 1357,1357,1357,1357,1357,1357,1357,1357,R-HSA-5635851,GLI proteins bind promoters of Hh responsive genes to promote transcription,REACTOME,pathway,PATHWAY_1357 |
| 1358,1358,1358,1358,1358,1358,1358,1358,R-HSA-109703,PKB-mediated events,REACTOME,pathway,PATHWAY_1358 |
| 1359,1359,1359,1359,1359,1359,1359,1359,R-HSA-8948700,Competing endogenous RNAs (ceRNAs) regulate PTEN translation,REACTOME,pathway,PATHWAY_1359 |
| 1360,1360,1360,1360,1360,1360,1360,1360,R-HSA-9034013,NTF3 activates NTRK3 signaling,REACTOME,pathway,PATHWAY_1360 |
| 1361,1361,1361,1361,1361,1361,1361,1361,R-HSA-9694594,Maturation of protein M,REACTOME,pathway,PATHWAY_1361 |
| 1362,1362,1362,1362,1362,1362,1362,1362,R-HSA-9603381,Activated NTRK3 signals through PI3K,REACTOME,pathway,PATHWAY_1362 |
| 1363,1363,1363,1363,1363,1363,1363,1363,R-HSA-5620920,Cargo trafficking to the periciliary membrane,REACTOME,pathway,PATHWAY_1363 |
| 1364,1364,1364,1364,1364,1364,1364,1364,R-HSA-1606322,ZBP1(DAI) mediated induction of type I IFNs,REACTOME,pathway,PATHWAY_1364 |
| 1365,1365,1365,1365,1365,1365,1365,1365,R-HSA-5682910,LGI-ADAM interactions,REACTOME,pathway,PATHWAY_1365 |
| 1366,1366,1366,1366,1366,1366,1366,1366,R-HSA-177539,Autointegration results in viral DNA circles,REACTOME,pathway,PATHWAY_1366 |
| 1367,1367,1367,1367,1367,1367,1367,1367,R-HSA-9036092,Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI),REACTOME,pathway,PATHWAY_1367 |
| 1368,1368,1368,1368,1368,1368,1368,1368,R-HSA-5619107,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),REACTOME,pathway,PATHWAY_1368 |
| 1369,1369,1369,1369,1369,1369,1369,1369,R-HSA-9630794,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,REACTOME,pathway,PATHWAY_1369 |
| 1370,1370,1370,1370,1370,1370,1370,1370,R-HSA-3814836,Glycogen storage disease type XV (GYG1),REACTOME,pathway,PATHWAY_1370 |
| 1371,1371,1371,1371,1371,1371,1371,1371,R-HSA-2172127,DAP12 interactions,REACTOME,pathway,PATHWAY_1371 |
| 1372,1372,1372,1372,1372,1372,1372,1372,R-HSA-70370,Galactose catabolism,REACTOME,pathway,PATHWAY_1372 |
| 1373,1373,1373,1373,1373,1373,1373,1373,R-HSA-168325,Viral Messenger RNA Synthesis,REACTOME,pathway,PATHWAY_1373 |
| 1374,1374,1374,1374,1374,1374,1374,1374,R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,REACTOME,pathway,PATHWAY_1374 |
| 1375,1375,1375,1375,1375,1375,1375,1375,R-HSA-2161517,Abacavir transmembrane transport,REACTOME,pathway,PATHWAY_1375 |
| 1376,1376,1376,1376,1376,1376,1376,1376,R-HSA-4839735,Signaling by AXIN mutants,REACTOME,pathway,PATHWAY_1376 |
| 1377,1377,1377,1377,1377,1377,1377,1377,R-HSA-447041,CHL1 interactions,REACTOME,pathway,PATHWAY_1377 |
| 1378,1378,1378,1378,1378,1378,1378,1378,R-HSA-201451,Signaling by BMP,REACTOME,pathway,PATHWAY_1378 |
| 1379,1379,1379,1379,1379,1379,1379,1379,R-HSA-9828211,"Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation",REACTOME,pathway,PATHWAY_1379 |
| 1380,1380,1380,1380,1380,1380,1380,1380,R-HSA-442742,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,REACTOME,pathway,PATHWAY_1380 |
| 1381,1381,1381,1381,1381,1381,1381,1381,R-HSA-1614603,Cysteine formation from homocysteine,REACTOME,pathway,PATHWAY_1381 |
| 1382,1382,1382,1382,1382,1382,1382,1382,R-HSA-156711,Polo-like kinase mediated events,REACTOME,pathway,PATHWAY_1382 |
| 1383,1383,1383,1383,1383,1383,1383,1383,R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,REACTOME,pathway,PATHWAY_1383 |
| 1384,1384,1384,1384,1384,1384,1384,1384,R-HSA-9865113,Loss-of-function mutations in DBT cause MSUD2,REACTOME,pathway,PATHWAY_1384 |
| 1385,1385,1385,1385,1385,1385,1385,1385,R-HSA-5656169,Termination of translesion DNA synthesis,REACTOME,pathway,PATHWAY_1385 |
| 1386,1386,1386,1386,1386,1386,1386,1386,R-HSA-6811555,PI5P Regulates TP53 Acetylation,REACTOME,pathway,PATHWAY_1386 |
| 1387,1387,1387,1387,1387,1387,1387,1387,R-HSA-5620916,VxPx cargo-targeting to cilium,REACTOME,pathway,PATHWAY_1387 |
| 1388,1388,1388,1388,1388,1388,1388,1388,R-HSA-1222556,ROS and RNS production in phagocytes,REACTOME,pathway,PATHWAY_1388 |
| 1389,1389,1389,1389,1389,1389,1389,1389,R-HSA-8865999,MET activates PTPN11,REACTOME,pathway,PATHWAY_1389 |
| 1390,1390,1390,1390,1390,1390,1390,1390,R-HSA-8963888,Chylomicron assembly,REACTOME,pathway,PATHWAY_1390 |
| 1391,1391,1391,1391,1391,1391,1391,1391,R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,REACTOME,pathway,PATHWAY_1391 |
| 1392,1392,1392,1392,1392,1392,1392,1392,R-HSA-8875360,InlB-mediated entry of Listeria monocytogenes into host cell,REACTOME,pathway,PATHWAY_1392 |
| 1393,1393,1393,1393,1393,1393,1393,1393,R-HSA-3359457,Defective CBLIF causes IFD,REACTOME,pathway,PATHWAY_1393 |
| 1394,1394,1394,1394,1394,1394,1394,1394,R-HSA-73884,Base Excision Repair,REACTOME,pathway,PATHWAY_1394 |
| 1395,1395,1395,1395,1395,1395,1395,1395,R-HSA-9022707,MECP2 regulates transcription factors,REACTOME,pathway,PATHWAY_1395 |
| 1396,1396,1396,1396,1396,1396,1396,1396,R-HSA-380287,Centrosome maturation,REACTOME,pathway,PATHWAY_1396 |
| 1397,1397,1397,1397,1397,1397,1397,1397,R-HSA-6802949,Signaling by RAS mutants,REACTOME,pathway,PATHWAY_1397 |
| 1398,1398,1398,1398,1398,1398,1398,1398,R-HSA-8847993,ERBB2 Activates PTK6 Signaling,REACTOME,pathway,PATHWAY_1398 |
| 1399,1399,1399,1399,1399,1399,1399,1399,R-HSA-9006936,Signaling by TGFB family members,REACTOME,pathway,PATHWAY_1399 |
| 1400,1400,1400,1400,1400,1400,1400,1400,R-HSA-1855215,IPs transport between ER lumen and cytosol,REACTOME,pathway,PATHWAY_1400 |
| 1401,1401,1401,1401,1401,1401,1401,1401,R-HSA-5387390,Hh mutants abrogate ligand secretion,REACTOME,pathway,PATHWAY_1401 |
| 1402,1402,1402,1402,1402,1402,1402,1402,R-HSA-5619039,"Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)",REACTOME,pathway,PATHWAY_1402 |
| 1403,1403,1403,1403,1403,1403,1403,1403,R-HSA-5579006,Defective GSS causes GSS deficiency,REACTOME,pathway,PATHWAY_1403 |
| 1404,1404,1404,1404,1404,1404,1404,1404,R-HSA-1362277,Transcription of E2F targets under negative control by DREAM complex,REACTOME,pathway,PATHWAY_1404 |
| 1405,1405,1405,1405,1405,1405,1405,1405,R-HSA-5610783,Degradation of GLI2 by the proteasome,REACTOME,pathway,PATHWAY_1405 |
| 1406,1406,1406,1406,1406,1406,1406,1406,R-HSA-112316,Neuronal System,REACTOME,pathway,PATHWAY_1406 |
| 1407,1407,1407,1407,1407,1407,1407,1407,R-HSA-9702506,Drug resistance of FLT3 mutants,REACTOME,pathway,PATHWAY_1407 |
| 1408,1408,1408,1408,1408,1408,1408,1408,R-HSA-9914274,3-methylglutaconic aciduria,REACTOME,pathway,PATHWAY_1408 |
| 1409,1409,1409,1409,1409,1409,1409,1409,R-HSA-141405,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,REACTOME,pathway,PATHWAY_1409 |
| 1410,1410,1410,1410,1410,1410,1410,1410,R-HSA-3232118,SUMOylation of transcription factors,REACTOME,pathway,PATHWAY_1410 |
| 1411,1411,1411,1411,1411,1411,1411,1411,R-HSA-5686938,Regulation of TLR by endogenous ligand,REACTOME,pathway,PATHWAY_1411 |
| 1412,1412,1412,1412,1412,1412,1412,1412,R-HSA-4551638,SUMOylation of chromatin organization proteins,REACTOME,pathway,PATHWAY_1412 |
| 1413,1413,1413,1413,1413,1413,1413,1413,R-HSA-400511,"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",REACTOME,pathway,PATHWAY_1413 |
| 1414,1414,1414,1414,1414,1414,1414,1414,R-HSA-2980736,Peptide hormone metabolism,REACTOME,pathway,PATHWAY_1414 |
| 1415,1415,1415,1415,1415,1415,1415,1415,R-HSA-6798163,Choline catabolism,REACTOME,pathway,PATHWAY_1415 |
| 1416,1416,1416,1416,1416,1416,1416,1416,R-HSA-111471,Apoptotic factor-mediated response,REACTOME,pathway,PATHWAY_1416 |
| 1417,1417,1417,1417,1417,1417,1417,1417,R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",REACTOME,pathway,PATHWAY_1417 |
| 1418,1418,1418,1418,1418,1418,1418,1418,R-HSA-881907,Gastrin-CREB signalling pathway via PKC and MAPK,REACTOME,pathway,PATHWAY_1418 |
| 1419,1419,1419,1419,1419,1419,1419,1419,R-HSA-164843,2-LTR circle formation,REACTOME,pathway,PATHWAY_1419 |
| 1420,1420,1420,1420,1420,1420,1420,1420,R-HSA-111446,Activation of BIM and translocation to mitochondria ,REACTOME,pathway,PATHWAY_1420 |
| 1421,1421,1421,1421,1421,1421,1421,1421,R-HSA-114604,GPVI-mediated activation cascade,REACTOME,pathway,PATHWAY_1421 |
| 1422,1422,1422,1422,1422,1422,1422,1422,R-HSA-199992,trans-Golgi Network Vesicle Budding,REACTOME,pathway,PATHWAY_1422 |
| 1423,1423,1423,1423,1423,1423,1423,1423,R-HSA-5619060,Defective CP causes aceruloplasminemia (ACERULOP),REACTOME,pathway,PATHWAY_1423 |
| 1424,1424,1424,1424,1424,1424,1424,1424,R-HSA-9854907,Regulation of MITF-M dependent genes involved in metabolism,REACTOME,pathway,PATHWAY_1424 |
| 1425,1425,1425,1425,1425,1425,1425,1425,R-HSA-210500,Glutamate Neurotransmitter Release Cycle,REACTOME,pathway,PATHWAY_1425 |
| 1426,1426,1426,1426,1426,1426,1426,1426,R-HSA-210747,Regulation of gene expression in early pancreatic precursor cells,REACTOME,pathway,PATHWAY_1426 |
| 1427,1427,1427,1427,1427,1427,1427,1427,R-HSA-5619043,Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1),REACTOME,pathway,PATHWAY_1427 |
| 1428,1428,1428,1428,1428,1428,1428,1428,R-HSA-5579028,Defective CYP17A1 causes AH5,REACTOME,pathway,PATHWAY_1428 |
| 1429,1429,1429,1429,1429,1429,1429,1429,R-HSA-9013694,Signaling by NOTCH4,REACTOME,pathway,PATHWAY_1429 |
| 1430,1430,1430,1430,1430,1430,1430,1430,R-HSA-111932,CaMK IV-mediated phosphorylation of CREB,REACTOME,pathway,PATHWAY_1430 |
| 1431,1431,1431,1431,1431,1431,1431,1431,R-HSA-1643685,Disease,REACTOME,pathway,PATHWAY_1431 |
| 1432,1432,1432,1432,1432,1432,1432,1432,R-HSA-1222541,Cell redox homeostasis,REACTOME,pathway,PATHWAY_1432 |
| 1433,1433,1433,1433,1433,1433,1433,1433,R-HSA-419408,Lysosphingolipid and LPA receptors,REACTOME,pathway,PATHWAY_1433 |
| 1434,1434,1434,1434,1434,1434,1434,1434,R-HSA-5693538,Homology Directed Repair,REACTOME,pathway,PATHWAY_1434 |
| 1435,1435,1435,1435,1435,1435,1435,1435,R-HSA-918233,TRAF3-dependent IRF activation pathway,REACTOME,pathway,PATHWAY_1435 |
| 1436,1436,1436,1436,1436,1436,1436,1436,R-HSA-3214847,HATs acetylate histones,REACTOME,pathway,PATHWAY_1436 |
| 1437,1437,1437,1437,1437,1437,1437,1437,R-HSA-112382,Formation of RNA Pol II elongation complex ,REACTOME,pathway,PATHWAY_1437 |
| 1438,1438,1438,1438,1438,1438,1438,1438,R-HSA-8877330,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),REACTOME,pathway,PATHWAY_1438 |
| 1439,1439,1439,1439,1439,1439,1439,1439,R-HSA-211163,AKT-mediated inactivation of FOXO1A,REACTOME,pathway,PATHWAY_1439 |
| 1440,1440,1440,1440,1440,1440,1440,1440,R-HSA-9825895,"Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence",REACTOME,pathway,PATHWAY_1440 |
| 1441,1441,1441,1441,1441,1441,1441,1441,R-HSA-390522,Striated Muscle Contraction,REACTOME,pathway,PATHWAY_1441 |
| 1442,1442,1442,1442,1442,1442,1442,1442,R-HSA-196780,Biotin transport and metabolism,REACTOME,pathway,PATHWAY_1442 |
| 1443,1443,1443,1443,1443,1443,1443,1443,R-HSA-73927,Depurination,REACTOME,pathway,PATHWAY_1443 |
| 1444,1444,1444,1444,1444,1444,1444,1444,R-HSA-210991,Basigin interactions,REACTOME,pathway,PATHWAY_1444 |
| 1445,1445,1445,1445,1445,1445,1445,1445,R-HSA-9764302,Regulation of CDH19 Expression and Function,REACTOME,pathway,PATHWAY_1445 |
| 1446,1446,1446,1446,1446,1446,1446,1446,R-HSA-432030,Transport of glycerol from adipocytes to the liver by Aquaporins,REACTOME,pathway,PATHWAY_1446 |
| 1447,1447,1447,1447,1447,1447,1447,1447,R-HSA-418592,ADP signalling through P2Y purinoceptor 1,REACTOME,pathway,PATHWAY_1447 |
| 1448,1448,1448,1448,1448,1448,1448,1448,R-HSA-9012852,Signaling by NOTCH3,REACTOME,pathway,PATHWAY_1448 |
| 1449,1449,1449,1449,1449,1449,1449,1449,R-HSA-3371556,Cellular response to heat stress,REACTOME,pathway,PATHWAY_1449 |
| 1450,1450,1450,1450,1450,1450,1450,1450,R-HSA-112310,Neurotransmitter release cycle,REACTOME,pathway,PATHWAY_1450 |
| 1451,1451,1451,1451,1451,1451,1451,1451,R-HSA-74751,Insulin receptor signalling cascade,REACTOME,pathway,PATHWAY_1451 |
| 1452,1452,1452,1452,1452,1452,1452,1452,R-HSA-9828806,Maturation of hRSV A proteins,REACTOME,pathway,PATHWAY_1452 |
| 1453,1453,1453,1453,1453,1453,1453,1453,R-HSA-76061,RNA Polymerase III Transcription Initiation From Type 1 Promoter,REACTOME,pathway,PATHWAY_1453 |
| 1454,1454,1454,1454,1454,1454,1454,1454,R-HSA-72662,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",REACTOME,pathway,PATHWAY_1454 |
| 1455,1455,1455,1455,1455,1455,1455,1455,R-HSA-1280218,Adaptive Immune System,REACTOME,pathway,PATHWAY_1455 |
| 1456,1456,1456,1456,1456,1456,1456,1456,R-HSA-167161,HIV Transcription Initiation,REACTOME,pathway,PATHWAY_1456 |
| 1457,1457,1457,1457,1457,1457,1457,1457,R-HSA-6804754,Regulation of TP53 Expression,REACTOME,pathway,PATHWAY_1457 |
| 1458,1458,1458,1458,1458,1458,1458,1458,R-HSA-9634600,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",REACTOME,pathway,PATHWAY_1458 |
| 1459,1459,1459,1459,1459,1459,1459,1459,R-HSA-5334118,DNA methylation,REACTOME,pathway,PATHWAY_1459 |
| 1460,1460,1460,1460,1460,1460,1460,1460,R-HSA-9629569,Protein hydroxylation,REACTOME,pathway,PATHWAY_1460 |
| 1461,1461,1461,1461,1461,1461,1461,1461,R-HSA-77387,Insulin receptor recycling,REACTOME,pathway,PATHWAY_1461 |
| 1462,1462,1462,1462,1462,1462,1462,1462,R-HSA-388844,Receptor-type tyrosine-protein phosphatases,REACTOME,pathway,PATHWAY_1462 |
| 1463,1463,1463,1463,1463,1463,1463,1463,R-HSA-9665246,Resistance of ERBB2 KD mutants to neratinib,REACTOME,pathway,PATHWAY_1463 |
| 1464,1464,1464,1464,1464,1464,1464,1464,R-HSA-1482788,Acyl chain remodelling of PC,REACTOME,pathway,PATHWAY_1464 |
| 1465,1465,1465,1465,1465,1465,1465,1465,R-HSA-71262,Carnitine synthesis,REACTOME,pathway,PATHWAY_1465 |
| 1466,1466,1466,1466,1466,1466,1466,1466,R-HSA-442380,Zinc influx into cells by the SLC39 gene family,REACTOME,pathway,PATHWAY_1466 |
| 1467,1467,1467,1467,1467,1467,1467,1467,R-HSA-5602566,TICAM1 deficiency - HSE,REACTOME,pathway,PATHWAY_1467 |
| 1468,1468,1468,1468,1468,1468,1468,1468,R-HSA-9669938,Signaling by KIT in disease,REACTOME,pathway,PATHWAY_1468 |
| 1469,1469,1469,1469,1469,1469,1469,1469,R-HSA-9730628,Sensory perception of salty taste,REACTOME,pathway,PATHWAY_1469 |
| 1470,1470,1470,1470,1470,1470,1470,1470,R-HSA-9014325,"TICAM1,TRAF6-dependent induction of TAK1 complex",REACTOME,pathway,PATHWAY_1470 |
| 1471,1471,1471,1471,1471,1471,1471,1471,R-HSA-4043916,Defective MPI causes MPI-CDG,REACTOME,pathway,PATHWAY_1471 |
| 1472,1472,1472,1472,1472,1472,1472,1472,R-HSA-5685942,HDR through Homologous Recombination (HRR),REACTOME,pathway,PATHWAY_1472 |
| 1473,1473,1473,1473,1473,1473,1473,1473,R-HSA-9702636,tandutinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_1473 |
| 1474,1474,1474,1474,1474,1474,1474,1474,R-HSA-110331,Cleavage of the damaged purine,REACTOME,pathway,PATHWAY_1474 |
| 1475,1475,1475,1475,1475,1475,1475,1475,R-HSA-3296197,Hydroxycarboxylic acid-binding receptors,REACTOME,pathway,PATHWAY_1475 |
| 1476,1476,1476,1476,1476,1476,1476,1476,R-HSA-197264,Nicotinamide salvaging,REACTOME,pathway,PATHWAY_1476 |
| 1477,1477,1477,1477,1477,1477,1477,1477,R-HSA-190242,FGFR1 ligand binding and activation,REACTOME,pathway,PATHWAY_1477 |
| 1478,1478,1478,1478,1478,1478,1478,1478,R-HSA-9818026,NFE2L2 regulating inflammation associated genes,REACTOME,pathway,PATHWAY_1478 |
| 1479,1479,1479,1479,1479,1479,1479,1479,R-HSA-450302,activated TAK1 mediates p38 MAPK activation,REACTOME,pathway,PATHWAY_1479 |
| 1480,1480,1480,1480,1480,1480,1480,1480,R-HSA-392170,ADP signalling through P2Y purinoceptor 12,REACTOME,pathway,PATHWAY_1480 |
| 1481,1481,1481,1481,1481,1481,1481,1481,R-HSA-9026766,Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),REACTOME,pathway,PATHWAY_1481 |
| 1482,1482,1482,1482,1482,1482,1482,1482,R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,REACTOME,pathway,PATHWAY_1482 |
| 1483,1483,1483,1483,1483,1483,1483,1483,R-HSA-9037629,Lewis blood group biosynthesis,REACTOME,pathway,PATHWAY_1483 |
| 1484,1484,1484,1484,1484,1484,1484,1484,R-HSA-3232142,SUMOylation of ubiquitinylation proteins,REACTOME,pathway,PATHWAY_1484 |
| 1485,1485,1485,1485,1485,1485,1485,1485,R-HSA-5250971,Toxicity of botulinum toxin type C (botC),REACTOME,pathway,PATHWAY_1485 |
| 1486,1486,1486,1486,1486,1486,1486,1486,R-HSA-3296482,Defects in vitamin and cofactor metabolism,REACTOME,pathway,PATHWAY_1486 |
| 1487,1487,1487,1487,1487,1487,1487,1487,R-HSA-69481,G2/M Checkpoints,REACTOME,pathway,PATHWAY_1487 |
| 1488,1488,1488,1488,1488,1488,1488,1488,R-HSA-418346,Platelet homeostasis,REACTOME,pathway,PATHWAY_1488 |
| 1489,1489,1489,1489,1489,1489,1489,1489,R-HSA-2187335,The retinoid cycle in cones (daylight vision),REACTOME,pathway,PATHWAY_1489 |
| 1490,1490,1490,1490,1490,1490,1490,1490,R-HSA-8854214,TBC/RABGAPs,REACTOME,pathway,PATHWAY_1490 |
| 1491,1491,1491,1491,1491,1491,1491,1491,R-HSA-9668328,Sealing of the nuclear envelope (NE) by ESCRT-III,REACTOME,pathway,PATHWAY_1491 |
| 1492,1492,1492,1492,1492,1492,1492,1492,R-HSA-480985,Synthesis of dolichyl-phosphate-glucose,REACTOME,pathway,PATHWAY_1492 |
| 1493,1493,1493,1493,1493,1493,1493,1493,R-HSA-9673240,Defective gamma-carboxylation of F9,REACTOME,pathway,PATHWAY_1493 |
| 1494,1494,1494,1494,1494,1494,1494,1494,R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,REACTOME,pathway,PATHWAY_1494 |
| 1495,1495,1495,1495,1495,1495,1495,1495,R-HSA-983169,Class I MHC mediated antigen processing & presentation,REACTOME,pathway,PATHWAY_1495 |
| 1496,1496,1496,1496,1496,1496,1496,1496,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,REACTOME,pathway,PATHWAY_1496 |
| 1497,1497,1497,1497,1497,1497,1497,1497,R-HSA-163685,Integration of energy metabolism,REACTOME,pathway,PATHWAY_1497 |
| 1498,1498,1498,1498,1498,1498,1498,1498,R-HSA-202427,Phosphorylation of CD3 and TCR zeta chains,REACTOME,pathway,PATHWAY_1498 |
| 1499,1499,1499,1499,1499,1499,1499,1499,R-HSA-3785653,Myoclonic epilepsy of Lafora,REACTOME,pathway,PATHWAY_1499 |
| 1500,1500,1500,1500,1500,1500,1500,1500,R-HSA-9702590,gilteritinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_1500 |
| 1501,1501,1501,1501,1501,1501,1501,1501,R-HSA-5696395,Formation of Incision Complex in GG-NER,REACTOME,pathway,PATHWAY_1501 |
| 1502,1502,1502,1502,1502,1502,1502,1502,R-HSA-373753,Nephrin family interactions,REACTOME,pathway,PATHWAY_1502 |
| 1503,1503,1503,1503,1503,1503,1503,1503,R-HSA-9670613,Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations,REACTOME,pathway,PATHWAY_1503 |
| 1504,1504,1504,1504,1504,1504,1504,1504,R-HSA-9673202,Defective F9 variant does not activate FX,REACTOME,pathway,PATHWAY_1504 |
| 1505,1505,1505,1505,1505,1505,1505,1505,R-HSA-194138,Signaling by VEGF,REACTOME,pathway,PATHWAY_1505 |
| 1506,1506,1506,1506,1506,1506,1506,1506,R-HSA-162592,Integration of provirus,REACTOME,pathway,PATHWAY_1506 |
| 1507,1507,1507,1507,1507,1507,1507,1507,R-HSA-190236,Signaling by FGFR,REACTOME,pathway,PATHWAY_1507 |
| 1508,1508,1508,1508,1508,1508,1508,1508,R-HSA-1296346,Tandem pore domain potassium channels,REACTOME,pathway,PATHWAY_1508 |
| 1509,1509,1509,1509,1509,1509,1509,1509,R-HSA-5173105,O-linked glycosylation,REACTOME,pathway,PATHWAY_1509 |
| 1510,1510,1510,1510,1510,1510,1510,1510,R-HSA-1480926,O2/CO2 exchange in erythrocytes,REACTOME,pathway,PATHWAY_1510 |
| 1511,1511,1511,1511,1511,1511,1511,1511,R-HSA-9842860,Regulation of endogenous retroelements,REACTOME,pathway,PATHWAY_1511 |
| 1512,1512,1512,1512,1512,1512,1512,1512,R-HSA-9834752,Respiratory syncytial virus genome replication,REACTOME,pathway,PATHWAY_1512 |
| 1513,1513,1513,1513,1513,1513,1513,1513,R-HSA-1630316,Glycosaminoglycan metabolism,REACTOME,pathway,PATHWAY_1513 |
| 1514,1514,1514,1514,1514,1514,1514,1514,R-HSA-112399,IRS-mediated signalling,REACTOME,pathway,PATHWAY_1514 |
| 1515,1515,1515,1515,1515,1515,1515,1515,R-HSA-1855156,IPs transport between ER lumen and nucleus,REACTOME,pathway,PATHWAY_1515 |
| 1516,1516,1516,1516,1516,1516,1516,1516,R-HSA-4085377,SUMOylation of SUMOylation proteins,REACTOME,pathway,PATHWAY_1516 |
| 1517,1517,1517,1517,1517,1517,1517,1517,R-HSA-2393930,Phosphate bond hydrolysis by NUDT proteins,REACTOME,pathway,PATHWAY_1517 |
| 1518,1518,1518,1518,1518,1518,1518,1518,R-HSA-5602571,TRAF3 deficiency - HSE,REACTOME,pathway,PATHWAY_1518 |
| 1519,1519,1519,1519,1519,1519,1519,1519,R-HSA-187687,Signalling to ERKs,REACTOME,pathway,PATHWAY_1519 |
| 1520,1520,1520,1520,1520,1520,1520,1520,R-HSA-5619092,"Defective SLC9A6 causes X-linked, syndromic mental retardation,, Christianson type (MRXSCH)",REACTOME,pathway,PATHWAY_1520 |
| 1521,1521,1521,1521,1521,1521,1521,1521,R-HSA-8941332,RUNX2 regulates genes involved in cell migration,REACTOME,pathway,PATHWAY_1521 |
| 1522,1522,1522,1522,1522,1522,1522,1522,R-HSA-9672387,Defective F8 accelerates dissociation of the A2 domain,REACTOME,pathway,PATHWAY_1522 |
| 1523,1523,1523,1523,1523,1523,1523,1523,R-HSA-9704646,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,REACTOME,pathway,PATHWAY_1523 |
| 1524,1524,1524,1524,1524,1524,1524,1524,R-HSA-9668250,Defective factor IX causes hemophilia B,REACTOME,pathway,PATHWAY_1524 |
| 1525,1525,1525,1525,1525,1525,1525,1525,R-HSA-5221030,"TET1,2,3 and TDG demethylate DNA",REACTOME,pathway,PATHWAY_1525 |
| 1526,1526,1526,1526,1526,1526,1526,1526,R-HSA-5609977,Defective GALE causes EDG,REACTOME,pathway,PATHWAY_1526 |
| 1527,1527,1527,1527,1527,1527,1527,1527,R-HSA-3248023,Regulation by TREX1,REACTOME,pathway,PATHWAY_1527 |
| 1528,1528,1528,1528,1528,1528,1528,1528,R-HSA-450520,HuR (ELAVL1) binds and stabilizes mRNA,REACTOME,pathway,PATHWAY_1528 |
| 1529,1529,1529,1529,1529,1529,1529,1529,R-HSA-380095,Tachykinin receptors bind tachykinins,REACTOME,pathway,PATHWAY_1529 |
| 1530,1530,1530,1530,1530,1530,1530,1530,R-HSA-1296041,Activation of G protein gated Potassium channels,REACTOME,pathway,PATHWAY_1530 |
| 1531,1531,1531,1531,1531,1531,1531,1531,R-HSA-76042,RNA Polymerase II Transcription Initiation And Promoter Clearance,REACTOME,pathway,PATHWAY_1531 |
| 1532,1532,1532,1532,1532,1532,1532,1532,R-HSA-3595172,Defective CHST3 causes SEDCJD,REACTOME,pathway,PATHWAY_1532 |
| 1533,1533,1533,1533,1533,1533,1533,1533,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,REACTOME,pathway,PATHWAY_1533 |
| 1534,1534,1534,1534,1534,1534,1534,1534,R-HSA-1483196,PI and PC transport between ER and Golgi membranes,REACTOME,pathway,PATHWAY_1534 |
| 1535,1535,1535,1535,1535,1535,1535,1535,R-HSA-8877627,Vitamin E transport,REACTOME,pathway,PATHWAY_1535 |
| 1536,1536,1536,1536,1536,1536,1536,1536,R-HSA-9026286,Biosynthesis of DPAn-3-derived protectins and resolvins,REACTOME,pathway,PATHWAY_1536 |
| 1537,1537,1537,1537,1537,1537,1537,1537,R-HSA-9610379,HCMV Late Events,REACTOME,pathway,PATHWAY_1537 |
| 1538,1538,1538,1538,1538,1538,1538,1538,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,REACTOME,pathway,PATHWAY_1538 |
| 1539,1539,1539,1539,1539,1539,1539,1539,R-HSA-112315,Transmission across Chemical Synapses,REACTOME,pathway,PATHWAY_1539 |
| 1540,1540,1540,1540,1540,1540,1540,1540,R-HSA-8939245,RUNX1 regulates transcription of genes involved in BCR signaling,REACTOME,pathway,PATHWAY_1540 |
| 1541,1541,1541,1541,1541,1541,1541,1541,R-HSA-5260271,Diseases of Immune System,REACTOME,pathway,PATHWAY_1541 |
| 1542,1542,1542,1542,1542,1542,1542,1542,R-HSA-5205647,Mitophagy,REACTOME,pathway,PATHWAY_1542 |
| 1543,1543,1543,1543,1543,1543,1543,1543,R-HSA-112409,RAF-independent MAPK1/3 activation,REACTOME,pathway,PATHWAY_1543 |
| 1544,1544,1544,1544,1544,1544,1544,1544,R-HSA-8956320,Nucleotide biosynthesis,REACTOME,pathway,PATHWAY_1544 |
| 1545,1545,1545,1545,1545,1545,1545,1545,R-HSA-9697154,Disorders of Nervous System Development,REACTOME,pathway,PATHWAY_1545 |
| 1546,1546,1546,1546,1546,1546,1546,1546,R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,REACTOME,pathway,PATHWAY_1546 |
| 1547,1547,1547,1547,1547,1547,1547,1547,R-HSA-111448,Activation of NOXA and translocation to mitochondria,REACTOME,pathway,PATHWAY_1547 |
| 1548,1548,1548,1548,1548,1548,1548,1548,R-HSA-77595,Processing of Intronless Pre-mRNAs,REACTOME,pathway,PATHWAY_1548 |
| 1549,1549,1549,1549,1549,1549,1549,1549,R-HSA-8951936,RUNX3 regulates p14-ARF,REACTOME,pathway,PATHWAY_1549 |
| 1550,1550,1550,1550,1550,1550,1550,1550,R-HSA-991365,Activation of GABAB receptors,REACTOME,pathway,PATHWAY_1550 |
| 1551,1551,1551,1551,1551,1551,1551,1551,R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,REACTOME,pathway,PATHWAY_1551 |
| 1552,1552,1552,1552,1552,1552,1552,1552,R-HSA-3928662,EPHB-mediated forward signaling,REACTOME,pathway,PATHWAY_1552 |
| 1553,1553,1553,1553,1553,1553,1553,1553,R-HSA-9831926,Nephron development,REACTOME,pathway,PATHWAY_1553 |
| 1554,1554,1554,1554,1554,1554,1554,1554,R-HSA-5619113,Defective SLC3A1 causes cystinuria (CSNU),REACTOME,pathway,PATHWAY_1554 |
| 1555,1555,1555,1555,1555,1555,1555,1555,R-HSA-9656223,Signaling by RAF1 mutants,REACTOME,pathway,PATHWAY_1555 |
| 1556,1556,1556,1556,1556,1556,1556,1556,R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,REACTOME,pathway,PATHWAY_1556 |
| 1557,1557,1557,1557,1557,1557,1557,1557,R-HSA-5619085,Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1),REACTOME,pathway,PATHWAY_1557 |
| 1558,1558,1558,1558,1558,1558,1558,1558,R-HSA-450321,JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1,REACTOME,pathway,PATHWAY_1558 |
| 1559,1559,1559,1559,1559,1559,1559,1559,R-HSA-1650814,Collagen biosynthesis and modifying enzymes,REACTOME,pathway,PATHWAY_1559 |
| 1560,1560,1560,1560,1560,1560,1560,1560,R-HSA-3858516,Glycogen storage disease type 0 (liver GYS2),REACTOME,pathway,PATHWAY_1560 |
| 1561,1561,1561,1561,1561,1561,1561,1561,R-HSA-190704,Oligomerization of connexins into connexons,REACTOME,pathway,PATHWAY_1561 |
| 1562,1562,1562,1562,1562,1562,1562,1562,R-HSA-964827,"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",REACTOME,pathway,PATHWAY_1562 |
| 1563,1563,1563,1563,1563,1563,1563,1563,R-HSA-163615,PKA activation,REACTOME,pathway,PATHWAY_1563 |
| 1564,1564,1564,1564,1564,1564,1564,1564,R-HSA-2024096,HS-GAG degradation,REACTOME,pathway,PATHWAY_1564 |
| 1565,1565,1565,1565,1565,1565,1565,1565,R-HSA-4793950,Defective MAN1B1 causes MRT15,REACTOME,pathway,PATHWAY_1565 |
| 1566,1566,1566,1566,1566,1566,1566,1566,R-HSA-5083629,"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2",REACTOME,pathway,PATHWAY_1566 |
| 1567,1567,1567,1567,1567,1567,1567,1567,R-HSA-69610,p53-Independent DNA Damage Response,REACTOME,pathway,PATHWAY_1567 |
| 1568,1568,1568,1568,1568,1568,1568,1568,R-HSA-9013695,NOTCH4 Intracellular Domain Regulates Transcription,REACTOME,pathway,PATHWAY_1568 |
| 1569,1569,1569,1569,1569,1569,1569,1569,R-HSA-6807070,PTEN Regulation,REACTOME,pathway,PATHWAY_1569 |
| 1570,1570,1570,1570,1570,1570,1570,1570,R-HSA-212436,Generic Transcription Pathway,REACTOME,pathway,PATHWAY_1570 |
| 1571,1571,1571,1571,1571,1571,1571,1571,R-HSA-110328,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,REACTOME,pathway,PATHWAY_1571 |
| 1572,1572,1572,1572,1572,1572,1572,1572,R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,REACTOME,pathway,PATHWAY_1572 |
| 1573,1573,1573,1573,1573,1573,1573,1573,R-HSA-5660668,CLEC7A/inflammasome pathway,REACTOME,pathway,PATHWAY_1573 |
| 1574,1574,1574,1574,1574,1574,1574,1574,R-HSA-5619054,"Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)",REACTOME,pathway,PATHWAY_1574 |
| 1575,1575,1575,1575,1575,1575,1575,1575,R-HSA-205025,NADE modulates death signalling,REACTOME,pathway,PATHWAY_1575 |
| 1576,1576,1576,1576,1576,1576,1576,1576,R-HSA-6782315,tRNA modification in the nucleus and cytosol,REACTOME,pathway,PATHWAY_1576 |
| 1577,1577,1577,1577,1577,1577,1577,1577,R-HSA-418360,Platelet calcium homeostasis,REACTOME,pathway,PATHWAY_1577 |
| 1578,1578,1578,1578,1578,1578,1578,1578,R-HSA-9687136,Aberrant regulation of mitotic exit in cancer due to RB1 defects,REACTOME,pathway,PATHWAY_1578 |
| 1579,1579,1579,1579,1579,1579,1579,1579,R-HSA-5579031,Defective ACTH causes obesity and POMCD,REACTOME,pathway,PATHWAY_1579 |
| 1580,1580,1580,1580,1580,1580,1580,1580,R-HSA-4655427,SUMOylation of DNA methylation proteins,REACTOME,pathway,PATHWAY_1580 |
| 1581,1581,1581,1581,1581,1581,1581,1581,R-HSA-1855170,IPs transport between nucleus and cytosol,REACTOME,pathway,PATHWAY_1581 |
| 1582,1582,1582,1582,1582,1582,1582,1582,R-HSA-9018678,Biosynthesis of specialized proresolving mediators (SPMs),REACTOME,pathway,PATHWAY_1582 |
| 1583,1583,1583,1583,1583,1583,1583,1583,R-HSA-8866904,Negative regulation of activity of TFAP2 (AP-2) family transcription factors,REACTOME,pathway,PATHWAY_1583 |
| 1584,1584,1584,1584,1584,1584,1584,1584,R-HSA-186797,Signaling by PDGF,REACTOME,pathway,PATHWAY_1584 |
| 1585,1585,1585,1585,1585,1585,1585,1585,R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,REACTOME,pathway,PATHWAY_1585 |
| 1586,1586,1586,1586,1586,1586,1586,1586,R-HSA-8985947,Interleukin-9 signaling,REACTOME,pathway,PATHWAY_1586 |
| 1587,1587,1587,1587,1587,1587,1587,1587,R-HSA-1428517,Aerobic respiration and respiratory electron transport,REACTOME,pathway,PATHWAY_1587 |
| 1588,1588,1588,1588,1588,1588,1588,1588,R-HSA-8963898,Plasma lipoprotein assembly,REACTOME,pathway,PATHWAY_1588 |
| 1589,1589,1589,1589,1589,1589,1589,1589,R-HSA-5619094,Variant SLC6A14 may confer susceptibility towards obesity,REACTOME,pathway,PATHWAY_1589 |
| 1590,1590,1590,1590,1590,1590,1590,1590,R-HSA-5627123,RHO GTPases activate PAKs,REACTOME,pathway,PATHWAY_1590 |
| 1591,1591,1591,1591,1591,1591,1591,1591,R-HSA-204174,Regulation of pyruvate dehydrogenase (PDH) complex,REACTOME,pathway,PATHWAY_1591 |
| 1592,1592,1592,1592,1592,1592,1592,1592,R-HSA-3656248,Defective HEXB causes GM2G2,REACTOME,pathway,PATHWAY_1592 |
| 1593,1593,1593,1593,1593,1593,1593,1593,R-HSA-446193,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",REACTOME,pathway,PATHWAY_1593 |
| 1594,1594,1594,1594,1594,1594,1594,1594,R-HSA-9823730,Formation of definitive endoderm,REACTOME,pathway,PATHWAY_1594 |
| 1595,1595,1595,1595,1595,1595,1595,1595,R-HSA-2142670,Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),REACTOME,pathway,PATHWAY_1595 |
| 1596,1596,1596,1596,1596,1596,1596,1596,R-HSA-9005895,Pervasive developmental disorders,REACTOME,pathway,PATHWAY_1596 |
| 1597,1597,1597,1597,1597,1597,1597,1597,R-HSA-76002,"Platelet activation, signaling and aggregation",REACTOME,pathway,PATHWAY_1597 |
| 1598,1598,1598,1598,1598,1598,1598,1598,R-HSA-3371453,Regulation of HSF1-mediated heat shock response,REACTOME,pathway,PATHWAY_1598 |
| 1599,1599,1599,1599,1599,1599,1599,1599,R-HSA-977068,Termination of O-glycan biosynthesis,REACTOME,pathway,PATHWAY_1599 |
| 1600,1600,1600,1600,1600,1600,1600,1600,R-HSA-5654689,PI-3K cascade:FGFR1,REACTOME,pathway,PATHWAY_1600 |
| 1601,1601,1601,1601,1601,1601,1601,1601,R-HSA-3878781,Glycogen storage disease type IV (GBE1),REACTOME,pathway,PATHWAY_1601 |
| 1602,1602,1602,1602,1602,1602,1602,1602,R-HSA-5632928,Defective Mismatch Repair Associated With MSH2,REACTOME,pathway,PATHWAY_1602 |
| 1603,1603,1603,1603,1603,1603,1603,1603,R-HSA-9633012,Response of EIF2AK4 (GCN2) to amino acid deficiency,REACTOME,pathway,PATHWAY_1603 |
| 1604,1604,1604,1604,1604,1604,1604,1604,R-HSA-73854,RNA Polymerase I Promoter Clearance,REACTOME,pathway,PATHWAY_1604 |
| 1605,1605,1605,1605,1605,1605,1605,1605,R-HSA-72163,mRNA Splicing - Major Pathway,REACTOME,pathway,PATHWAY_1605 |
| 1606,1606,1606,1606,1606,1606,1606,1606,R-HSA-168274,Export of Viral Ribonucleoproteins from Nucleus,REACTOME,pathway,PATHWAY_1606 |
| 1607,1607,1607,1607,1607,1607,1607,1607,R-HSA-68867,Assembly of the pre-replicative complex,REACTOME,pathway,PATHWAY_1607 |
| 1608,1608,1608,1608,1608,1608,1608,1608,R-HSA-9726840,SHOC2 M1731 mutant abolishes MRAS complex function,REACTOME,pathway,PATHWAY_1608 |
| 1609,1609,1609,1609,1609,1609,1609,1609,R-HSA-72165,mRNA Splicing - Minor Pathway,REACTOME,pathway,PATHWAY_1609 |
| 1610,1610,1610,1610,1610,1610,1610,1610,R-HSA-9717264,ASP-3026-resistant ALK mutants,REACTOME,pathway,PATHWAY_1610 |
| 1611,1611,1611,1611,1611,1611,1611,1611,R-HSA-399710,Activation of AMPA receptors,REACTOME,pathway,PATHWAY_1611 |
| 1612,1612,1612,1612,1612,1612,1612,1612,R-HSA-113501,Inhibition of replication initiation of damaged DNA by RB1/E2F1,REACTOME,pathway,PATHWAY_1612 |
| 1613,1613,1613,1613,1613,1613,1613,1613,R-HSA-73857,RNA Polymerase II Transcription,REACTOME,pathway,PATHWAY_1613 |
| 1614,1614,1614,1614,1614,1614,1614,1614,R-HSA-5619115,Disorders of transmembrane transporters,REACTOME,pathway,PATHWAY_1614 |
| 1615,1615,1615,1615,1615,1615,1615,1615,R-HSA-422085,"Synthesis, secretion, and deacylation of Ghrelin",REACTOME,pathway,PATHWAY_1615 |
| 1616,1616,1616,1616,1616,1616,1616,1616,R-HSA-196854,Metabolism of vitamins and cofactors,REACTOME,pathway,PATHWAY_1616 |
| 1617,1617,1617,1617,1617,1617,1617,1617,R-HSA-9678110,Attachment and Entry,REACTOME,pathway,PATHWAY_1617 |
| 1618,1618,1618,1618,1618,1618,1618,1618,R-HSA-72702,Ribosomal scanning and start codon recognition,REACTOME,pathway,PATHWAY_1618 |
| 1619,1619,1619,1619,1619,1619,1619,1619,R-HSA-159763,Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,REACTOME,pathway,PATHWAY_1619 |
| 1620,1620,1620,1620,1620,1620,1620,1620,R-HSA-8941333,RUNX2 regulates genes involved in differentiation of myeloid cells,REACTOME,pathway,PATHWAY_1620 |
| 1621,1621,1621,1621,1621,1621,1621,1621,R-HSA-499943,Interconversion of nucleotide di- and triphosphates,REACTOME,pathway,PATHWAY_1621 |
| 1622,1622,1622,1622,1622,1622,1622,1622,R-HSA-397014,Muscle contraction,REACTOME,pathway,PATHWAY_1622 |
| 1623,1623,1623,1623,1623,1623,1623,1623,R-HSA-9856651,MITF-M-dependent gene expression,REACTOME,pathway,PATHWAY_1623 |
| 1624,1624,1624,1624,1624,1624,1624,1624,R-HSA-9700645,ALK mutants bind TKIs,REACTOME,pathway,PATHWAY_1624 |
| 1625,1625,1625,1625,1625,1625,1625,1625,R-HSA-5603029,IkBA variant leads to EDA-ID,REACTOME,pathway,PATHWAY_1625 |
| 1626,1626,1626,1626,1626,1626,1626,1626,R-HSA-446210,Synthesis of UDP-N-acetyl-glucosamine,REACTOME,pathway,PATHWAY_1626 |
| 1627,1627,1627,1627,1627,1627,1627,1627,R-HSA-917977,Transferrin endocytosis and recycling,REACTOME,pathway,PATHWAY_1627 |
| 1628,1628,1628,1628,1628,1628,1628,1628,R-HSA-1250196,SHC1 events in ERBB2 signaling,REACTOME,pathway,PATHWAY_1628 |
| 1629,1629,1629,1629,1629,1629,1629,1629,R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,REACTOME,pathway,PATHWAY_1629 |
| 1630,1630,1630,1630,1630,1630,1630,1630,R-HSA-9772573,Late SARS-CoV-2 Infection Events,REACTOME,pathway,PATHWAY_1630 |
| 1631,1631,1631,1631,1631,1631,1631,1631,R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,REACTOME,pathway,PATHWAY_1631 |
| 1632,1632,1632,1632,1632,1632,1632,1632,R-HSA-140342,Apoptosis induced DNA fragmentation,REACTOME,pathway,PATHWAY_1632 |
| 1633,1633,1633,1633,1633,1633,1633,1633,R-HSA-192814,vRNA Synthesis,REACTOME,pathway,PATHWAY_1633 |
| 1634,1634,1634,1634,1634,1634,1634,1634,R-HSA-4549349,Defective ALG2 causes CDG-1i,REACTOME,pathway,PATHWAY_1634 |
| 1635,1635,1635,1635,1635,1635,1635,1635,R-HSA-112303,Electric Transmission Across Gap Junctions,REACTOME,pathway,PATHWAY_1635 |
| 1636,1636,1636,1636,1636,1636,1636,1636,R-HSA-4085011,"Defective GNE causes sialuria, NK and IBM2",REACTOME,pathway,PATHWAY_1636 |
| 1637,1637,1637,1637,1637,1637,1637,1637,R-HSA-3301854,Nuclear Pore Complex (NPC) Disassembly,REACTOME,pathway,PATHWAY_1637 |
| 1638,1638,1638,1638,1638,1638,1638,1638,R-HSA-176033,Interactions of Vpr with host cellular proteins,REACTOME,pathway,PATHWAY_1638 |
| 1639,1639,1639,1639,1639,1639,1639,1639,R-HSA-69541,Stabilization of p53,REACTOME,pathway,PATHWAY_1639 |
| 1640,1640,1640,1640,1640,1640,1640,1640,R-HSA-76046,RNA Polymerase III Transcription Initiation,REACTOME,pathway,PATHWAY_1640 |
| 1641,1641,1641,1641,1641,1641,1641,1641,R-HSA-9840373,Cellular response to mitochondrial stress,REACTOME,pathway,PATHWAY_1641 |
| 1642,1642,1642,1642,1642,1642,1642,1642,R-HSA-9648895,Response of EIF2AK1 (HRI) to heme deficiency,REACTOME,pathway,PATHWAY_1642 |
| 1643,1643,1643,1643,1643,1643,1643,1643,R-HSA-4839744,Signaling by APC mutants,REACTOME,pathway,PATHWAY_1643 |
| 1644,1644,1644,1644,1644,1644,1644,1644,R-HSA-5602680,MyD88 deficiency (TLR5),REACTOME,pathway,PATHWAY_1644 |
| 1645,1645,1645,1645,1645,1645,1645,1645,R-HSA-211859,Biological oxidations,REACTOME,pathway,PATHWAY_1645 |
| 1646,1646,1646,1646,1646,1646,1646,1646,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),REACTOME,pathway,PATHWAY_1646 |
| 1647,1647,1647,1647,1647,1647,1647,1647,R-HSA-5674135,MAP2K and MAPK activation,REACTOME,pathway,PATHWAY_1647 |
| 1648,1648,1648,1648,1648,1648,1648,1648,R-HSA-5638302,Signaling by Overexpressed Wild-Type EGFR in Cancer,REACTOME,pathway,PATHWAY_1648 |
| 1649,1649,1649,1649,1649,1649,1649,1649,R-HSA-167152,Formation of HIV elongation complex in the absence of HIV Tat,REACTOME,pathway,PATHWAY_1649 |
| 1650,1650,1650,1650,1650,1650,1650,1650,R-HSA-3359485,Defective CD320 causes MMATC,REACTOME,pathway,PATHWAY_1650 |
| 1651,1651,1651,1651,1651,1651,1651,1651,R-HSA-937039,IRAK1 recruits IKK complex,REACTOME,pathway,PATHWAY_1651 |
| 1652,1652,1652,1652,1652,1652,1652,1652,R-HSA-446107,Type I hemidesmosome assembly,REACTOME,pathway,PATHWAY_1652 |
| 1653,1653,1653,1653,1653,1653,1653,1653,R-HSA-6803205,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,REACTOME,pathway,PATHWAY_1653 |
| 1654,1654,1654,1654,1654,1654,1654,1654,R-HSA-9694271,Assembly of the SARS-CoV-2 Replication-Transcription Complex (RTC),REACTOME,pathway,PATHWAY_1654 |
| 1655,1655,1655,1655,1655,1655,1655,1655,R-HSA-1296025,ATP sensitive Potassium channels,REACTOME,pathway,PATHWAY_1655 |
| 1656,1656,1656,1656,1656,1656,1656,1656,R-HSA-3595174,"Defective CHST14 causes EDS, musculocontractural type",REACTOME,pathway,PATHWAY_1656 |
| 1657,1657,1657,1657,1657,1657,1657,1657,R-HSA-111458,Formation of apoptosome,REACTOME,pathway,PATHWAY_1657 |
| 1658,1658,1658,1658,1658,1658,1658,1658,R-HSA-6787639,GDP-fucose biosynthesis,REACTOME,pathway,PATHWAY_1658 |
| 1659,1659,1659,1659,1659,1659,1659,1659,R-HSA-73930,Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,REACTOME,pathway,PATHWAY_1659 |
| 1660,1660,1660,1660,1660,1660,1660,1660,R-HSA-9671793,Diseases of hemostasis,REACTOME,pathway,PATHWAY_1660 |
| 1661,1661,1661,1661,1661,1661,1661,1661,R-HSA-351200,Interconversion of polyamines,REACTOME,pathway,PATHWAY_1661 |
| 1662,1662,1662,1662,1662,1662,1662,1662,R-HSA-9734207,Nucleotide salvage defects,REACTOME,pathway,PATHWAY_1662 |
| 1663,1663,1663,1663,1663,1663,1663,1663,R-HSA-166208,mTORC1-mediated signalling,REACTOME,pathway,PATHWAY_1663 |
| 1664,1664,1664,1664,1664,1664,1664,1664,R-HSA-2730905,Role of LAT2/NTAL/LAB on calcium mobilization,REACTOME,pathway,PATHWAY_1664 |
| 1665,1665,1665,1665,1665,1665,1665,1665,R-HSA-5632987,Defective Mismatch Repair Associated With PMS2,REACTOME,pathway,PATHWAY_1665 |
| 1666,1666,1666,1666,1666,1666,1666,1666,R-HSA-72764,Eukaryotic Translation Termination,REACTOME,pathway,PATHWAY_1666 |
| 1667,1667,1667,1667,1667,1667,1667,1667,R-HSA-428559,Proton-coupled neutral amino acid transporters,REACTOME,pathway,PATHWAY_1667 |
| 1668,1668,1668,1668,1668,1668,1668,1668,R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,REACTOME,pathway,PATHWAY_1668 |
| 1669,1669,1669,1669,1669,1669,1669,1669,R-HSA-164525,Plus-strand DNA synthesis,REACTOME,pathway,PATHWAY_1669 |
| 1670,1670,1670,1670,1670,1670,1670,1670,R-HSA-9837999,Mitochondrial protein degradation,REACTOME,pathway,PATHWAY_1670 |
| 1671,1671,1671,1671,1671,1671,1671,1671,R-HSA-201681,TCF dependent signaling in response to WNT,REACTOME,pathway,PATHWAY_1671 |
| 1672,1672,1672,1672,1672,1672,1672,1672,R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,REACTOME,pathway,PATHWAY_1672 |
| 1673,1673,1673,1673,1673,1673,1673,1673,R-HSA-447115,Interleukin-12 family signaling,REACTOME,pathway,PATHWAY_1673 |
| 1674,1674,1674,1674,1674,1674,1674,1674,R-HSA-76071,RNA Polymerase III Transcription Initiation From Type 3 Promoter,REACTOME,pathway,PATHWAY_1674 |
| 1675,1675,1675,1675,1675,1675,1675,1675,R-HSA-77286,mitochondrial fatty acid beta-oxidation of saturated fatty acids,REACTOME,pathway,PATHWAY_1675 |
| 1676,1676,1676,1676,1676,1676,1676,1676,R-HSA-198745,Signalling to STAT3,REACTOME,pathway,PATHWAY_1676 |
| 1677,1677,1677,1677,1677,1677,1677,1677,R-HSA-4755579,"Defective SRD5A3 causes SRD5A3-CDG, KHRZ",REACTOME,pathway,PATHWAY_1677 |
| 1678,1678,1678,1678,1678,1678,1678,1678,R-HSA-5653890,Lactose synthesis,REACTOME,pathway,PATHWAY_1678 |
| 1679,1679,1679,1679,1679,1679,1679,1679,R-HSA-5619078,Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C),REACTOME,pathway,PATHWAY_1679 |
| 1680,1680,1680,1680,1680,1680,1680,1680,R-HSA-4720475,Defective ALG3 causes CDG-1d,REACTOME,pathway,PATHWAY_1680 |
| 1681,1681,1681,1681,1681,1681,1681,1681,R-HSA-8939246,RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,REACTOME,pathway,PATHWAY_1681 |
| 1682,1682,1682,1682,1682,1682,1682,1682,R-HSA-210744,Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,REACTOME,pathway,PATHWAY_1682 |
| 1683,1683,1683,1683,1683,1683,1683,1683,R-HSA-2408552,Methylation of MeSeH for excretion,REACTOME,pathway,PATHWAY_1683 |
| 1684,1684,1684,1684,1684,1684,1684,1684,R-HSA-389542,NADPH regeneration,REACTOME,pathway,PATHWAY_1684 |
| 1685,1685,1685,1685,1685,1685,1685,1685,R-HSA-9758941,Gastrulation,REACTOME,pathway,PATHWAY_1685 |
| 1686,1686,1686,1686,1686,1686,1686,1686,R-HSA-1299344,TWIK-related spinal cord K+ channel (TRESK),REACTOME,pathway,PATHWAY_1686 |
| 1687,1687,1687,1687,1687,1687,1687,1687,R-HSA-5619104,Defective SLC12A1 causes Bartter syndrome 1 (BS1),REACTOME,pathway,PATHWAY_1687 |
| 1688,1688,1688,1688,1688,1688,1688,1688,R-HSA-5633231,Defective ALG14 causes ALG14-CMS,REACTOME,pathway,PATHWAY_1688 |
| 1689,1689,1689,1689,1689,1689,1689,1689,R-HSA-9730737,Alkylating DNA damage induced by chemotherapeutic drugs,REACTOME,pathway,PATHWAY_1689 |
| 1690,1690,1690,1690,1690,1690,1690,1690,R-HSA-3772470,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,REACTOME,pathway,PATHWAY_1690 |
| 1691,1691,1691,1691,1691,1691,1691,1691,R-HSA-3656244,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),REACTOME,pathway,PATHWAY_1691 |
| 1692,1692,1692,1692,1692,1692,1692,1692,R-HSA-9664873,Pexophagy,REACTOME,pathway,PATHWAY_1692 |
| 1693,1693,1693,1693,1693,1693,1693,1693,R-HSA-73843,5-Phosphoribose 1-diphosphate biosynthesis,REACTOME,pathway,PATHWAY_1693 |
| 1694,1694,1694,1694,1694,1694,1694,1694,R-HSA-168268,Virus Assembly and Release,REACTOME,pathway,PATHWAY_1694 |
| 1695,1695,1695,1695,1695,1695,1695,1695,R-HSA-3323169,Defects in biotin (Btn) metabolism,REACTOME,pathway,PATHWAY_1695 |
| 1696,1696,1696,1696,1696,1696,1696,1696,R-HSA-5693607,Processing of DNA double-strand break ends,REACTOME,pathway,PATHWAY_1696 |
| 1697,1697,1697,1697,1697,1697,1697,1697,R-HSA-9683683,Maturation of protein E,REACTOME,pathway,PATHWAY_1697 |
| 1698,1698,1698,1698,1698,1698,1698,1698,R-HSA-9637679,Escape of Mtb from the phagocyte,REACTOME,pathway,PATHWAY_1698 |
| 1699,1699,1699,1699,1699,1699,1699,1699,R-HSA-9679504,Translation of Replicase and Assembly of the Replication Transcription Complex,REACTOME,pathway,PATHWAY_1699 |
| 1700,1700,1700,1700,1700,1700,1700,1700,R-HSA-2142850,Hyaluronan biosynthesis and export,REACTOME,pathway,PATHWAY_1700 |
| 1701,1701,1701,1701,1701,1701,1701,1701,R-HSA-5619045,Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM),REACTOME,pathway,PATHWAY_1701 |
| 1702,1702,1702,1702,1702,1702,1702,1702,R-HSA-171306,Packaging Of Telomere Ends,REACTOME,pathway,PATHWAY_1702 |
| 1703,1703,1703,1703,1703,1703,1703,1703,R-HSA-444473,Formyl peptide receptors bind formyl peptides and many other ligands,REACTOME,pathway,PATHWAY_1703 |
| 1704,1704,1704,1704,1704,1704,1704,1704,R-HSA-1462054,Alpha-defensins,REACTOME,pathway,PATHWAY_1704 |
| 1705,1705,1705,1705,1705,1705,1705,1705,R-HSA-9648025,EML4 and NUDC in mitotic spindle formation,REACTOME,pathway,PATHWAY_1705 |
| 1706,1706,1706,1706,1706,1706,1706,1706,R-HSA-9710421,Defective pyroptosis,REACTOME,pathway,PATHWAY_1706 |
| 1707,1707,1707,1707,1707,1707,1707,1707,R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",REACTOME,pathway,PATHWAY_1707 |
| 1708,1708,1708,1708,1708,1708,1708,1708,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,REACTOME,pathway,PATHWAY_1708 |
| 1709,1709,1709,1709,1709,1709,1709,1709,R-HSA-3000171,Non-integrin membrane-ECM interactions,REACTOME,pathway,PATHWAY_1709 |
| 1710,1710,1710,1710,1710,1710,1710,1710,R-HSA-74160,Gene expression (Transcription),REACTOME,pathway,PATHWAY_1710 |
| 1711,1711,1711,1711,1711,1711,1711,1711,R-HSA-73980,RNA Polymerase III Transcription Termination,REACTOME,pathway,PATHWAY_1711 |
| 1712,1712,1712,1712,1712,1712,1712,1712,R-HSA-6783984,Glycine degradation,REACTOME,pathway,PATHWAY_1712 |
| 1713,1713,1713,1713,1713,1713,1713,1713,R-HSA-2871809,FCERI mediated Ca+2 mobilization,REACTOME,pathway,PATHWAY_1713 |
| 1714,1714,1714,1714,1714,1714,1714,1714,R-HSA-5619507,Activation of HOX genes during differentiation,REACTOME,pathway,PATHWAY_1714 |
| 1715,1715,1715,1715,1715,1715,1715,1715,R-HSA-2151209,Activation of PPARGC1A (PGC-1alpha) by phosphorylation,REACTOME,pathway,PATHWAY_1715 |
| 1716,1716,1716,1716,1716,1716,1716,1716,R-HSA-5659996,RPIA deficiency: failed conversion of R5P to RU5P,REACTOME,pathway,PATHWAY_1716 |
| 1717,1717,1717,1717,1717,1717,1717,1717,R-HSA-5662702,Melanin biosynthesis,REACTOME,pathway,PATHWAY_1717 |
| 1718,1718,1718,1718,1718,1718,1718,1718,R-HSA-141430,Inactivation of APC/C via direct inhibition of the APC/C complex,REACTOME,pathway,PATHWAY_1718 |
| 1719,1719,1719,1719,1719,1719,1719,1719,R-HSA-975578,Reactions specific to the complex N-glycan synthesis pathway,REACTOME,pathway,PATHWAY_1719 |
| 1720,1720,1720,1720,1720,1720,1720,1720,R-HSA-9845621,Defective VWF cleavage by ADAMTS13 variant,REACTOME,pathway,PATHWAY_1720 |
| 1721,1721,1721,1721,1721,1721,1721,1721,R-HSA-9632697,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4,REACTOME,pathway,PATHWAY_1721 |
| 1722,1722,1722,1722,1722,1722,1722,1722,R-HSA-193807,Synthesis of bile acids and bile salts via 27-hydroxycholesterol,REACTOME,pathway,PATHWAY_1722 |
| 1723,1723,1723,1723,1723,1723,1723,1723,R-HSA-9918454,Defective visual phototransduction due to ABCA4 loss of function,REACTOME,pathway,PATHWAY_1723 |
| 1724,1724,1724,1724,1724,1724,1724,1724,R-HSA-391908,Prostanoid ligand receptors,REACTOME,pathway,PATHWAY_1724 |
| 1725,1725,1725,1725,1725,1725,1725,1725,R-HSA-5619114,Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),REACTOME,pathway,PATHWAY_1725 |
| 1726,1726,1726,1726,1726,1726,1726,1726,R-HSA-392023,Adrenaline signalling through Alpha-2 adrenergic receptor,REACTOME,pathway,PATHWAY_1726 |
| 1727,1727,1727,1727,1727,1727,1727,1727,R-HSA-162589,Reverse Transcription of HIV RNA,REACTOME,pathway,PATHWAY_1727 |
| 1728,1728,1728,1728,1728,1728,1728,1728,R-HSA-177135,Conjugation of benzoate with glycine,REACTOME,pathway,PATHWAY_1728 |
| 1729,1729,1729,1729,1729,1729,1729,1729,R-HSA-5358749,CTNNB1 S37 mutants aren't phosphorylated,REACTOME,pathway,PATHWAY_1729 |
| 1730,1730,1730,1730,1730,1730,1730,1730,R-HSA-8964011,HDL clearance,REACTOME,pathway,PATHWAY_1730 |
| 1731,1731,1731,1731,1731,1731,1731,1731,R-HSA-9706377,FLT3 signaling by CBL mutants,REACTOME,pathway,PATHWAY_1731 |
| 1732,1732,1732,1732,1732,1732,1732,1732,R-HSA-380972,Energy dependent regulation of mTOR by LKB1-AMPK,REACTOME,pathway,PATHWAY_1732 |
| 1733,1733,1733,1733,1733,1733,1733,1733,R-HSA-4839748,Signaling by AMER1 mutants,REACTOME,pathway,PATHWAY_1733 |
| 1734,1734,1734,1734,1734,1734,1734,1734,R-HSA-5675221,Negative regulation of MAPK pathway,REACTOME,pathway,PATHWAY_1734 |
| 1735,1735,1735,1735,1735,1735,1735,1735,R-HSA-5628897,TP53 Regulates Metabolic Genes,REACTOME,pathway,PATHWAY_1735 |
| 1736,1736,1736,1736,1736,1736,1736,1736,R-HSA-5619037,Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),REACTOME,pathway,PATHWAY_1736 |
| 1737,1737,1737,1737,1737,1737,1737,1737,R-HSA-5578997,Defective AHCY causes HMAHCHD,REACTOME,pathway,PATHWAY_1737 |
| 1738,1738,1738,1738,1738,1738,1738,1738,R-HSA-193993,Mineralocorticoid biosynthesis,REACTOME,pathway,PATHWAY_1738 |
| 1739,1739,1739,1739,1739,1739,1739,1739,R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,REACTOME,pathway,PATHWAY_1739 |
| 1740,1740,1740,1740,1740,1740,1740,1740,R-HSA-983705,Signaling by the B Cell Receptor (BCR),REACTOME,pathway,PATHWAY_1740 |
| 1741,1741,1741,1741,1741,1741,1741,1741,R-HSA-9674519,Defective F8 sulfation at Y1699,REACTOME,pathway,PATHWAY_1741 |
| 1742,1742,1742,1742,1742,1742,1742,1742,R-HSA-888568,GABA synthesis,REACTOME,pathway,PATHWAY_1742 |
| 1743,1743,1743,1743,1743,1743,1743,1743,R-HSA-6788467,IL-6-type cytokine receptor ligand interactions,REACTOME,pathway,PATHWAY_1743 |
| 1744,1744,1744,1744,1744,1744,1744,1744,R-HSA-2206285,MPS VI - Maroteaux-Lamy syndrome,REACTOME,pathway,PATHWAY_1744 |
| 1745,1745,1745,1745,1745,1745,1745,1745,R-HSA-139853,Elevation of cytosolic Ca2+ levels,REACTOME,pathway,PATHWAY_1745 |
| 1746,1746,1746,1746,1746,1746,1746,1746,R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,REACTOME,pathway,PATHWAY_1746 |
| 1747,1747,1747,1747,1747,1747,1747,1747,R-HSA-2206290,MPS IV - Morquio syndrome A,REACTOME,pathway,PATHWAY_1747 |
| 1748,1748,1748,1748,1748,1748,1748,1748,R-HSA-2262752,Cellular responses to stress,REACTOME,pathway,PATHWAY_1748 |
| 1749,1749,1749,1749,1749,1749,1749,1749,R-HSA-8866423,VLDL assembly,REACTOME,pathway,PATHWAY_1749 |
| 1750,1750,1750,1750,1750,1750,1750,1750,R-HSA-4615885,SUMOylation of DNA replication proteins,REACTOME,pathway,PATHWAY_1750 |
| 1751,1751,1751,1751,1751,1751,1751,1751,R-HSA-9824446,Viral Infection Pathways,REACTOME,pathway,PATHWAY_1751 |
| 1752,1752,1752,1752,1752,1752,1752,1752,R-HSA-397795,G-protein beta:gamma signalling,REACTOME,pathway,PATHWAY_1752 |
| 1753,1753,1753,1753,1753,1753,1753,1753,R-HSA-389977,Post-chaperonin tubulin folding pathway,REACTOME,pathway,PATHWAY_1753 |
| 1754,1754,1754,1754,1754,1754,1754,1754,R-HSA-9018519,Estrogen-dependent gene expression,REACTOME,pathway,PATHWAY_1754 |
| 1755,1755,1755,1755,1755,1755,1755,1755,R-HSA-388841,Regulation of T cell activation by CD28 family,REACTOME,pathway,PATHWAY_1755 |
| 1756,1756,1756,1756,1756,1756,1756,1756,R-HSA-5619108,Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS),REACTOME,pathway,PATHWAY_1756 |
| 1757,1757,1757,1757,1757,1757,1757,1757,R-HSA-196299,Beta-catenin phosphorylation cascade,REACTOME,pathway,PATHWAY_1757 |
| 1758,1758,1758,1758,1758,1758,1758,1758,R-HSA-2033515,t(4 |
| 1759,1759,1759,1759,1759,1759,1759,1759,R-HSA-166665,Terminal pathway of complement,REACTOME,pathway,PATHWAY_1759 |
| 1760,1760,1760,1760,1760,1760,1760,1760,R-HSA-9865881,Complex III assembly,REACTOME,pathway,PATHWAY_1760 |
| 1761,1761,1761,1761,1761,1761,1761,1761,R-HSA-5632968,Defective Mismatch Repair Associated With MSH6,REACTOME,pathway,PATHWAY_1761 |
| 1762,1762,1762,1762,1762,1762,1762,1762,R-HSA-9821002,Chromatin modifications during the maternal to zygotic transition (MZT),REACTOME,pathway,PATHWAY_1762 |
| 1763,1763,1763,1763,1763,1763,1763,1763,R-HSA-75067,Processing of Capped Intronless Pre-mRNA,REACTOME,pathway,PATHWAY_1763 |
| 1764,1764,1764,1764,1764,1764,1764,1764,R-HSA-997272,Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits,REACTOME,pathway,PATHWAY_1764 |
| 1765,1765,1765,1765,1765,1765,1765,1765,R-HSA-447038,NrCAM interactions,REACTOME,pathway,PATHWAY_1765 |
| 1766,1766,1766,1766,1766,1766,1766,1766,R-HSA-1237044,Erythrocytes take up carbon dioxide and release oxygen,REACTOME,pathway,PATHWAY_1766 |
| 1767,1767,1767,1767,1767,1767,1767,1767,R-HSA-9758890,Transport of RCbl within the body,REACTOME,pathway,PATHWAY_1767 |
| 1768,1768,1768,1768,1768,1768,1768,1768,R-HSA-6781827,Transcription-Coupled Nucleotide Excision Repair (TC-NER),REACTOME,pathway,PATHWAY_1768 |
| 1769,1769,1769,1769,1769,1769,1769,1769,R-HSA-68952,DNA replication initiation,REACTOME,pathway,PATHWAY_1769 |
| 1770,1770,1770,1770,1770,1770,1770,1770,R-HSA-9918442,Defective visual phototransduction due to LRAT loss of function,REACTOME,pathway,PATHWAY_1770 |
| 1771,1771,1771,1771,1771,1771,1771,1771,R-HSA-211728,Regulation of PAK-2p34 activity by PS-GAP/RHG10,REACTOME,pathway,PATHWAY_1771 |
| 1772,1772,1772,1772,1772,1772,1772,1772,R-HSA-1632852,Macroautophagy,REACTOME,pathway,PATHWAY_1772 |
| 1773,1773,1773,1773,1773,1773,1773,1773,R-HSA-9683686,Maturation of spike protein,REACTOME,pathway,PATHWAY_1773 |
| 1774,1774,1774,1774,1774,1774,1774,1774,R-HSA-8851680,Butyrophilin (BTN) family interactions,REACTOME,pathway,PATHWAY_1774 |
| 1775,1775,1775,1775,1775,1775,1775,1775,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,REACTOME,pathway,PATHWAY_1775 |
| 1776,1776,1776,1776,1776,1776,1776,1776,R-HSA-202733,Cell surface interactions at the vascular wall,REACTOME,pathway,PATHWAY_1776 |
| 1777,1777,1777,1777,1777,1777,1777,1777,R-HSA-5619089,Defective SLC6A5 causes hyperekplexia 3 (HKPX3),REACTOME,pathway,PATHWAY_1777 |
| 1778,1778,1778,1778,1778,1778,1778,1778,R-HSA-69183,Processive synthesis on the lagging strand,REACTOME,pathway,PATHWAY_1778 |
| 1779,1779,1779,1779,1779,1779,1779,1779,R-HSA-9608290,Defective MUTYH substrate processing,REACTOME,pathway,PATHWAY_1779 |
| 1780,1780,1780,1780,1780,1780,1780,1780,R-HSA-9683610,Maturation of nucleoprotein,REACTOME,pathway,PATHWAY_1780 |
| 1781,1781,1781,1781,1781,1781,1781,1781,R-HSA-380615,Serotonin clearance from the synaptic cleft,REACTOME,pathway,PATHWAY_1781 |
| 1782,1782,1782,1782,1782,1782,1782,1782,R-HSA-167242,Abortive elongation of HIV-1 transcript in the absence of Tat,REACTOME,pathway,PATHWAY_1782 |
| 1783,1783,1783,1783,1783,1783,1783,1783,R-HSA-9702998,linifanib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_1783 |
| 1784,1784,1784,1784,1784,1784,1784,1784,R-HSA-9833110,RSV-host interactions,REACTOME,pathway,PATHWAY_1784 |
| 1785,1785,1785,1785,1785,1785,1785,1785,R-HSA-9772572,Early SARS-CoV-2 Infection Events,REACTOME,pathway,PATHWAY_1785 |
| 1786,1786,1786,1786,1786,1786,1786,1786,R-HSA-9673013,Diseases of Telomere Maintenance,REACTOME,pathway,PATHWAY_1786 |
| 1787,1787,1787,1787,1787,1787,1787,1787,R-HSA-9913635,Strand-asynchronous mitochondrial DNA replication,REACTOME,pathway,PATHWAY_1787 |
| 1788,1788,1788,1788,1788,1788,1788,1788,R-HSA-418890,Role of second messengers in netrin-1 signaling,REACTOME,pathway,PATHWAY_1788 |
| 1789,1789,1789,1789,1789,1789,1789,1789,R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,REACTOME,pathway,PATHWAY_1789 |
| 1790,1790,1790,1790,1790,1790,1790,1790,R-HSA-211999,CYP2E1 reactions,REACTOME,pathway,PATHWAY_1790 |
| 1791,1791,1791,1791,1791,1791,1791,1791,R-HSA-5666185,RHO GTPases Activate Rhotekin and Rhophilins,REACTOME,pathway,PATHWAY_1791 |
| 1792,1792,1792,1792,1792,1792,1792,1792,R-HSA-8876725,Protein methylation,REACTOME,pathway,PATHWAY_1792 |
| 1793,1793,1793,1793,1793,1793,1793,1793,R-HSA-196108,Pregnenolone biosynthesis,REACTOME,pathway,PATHWAY_1793 |
| 1794,1794,1794,1794,1794,1794,1794,1794,R-HSA-157118,Signaling by NOTCH,REACTOME,pathway,PATHWAY_1794 |
| 1795,1795,1795,1795,1795,1795,1795,1795,R-HSA-5619088,"Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)",REACTOME,pathway,PATHWAY_1795 |
| 1796,1796,1796,1796,1796,1796,1796,1796,R-HSA-1461973,Defensins,REACTOME,pathway,PATHWAY_1796 |
| 1797,1797,1797,1797,1797,1797,1797,1797,R-HSA-8963901,Chylomicron remodeling,REACTOME,pathway,PATHWAY_1797 |
| 1798,1798,1798,1798,1798,1798,1798,1798,R-HSA-9609690,HCMV Early Events,REACTOME,pathway,PATHWAY_1798 |
| 1799,1799,1799,1799,1799,1799,1799,1799,R-HSA-203754,NOSIP mediated eNOS trafficking,REACTOME,pathway,PATHWAY_1799 |
| 1800,1800,1800,1800,1800,1800,1800,1800,R-HSA-167200,Formation of HIV-1 elongation complex containing HIV-1 Tat,REACTOME,pathway,PATHWAY_1800 |
| 1801,1801,1801,1801,1801,1801,1801,1801,R-HSA-9648002,RAS processing,REACTOME,pathway,PATHWAY_1801 |
| 1802,1802,1802,1802,1802,1802,1802,1802,R-HSA-1483257,Phospholipid metabolism,REACTOME,pathway,PATHWAY_1802 |
| 1803,1803,1803,1803,1803,1803,1803,1803,R-HSA-9029558,NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,REACTOME,pathway,PATHWAY_1803 |
| 1804,1804,1804,1804,1804,1804,1804,1804,R-HSA-9649913,RAS GTPase cycle mutants,REACTOME,pathway,PATHWAY_1804 |
| 1805,1805,1805,1805,1805,1805,1805,1805,R-HSA-9675132,Diseases of cellular response to stress,REACTOME,pathway,PATHWAY_1805 |
| 1806,1806,1806,1806,1806,1806,1806,1806,R-HSA-4419969,Depolymerization of the Nuclear Lamina,REACTOME,pathway,PATHWAY_1806 |
| 1807,1807,1807,1807,1807,1807,1807,1807,R-HSA-9660826,Purinergic signaling in leishmaniasis infection,REACTOME,pathway,PATHWAY_1807 |
| 1808,1808,1808,1808,1808,1808,1808,1808,R-HSA-9609523,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,REACTOME,pathway,PATHWAY_1808 |
| 1809,1809,1809,1809,1809,1809,1809,1809,R-HSA-1483249,Inositol phosphate metabolism,REACTOME,pathway,PATHWAY_1809 |
| 1810,1810,1810,1810,1810,1810,1810,1810,R-HSA-180786,Extension of Telomeres,REACTOME,pathway,PATHWAY_1810 |
| 1811,1811,1811,1811,1811,1811,1811,1811,R-HSA-199977,ER to Golgi Anterograde Transport,REACTOME,pathway,PATHWAY_1811 |
| 1812,1812,1812,1812,1812,1812,1812,1812,R-HSA-2023837,Signaling by FGFR2 amplification mutants,REACTOME,pathway,PATHWAY_1812 |
| 1813,1813,1813,1813,1813,1813,1813,1813,R-HSA-451307,Activation of Na-permeable kainate receptors,REACTOME,pathway,PATHWAY_1813 |
| 1814,1814,1814,1814,1814,1814,1814,1814,R-HSA-5362517,Signaling by Retinoic Acid,REACTOME,pathway,PATHWAY_1814 |
| 1815,1815,1815,1815,1815,1815,1815,1815,R-HSA-70895,Branched-chain amino acid catabolism,REACTOME,pathway,PATHWAY_1815 |
| 1816,1816,1816,1816,1816,1816,1816,1816,R-HSA-6807062,Cholesterol biosynthesis via lathosterol,REACTOME,pathway,PATHWAY_1816 |
| 1817,1817,1817,1817,1817,1817,1817,1817,R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,REACTOME,pathway,PATHWAY_1817 |
| 1818,1818,1818,1818,1818,1818,1818,1818,R-HSA-5632927,Defective Mismatch Repair Associated With MSH3,REACTOME,pathway,PATHWAY_1818 |
| 1819,1819,1819,1819,1819,1819,1819,1819,R-HSA-5620912,Anchoring of the basal body to the plasma membrane,REACTOME,pathway,PATHWAY_1819 |
| 1820,1820,1820,1820,1820,1820,1820,1820,R-HSA-8963676,Intestinal absorption,REACTOME,pathway,PATHWAY_1820 |
| 1821,1821,1821,1821,1821,1821,1821,1821,R-HSA-9675136,Diseases of DNA Double-Strand Break Repair,REACTOME,pathway,PATHWAY_1821 |
| 1822,1822,1822,1822,1822,1822,1822,1822,R-HSA-9820965,"Respiratory syncytial virus (RSV) genome replication, transcription and translation",REACTOME,pathway,PATHWAY_1822 |
| 1823,1823,1823,1823,1823,1823,1823,1823,R-HSA-975110,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,REACTOME,pathway,PATHWAY_1823 |
| 1824,1824,1824,1824,1824,1824,1824,1824,R-HSA-9020956,Interleukin-27 signaling,REACTOME,pathway,PATHWAY_1824 |
| 1825,1825,1825,1825,1825,1825,1825,1825,R-HSA-173107,Binding and entry of HIV virion,REACTOME,pathway,PATHWAY_1825 |
| 1826,1826,1826,1826,1826,1826,1826,1826,R-HSA-5683826,Surfactant metabolism,REACTOME,pathway,PATHWAY_1826 |
| 1827,1827,1827,1827,1827,1827,1827,1827,R-HSA-6783310,Fanconi Anemia Pathway,REACTOME,pathway,PATHWAY_1827 |
| 1828,1828,1828,1828,1828,1828,1828,1828,R-HSA-189451,Heme biosynthesis,REACTOME,pathway,PATHWAY_1828 |
| 1829,1829,1829,1829,1829,1829,1829,1829,R-HSA-189483,Heme degradation,REACTOME,pathway,PATHWAY_1829 |
| 1830,1830,1830,1830,1830,1830,1830,1830,R-HSA-9663199,Defective DNA double strand break response due to BRCA1 loss of function,REACTOME,pathway,PATHWAY_1830 |
| 1831,1831,1831,1831,1831,1831,1831,1831,R-HSA-5655291,Signaling by FGFR4 in disease,REACTOME,pathway,PATHWAY_1831 |
| 1832,1832,1832,1832,1832,1832,1832,1832,R-HSA-5467333,APC truncation mutants are not K63 polyubiquitinated,REACTOME,pathway,PATHWAY_1832 |
| 1833,1833,1833,1833,1833,1833,1833,1833,R-HSA-5689877,Josephin domain DUBs,REACTOME,pathway,PATHWAY_1833 |
| 1834,1834,1834,1834,1834,1834,1834,1834,R-HSA-9824585,Regulation of MITF-M-dependent genes involved in pigmentation,REACTOME,pathway,PATHWAY_1834 |
| 1835,1835,1835,1835,1835,1835,1835,1835,R-HSA-199991,Membrane Trafficking,REACTOME,pathway,PATHWAY_1835 |
| 1836,1836,1836,1836,1836,1836,1836,1836,R-HSA-9634635,Estrogen-stimulated signaling through PRKCZ,REACTOME,pathway,PATHWAY_1836 |
| 1837,1837,1837,1837,1837,1837,1837,1837,R-HSA-179409,APC-Cdc20 mediated degradation of Nek2A,REACTOME,pathway,PATHWAY_1837 |
| 1838,1838,1838,1838,1838,1838,1838,1838,R-HSA-5619097,Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH),REACTOME,pathway,PATHWAY_1838 |
| 1839,1839,1839,1839,1839,1839,1839,1839,R-HSA-5635838,Activation of SMO,REACTOME,pathway,PATHWAY_1839 |
| 1840,1840,1840,1840,1840,1840,1840,1840,R-HSA-164940,Nef mediated downregulation of MHC class I complex cell surface expression,REACTOME,pathway,PATHWAY_1840 |
| 1841,1841,1841,1841,1841,1841,1841,1841,R-HSA-2206280,MPS IX - Natowicz syndrome,REACTOME,pathway,PATHWAY_1841 |
| 1842,1842,1842,1842,1842,1842,1842,1842,R-HSA-9856649,Transcriptional and post-translational regulation of MITF-M expression and activity,REACTOME,pathway,PATHWAY_1842 |
| 1843,1843,1843,1843,1843,1843,1843,1843,R-HSA-73614,Pyrimidine salvage,REACTOME,pathway,PATHWAY_1843 |
| 1844,1844,1844,1844,1844,1844,1844,1844,R-HSA-171007,p38MAPK events,REACTOME,pathway,PATHWAY_1844 |
| 1845,1845,1845,1845,1845,1845,1845,1845,R-HSA-73776,RNA Polymerase II Promoter Escape,REACTOME,pathway,PATHWAY_1845 |
| 1846,1846,1846,1846,1846,1846,1846,1846,R-HSA-6804758,Regulation of TP53 Activity through Acetylation,REACTOME,pathway,PATHWAY_1846 |
| 1847,1847,1847,1847,1847,1847,1847,1847,R-HSA-9005891,Loss of function of MECP2 in Rett syndrome,REACTOME,pathway,PATHWAY_1847 |
| 1848,1848,1848,1848,1848,1848,1848,1848,R-HSA-9674415,Drug resistance of PDGFR mutants,REACTOME,pathway,PATHWAY_1848 |
| 1849,1849,1849,1849,1849,1849,1849,1849,R-HSA-5655302,Signaling by FGFR1 in disease,REACTOME,pathway,PATHWAY_1849 |
| 1850,1850,1850,1850,1850,1850,1850,1850,R-HSA-5654227,Phospholipase C-mediated cascade |
| 1851,1851,1851,1851,1851,1851,1851,1851,R-HSA-9762292,Regulation of CDH11 function,REACTOME,pathway,PATHWAY_1851 |
| 1852,1852,1852,1852,1852,1852,1852,1852,R-HSA-774815,Nucleosome assembly,REACTOME,pathway,PATHWAY_1852 |
| 1853,1853,1853,1853,1853,1853,1853,1853,R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,REACTOME,pathway,PATHWAY_1853 |
| 1854,1854,1854,1854,1854,1854,1854,1854,R-HSA-162909,Host Interactions of HIV factors,REACTOME,pathway,PATHWAY_1854 |
| 1855,1855,1855,1855,1855,1855,1855,1855,R-HSA-5579011,Defective CYP2U1 causes SPG56,REACTOME,pathway,PATHWAY_1855 |
| 1856,1856,1856,1856,1856,1856,1856,1856,R-HSA-435354,Zinc transporters,REACTOME,pathway,PATHWAY_1856 |
| 1857,1857,1857,1857,1857,1857,1857,1857,R-HSA-5619063,Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS),REACTOME,pathway,PATHWAY_1857 |
| 1858,1858,1858,1858,1858,1858,1858,1858,R-HSA-5687128,MAPK6/MAPK4 signaling,REACTOME,pathway,PATHWAY_1858 |
| 1859,1859,1859,1859,1859,1859,1859,1859,R-HSA-8854691,Interleukin-20 family signaling,REACTOME,pathway,PATHWAY_1859 |
| 1860,1860,1860,1860,1860,1860,1860,1860,R-HSA-418886,Netrin mediated repulsion signals,REACTOME,pathway,PATHWAY_1860 |
| 1861,1861,1861,1861,1861,1861,1861,1861,R-HSA-5654699,SHC-mediated cascade:FGFR2,REACTOME,pathway,PATHWAY_1861 |
| 1862,1862,1862,1862,1862,1862,1862,1862,R-HSA-196757,Metabolism of folate and pterines,REACTOME,pathway,PATHWAY_1862 |
| 1863,1863,1863,1863,1863,1863,1863,1863,R-HSA-77108,Utilization of Ketone Bodies,REACTOME,pathway,PATHWAY_1863 |
| 1864,1864,1864,1864,1864,1864,1864,1864,R-HSA-5655253,Signaling by FGFR2 in disease,REACTOME,pathway,PATHWAY_1864 |
| 1865,1865,1865,1865,1865,1865,1865,1865,R-HSA-5624958,ARL13B-mediated ciliary trafficking of INPP5E,REACTOME,pathway,PATHWAY_1865 |
| 1866,1866,1866,1866,1866,1866,1866,1866,R-HSA-3000178,ECM proteoglycans,REACTOME,pathway,PATHWAY_1866 |
| 1867,1867,1867,1867,1867,1867,1867,1867,R-HSA-9759218,Cobalamin (Cbl) metabolism,REACTOME,pathway,PATHWAY_1867 |
| 1868,1868,1868,1868,1868,1868,1868,1868,R-HSA-190371,FGFR3b ligand binding and activation,REACTOME,pathway,PATHWAY_1868 |
| 1869,1869,1869,1869,1869,1869,1869,1869,R-HSA-210993,Tie2 Signaling,REACTOME,pathway,PATHWAY_1869 |
| 1870,1870,1870,1870,1870,1870,1870,1870,R-HSA-6803544,Ion influx/efflux at host-pathogen interface,REACTOME,pathway,PATHWAY_1870 |
| 1871,1871,1871,1871,1871,1871,1871,1871,R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,REACTOME,pathway,PATHWAY_1871 |
| 1872,1872,1872,1872,1872,1872,1872,1872,R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,REACTOME,pathway,PATHWAY_1872 |
| 1873,1873,1873,1873,1873,1873,1873,1873,R-HSA-975144,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,REACTOME,pathway,PATHWAY_1873 |
| 1874,1874,1874,1874,1874,1874,1874,1874,R-HSA-2160456,Phenylketonuria,REACTOME,pathway,PATHWAY_1874 |
| 1875,1875,1875,1875,1875,1875,1875,1875,R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,REACTOME,pathway,PATHWAY_1875 |
| 1876,1876,1876,1876,1876,1876,1876,1876,R-HSA-217271,FMO oxidises nucleophiles,REACTOME,pathway,PATHWAY_1876 |
| 1877,1877,1877,1877,1877,1877,1877,1877,R-HSA-204005,COPII-mediated vesicle transport,REACTOME,pathway,PATHWAY_1877 |
| 1878,1878,1878,1878,1878,1878,1878,1878,R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,REACTOME,pathway,PATHWAY_1878 |
| 1879,1879,1879,1879,1879,1879,1879,1879,R-HSA-3371568,Attenuation phase,REACTOME,pathway,PATHWAY_1879 |
| 1880,1880,1880,1880,1880,1880,1880,1880,R-HSA-5617833,Cilium Assembly,REACTOME,pathway,PATHWAY_1880 |
| 1881,1881,1881,1881,1881,1881,1881,1881,R-HSA-1660502,PIPs transport between early and late endosome membranes,REACTOME,pathway,PATHWAY_1881 |
| 1882,1882,1882,1882,1882,1882,1882,1882,R-HSA-9752946,Expression and translocation of olfactory receptors,REACTOME,pathway,PATHWAY_1882 |
| 1883,1883,1883,1883,1883,1883,1883,1883,R-HSA-9839389,TGFBR3 regulates TGF-beta signaling,REACTOME,pathway,PATHWAY_1883 |
| 1884,1884,1884,1884,1884,1884,1884,1884,R-HSA-8964058,HDL remodeling,REACTOME,pathway,PATHWAY_1884 |
| 1885,1885,1885,1885,1885,1885,1885,1885,R-HSA-5690714,CD22 mediated BCR regulation,REACTOME,pathway,PATHWAY_1885 |
| 1886,1886,1886,1886,1886,1886,1886,1886,R-HSA-5579030,Defective CYP19A1 causes AEXS,REACTOME,pathway,PATHWAY_1886 |
| 1887,1887,1887,1887,1887,1887,1887,1887,R-HSA-418217,G beta:gamma signalling through PLC beta,REACTOME,pathway,PATHWAY_1887 |
| 1888,1888,1888,1888,1888,1888,1888,1888,R-HSA-8955332,Carboxyterminal post-translational modifications of tubulin,REACTOME,pathway,PATHWAY_1888 |
| 1889,1889,1889,1889,1889,1889,1889,1889,R-HSA-5654219,Phospholipase C-mediated cascade: FGFR1,REACTOME,pathway,PATHWAY_1889 |
| 1890,1890,1890,1890,1890,1890,1890,1890,R-HSA-1483213,Synthesis of PE,REACTOME,pathway,PATHWAY_1890 |
| 1891,1891,1891,1891,1891,1891,1891,1891,R-HSA-190374,FGFR1c and Klotho ligand binding and activation,REACTOME,pathway,PATHWAY_1891 |
| 1892,1892,1892,1892,1892,1892,1892,1892,R-HSA-3065679,SUMO is proteolytically processed,REACTOME,pathway,PATHWAY_1892 |
| 1893,1893,1893,1893,1893,1893,1893,1893,R-HSA-180910,Vpr-mediated nuclear import of PICs,REACTOME,pathway,PATHWAY_1893 |
| 1894,1894,1894,1894,1894,1894,1894,1894,R-HSA-1296061,HCN channels,REACTOME,pathway,PATHWAY_1894 |
| 1895,1895,1895,1895,1895,1895,1895,1895,R-HSA-381119,Unfolded Protein Response (UPR),REACTOME,pathway,PATHWAY_1895 |
| 1896,1896,1896,1896,1896,1896,1896,1896,R-HSA-9636467,Blockage of phagosome acidification,REACTOME,pathway,PATHWAY_1896 |
| 1897,1897,1897,1897,1897,1897,1897,1897,R-HSA-5578749,Transcriptional regulation by small RNAs,REACTOME,pathway,PATHWAY_1897 |
| 1898,1898,1898,1898,1898,1898,1898,1898,R-HSA-5654704,SHC-mediated cascade:FGFR3,REACTOME,pathway,PATHWAY_1898 |
| 1899,1899,1899,1899,1899,1899,1899,1899,R-HSA-9820952,Respiratory Syncytial Virus Infection Pathway,REACTOME,pathway,PATHWAY_1899 |
| 1900,1900,1900,1900,1900,1900,1900,1900,R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,REACTOME,pathway,PATHWAY_1900 |
| 1901,1901,1901,1901,1901,1901,1901,1901,R-HSA-5579029,Metabolic disorders of biological oxidation enzymes,REACTOME,pathway,PATHWAY_1901 |
| 1902,1902,1902,1902,1902,1902,1902,1902,R-HSA-69242,S Phase,REACTOME,pathway,PATHWAY_1902 |
| 1903,1903,1903,1903,1903,1903,1903,1903,R-HSA-5358346,Hedgehog ligand biogenesis,REACTOME,pathway,PATHWAY_1903 |
| 1904,1904,1904,1904,1904,1904,1904,1904,R-HSA-5658471,Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),REACTOME,pathway,PATHWAY_1904 |
| 1905,1905,1905,1905,1905,1905,1905,1905,R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,REACTOME,pathway,PATHWAY_1905 |
| 1906,1906,1906,1906,1906,1906,1906,1906,R-HSA-8849470,PTK6 Regulates Cell Cycle,REACTOME,pathway,PATHWAY_1906 |
| 1907,1907,1907,1907,1907,1907,1907,1907,R-HSA-6791226,Major pathway of rRNA processing in the nucleolus and cytosol,REACTOME,pathway,PATHWAY_1907 |
| 1908,1908,1908,1908,1908,1908,1908,1908,R-HSA-418594,G alpha (i) signalling events,REACTOME,pathway,PATHWAY_1908 |
| 1909,1909,1909,1909,1909,1909,1909,1909,R-HSA-8963896,HDL assembly,REACTOME,pathway,PATHWAY_1909 |
| 1910,1910,1910,1910,1910,1910,1910,1910,R-HSA-5652084,Fructose metabolism,REACTOME,pathway,PATHWAY_1910 |
| 1911,1911,1911,1911,1911,1911,1911,1911,R-HSA-5654695,PI-3K cascade:FGFR2,REACTOME,pathway,PATHWAY_1911 |
| 1912,1912,1912,1912,1912,1912,1912,1912,R-HSA-9665737,Drug resistance in ERBB2 TMD/JMD mutants,REACTOME,pathway,PATHWAY_1912 |
| 1913,1913,1913,1913,1913,1913,1913,1913,R-HSA-5674499,Negative feedback regulation of MAPK pathway,REACTOME,pathway,PATHWAY_1913 |
| 1914,1914,1914,1914,1914,1914,1914,1914,R-HSA-5603027,IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR),REACTOME,pathway,PATHWAY_1914 |
| 1915,1915,1915,1915,1915,1915,1915,1915,R-HSA-3000471,Scavenging by Class B Receptors,REACTOME,pathway,PATHWAY_1915 |
| 1916,1916,1916,1916,1916,1916,1916,1916,R-HSA-4755583,Defective DOLK causes DOLK-CDG,REACTOME,pathway,PATHWAY_1916 |
| 1917,1917,1917,1917,1917,1917,1917,1917,R-HSA-164516,Minus-strand DNA synthesis,REACTOME,pathway,PATHWAY_1917 |
| 1918,1918,1918,1918,1918,1918,1918,1918,R-HSA-3656532,TGFBR1 KD Mutants in Cancer,REACTOME,pathway,PATHWAY_1918 |
| 1919,1919,1919,1919,1919,1919,1919,1919,R-HSA-5357786,TNFR1-induced proapoptotic signaling,REACTOME,pathway,PATHWAY_1919 |
| 1920,1920,1920,1920,1920,1920,1920,1920,R-HSA-9717319,brigatinib-resistant ALK mutants,REACTOME,pathway,PATHWAY_1920 |
| 1921,1921,1921,1921,1921,1921,1921,1921,R-HSA-77350,Beta oxidation of hexanoyl-CoA to butanoyl-CoA,REACTOME,pathway,PATHWAY_1921 |
| 1922,1922,1922,1922,1922,1922,1922,1922,R-HSA-8937144,Aryl hydrocarbon receptor signalling,REACTOME,pathway,PATHWAY_1922 |
| 1923,1923,1923,1923,1923,1923,1923,1923,R-HSA-9673221,Defective F9 activation,REACTOME,pathway,PATHWAY_1923 |
| 1924,1924,1924,1924,1924,1924,1924,1924,R-HSA-6814848,Glycerophospholipid catabolism,REACTOME,pathway,PATHWAY_1924 |
| 1925,1925,1925,1925,1925,1925,1925,1925,R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,REACTOME,pathway,PATHWAY_1925 |
| 1926,1926,1926,1926,1926,1926,1926,1926,R-HSA-9918438,Defective visual phototransduction due to RDH5 loss of function,REACTOME,pathway,PATHWAY_1926 |
| 1927,1927,1927,1927,1927,1927,1927,1927,R-HSA-9709275,Impaired BRCA2 translocation to the nucleus,REACTOME,pathway,PATHWAY_1927 |
| 1928,1928,1928,1928,1928,1928,1928,1928,R-HSA-5653656,Vesicle-mediated transport,REACTOME,pathway,PATHWAY_1928 |
| 1929,1929,1929,1929,1929,1929,1929,1929,R-HSA-8852405,Signaling by MST1,REACTOME,pathway,PATHWAY_1929 |
| 1930,1930,1930,1930,1930,1930,1930,1930,R-HSA-1474151,"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",REACTOME,pathway,PATHWAY_1930 |
| 1931,1931,1931,1931,1931,1931,1931,1931,R-HSA-180689,APOBEC3G mediated resistance to HIV-1 infection,REACTOME,pathway,PATHWAY_1931 |
| 1932,1932,1932,1932,1932,1932,1932,1932,R-HSA-3215018,Processing and activation of SUMO,REACTOME,pathway,PATHWAY_1932 |
| 1933,1933,1933,1933,1933,1933,1933,1933,R-HSA-5654706,FRS-mediated FGFR3 signaling,REACTOME,pathway,PATHWAY_1933 |
| 1934,1934,1934,1934,1934,1934,1934,1934,R-HSA-2979096,NOTCH2 Activation and Transmission of Signal to the Nucleus,REACTOME,pathway,PATHWAY_1934 |
| 1935,1935,1935,1935,1935,1935,1935,1935,R-HSA-191859,snRNP Assembly,REACTOME,pathway,PATHWAY_1935 |
| 1936,1936,1936,1936,1936,1936,1936,1936,R-HSA-71387,Metabolism of carbohydrates,REACTOME,pathway,PATHWAY_1936 |
| 1937,1937,1937,1937,1937,1937,1937,1937,R-HSA-5579022,Defective GGT1 causes GLUTH,REACTOME,pathway,PATHWAY_1937 |
| 1938,1938,1938,1938,1938,1938,1938,1938,R-HSA-168288,Fusion of the Influenza Virion to the Host Cell Endosome,REACTOME,pathway,PATHWAY_1938 |
| 1939,1939,1939,1939,1939,1939,1939,1939,R-HSA-5467345,Deletions in the AXIN1 gene destabilize the destruction complex,REACTOME,pathway,PATHWAY_1939 |
| 1940,1940,1940,1940,1940,1940,1940,1940,R-HSA-9734091,Drug-mediated inhibition of MET activation,REACTOME,pathway,PATHWAY_1940 |
| 1941,1941,1941,1941,1941,1941,1941,1941,R-HSA-2206302,MPS I - Hurler syndrome,REACTOME,pathway,PATHWAY_1941 |
| 1942,1942,1942,1942,1942,1942,1942,1942,R-HSA-9034864,Activated NTRK3 signals through RAS,REACTOME,pathway,PATHWAY_1942 |
| 1943,1943,1943,1943,1943,1943,1943,1943,R-HSA-72202,Transport of Mature Transcript to Cytoplasm,REACTOME,pathway,PATHWAY_1943 |
| 1944,1944,1944,1944,1944,1944,1944,1944,R-HSA-5619049,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),REACTOME,pathway,PATHWAY_1944 |
| 1945,1945,1945,1945,1945,1945,1945,1945,R-HSA-5678420,"Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome",REACTOME,pathway,PATHWAY_1945 |
| 1946,1946,1946,1946,1946,1946,1946,1946,R-HSA-195258,RHO GTPase Effectors,REACTOME,pathway,PATHWAY_1946 |
| 1947,1947,1947,1947,1947,1947,1947,1947,R-HSA-9823587,Defects of platelet adhesion to exposed collagen,REACTOME,pathway,PATHWAY_1947 |
| 1948,1948,1948,1948,1948,1948,1948,1948,R-HSA-9725554,Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin,REACTOME,pathway,PATHWAY_1948 |
| 1949,1949,1949,1949,1949,1949,1949,1949,R-HSA-5578775,Ion homeostasis,REACTOME,pathway,PATHWAY_1949 |
| 1950,1950,1950,1950,1950,1950,1950,1950,R-HSA-170145,Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes,REACTOME,pathway,PATHWAY_1950 |
| 1951,1951,1951,1951,1951,1951,1951,1951,R-HSA-9673768,Signaling by membrane-tethered fusions of PDGFRA or PDGFRB,REACTOME,pathway,PATHWAY_1951 |
| 1952,1952,1952,1952,1952,1952,1952,1952,R-HSA-70171,Glycolysis,REACTOME,pathway,PATHWAY_1952 |
| 1953,1953,1953,1953,1953,1953,1953,1953,R-HSA-8963691,Phenylalanine and tyrosine metabolism,REACTOME,pathway,PATHWAY_1953 |
| 1954,1954,1954,1954,1954,1954,1954,1954,R-HSA-5654700,FRS-mediated FGFR2 signaling,REACTOME,pathway,PATHWAY_1954 |
| 1955,1955,1955,1955,1955,1955,1955,1955,R-HSA-190828,Gap junction trafficking,REACTOME,pathway,PATHWAY_1955 |
| 1956,1956,1956,1956,1956,1956,1956,1956,R-HSA-5637815,Signaling by Ligand-Responsive EGFR Variants in Cancer,REACTOME,pathway,PATHWAY_1956 |
| 1957,1957,1957,1957,1957,1957,1957,1957,R-HSA-9717207,"Sensory perception of sweet, bitter, and umami (glutamate) taste",REACTOME,pathway,PATHWAY_1957 |
| 1958,1958,1958,1958,1958,1958,1958,1958,R-HSA-8863795,Downregulation of ERBB2 signaling,REACTOME,pathway,PATHWAY_1958 |
| 1959,1959,1959,1959,1959,1959,1959,1959,R-HSA-77042,Formation of editosomes by ADAR proteins,REACTOME,pathway,PATHWAY_1959 |
| 1960,1960,1960,1960,1960,1960,1960,1960,R-HSA-1482801,Acyl chain remodelling of PS,REACTOME,pathway,PATHWAY_1960 |
| 1961,1961,1961,1961,1961,1961,1961,1961,R-HSA-1566977,Fibronectin matrix formation,REACTOME,pathway,PATHWAY_1961 |
| 1962,1962,1962,1962,1962,1962,1962,1962,R-HSA-9865114,Maple Syrup Urine Disease,REACTOME,pathway,PATHWAY_1962 |
| 1963,1963,1963,1963,1963,1963,1963,1963,R-HSA-5609974,Defective PGM1 causes PGM1-CDG,REACTOME,pathway,PATHWAY_1963 |
| 1964,1964,1964,1964,1964,1964,1964,1964,R-HSA-5368598,Negative regulation of TCF-dependent signaling by DVL-interacting proteins,REACTOME,pathway,PATHWAY_1964 |
| 1965,1965,1965,1965,1965,1965,1965,1965,R-HSA-5687583,Defective SLC34A2 causes PALM,REACTOME,pathway,PATHWAY_1965 |
| 1966,1966,1966,1966,1966,1966,1966,1966,R-HSA-69620,Cell Cycle Checkpoints,REACTOME,pathway,PATHWAY_1966 |
| 1967,1967,1967,1967,1967,1967,1967,1967,R-HSA-2243919,Crosslinking of collagen fibrils,REACTOME,pathway,PATHWAY_1967 |
| 1968,1968,1968,1968,1968,1968,1968,1968,R-HSA-6791055,"TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P",REACTOME,pathway,PATHWAY_1968 |
| 1969,1969,1969,1969,1969,1969,1969,1969,R-HSA-109606,Intrinsic Pathway for Apoptosis,REACTOME,pathway,PATHWAY_1969 |
| 1970,1970,1970,1970,1970,1970,1970,1970,R-HSA-193144,Estrogen biosynthesis,REACTOME,pathway,PATHWAY_1970 |
| 1971,1971,1971,1971,1971,1971,1971,1971,R-HSA-5658034,HHAT G278V doesn't palmitoylate Hh-Np,REACTOME,pathway,PATHWAY_1971 |
| 1972,1972,1972,1972,1972,1972,1972,1972,R-HSA-9708296,"tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis",REACTOME,pathway,PATHWAY_1972 |
| 1973,1973,1973,1973,1973,1973,1973,1973,R-HSA-418555,G alpha (s) signalling events,REACTOME,pathway,PATHWAY_1973 |
| 1974,1974,1974,1974,1974,1974,1974,1974,R-HSA-6806667,Metabolism of fat-soluble vitamins,REACTOME,pathway,PATHWAY_1974 |
| 1975,1975,1975,1975,1975,1975,1975,1975,R-HSA-3359475,"Defective MMAA causes MMA, cblA type",REACTOME,pathway,PATHWAY_1975 |
| 1976,1976,1976,1976,1976,1976,1976,1976,R-HSA-210990,PECAM1 interactions,REACTOME,pathway,PATHWAY_1976 |
| 1977,1977,1977,1977,1977,1977,1977,1977,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,REACTOME,pathway,PATHWAY_1977 |
| 1978,1978,1978,1978,1978,1978,1978,1978,R-HSA-389359,CD28 dependent Vav1 pathway,REACTOME,pathway,PATHWAY_1978 |
| 1979,1979,1979,1979,1979,1979,1979,1979,R-HSA-383280,Nuclear Receptor transcription pathway,REACTOME,pathway,PATHWAY_1979 |
| 1980,1980,1980,1980,1980,1980,1980,1980,R-HSA-162588,Budding and maturation of HIV virion,REACTOME,pathway,PATHWAY_1980 |
| 1981,1981,1981,1981,1981,1981,1981,1981,R-HSA-5627083,RHO GTPases regulate CFTR trafficking,REACTOME,pathway,PATHWAY_1981 |
| 1982,1982,1982,1982,1982,1982,1982,1982,R-HSA-167590,Nef Mediated CD4 Down-regulation,REACTOME,pathway,PATHWAY_1982 |
| 1983,1983,1983,1983,1983,1983,1983,1983,R-HSA-1251985,Nuclear signaling by ERBB4,REACTOME,pathway,PATHWAY_1983 |
| 1984,1984,1984,1984,1984,1984,1984,1984,R-HSA-9916722,3-hydroxyisobutyryl-CoA hydrolase deficiency,REACTOME,pathway,PATHWAY_1984 |
| 1985,1985,1985,1985,1985,1985,1985,1985,R-HSA-209822,Glycoprotein hormones,REACTOME,pathway,PATHWAY_1985 |
| 1986,1986,1986,1986,1986,1986,1986,1986,R-HSA-75876,Synthesis of very long-chain fatty acyl-CoAs,REACTOME,pathway,PATHWAY_1986 |
| 1987,1987,1987,1987,1987,1987,1987,1987,R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,REACTOME,pathway,PATHWAY_1987 |
| 1988,1988,1988,1988,1988,1988,1988,1988,R-HSA-8951671,RUNX3 regulates YAP1-mediated transcription,REACTOME,pathway,PATHWAY_1988 |
| 1989,1989,1989,1989,1989,1989,1989,1989,R-HSA-9665348,Signaling by ERBB2 ECD mutants,REACTOME,pathway,PATHWAY_1989 |
| 1990,1990,1990,1990,1990,1990,1990,1990,R-HSA-5657560,Hereditary fructose intolerance,REACTOME,pathway,PATHWAY_1990 |
| 1991,1991,1991,1991,1991,1991,1991,1991,R-HSA-5579032,Defective TBXAS1 causes GHDD,REACTOME,pathway,PATHWAY_1991 |
| 1992,1992,1992,1992,1992,1992,1992,1992,R-HSA-9031528,NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,REACTOME,pathway,PATHWAY_1992 |
| 1993,1993,1993,1993,1993,1993,1993,1993,R-HSA-5362798,Release of Hh-Np from the secreting cell,REACTOME,pathway,PATHWAY_1993 |
| 1994,1994,1994,1994,1994,1994,1994,1994,R-HSA-9735786,Nucleotide catabolism defects,REACTOME,pathway,PATHWAY_1994 |
| 1995,1995,1995,1995,1995,1995,1995,1995,R-HSA-9821993,Replacement of protamines by nucleosomes in the male pronucleus,REACTOME,pathway,PATHWAY_1995 |
| 1996,1996,1996,1996,1996,1996,1996,1996,R-HSA-912631,Regulation of signaling by CBL,REACTOME,pathway,PATHWAY_1996 |
| 1997,1997,1997,1997,1997,1997,1997,1997,R-HSA-1474290,Collagen formation,REACTOME,pathway,PATHWAY_1997 |
| 1998,1998,1998,1998,1998,1998,1998,1998,R-HSA-5619111,Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1),REACTOME,pathway,PATHWAY_1998 |
| 1999,1999,1999,1999,1999,1999,1999,1999,R-HSA-187024,NGF-independant TRKA activation,REACTOME,pathway,PATHWAY_1999 |
| 2000,2000,2000,2000,2000,2000,2000,2000,R-HSA-416700,Other semaphorin interactions,REACTOME,pathway,PATHWAY_2000 |
| 2001,2001,2001,2001,2001,2001,2001,2001,R-HSA-6805567,Keratinization,REACTOME,pathway,PATHWAY_2001 |
| 2002,2002,2002,2002,2002,2002,2002,2002,R-HSA-9013957,TLR3-mediated TICAM1-dependent programmed cell death,REACTOME,pathway,PATHWAY_2002 |
| 2003,2003,2003,2003,2003,2003,2003,2003,R-HSA-1369062,ABC transporters in lipid homeostasis,REACTOME,pathway,PATHWAY_2003 |
| 2004,2004,2004,2004,2004,2004,2004,2004,R-HSA-168638,NOD1/2 Signaling Pathway,REACTOME,pathway,PATHWAY_2004 |
| 2005,2005,2005,2005,2005,2005,2005,2005,R-HSA-5619084,ABC transporter disorders,REACTOME,pathway,PATHWAY_2005 |
| 2006,2006,2006,2006,2006,2006,2006,2006,R-HSA-9605310,Defective Base Excision Repair Associated with MUTYH,REACTOME,pathway,PATHWAY_2006 |
| 2007,2007,2007,2007,2007,2007,2007,2007,R-HSA-9674401,Sunitinib-resistant PDGFR mutants,REACTOME,pathway,PATHWAY_2007 |
| 2008,2008,2008,2008,2008,2008,2008,2008,R-HSA-4641263,Regulation of FZD by ubiquitination,REACTOME,pathway,PATHWAY_2008 |
| 2009,2009,2009,2009,2009,2009,2009,2009,R-HSA-156588,Glucuronidation,REACTOME,pathway,PATHWAY_2009 |
| 2010,2010,2010,2010,2010,2010,2010,2010,R-HSA-391906,Leukotriene receptors,REACTOME,pathway,PATHWAY_2010 |
| 2011,2011,2011,2011,2011,2011,2011,2011,R-HSA-9845614,Sphingolipid catabolism,REACTOME,pathway,PATHWAY_2011 |
| 2012,2012,2012,2012,2012,2012,2012,2012,R-HSA-140875,Common Pathway of Fibrin Clot Formation,REACTOME,pathway,PATHWAY_2012 |
| 2013,2013,2013,2013,2013,2013,2013,2013,R-HSA-8941326,RUNX2 regulates bone development,REACTOME,pathway,PATHWAY_2013 |
| 2014,2014,2014,2014,2014,2014,2014,2014,R-HSA-9006931,Signaling by Nuclear Receptors,REACTOME,pathway,PATHWAY_2014 |
| 2015,2015,2015,2015,2015,2015,2015,2015,R-HSA-2644603,Signaling by NOTCH1 in Cancer,REACTOME,pathway,PATHWAY_2015 |
| 2016,2016,2016,2016,2016,2016,2016,2016,R-HSA-5626467,RHO GTPases activate IQGAPs,REACTOME,pathway,PATHWAY_2016 |
| 2017,2017,2017,2017,2017,2017,2017,2017,R-HSA-5619042,Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN),REACTOME,pathway,PATHWAY_2017 |
| 2018,2018,2018,2018,2018,2018,2018,2018,R-HSA-8939902,Regulation of RUNX2 expression and activity,REACTOME,pathway,PATHWAY_2018 |
| 2019,2019,2019,2019,2019,2019,2019,2019,R-HSA-211958,Miscellaneous substrates,REACTOME,pathway,PATHWAY_2019 |
| 2020,2020,2020,2020,2020,2020,2020,2020,R-HSA-156584,Cytosolic sulfonation of small molecules,REACTOME,pathway,PATHWAY_2020 |
| 2021,2021,2021,2021,2021,2021,2021,2021,R-HSA-9912529,H139Hfs13* PPM1K causes a mild variant of MSUD,REACTOME,pathway,PATHWAY_2021 |
| 2022,2022,2022,2022,2022,2022,2022,2022,R-HSA-1234174,Cellular response to hypoxia,REACTOME,pathway,PATHWAY_2022 |
| 2023,2023,2023,2023,2023,2023,2023,2023,R-HSA-425381,Bicarbonate transporters,REACTOME,pathway,PATHWAY_2023 |
| 2024,2024,2024,2024,2024,2024,2024,2024,R-HSA-4085001,Sialic acid metabolism,REACTOME,pathway,PATHWAY_2024 |
| 2025,2025,2025,2025,2025,2025,2025,2025,R-HSA-176034,Interactions of Tat with host cellular proteins,REACTOME,pathway,PATHWAY_2025 |
| 2026,2026,2026,2026,2026,2026,2026,2026,R-HSA-9645135,STAT5 Activation,REACTOME,pathway,PATHWAY_2026 |
| 2027,2027,2027,2027,2027,2027,2027,2027,R-HSA-9839383,TGFBR3 PTM regulation,REACTOME,pathway,PATHWAY_2027 |
| 2028,2028,2028,2028,2028,2028,2028,2028,R-HSA-372708,p130Cas linkage to MAPK signaling for integrins,REACTOME,pathway,PATHWAY_2028 |
| 2029,2029,2029,2029,2029,2029,2029,2029,R-HSA-5218920,VEGFR2 mediated vascular permeability,REACTOME,pathway,PATHWAY_2029 |
| 2030,2030,2030,2030,2030,2030,2030,2030,R-HSA-168336,Uncoating of the Influenza Virion,REACTOME,pathway,PATHWAY_2030 |
| 2031,2031,2031,2031,2031,2031,2031,2031,R-HSA-9007892,Interleukin-38 signaling,REACTOME,pathway,PATHWAY_2031 |
| 2032,2032,2032,2032,2032,2032,2032,2032,R-HSA-9758881,Uptake of dietary cobalamins into enterocytes,REACTOME,pathway,PATHWAY_2032 |
| 2033,2033,2033,2033,2033,2033,2033,2033,R-HSA-9662361,Sensory processing of sound by outer hair cells of the cochlea,REACTOME,pathway,PATHWAY_2033 |
| 2034,2034,2034,2034,2034,2034,2034,2034,R-HSA-68875,Mitotic Prophase,REACTOME,pathway,PATHWAY_2034 |
| 2035,2035,2035,2035,2035,2035,2035,2035,R-HSA-110313,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,REACTOME,pathway,PATHWAY_2035 |
| 2036,2036,2036,2036,2036,2036,2036,2036,R-HSA-450604,KSRP (KHSRP) binds and destabilizes mRNA,REACTOME,pathway,PATHWAY_2036 |
| 2037,2037,2037,2037,2037,2037,2037,2037,R-HSA-9823739,Formation of the anterior neural plate,REACTOME,pathway,PATHWAY_2037 |
| 2038,2038,2038,2038,2038,2038,2038,2038,R-HSA-9645723,Diseases of programmed cell death,REACTOME,pathway,PATHWAY_2038 |
| 2039,2039,2039,2039,2039,2039,2039,2039,R-HSA-9837092,FASTK family proteins regulate processing and stability of mitochondrial RNAs,REACTOME,pathway,PATHWAY_2039 |
| 2040,2040,2040,2040,2040,2040,2040,2040,R-HSA-9664420,Killing mechanisms,REACTOME,pathway,PATHWAY_2040 |
| 2041,2041,2041,2041,2041,2041,2041,2041,R-HSA-9013424,RHOV GTPase cycle,REACTOME,pathway,PATHWAY_2041 |
| 2042,2042,2042,2042,2042,2042,2042,2042,R-HSA-5579010,Defective CYP24A1 causes HCAI,REACTOME,pathway,PATHWAY_2042 |
| 2043,2043,2043,2043,2043,2043,2043,2043,R-HSA-2672351,Stimuli-sensing channels,REACTOME,pathway,PATHWAY_2043 |
| 2044,2044,2044,2044,2044,2044,2044,2044,R-HSA-9664417,Leishmania phagocytosis,REACTOME,pathway,PATHWAY_2044 |
| 2045,2045,2045,2045,2045,2045,2045,2045,R-HSA-9669926,Nilotinib-resistant KIT mutants,REACTOME,pathway,PATHWAY_2045 |
| 2046,2046,2046,2046,2046,2046,2046,2046,R-HSA-169131,Inhibition of PKR,REACTOME,pathway,PATHWAY_2046 |
| 2047,2047,2047,2047,2047,2047,2047,2047,R-HSA-5694530,Cargo concentration in the ER,REACTOME,pathway,PATHWAY_2047 |
| 2048,2048,2048,2048,2048,2048,2048,2048,R-HSA-9706019,RHOBTB3 ATPase cycle,REACTOME,pathway,PATHWAY_2048 |
| 2049,2049,2049,2049,2049,2049,2049,2049,R-HSA-2474795,Diseases associated with visual transduction,REACTOME,pathway,PATHWAY_2049 |
| 2050,2050,2050,2050,2050,2050,2050,2050,R-HSA-1430728,Metabolism,REACTOME,pathway,PATHWAY_2050 |
| 2051,2051,2051,2051,2051,2051,2051,2051,R-HSA-77305,Beta oxidation of palmitoyl-CoA to myristoyl-CoA,REACTOME,pathway,PATHWAY_2051 |
| 2052,2052,2052,2052,2052,2052,2052,2052,R-HSA-9634285,Constitutive Signaling by Overexpressed ERBB2,REACTOME,pathway,PATHWAY_2052 |
| 2053,2053,2053,2053,2053,2053,2053,2053,R-HSA-351202,Metabolism of polyamines,REACTOME,pathway,PATHWAY_2053 |
| 2054,2054,2054,2054,2054,2054,2054,2054,R-HSA-6806942,MET Receptor Activation,REACTOME,pathway,PATHWAY_2054 |
| 2055,2055,2055,2055,2055,2055,2055,2055,R-HSA-9669935,Signaling by juxtamembrane domain KIT mutants,REACTOME,pathway,PATHWAY_2055 |
| 2056,2056,2056,2056,2056,2056,2056,2056,R-HSA-9683701,Translation of Structural Proteins,REACTOME,pathway,PATHWAY_2056 |
| 2057,2057,2057,2057,2057,2057,2057,2057,R-HSA-1660514,Synthesis of PIPs at the Golgi membrane,REACTOME,pathway,PATHWAY_2057 |
| 2058,2058,2058,2058,2058,2058,2058,2058,R-HSA-9754119,Drug-mediated inhibition of CDK4/CDK6 activity,REACTOME,pathway,PATHWAY_2058 |
| 2059,2059,2059,2059,2059,2059,2059,2059,R-HSA-1299308,Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),REACTOME,pathway,PATHWAY_2059 |
| 2060,2060,2060,2060,2060,2060,2060,2060,R-HSA-193048,Androgen biosynthesis,REACTOME,pathway,PATHWAY_2060 |
| 2061,2061,2061,2061,2061,2061,2061,2061,R-HSA-5579009,Defective CYP11B2 causes CMO-1 deficiency,REACTOME,pathway,PATHWAY_2061 |
| 2062,2062,2062,2062,2062,2062,2062,2062,R-HSA-6782210,Gap-filling DNA repair synthesis and ligation in TC-NER,REACTOME,pathway,PATHWAY_2062 |
| 2063,2063,2063,2063,2063,2063,2063,2063,R-HSA-450294,MAP kinase activation,REACTOME,pathway,PATHWAY_2063 |
| 2064,2064,2064,2064,2064,2064,2064,2064,R-HSA-9824443,Parasitic Infection Pathways,REACTOME,pathway,PATHWAY_2064 |
| 2065,2065,2065,2065,2065,2065,2065,2065,R-HSA-5619058,"Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)",REACTOME,pathway,PATHWAY_2065 |
| 2066,2066,2066,2066,2066,2066,2066,2066,R-HSA-69166,Removal of the Flap Intermediate,REACTOME,pathway,PATHWAY_2066 |
| 2067,2067,2067,2067,2067,2067,2067,2067,R-HSA-168271,Transport of Ribonucleoproteins into the Host Nucleus,REACTOME,pathway,PATHWAY_2067 |
| 2068,2068,2068,2068,2068,2068,2068,2068,R-HSA-9733709,Cardiogenesis,REACTOME,pathway,PATHWAY_2068 |
| 2069,2069,2069,2069,2069,2069,2069,2069,R-HSA-8943723,Regulation of PTEN mRNA translation,REACTOME,pathway,PATHWAY_2069 |
| 2070,2070,2070,2070,2070,2070,2070,2070,R-HSA-9026357,NTF4 activates NTRK2 (TRKB) signaling,REACTOME,pathway,PATHWAY_2070 |
| 2071,2071,2071,2071,2071,2071,2071,2071,R-HSA-2586552,Signaling by Leptin,REACTOME,pathway,PATHWAY_2071 |
| 2072,2072,2072,2072,2072,2072,2072,2072,R-HSA-2173791,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),REACTOME,pathway,PATHWAY_2072 |
| 2073,2073,2073,2073,2073,2073,2073,2073,R-HSA-2978092,Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,REACTOME,pathway,PATHWAY_2073 |
| 2074,2074,2074,2074,2074,2074,2074,2074,R-HSA-629587,Highly sodium permeable postsynaptic acetylcholine nicotinic receptors,REACTOME,pathway,PATHWAY_2074 |
| 2075,2075,2075,2075,2075,2075,2075,2075,R-HSA-9693928,Defective RIPK1-mediated regulated necrosis,REACTOME,pathway,PATHWAY_2075 |
| 2076,2076,2076,2076,2076,2076,2076,2076,R-HSA-622327,Postsynaptic nicotinic acetylcholine receptors,REACTOME,pathway,PATHWAY_2076 |
| 2077,2077,2077,2077,2077,2077,2077,2077,R-HSA-5263617,Metabolism of ingested MeSeO2H into MeSeH,REACTOME,pathway,PATHWAY_2077 |
| 2078,2078,2078,2078,2078,2078,2078,2078,R-HSA-5213460,RIPK1-mediated regulated necrosis,REACTOME,pathway,PATHWAY_2078 |
| 2079,2079,2079,2079,2079,2079,2079,2079,R-HSA-8948751,Regulation of PTEN stability and activity,REACTOME,pathway,PATHWAY_2079 |
| 2080,2080,2080,2080,2080,2080,2080,2080,R-HSA-9672395,Defective F8 binding to the cell membrane,REACTOME,pathway,PATHWAY_2080 |
| 2081,2081,2081,2081,2081,2081,2081,2081,R-HSA-209968,Thyroxine biosynthesis,REACTOME,pathway,PATHWAY_2081 |
| 2082,2082,2082,2082,2082,2082,2082,2082,R-HSA-111997,CaM pathway,REACTOME,pathway,PATHWAY_2082 |
| 2083,2083,2083,2083,2083,2083,2083,2083,R-HSA-68616,Assembly of the ORC complex at the origin of replication,REACTOME,pathway,PATHWAY_2083 |
| 2084,2084,2084,2084,2084,2084,2084,2084,R-HSA-156590,Glutathione conjugation,REACTOME,pathway,PATHWAY_2084 |
| 2085,2085,2085,2085,2085,2085,2085,2085,R-HSA-9020591,Interleukin-12 signaling,REACTOME,pathway,PATHWAY_2085 |
| 2086,2086,2086,2086,2086,2086,2086,2086,R-HSA-451326,Activation of kainate receptors upon glutamate binding,REACTOME,pathway,PATHWAY_2086 |
| 2087,2087,2087,2087,2087,2087,2087,2087,R-HSA-167021,PLC-gamma1 signalling,REACTOME,pathway,PATHWAY_2087 |
| 2088,2088,2088,2088,2088,2088,2088,2088,R-HSA-4687000,Defective MPDU1 causes CDG-1f,REACTOME,pathway,PATHWAY_2088 |
| 2089,2089,2089,2089,2089,2089,2089,2089,R-HSA-9665686,Signaling by ERBB2 TMD/JMD mutants,REACTOME,pathway,PATHWAY_2089 |
| 2090,2090,2090,2090,2090,2090,2090,2090,R-HSA-156580,Phase II - Conjugation of compounds,REACTOME,pathway,PATHWAY_2090 |
| 2091,2091,2091,2091,2091,2091,2091,2091,R-HSA-3296469,Defects in cobalamin (B12) metabolism,REACTOME,pathway,PATHWAY_2091 |
| 2092,2092,2092,2092,2092,2092,2092,2092,R-HSA-975871,MyD88 cascade initiated on plasma membrane,REACTOME,pathway,PATHWAY_2092 |
| 2093,2093,2093,2093,2093,2093,2093,2093,R-HSA-202670,ERKs are inactivated,REACTOME,pathway,PATHWAY_2093 |
| 2094,2094,2094,2094,2094,2094,2094,2094,R-HSA-416993,Trafficking of GluR2-containing AMPA receptors,REACTOME,pathway,PATHWAY_2094 |
| 2095,2095,2095,2095,2095,2095,2095,2095,R-HSA-9755088,Ribavirin ADME,REACTOME,pathway,PATHWAY_2095 |
| 2096,2096,2096,2096,2096,2096,2096,2096,R-HSA-5684264,MAP3K8 (TPL2)-dependent MAPK1/3 activation,REACTOME,pathway,PATHWAY_2096 |
| 2097,2097,2097,2097,2097,2097,2097,2097,R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,REACTOME,pathway,PATHWAY_2097 |
| 2098,2098,2098,2098,2098,2098,2098,2098,R-HSA-198203,PI3K/AKT activation,REACTOME,pathway,PATHWAY_2098 |
| 2099,2099,2099,2099,2099,2099,2099,2099,R-HSA-75153,Apoptotic execution phase,REACTOME,pathway,PATHWAY_2099 |
| 2100,2100,2100,2100,2100,2100,2100,2100,R-HSA-9839373,Signaling by TGFBR3,REACTOME,pathway,PATHWAY_2100 |
| 2101,2101,2101,2101,2101,2101,2101,2101,R-HSA-8953854,Metabolism of RNA,REACTOME,pathway,PATHWAY_2101 |
| 2102,2102,2102,2102,2102,2102,2102,2102,R-HSA-6806003,Regulation of TP53 Expression and Degradation,REACTOME,pathway,PATHWAY_2102 |
| 2103,2103,2103,2103,2103,2103,2103,2103,R-HSA-5688426,Deubiquitination,REACTOME,pathway,PATHWAY_2103 |
| 2104,2104,2104,2104,2104,2104,2104,2104,R-HSA-5579012,Defective MAOA causes BRUNS,REACTOME,pathway,PATHWAY_2104 |
| 2105,2105,2105,2105,2105,2105,2105,2105,R-HSA-9735763,Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine,REACTOME,pathway,PATHWAY_2105 |
| 2106,2106,2106,2106,2106,2106,2106,2106,R-HSA-2022857,Keratan sulfate degradation,REACTOME,pathway,PATHWAY_2106 |
| 2107,2107,2107,2107,2107,2107,2107,2107,R-HSA-8963899,Plasma lipoprotein remodeling,REACTOME,pathway,PATHWAY_2107 |
| 2108,2108,2108,2108,2108,2108,2108,2108,R-HSA-1855167,Synthesis of pyrophosphates in the cytosol,REACTOME,pathway,PATHWAY_2108 |
| 2109,2109,2109,2109,2109,2109,2109,2109,R-HSA-2206308,MPS IV - Morquio syndrome B,REACTOME,pathway,PATHWAY_2109 |
| 2110,2110,2110,2110,2110,2110,2110,2110,R-HSA-170834,Signaling by TGF-beta Receptor Complex,REACTOME,pathway,PATHWAY_2110 |
| 2111,2111,2111,2111,2111,2111,2111,2111,R-HSA-174417,Telomere C-strand (Lagging Strand) Synthesis,REACTOME,pathway,PATHWAY_2111 |
| 2112,2112,2112,2112,2112,2112,2112,2112,R-HSA-9027277,Erythropoietin activates Phospholipase C gamma (PLCG),REACTOME,pathway,PATHWAY_2112 |
| 2113,2113,2113,2113,2113,2113,2113,2113,R-HSA-5576892,Phase 0 - rapid depolarisation,REACTOME,pathway,PATHWAY_2113 |
| 2114,2114,2114,2114,2114,2114,2114,2114,R-HSA-9669936,Sorafenib-resistant KIT mutants,REACTOME,pathway,PATHWAY_2114 |
| 2115,2115,2115,2115,2115,2115,2115,2115,R-HSA-3560783,"Defective B4GALT7 causes EDS, progeroid type",REACTOME,pathway,PATHWAY_2115 |
| 2116,2116,2116,2116,2116,2116,2116,2116,R-HSA-1614635,Sulfur amino acid metabolism,REACTOME,pathway,PATHWAY_2116 |
| 2117,2117,2117,2117,2117,2117,2117,2117,R-HSA-9840309,Glycosphingolipid biosynthesis,REACTOME,pathway,PATHWAY_2117 |
| 2118,2118,2118,2118,2118,2118,2118,2118,R-HSA-9763198,Impaired BRCA2 binding to SEM1 (DSS1),REACTOME,pathway,PATHWAY_2118 |
| 2119,2119,2119,2119,2119,2119,2119,2119,R-HSA-1296072,Voltage gated Potassium channels,REACTOME,pathway,PATHWAY_2119 |
| 2120,2120,2120,2120,2120,2120,2120,2120,R-HSA-164939,Nef mediated downregulation of CD28 cell surface expression,REACTOME,pathway,PATHWAY_2120 |
| 2121,2121,2121,2121,2121,2121,2121,2121,R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,REACTOME,pathway,PATHWAY_2121 |
| 2122,2122,2122,2122,2122,2122,2122,2122,R-HSA-193704,p75 NTR receptor-mediated signalling,REACTOME,pathway,PATHWAY_2122 |
| 2123,2123,2123,2123,2123,2123,2123,2123,R-HSA-77310,Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,REACTOME,pathway,PATHWAY_2123 |
| 2124,2124,2124,2124,2124,2124,2124,2124,R-HSA-611105,Respiratory electron transport,REACTOME,pathway,PATHWAY_2124 |
| 2125,2125,2125,2125,2125,2125,2125,2125,R-HSA-917937,Iron uptake and transport,REACTOME,pathway,PATHWAY_2125 |
| 2126,2126,2126,2126,2126,2126,2126,2126,R-HSA-9018682,Biosynthesis of maresins,REACTOME,pathway,PATHWAY_2126 |
| 2127,2127,2127,2127,2127,2127,2127,2127,R-HSA-9665249,Resistance of ERBB2 KD mutants to afatinib,REACTOME,pathway,PATHWAY_2127 |
| 2128,2128,2128,2128,2128,2128,2128,2128,R-HSA-909733,Interferon alpha/beta signaling,REACTOME,pathway,PATHWAY_2128 |
| 2129,2129,2129,2129,2129,2129,2129,2129,R-HSA-376172,DSCAM interactions,REACTOME,pathway,PATHWAY_2129 |
| 2130,2130,2130,2130,2130,2130,2130,2130,R-HSA-5658442,Regulation of RAS by GAPs,REACTOME,pathway,PATHWAY_2130 |
| 2131,2131,2131,2131,2131,2131,2131,2131,R-HSA-9918436,Defective visual phototransduction due to OPN1MW loss of function,REACTOME,pathway,PATHWAY_2131 |
| 2132,2132,2132,2132,2132,2132,2132,2132,R-HSA-381042,PERK regulates gene expression,REACTOME,pathway,PATHWAY_2132 |
| 2133,2133,2133,2133,2133,2133,2133,2133,R-HSA-1980145,Signaling by NOTCH2,REACTOME,pathway,PATHWAY_2133 |
| 2134,2134,2134,2134,2134,2134,2134,2134,R-HSA-8948747,Regulation of PTEN localization,REACTOME,pathway,PATHWAY_2134 |
| 2135,2135,2135,2135,2135,2135,2135,2135,R-HSA-73933,Resolution of Abasic Sites (AP sites),REACTOME,pathway,PATHWAY_2135 |
| 2136,2136,2136,2136,2136,2136,2136,2136,R-HSA-1300645,Acrosome Reaction and Sperm:Oocyte Membrane Binding,REACTOME,pathway,PATHWAY_2136 |
| 2137,2137,2137,2137,2137,2137,2137,2137,R-HSA-9639775,Antimicrobial action and antimicrobial resistance in Mtb,REACTOME,pathway,PATHWAY_2137 |
| 2138,2138,2138,2138,2138,2138,2138,2138,R-HSA-916853,Degradation of GABA,REACTOME,pathway,PATHWAY_2138 |
| 2139,2139,2139,2139,2139,2139,2139,2139,R-HSA-975155,MyD88 dependent cascade initiated on endosome,REACTOME,pathway,PATHWAY_2139 |
| 2140,2140,2140,2140,2140,2140,2140,2140,R-HSA-216083,Integrin cell surface interactions,REACTOME,pathway,PATHWAY_2140 |
| 2141,2141,2141,2141,2141,2141,2141,2141,R-HSA-74217,Purine salvage,REACTOME,pathway,PATHWAY_2141 |
| 2142,2142,2142,2142,2142,2142,2142,2142,R-HSA-8849471,"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",REACTOME,pathway,PATHWAY_2142 |
| 2143,2143,2143,2143,2143,2143,2143,2143,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,REACTOME,pathway,PATHWAY_2143 |
| 2144,2144,2144,2144,2144,2144,2144,2144,R-HSA-8983432,Interleukin-15 signaling,REACTOME,pathway,PATHWAY_2144 |
| 2145,2145,2145,2145,2145,2145,2145,2145,R-HSA-5419276,Mitochondrial translation termination,REACTOME,pathway,PATHWAY_2145 |
| 2146,2146,2146,2146,2146,2146,2146,2146,R-HSA-420597,Nectin/Necl trans heterodimerization,REACTOME,pathway,PATHWAY_2146 |
| 2147,2147,2147,2147,2147,2147,2147,2147,R-HSA-1222387,Tolerance of reactive oxygen produced by macrophages,REACTOME,pathway,PATHWAY_2147 |
| 2148,2148,2148,2148,2148,2148,2148,2148,R-HSA-5684045,Defective ABCD1 causes ALD,REACTOME,pathway,PATHWAY_2148 |
| 2149,2149,2149,2149,2149,2149,2149,2149,R-HSA-9857377,Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy,REACTOME,pathway,PATHWAY_2149 |
| 2150,2150,2150,2150,2150,2150,2150,2150,R-HSA-8943724,Regulation of PTEN gene transcription,REACTOME,pathway,PATHWAY_2150 |
| 2151,2151,2151,2151,2151,2151,2151,2151,R-HSA-9617629,Regulation of FOXO transcriptional activity by acetylation,REACTOME,pathway,PATHWAY_2151 |
| 2152,2152,2152,2152,2152,2152,2152,2152,R-HSA-9845576,Glycosphingolipid transport,REACTOME,pathway,PATHWAY_2152 |
| 2153,2153,2153,2153,2153,2153,2153,2153,R-HSA-9010553,Regulation of expression of SLITs and ROBOs,REACTOME,pathway,PATHWAY_2153 |
| 2154,2154,2154,2154,2154,2154,2154,2154,R-HSA-9637698,Phagocyte cell death caused by cytosolic Mtb,REACTOME,pathway,PATHWAY_2154 |
| 2155,2155,2155,2155,2155,2155,2155,2155,R-HSA-9672383,Defective factor IX causes thrombophilia,REACTOME,pathway,PATHWAY_2155 |
| 2156,2156,2156,2156,2156,2156,2156,2156,R-HSA-9660537,Signaling by MRAS-complex mutants,REACTOME,pathway,PATHWAY_2156 |
| 2157,2157,2157,2157,2157,2157,2157,2157,R-HSA-8942233,Intestinal infectious diseases,REACTOME,pathway,PATHWAY_2157 |
| 2158,2158,2158,2158,2158,2158,2158,2158,R-HSA-4608870,Asymmetric localization of PCP proteins,REACTOME,pathway,PATHWAY_2158 |
| 2159,2159,2159,2159,2159,2159,2159,2159,R-HSA-75896,Plasmalogen biosynthesis,REACTOME,pathway,PATHWAY_2159 |
| 2160,2160,2160,2160,2160,2160,2160,2160,R-HSA-381771,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",REACTOME,pathway,PATHWAY_2160 |
| 2161,2161,2161,2161,2161,2161,2161,2161,R-HSA-203927,MicroRNA (miRNA) biogenesis,REACTOME,pathway,PATHWAY_2161 |
| 2162,2162,2162,2162,2162,2162,2162,2162,R-HSA-5673000,RAF activation,REACTOME,pathway,PATHWAY_2162 |
| 2163,2163,2163,2163,2163,2163,2163,2163,R-HSA-9834899,Specification of the neural plate border,REACTOME,pathway,PATHWAY_2163 |
| 2164,2164,2164,2164,2164,2164,2164,2164,R-HSA-9696270,RND2 GTPase cycle,REACTOME,pathway,PATHWAY_2164 |
| 2165,2165,2165,2165,2165,2165,2165,2165,R-HSA-5619072,Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M),REACTOME,pathway,PATHWAY_2165 |
| 2166,2166,2166,2166,2166,2166,2166,2166,R-HSA-9663891,Selective autophagy,REACTOME,pathway,PATHWAY_2166 |
| 2167,2167,2167,2167,2167,2167,2167,2167,R-HSA-9013149,RAC1 GTPase cycle,REACTOME,pathway,PATHWAY_2167 |
| 2168,2168,2168,2168,2168,2168,2168,2168,R-HSA-9630221,Defective NTHL1 substrate processing,REACTOME,pathway,PATHWAY_2168 |
| 2169,2169,2169,2169,2169,2169,2169,2169,R-HSA-195253,Degradation of beta-catenin by the destruction complex,REACTOME,pathway,PATHWAY_2169 |
| 2170,2170,2170,2170,2170,2170,2170,2170,R-HSA-1660661,Sphingolipid de novo biosynthesis,REACTOME,pathway,PATHWAY_2170 |
| 2171,2171,2171,2171,2171,2171,2171,2171,R-HSA-5619070,Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),REACTOME,pathway,PATHWAY_2171 |
| 2172,2172,2172,2172,2172,2172,2172,2172,R-HSA-5688399,Defective ABCA3 causes SMDP3,REACTOME,pathway,PATHWAY_2172 |
| 2173,2173,2173,2173,2173,2173,2173,2173,R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),REACTOME,pathway,PATHWAY_2173 |
| 2174,2174,2174,2174,2174,2174,2174,2174,R-HSA-6809583,Retinoid metabolism disease events,REACTOME,pathway,PATHWAY_2174 |
| 2175,2175,2175,2175,2175,2175,2175,2175,R-HSA-9665245,Resistance of ERBB2 KD mutants to tesevatinib,REACTOME,pathway,PATHWAY_2175 |
| 2176,2176,2176,2176,2176,2176,2176,2176,R-HSA-4641262,Disassembly of the destruction complex and recruitment of AXIN to the membrane,REACTOME,pathway,PATHWAY_2176 |
| 2177,2177,2177,2177,2177,2177,2177,2177,R-HSA-5621575,CD209 (DC-SIGN) signaling,REACTOME,pathway,PATHWAY_2177 |
| 2178,2178,2178,2178,2178,2178,2178,2178,R-HSA-5654727,Negative regulation of FGFR2 signaling,REACTOME,pathway,PATHWAY_2178 |
| 2179,2179,2179,2179,2179,2179,2179,2179,R-HSA-112307,Transmission across Electrical Synapses ,REACTOME,pathway,PATHWAY_2179 |
| 2180,2180,2180,2180,2180,2180,2180,2180,R-HSA-9664323,FCGR3A-mediated IL10 synthesis,REACTOME,pathway,PATHWAY_2180 |
| 2181,2181,2181,2181,2181,2181,2181,2181,R-HSA-3560792,Defective SLC26A2 causes chondrodysplasias,REACTOME,pathway,PATHWAY_2181 |
| 2182,2182,2182,2182,2182,2182,2182,2182,R-HSA-5654738,Signaling by FGFR2,REACTOME,pathway,PATHWAY_2182 |
| 2183,2183,2183,2183,2183,2183,2183,2183,R-HSA-3282872,Severe congenital neutropenia type 4 (G6PC3),REACTOME,pathway,PATHWAY_2183 |
| 2184,2184,2184,2184,2184,2184,2184,2184,R-HSA-193697,p75NTR regulates axonogenesis,REACTOME,pathway,PATHWAY_2184 |
| 2185,2185,2185,2185,2185,2185,2185,2185,R-HSA-168298,Release,REACTOME,pathway,PATHWAY_2185 |
| 2186,2186,2186,2186,2186,2186,2186,2186,R-HSA-8964041,LDL remodeling,REACTOME,pathway,PATHWAY_2186 |
| 2187,2187,2187,2187,2187,2187,2187,2187,R-HSA-69895,Transcriptional activation of cell cycle inhibitor p21 ,REACTOME,pathway,PATHWAY_2187 |
| 2188,2188,2188,2188,2188,2188,2188,2188,R-HSA-877300,Interferon gamma signaling,REACTOME,pathway,PATHWAY_2188 |
| 2189,2189,2189,2189,2189,2189,2189,2189,R-HSA-209543,p75NTR recruits signalling complexes,REACTOME,pathway,PATHWAY_2189 |
| 2190,2190,2190,2190,2190,2190,2190,2190,R-HSA-2033514,FGFR3 mutant receptor activation,REACTOME,pathway,PATHWAY_2190 |
| 2191,2191,2191,2191,2191,2191,2191,2191,R-HSA-182218,Nef Mediated CD8 Down-regulation,REACTOME,pathway,PATHWAY_2191 |
| 2192,2192,2192,2192,2192,2192,2192,2192,R-HSA-4341670,Defective NEU1 causes sialidosis,REACTOME,pathway,PATHWAY_2192 |
| 2193,2193,2193,2193,2193,2193,2193,2193,R-HSA-3214842,HDMs demethylate histones,REACTOME,pathway,PATHWAY_2193 |
| 2194,2194,2194,2194,2194,2194,2194,2194,R-HSA-9634815,Transcriptional Regulation by NPAS4,REACTOME,pathway,PATHWAY_2194 |
| 2195,2195,2195,2195,2195,2195,2195,2195,R-HSA-181430,Norepinephrine Neurotransmitter Release Cycle,REACTOME,pathway,PATHWAY_2195 |
| 2196,2196,2196,2196,2196,2196,2196,2196,R-HSA-211981,Xenobiotics,REACTOME,pathway,PATHWAY_2196 |
| 2197,2197,2197,2197,2197,2197,2197,2197,R-HSA-5632681,Ligand-receptor interactions,REACTOME,pathway,PATHWAY_2197 |
| 2198,2198,2198,2198,2198,2198,2198,2198,R-HSA-9615933,Postmitotic nuclear pore complex (NPC) reformation,REACTOME,pathway,PATHWAY_2198 |
| 2199,2199,2199,2199,2199,2199,2199,2199,R-HSA-8978934,Metabolism of cofactors,REACTOME,pathway,PATHWAY_2199 |
| 2200,2200,2200,2200,2200,2200,2200,2200,R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,REACTOME,pathway,PATHWAY_2200 |
| 2201,2201,2201,2201,2201,2201,2201,2201,R-HSA-354192,Integrin signaling,REACTOME,pathway,PATHWAY_2201 |
| 2202,2202,2202,2202,2202,2202,2202,2202,R-HSA-9646399,Aggrephagy,REACTOME,pathway,PATHWAY_2202 |
| 2203,2203,2203,2203,2203,2203,2203,2203,R-HSA-9012546,Interleukin-18 signaling,REACTOME,pathway,PATHWAY_2203 |
| 2204,2204,2204,2204,2204,2204,2204,2204,R-HSA-5689901,Metalloprotease DUBs,REACTOME,pathway,PATHWAY_2204 |
| 2205,2205,2205,2205,2205,2205,2205,2205,R-HSA-9033241,Peroxisomal protein import,REACTOME,pathway,PATHWAY_2205 |
| 2206,2206,2206,2206,2206,2206,2206,2206,R-HSA-2555396,Mitotic Metaphase and Anaphase,REACTOME,pathway,PATHWAY_2206 |
| 2207,2207,2207,2207,2207,2207,2207,2207,R-HSA-9725370,Signaling by ALK fusions and activated point mutants,REACTOME,pathway,PATHWAY_2207 |
| 2208,2208,2208,2208,2208,2208,2208,2208,R-HSA-5619083,"Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)",REACTOME,pathway,PATHWAY_2208 |
| 2209,2209,2209,2209,2209,2209,2209,2209,R-HSA-2173788,Downregulation of TGF-beta receptor signaling,REACTOME,pathway,PATHWAY_2209 |
| 2210,2210,2210,2210,2210,2210,2210,2210,R-HSA-8978868,Fatty acid metabolism,REACTOME,pathway,PATHWAY_2210 |
| 2211,2211,2211,2211,2211,2211,2211,2211,R-HSA-354194,GRB2:SOS provides linkage to MAPK signaling for Integrins ,REACTOME,pathway,PATHWAY_2211 |
| 2212,2212,2212,2212,2212,2212,2212,2212,R-HSA-166020,Transfer of LPS from LBP carrier to CD14,REACTOME,pathway,PATHWAY_2212 |
| 2213,2213,2213,2213,2213,2213,2213,2213,R-HSA-166187,Mitochondrial Uncoupling,REACTOME,pathway,PATHWAY_2213 |
| 2214,2214,2214,2214,2214,2214,2214,2214,R-HSA-70326,Glucose metabolism,REACTOME,pathway,PATHWAY_2214 |
| 2215,2215,2215,2215,2215,2215,2215,2215,R-HSA-194306,Neurophilin interactions with VEGF and VEGFR,REACTOME,pathway,PATHWAY_2215 |
| 2216,2216,2216,2216,2216,2216,2216,2216,R-HSA-9630791,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4,REACTOME,pathway,PATHWAY_2216 |
| 2217,2217,2217,2217,2217,2217,2217,2217,R-HSA-9619229,Activation of RAC1 downstream of NMDARs,REACTOME,pathway,PATHWAY_2217 |
| 2218,2218,2218,2218,2218,2218,2218,2218,R-HSA-5576890,Phase 3 - rapid repolarisation,REACTOME,pathway,PATHWAY_2218 |
| 2219,2219,2219,2219,2219,2219,2219,2219,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),REACTOME,pathway,PATHWAY_2219 |
| 2220,2220,2220,2220,2220,2220,2220,2220,R-HSA-5619040,Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1),REACTOME,pathway,PATHWAY_2220 |
| 2221,2221,2221,2221,2221,2221,2221,2221,R-HSA-392851,Prostacyclin signalling through prostacyclin receptor,REACTOME,pathway,PATHWAY_2221 |
| 2222,2222,2222,2222,2222,2222,2222,2222,R-HSA-389957,Prefoldin mediated transfer of substrate to CCT/TriC,REACTOME,pathway,PATHWAY_2222 |
| 2223,2223,2223,2223,2223,2223,2223,2223,R-HSA-6814122,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,REACTOME,pathway,PATHWAY_2223 |
| 2224,2224,2224,2224,2224,2224,2224,2224,R-HSA-5602498,MyD88 deficiency (TLR2/4),REACTOME,pathway,PATHWAY_2224 |
| 2225,2225,2225,2225,2225,2225,2225,2225,R-HSA-1483191,Synthesis of PC,REACTOME,pathway,PATHWAY_2225 |
| 2226,2226,2226,2226,2226,2226,2226,2226,R-HSA-9013425,RHOT1 GTPase cycle,REACTOME,pathway,PATHWAY_2226 |
| 2227,2227,2227,2227,2227,2227,2227,2227,R-HSA-111453,BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,REACTOME,pathway,PATHWAY_2227 |
| 2228,2228,2228,2228,2228,2228,2228,2228,R-HSA-3656253,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",REACTOME,pathway,PATHWAY_2228 |
| 2229,2229,2229,2229,2229,2229,2229,2229,R-HSA-141444,Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal,REACTOME,pathway,PATHWAY_2229 |
| 2230,2230,2230,2230,2230,2230,2230,2230,R-HSA-9670439,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",REACTOME,pathway,PATHWAY_2230 |
| 2231,2231,2231,2231,2231,2231,2231,2231,R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,REACTOME,pathway,PATHWAY_2231 |
| 2232,2232,2232,2232,2232,2232,2232,2232,R-HSA-3000170,Syndecan interactions,REACTOME,pathway,PATHWAY_2232 |
| 2233,2233,2233,2233,2233,2233,2233,2233,R-HSA-444257,RSK activation,REACTOME,pathway,PATHWAY_2233 |
| 2234,2234,2234,2234,2234,2234,2234,2234,R-HSA-159231,Transport of Mature mRNA Derived from an Intronless Transcript,REACTOME,pathway,PATHWAY_2234 |
| 2235,2235,2235,2235,2235,2235,2235,2235,R-HSA-9683673,Maturation of protein 3a,REACTOME,pathway,PATHWAY_2235 |
| 2236,2236,2236,2236,2236,2236,2236,2236,R-HSA-1222538,Tolerance by Mtb to nitric oxide produced by macrophages,REACTOME,pathway,PATHWAY_2236 |
| 2237,2237,2237,2237,2237,2237,2237,2237,R-HSA-2022377,Metabolism of Angiotensinogen to Angiotensins,REACTOME,pathway,PATHWAY_2237 |
| 2238,2238,2238,2238,2238,2238,2238,2238,R-HSA-9705683,SARS-CoV-2-host interactions,REACTOME,pathway,PATHWAY_2238 |
| 2239,2239,2239,2239,2239,2239,2239,2239,R-HSA-5654688,SHC-mediated cascade:FGFR1,REACTOME,pathway,PATHWAY_2239 |
| 2240,2240,2240,2240,2240,2240,2240,2240,R-HSA-9833576,CDH11 homotypic and heterotypic interactions,REACTOME,pathway,PATHWAY_2240 |
| 2241,2241,2241,2241,2241,2241,2241,2241,R-HSA-1810476,RIP-mediated NFkB activation via ZBP1,REACTOME,pathway,PATHWAY_2241 |
| 2242,2242,2242,2242,2242,2242,2242,2242,R-HSA-8851907,MET activates PI3K/AKT signaling,REACTOME,pathway,PATHWAY_2242 |
| 2243,2243,2243,2243,2243,2243,2243,2243,R-HSA-2660826,Constitutive Signaling by NOTCH1 t(7 |
| 2244,2244,2244,2244,2244,2244,2244,2244,R-HSA-5579027,Defective CYP27B1 causes VDDR1B,REACTOME,pathway,PATHWAY_2244 |
| 2245,2245,2245,2245,2245,2245,2245,2245,R-HSA-176974,Unwinding of DNA,REACTOME,pathway,PATHWAY_2245 |
| 2246,2246,2246,2246,2246,2246,2246,2246,R-HSA-9623433,NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,REACTOME,pathway,PATHWAY_2246 |
| 2247,2247,2247,2247,2247,2247,2247,2247,R-HSA-111465,Apoptotic cleavage of cellular proteins,REACTOME,pathway,PATHWAY_2247 |
| 2248,2248,2248,2248,2248,2248,2248,2248,R-HSA-9636383,Prevention of phagosomal-lysosomal fusion,REACTOME,pathway,PATHWAY_2248 |
| 2249,2249,2249,2249,2249,2249,2249,2249,R-HSA-71240,Tryptophan catabolism,REACTOME,pathway,PATHWAY_2249 |
| 2250,2250,2250,2250,2250,2250,2250,2250,R-HSA-9907570,Loss-of-function mutations in DLD cause MSUD3/DLDD,REACTOME,pathway,PATHWAY_2250 |
| 2251,2251,2251,2251,2251,2251,2251,2251,R-HSA-3214841,PKMTs methylate histone lysines,REACTOME,pathway,PATHWAY_2251 |
| 2252,2252,2252,2252,2252,2252,2252,2252,R-HSA-5676594,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,REACTOME,pathway,PATHWAY_2252 |
| 2253,2253,2253,2253,2253,2253,2253,2253,R-HSA-5689880,Ub-specific processing proteases,REACTOME,pathway,PATHWAY_2253 |
| 2254,2254,2254,2254,2254,2254,2254,2254,R-HSA-9711097,Cellular response to starvation,REACTOME,pathway,PATHWAY_2254 |
| 2255,2255,2255,2255,2255,2255,2255,2255,R-HSA-9700649,Drug resistance of ALK mutants,REACTOME,pathway,PATHWAY_2255 |
| 2256,2256,2256,2256,2256,2256,2256,2256,R-HSA-9818025,NFE2L2 regulating TCA cycle genes,REACTOME,pathway,PATHWAY_2256 |
| 2257,2257,2257,2257,2257,2257,2257,2257,R-HSA-5685939,HDR through MMEJ (alt-NHEJ),REACTOME,pathway,PATHWAY_2257 |
| 2258,2258,2258,2258,2258,2258,2258,2258,R-HSA-2028269,Signaling by Hippo,REACTOME,pathway,PATHWAY_2258 |
| 2259,2259,2259,2259,2259,2259,2259,2259,R-HSA-1663150,The activation of arylsulfatases,REACTOME,pathway,PATHWAY_2259 |
| 2260,2260,2260,2260,2260,2260,2260,2260,R-HSA-5656364,Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM),REACTOME,pathway,PATHWAY_2260 |
| 2261,2261,2261,2261,2261,2261,2261,2261,R-HSA-5624138,Trafficking of myristoylated proteins to the cilium,REACTOME,pathway,PATHWAY_2261 |
| 2262,2262,2262,2262,2262,2262,2262,2262,R-HSA-8939242,RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,REACTOME,pathway,PATHWAY_2262 |
| 2263,2263,2263,2263,2263,2263,2263,2263,R-HSA-6790901,rRNA modification in the nucleus and cytosol,REACTOME,pathway,PATHWAY_2263 |
| 2264,2264,2264,2264,2264,2264,2264,2264,R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,REACTOME,pathway,PATHWAY_2264 |
| 2265,2265,2265,2265,2265,2265,2265,2265,R-HSA-69200,Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,REACTOME,pathway,PATHWAY_2265 |
| 2266,2266,2266,2266,2266,2266,2266,2266,R-HSA-69190,DNA strand elongation,REACTOME,pathway,PATHWAY_2266 |
| 2267,2267,2267,2267,2267,2267,2267,2267,R-HSA-8868766,rRNA processing in the mitochondrion,REACTOME,pathway,PATHWAY_2267 |
| 2268,2268,2268,2268,2268,2268,2268,2268,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,REACTOME,pathway,PATHWAY_2268 |
| 2269,2269,2269,2269,2269,2269,2269,2269,R-HSA-400253,Circadian Clock,REACTOME,pathway,PATHWAY_2269 |
| 2270,2270,2270,2270,2270,2270,2270,2270,R-HSA-1660517,Synthesis of PIPs at the late endosome membrane,REACTOME,pathway,PATHWAY_2270 |
| 2271,2271,2271,2271,2271,2271,2271,2271,R-HSA-1169408,ISG15 antiviral mechanism,REACTOME,pathway,PATHWAY_2271 |
| 2272,2272,2272,2272,2272,2272,2272,2272,R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,REACTOME,pathway,PATHWAY_2272 |
| 2273,2273,2273,2273,2273,2273,2273,2273,R-HSA-9694635,Translation of Structural Proteins,REACTOME,pathway,PATHWAY_2273 |
| 2274,2274,2274,2274,2274,2274,2274,2274,R-HSA-9917777,Epigenetic regulation by WDR5-containing histone modifying complexes,REACTOME,pathway,PATHWAY_2274 |
| 2275,2275,2275,2275,2275,2275,2275,2275,R-HSA-5579000,Defective CYP1B1 causes Glaucoma,REACTOME,pathway,PATHWAY_2275 |
| 2276,2276,2276,2276,2276,2276,2276,2276,R-HSA-6784531,tRNA processing in the nucleus,REACTOME,pathway,PATHWAY_2276 |
| 2277,2277,2277,2277,2277,2277,2277,2277,R-HSA-112311,Neurotransmitter clearance,REACTOME,pathway,PATHWAY_2277 |
| 2278,2278,2278,2278,2278,2278,2278,2278,R-HSA-1299361,TWIK-related alkaline pH activated K+ channel (TALK),REACTOME,pathway,PATHWAY_2278 |
| 2279,2279,2279,2279,2279,2279,2279,2279,R-HSA-1839122,Signaling by activated point mutants of FGFR1,REACTOME,pathway,PATHWAY_2279 |
| 2280,2280,2280,2280,2280,2280,2280,2280,R-HSA-9844594,Transcriptional regulation of brown and beige adipocyte differentiation by EBF2,REACTOME,pathway,PATHWAY_2280 |
| 2281,2281,2281,2281,2281,2281,2281,2281,R-HSA-212165,Epigenetic regulation of gene expression,REACTOME,pathway,PATHWAY_2281 |
| 2282,2282,2282,2282,2282,2282,2282,2282,R-HSA-425407,SLC-mediated transmembrane transport,REACTOME,pathway,PATHWAY_2282 |
| 2283,2283,2283,2283,2283,2283,2283,2283,R-HSA-1638091,Heparan sulfate/heparin (HS-GAG) metabolism,REACTOME,pathway,PATHWAY_2283 |
| 2284,2284,2284,2284,2284,2284,2284,2284,R-HSA-5339700,Signaling by TCF7L2 mutants,REACTOME,pathway,PATHWAY_2284 |
| 2285,2285,2285,2285,2285,2285,2285,2285,R-HSA-1912399,Pre-NOTCH Processing in the Endoplasmic Reticulum,REACTOME,pathway,PATHWAY_2285 |
| 2286,2286,2286,2286,2286,2286,2286,2286,R-HSA-977347,Serine biosynthesis,REACTOME,pathway,PATHWAY_2286 |
| 2287,2287,2287,2287,2287,2287,2287,2287,R-HSA-4549380,Defective ALG1 causes CDG-1k,REACTOME,pathway,PATHWAY_2287 |
| 2288,2288,2288,2288,2288,2288,2288,2288,R-HSA-390247,Beta-oxidation of very long chain fatty acids,REACTOME,pathway,PATHWAY_2288 |
| 2289,2289,2289,2289,2289,2289,2289,2289,R-HSA-399954,Sema3A PAK dependent Axon repulsion,REACTOME,pathway,PATHWAY_2289 |
| 2290,2290,2290,2290,2290,2290,2290,2290,R-HSA-75094,Formation of the Editosome,REACTOME,pathway,PATHWAY_2290 |
| 2291,2291,2291,2291,2291,2291,2291,2291,R-HSA-5619101,Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),REACTOME,pathway,PATHWAY_2291 |
| 2292,2292,2292,2292,2292,2292,2292,2292,R-HSA-2855086,Ficolins bind to repetitive carbohydrate structures on the target cell surface,REACTOME,pathway,PATHWAY_2292 |
| 2293,2293,2293,2293,2293,2293,2293,2293,R-HSA-9701193,Defective homologous recombination repair (HRR) due to PALB2 loss of function,REACTOME,pathway,PATHWAY_2293 |
| 2294,2294,2294,2294,2294,2294,2294,2294,R-HSA-71384,Ethanol oxidation,REACTOME,pathway,PATHWAY_2294 |
| 2295,2295,2295,2295,2295,2295,2295,2295,R-HSA-438064,Post NMDA receptor activation events,REACTOME,pathway,PATHWAY_2295 |
| 2296,2296,2296,2296,2296,2296,2296,2296,R-HSA-937041,IKK complex recruitment mediated by RIP1,REACTOME,pathway,PATHWAY_2296 |
| 2297,2297,2297,2297,2297,2297,2297,2297,R-HSA-5250958,Toxicity of botulinum toxin type B (botB),REACTOME,pathway,PATHWAY_2297 |
| 2298,2298,2298,2298,2298,2298,2298,2298,R-HSA-5619068,Defective SLC2A10 causes arterial tortuosity syndrome (ATS),REACTOME,pathway,PATHWAY_2298 |
| 2299,2299,2299,2299,2299,2299,2299,2299,R-HSA-2162123,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),REACTOME,pathway,PATHWAY_2299 |
| 2300,2300,2300,2300,2300,2300,2300,2300,R-HSA-8875513,MET interacts with TNS proteins,REACTOME,pathway,PATHWAY_2300 |
| 2301,2301,2301,2301,2301,2301,2301,2301,R-HSA-3371378,Regulation by c-FLIP,REACTOME,pathway,PATHWAY_2301 |
| 2302,2302,2302,2302,2302,2302,2302,2302,R-HSA-964739,N-glycan trimming and elongation in the cis-Golgi,REACTOME,pathway,PATHWAY_2302 |
| 2303,2303,2303,2303,2303,2303,2303,2303,R-HSA-9927354,Co-stimulation by ICOS,REACTOME,pathway,PATHWAY_2303 |
| 2304,2304,2304,2304,2304,2304,2304,2304,R-HSA-5693548,Sensing of DNA Double Strand Breaks,REACTOME,pathway,PATHWAY_2304 |
| 2305,2305,2305,2305,2305,2305,2305,2305,R-HSA-9027604,Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives,REACTOME,pathway,PATHWAY_2305 |
| 2306,2306,2306,2306,2306,2306,2306,2306,R-HSA-9013423,RAC3 GTPase cycle,REACTOME,pathway,PATHWAY_2306 |
| 2307,2307,2307,2307,2307,2307,2307,2307,R-HSA-2980767,"Activation of NIMA Kinases NEK9, NEK6, NEK7",REACTOME,pathway,PATHWAY_2307 |
| 2308,2308,2308,2308,2308,2308,2308,2308,R-HSA-427359,SIRT1 negatively regulates rRNA expression,REACTOME,pathway,PATHWAY_2308 |
| 2309,2309,2309,2309,2309,2309,2309,2309,R-HSA-195399,VEGF binds to VEGFR leading to receptor dimerization,REACTOME,pathway,PATHWAY_2309 |
| 2310,2310,2310,2310,2310,2310,2310,2310,R-HSA-2485179,Activation of the phototransduction cascade,REACTOME,pathway,PATHWAY_2310 |
| 2311,2311,2311,2311,2311,2311,2311,2311,R-HSA-5660724,Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),REACTOME,pathway,PATHWAY_2311 |
| 2312,2312,2312,2312,2312,2312,2312,2312,R-HSA-75953,RNA Polymerase II Transcription Initiation,REACTOME,pathway,PATHWAY_2312 |
| 2313,2313,2313,2313,2313,2313,2313,2313,R-HSA-9680187,Signaling by extracellular domain mutants of KIT,REACTOME,pathway,PATHWAY_2313 |
| 2314,2314,2314,2314,2314,2314,2314,2314,R-HSA-9845620,Enhanced binding of GP1BA variant to VWF multimer:collagen ,REACTOME,pathway,PATHWAY_2314 |
| 2315,2315,2315,2315,2315,2315,2315,2315,R-HSA-5683329,Defective ABCD4 causes MAHCJ,REACTOME,pathway,PATHWAY_2315 |
| 2316,2316,2316,2316,2316,2316,2316,2316,R-HSA-375281,Hormone ligand-binding receptors,REACTOME,pathway,PATHWAY_2316 |
| 2317,2317,2317,2317,2317,2317,2317,2317,R-HSA-9013407,RHOH GTPase cycle,REACTOME,pathway,PATHWAY_2317 |
| 2318,2318,2318,2318,2318,2318,2318,2318,R-HSA-5654710,PI-3K cascade:FGFR3,REACTOME,pathway,PATHWAY_2318 |
| 2319,2319,2319,2319,2319,2319,2319,2319,R-HSA-9711123,Cellular response to chemical stress,REACTOME,pathway,PATHWAY_2319 |
| 2320,2320,2320,2320,2320,2320,2320,2320,R-HSA-174430,Telomere C-strand synthesis initiation,REACTOME,pathway,PATHWAY_2320 |
| 2321,2321,2321,2321,2321,2321,2321,2321,R-HSA-8953750,Transcriptional Regulation by E2F6,REACTOME,pathway,PATHWAY_2321 |
| 2322,2322,2322,2322,2322,2322,2322,2322,R-HSA-379726,Mitochondrial tRNA aminoacylation,REACTOME,pathway,PATHWAY_2322 |
| 2323,2323,2323,2323,2323,2323,2323,2323,R-HSA-5693579,Homologous DNA Pairing and Strand Exchange,REACTOME,pathway,PATHWAY_2323 |
| 2324,2324,2324,2324,2324,2324,2324,2324,R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,REACTOME,pathway,PATHWAY_2324 |
| 2325,2325,2325,2325,2325,2325,2325,2325,R-HSA-433137,"Sodium-coupled sulphate, di- and tri-carboxylate transporters",REACTOME,pathway,PATHWAY_2325 |
| 2326,2326,2326,2326,2326,2326,2326,2326,R-HSA-5676590,NIK-->noncanonical NF-kB signaling,REACTOME,pathway,PATHWAY_2326 |
| 2327,2327,2327,2327,2327,2327,2327,2327,R-HSA-1299503,TWIK related potassium channel (TREK),REACTOME,pathway,PATHWAY_2327 |
| 2328,2328,2328,2328,2328,2328,2328,2328,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,REACTOME,pathway,PATHWAY_2328 |
| 2329,2329,2329,2329,2329,2329,2329,2329,R-HSA-9732724,IFNG signaling activates MAPKs,REACTOME,pathway,PATHWAY_2329 |
| 2330,2330,2330,2330,2330,2330,2330,2330,R-HSA-416550,Sema4D mediated inhibition of cell attachment and migration,REACTOME,pathway,PATHWAY_2330 |
| 2331,2331,2331,2331,2331,2331,2331,2331,R-HSA-5218900,CASP8 activity is inhibited,REACTOME,pathway,PATHWAY_2331 |
| 2332,2332,2332,2332,2332,2332,2332,2332,R-HSA-9684325,Maturation of replicase proteins,REACTOME,pathway,PATHWAY_2332 |
| 2333,2333,2333,2333,2333,2333,2333,2333,R-HSA-1222499,Latent infection - Other responses of Mtb to phagocytosis,REACTOME,pathway,PATHWAY_2333 |
| 2334,2334,2334,2334,2334,2334,2334,2334,R-HSA-419037,NCAM1 interactions,REACTOME,pathway,PATHWAY_2334 |
| 2335,2335,2335,2335,2335,2335,2335,2335,R-HSA-446728,Cell junction organization,REACTOME,pathway,PATHWAY_2335 |
| 2336,2336,2336,2336,2336,2336,2336,2336,R-HSA-9020702,Interleukin-1 signaling,REACTOME,pathway,PATHWAY_2336 |
| 2337,2337,2337,2337,2337,2337,2337,2337,R-HSA-420092,Glucagon-type ligand receptors,REACTOME,pathway,PATHWAY_2337 |
| 2338,2338,2338,2338,2338,2338,2338,2338,R-HSA-180292,GAB1 signalosome,REACTOME,pathway,PATHWAY_2338 |
| 2339,2339,2339,2339,2339,2339,2339,2339,R-HSA-451927,Interleukin-2 family signaling,REACTOME,pathway,PATHWAY_2339 |
| 2340,2340,2340,2340,2340,2340,2340,2340,R-HSA-190373,FGFR1c ligand binding and activation,REACTOME,pathway,PATHWAY_2340 |
| 2341,2341,2341,2341,2341,2341,2341,2341,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,REACTOME,pathway,PATHWAY_2341 |
| 2342,2342,2342,2342,2342,2342,2342,2342,R-HSA-389958,Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding,REACTOME,pathway,PATHWAY_2342 |
| 2343,2343,2343,2343,2343,2343,2343,2343,R-HSA-400508,"Incretin synthesis, secretion, and inactivation",REACTOME,pathway,PATHWAY_2343 |
| 2344,2344,2344,2344,2344,2344,2344,2344,R-HSA-5083628,"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",REACTOME,pathway,PATHWAY_2344 |
| 2345,2345,2345,2345,2345,2345,2345,2345,R-HSA-6781823,Formation of TC-NER Pre-Incision Complex,REACTOME,pathway,PATHWAY_2345 |
| 2346,2346,2346,2346,2346,2346,2346,2346,R-HSA-70263,Gluconeogenesis,REACTOME,pathway,PATHWAY_2346 |
| 2347,2347,2347,2347,2347,2347,2347,2347,R-HSA-9707587,Regulation of HMOX1 expression and activity,REACTOME,pathway,PATHWAY_2347 |
| 2348,2348,2348,2348,2348,2348,2348,2348,R-HSA-9630747,Diseases of Cellular Senescence,REACTOME,pathway,PATHWAY_2348 |
| 2349,2349,2349,2349,2349,2349,2349,2349,R-HSA-9007101,Rab regulation of trafficking,REACTOME,pathway,PATHWAY_2349 |
| 2350,2350,2350,2350,2350,2350,2350,2350,R-HSA-5358508,Mismatch Repair,REACTOME,pathway,PATHWAY_2350 |
| 2351,2351,2351,2351,2351,2351,2351,2351,R-HSA-196025,Formation of annular gap junctions,REACTOME,pathway,PATHWAY_2351 |
| 2352,2352,2352,2352,2352,2352,2352,2352,R-HSA-3359478,Defective MUT causes MMAM,REACTOME,pathway,PATHWAY_2352 |
| 2353,2353,2353,2353,2353,2353,2353,2353,R-HSA-2682334,EPH-Ephrin signaling,REACTOME,pathway,PATHWAY_2353 |
| 2354,2354,2354,2354,2354,2354,2354,2354,R-HSA-9679506,SARS-CoV Infections,REACTOME,pathway,PATHWAY_2354 |
| 2355,2355,2355,2355,2355,2355,2355,2355,R-HSA-5083636,Defective GALNT12 causes CRCS1,REACTOME,pathway,PATHWAY_2355 |
| 2356,2356,2356,2356,2356,2356,2356,2356,R-HSA-1253288,Downregulation of ERBB4 signaling,REACTOME,pathway,PATHWAY_2356 |
| 2357,2357,2357,2357,2357,2357,2357,2357,R-HSA-3656234,Defective HEXA causes GM2G1,REACTOME,pathway,PATHWAY_2357 |
| 2358,2358,2358,2358,2358,2358,2358,2358,R-HSA-430116,GP1b-IX-V activation signalling,REACTOME,pathway,PATHWAY_2358 |
| 2359,2359,2359,2359,2359,2359,2359,2359,R-HSA-5218859,Regulated Necrosis,REACTOME,pathway,PATHWAY_2359 |
| 2360,2360,2360,2360,2360,2360,2360,2360,R-HSA-156902,Peptide chain elongation,REACTOME,pathway,PATHWAY_2360 |
| 2361,2361,2361,2361,2361,2361,2361,2361,R-HSA-9657050,Defective OGG1 Localization,REACTOME,pathway,PATHWAY_2361 |
| 2362,2362,2362,2362,2362,2362,2362,2362,R-HSA-9674428,PDGFR mutants bind TKIs,REACTOME,pathway,PATHWAY_2362 |
| 2363,2363,2363,2363,2363,2363,2363,2363,R-HSA-157858,Gap junction trafficking and regulation,REACTOME,pathway,PATHWAY_2363 |
| 2364,2364,2364,2364,2364,2364,2364,2364,R-HSA-9699150,Defective DNA double strand break response due to BARD1 loss of function,REACTOME,pathway,PATHWAY_2364 |
| 2365,2365,2365,2365,2365,2365,2365,2365,R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,REACTOME,pathway,PATHWAY_2365 |
| 2366,2366,2366,2366,2366,2366,2366,2366,R-HSA-9754678,SARS-CoV-2 modulates host translation machinery,REACTOME,pathway,PATHWAY_2366 |
| 2367,2367,2367,2367,2367,2367,2367,2367,R-HSA-375165,NCAM signaling for neurite out-growth,REACTOME,pathway,PATHWAY_2367 |
| 2368,2368,2368,2368,2368,2368,2368,2368,R-HSA-877312,Regulation of IFNG signaling,REACTOME,pathway,PATHWAY_2368 |
| 2369,2369,2369,2369,2369,2369,2369,2369,R-HSA-2426168,Activation of gene expression by SREBF (SREBP),REACTOME,pathway,PATHWAY_2369 |
| 2370,2370,2370,2370,2370,2370,2370,2370,R-HSA-9603798,Class I peroxisomal membrane protein import,REACTOME,pathway,PATHWAY_2370 |
| 2371,2371,2371,2371,2371,2371,2371,2371,R-HSA-2424491,DAP12 signaling,REACTOME,pathway,PATHWAY_2371 |
| 2372,2372,2372,2372,2372,2372,2372,2372,R-HSA-164944,Nef and signal transduction,REACTOME,pathway,PATHWAY_2372 |
| 2373,2373,2373,2373,2373,2373,2373,2373,R-HSA-9726842,Gain-of-function MRAS complexes activate RAF signaling,REACTOME,pathway,PATHWAY_2373 |
| 2374,2374,2374,2374,2374,2374,2374,2374,R-HSA-5602415,UNC93B1 deficiency - HSE,REACTOME,pathway,PATHWAY_2374 |
| 2375,2375,2375,2375,2375,2375,2375,2375,R-HSA-190370,FGFR1b ligand binding and activation,REACTOME,pathway,PATHWAY_2375 |
| 2376,2376,2376,2376,2376,2376,2376,2376,R-HSA-9846298,Defective binding of VWF variant to GPIb:IX:V,REACTOME,pathway,PATHWAY_2376 |
| 2377,2377,2377,2377,2377,2377,2377,2377,R-HSA-69278,"Cell Cycle, Mitotic",REACTOME,pathway,PATHWAY_2377 |
| 2378,2378,2378,2378,2378,2378,2378,2378,R-HSA-727802,Transport of nucleotide sugars,REACTOME,pathway,PATHWAY_2378 |
| 2379,2379,2379,2379,2379,2379,2379,2379,R-HSA-77285,Beta oxidation of myristoyl-CoA to lauroyl-CoA,REACTOME,pathway,PATHWAY_2379 |
| 2380,2380,2380,2380,2380,2380,2380,2380,R-HSA-3134975,Regulation of innate immune responses to cytosolic DNA,REACTOME,pathway,PATHWAY_2380 |
| 2381,2381,2381,2381,2381,2381,2381,2381,R-HSA-180897,Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,REACTOME,pathway,PATHWAY_2381 |
| 2382,2382,2382,2382,2382,2382,2382,2382,R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds",REACTOME,pathway,PATHWAY_2382 |
| 2383,2383,2383,2383,2383,2383,2383,2383,R-HSA-114516,Disinhibition of SNARE formation,REACTOME,pathway,PATHWAY_2383 |
| 2384,2384,2384,2384,2384,2384,2384,2384,R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,REACTOME,pathway,PATHWAY_2384 |
| 2385,2385,2385,2385,2385,2385,2385,2385,R-HSA-1855184,IPs transport between cytosol and ER lumen,REACTOME,pathway,PATHWAY_2385 |
| 2386,2386,2386,2386,2386,2386,2386,2386,R-HSA-5545483,Defective Mismatch Repair Associated With MLH1,REACTOME,pathway,PATHWAY_2386 |
| 2387,2387,2387,2387,2387,2387,2387,2387,R-HSA-5676934,Protein repair,REACTOME,pathway,PATHWAY_2387 |
| 2388,2388,2388,2388,2388,2388,2388,2388,R-HSA-373755,Semaphorin interactions,REACTOME,pathway,PATHWAY_2388 |
| 2389,2389,2389,2389,2389,2389,2389,2389,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,REACTOME,pathway,PATHWAY_2389 |
| 2390,2390,2390,2390,2390,2390,2390,2390,R-HSA-391251,Protein folding,REACTOME,pathway,PATHWAY_2390 |
| 2391,2391,2391,2391,2391,2391,2391,2391,R-HSA-71064,Lysine catabolism,REACTOME,pathway,PATHWAY_2391 |
| 2392,2392,2392,2392,2392,2392,2392,2392,R-HSA-193639,p75NTR signals via NF-kB,REACTOME,pathway,PATHWAY_2392 |
| 2393,2393,2393,2393,2393,2393,2393,2393,R-HSA-8964540,Alanine metabolism,REACTOME,pathway,PATHWAY_2393 |
| 2394,2394,2394,2394,2394,2394,2394,2394,R-HSA-381038,XBP1(S) activates chaperone genes,REACTOME,pathway,PATHWAY_2394 |
| 2395,2395,2395,2395,2395,2395,2395,2395,R-HSA-9656249,Defective Base Excision Repair Associated with OGG1,REACTOME,pathway,PATHWAY_2395 |
| 2396,2396,2396,2396,2396,2396,2396,2396,R-HSA-9672397,Defective F8 secretion,REACTOME,pathway,PATHWAY_2396 |
| 2397,2397,2397,2397,2397,2397,2397,2397,R-HSA-5619073,Defective GCK causes maturity-onset diabetes of the young 2 (MODY2),REACTOME,pathway,PATHWAY_2397 |
| 2398,2398,2398,2398,2398,2398,2398,2398,R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,REACTOME,pathway,PATHWAY_2398 |
| 2399,2399,2399,2399,2399,2399,2399,2399,R-HSA-9006335,Signaling by Erythropoietin,REACTOME,pathway,PATHWAY_2399 |
| 2400,2400,2400,2400,2400,2400,2400,2400,R-HSA-6791462,"TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P",REACTOME,pathway,PATHWAY_2400 |
| 2401,2401,2401,2401,2401,2401,2401,2401,R-HSA-76066,RNA Polymerase III Transcription Initiation From Type 2 Promoter,REACTOME,pathway,PATHWAY_2401 |
| 2402,2402,2402,2402,2402,2402,2402,2402,R-HSA-5619102,SLC transporter disorders,REACTOME,pathway,PATHWAY_2402 |
| 2403,2403,2403,2403,2403,2403,2403,2403,R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,REACTOME,pathway,PATHWAY_2403 |
| 2404,2404,2404,2404,2404,2404,2404,2404,R-HSA-9022692,Regulation of MECP2 expression and activity,REACTOME,pathway,PATHWAY_2404 |
| 2405,2405,2405,2405,2405,2405,2405,2405,R-HSA-8854521,Interaction between PHLDA1 and AURKA,REACTOME,pathway,PATHWAY_2405 |
| 2406,2406,2406,2406,2406,2406,2406,2406,R-HSA-453274,Mitotic G2-G2/M phases,REACTOME,pathway,PATHWAY_2406 |
| 2407,2407,2407,2407,2407,2407,2407,2407,R-HSA-177162,Conjugation of phenylacetate with glutamine,REACTOME,pathway,PATHWAY_2407 |
| 2408,2408,2408,2408,2408,2408,2408,2408,R-HSA-453279,Mitotic G1 phase and G1/S transition,REACTOME,pathway,PATHWAY_2408 |
| 2409,2409,2409,2409,2409,2409,2409,2409,R-HSA-420029,Tight junction interactions,REACTOME,pathway,PATHWAY_2409 |
| 2410,2410,2410,2410,2410,2410,2410,2410,R-HSA-5696397,Gap-filling DNA repair synthesis and ligation in GG-NER,REACTOME,pathway,PATHWAY_2410 |
| 2411,2411,2411,2411,2411,2411,2411,2411,R-HSA-74749,Signal attenuation,REACTOME,pathway,PATHWAY_2411 |
| 2412,2412,2412,2412,2412,2412,2412,2412,R-HSA-9764260,Regulation of Expression and Function of Type II Classical Cadherins,REACTOME,pathway,PATHWAY_2412 |
| 2413,2413,2413,2413,2413,2413,2413,2413,R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,REACTOME,pathway,PATHWAY_2413 |
| 2414,2414,2414,2414,2414,2414,2414,2414,R-HSA-9762114,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,REACTOME,pathway,PATHWAY_2414 |
| 2415,2415,2415,2415,2415,2415,2415,2415,R-HSA-964975,Vitamin B6 activation to pyridoxal phosphate,REACTOME,pathway,PATHWAY_2415 |
| 2416,2416,2416,2416,2416,2416,2416,2416,R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,REACTOME,pathway,PATHWAY_2416 |
| 2417,2417,2417,2417,2417,2417,2417,2417,R-HSA-8979227,Triglyceride metabolism,REACTOME,pathway,PATHWAY_2417 |
| 2418,2418,2418,2418,2418,2418,2418,2418,R-HSA-6799198,Complex I biogenesis,REACTOME,pathway,PATHWAY_2418 |
| 2419,2419,2419,2419,2419,2419,2419,2419,R-HSA-112040,G-protein mediated events,REACTOME,pathway,PATHWAY_2419 |
| 2420,2420,2420,2420,2420,2420,2420,2420,R-HSA-2142700,Biosynthesis of Lipoxins (LX),REACTOME,pathway,PATHWAY_2420 |
| 2421,2421,2421,2421,2421,2421,2421,2421,R-HSA-2299718,Condensation of Prophase Chromosomes,REACTOME,pathway,PATHWAY_2421 |
| 2422,2422,2422,2422,2422,2422,2422,2422,R-HSA-9023661,Biosynthesis of E-series 18(R)-resolvins,REACTOME,pathway,PATHWAY_2422 |
| 2423,2423,2423,2423,2423,2423,2423,2423,R-HSA-9028731,Activated NTRK2 signals through FRS2 and FRS3,REACTOME,pathway,PATHWAY_2423 |
| 2424,2424,2424,2424,2424,2424,2424,2424,R-HSA-8939211,ESR-mediated signaling,REACTOME,pathway,PATHWAY_2424 |
| 2425,2425,2425,2425,2425,2425,2425,2425,R-HSA-8851708,Signaling by FGFR2 IIIa TM,REACTOME,pathway,PATHWAY_2425 |
| 2426,2426,2426,2426,2426,2426,2426,2426,R-HSA-5578998,Defective OPLAH causes OPLAHD,REACTOME,pathway,PATHWAY_2426 |
| 2427,2427,2427,2427,2427,2427,2427,2427,R-HSA-9025094,Biosynthesis of DPAn-3 SPMs,REACTOME,pathway,PATHWAY_2427 |
| 2428,2428,2428,2428,2428,2428,2428,2428,R-HSA-9652282,Drug-mediated inhibition of ERBB2 signaling,REACTOME,pathway,PATHWAY_2428 |
| 2429,2429,2429,2429,2429,2429,2429,2429,R-HSA-9709957,Sensory Perception,REACTOME,pathway,PATHWAY_2429 |
| 2430,2430,2430,2430,2430,2430,2430,2430,R-HSA-169893,Prolonged ERK activation events,REACTOME,pathway,PATHWAY_2430 |
| 2431,2431,2431,2431,2431,2431,2431,2431,R-HSA-912446,Meiotic recombination,REACTOME,pathway,PATHWAY_2431 |
| 2432,2432,2432,2432,2432,2432,2432,2432,R-HSA-189200,Cellular hexose transport,REACTOME,pathway,PATHWAY_2432 |
| 2433,2433,2433,2433,2433,2433,2433,2433,R-HSA-9734281,Defective HPRT1 disrupts guanine and hypoxanthine salvage,REACTOME,pathway,PATHWAY_2433 |
| 2434,2434,2434,2434,2434,2434,2434,2434,R-HSA-209952,Peptide hormone biosynthesis,REACTOME,pathway,PATHWAY_2434 |
| 2435,2435,2435,2435,2435,2435,2435,2435,R-HSA-8963684,Tyrosine catabolism,REACTOME,pathway,PATHWAY_2435 |
| 2436,2436,2436,2436,2436,2436,2436,2436,R-HSA-9679191,Potential therapeutics for SARS,REACTOME,pathway,PATHWAY_2436 |
| 2437,2437,2437,2437,2437,2437,2437,2437,R-HSA-9694322,Virion Assembly and Release,REACTOME,pathway,PATHWAY_2437 |
| 2438,2438,2438,2438,2438,2438,2438,2438,R-HSA-5654221,Phospholipase C-mediated cascade |
| 2439,2439,2439,2439,2439,2439,2439,2439,R-HSA-380108,Chemokine receptors bind chemokines,REACTOME,pathway,PATHWAY_2439 |
| 2440,2440,2440,2440,2440,2440,2440,2440,R-HSA-2470946,Cohesin Loading onto Chromatin,REACTOME,pathway,PATHWAY_2440 |
| 2441,2441,2441,2441,2441,2441,2441,2441,R-HSA-69563,p53-Dependent G1 DNA Damage Response,REACTOME,pathway,PATHWAY_2441 |
| 2442,2442,2442,2442,2442,2442,2442,2442,R-HSA-111461,Cytochrome c-mediated apoptotic response,REACTOME,pathway,PATHWAY_2442 |
| 2443,2443,2443,2443,2443,2443,2443,2443,R-HSA-168330,Viral RNP Complexes in the Host Cell Nucleus,REACTOME,pathway,PATHWAY_2443 |
| 2444,2444,2444,2444,2444,2444,2444,2444,R-HSA-9636667,Manipulation of host energy metabolism,REACTOME,pathway,PATHWAY_2444 |
| 2445,2445,2445,2445,2445,2445,2445,2445,R-HSA-3906995,Diseases associated with O-glycosylation of proteins,REACTOME,pathway,PATHWAY_2445 |
| 2446,2446,2446,2446,2446,2446,2446,2446,R-HSA-9020265,Biosynthesis of aspirin-triggered D-series resolvins,REACTOME,pathway,PATHWAY_2446 |
| 2447,2447,2447,2447,2447,2447,2447,2447,R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,REACTOME,pathway,PATHWAY_2447 |
| 2448,2448,2448,2448,2448,2448,2448,2448,R-HSA-5619053,Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP),REACTOME,pathway,PATHWAY_2448 |
| 2449,2449,2449,2449,2449,2449,2449,2449,R-HSA-3656243,Defective ST3GAL3 causes MCT12 and EIEE15,REACTOME,pathway,PATHWAY_2449 |
| 2450,2450,2450,2450,2450,2450,2450,2450,R-HSA-749476,RNA Polymerase III Abortive And Retractive Initiation,REACTOME,pathway,PATHWAY_2450 |
| 2451,2451,2451,2451,2451,2451,2451,2451,R-HSA-9913351,Formation of the dystrophin-glycoprotein complex (DGC),REACTOME,pathway,PATHWAY_2451 |
| 2452,2452,2452,2452,2452,2452,2452,2452,R-HSA-429947,Deadenylation of mRNA,REACTOME,pathway,PATHWAY_2452 |
| 2453,2453,2453,2453,2453,2453,2453,2453,R-HSA-9036866,Expression and Processing of Neurotrophins,REACTOME,pathway,PATHWAY_2453 |
| 2454,2454,2454,2454,2454,2454,2454,2454,R-HSA-9673770,Signaling by PDGFRA extracellular domain mutants,REACTOME,pathway,PATHWAY_2454 |
| 2455,2455,2455,2455,2455,2455,2455,2455,R-HSA-68962,Activation of the pre-replicative complex,REACTOME,pathway,PATHWAY_2455 |
| 2456,2456,2456,2456,2456,2456,2456,2456,R-HSA-1474165,Reproduction,REACTOME,pathway,PATHWAY_2456 |
| 2457,2457,2457,2457,2457,2457,2457,2457,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),REACTOME,pathway,PATHWAY_2457 |
| 2458,2458,2458,2458,2458,2458,2458,2458,R-HSA-8964315,G beta:gamma signalling through BTK,REACTOME,pathway,PATHWAY_2458 |
| 2459,2459,2459,2459,2459,2459,2459,2459,R-HSA-75893,TNF signaling,REACTOME,pathway,PATHWAY_2459 |
| 2460,2460,2460,2460,2460,2460,2460,2460,R-HSA-5654741,Signaling by FGFR3,REACTOME,pathway,PATHWAY_2460 |
| 2461,2461,2461,2461,2461,2461,2461,2461,R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,REACTOME,pathway,PATHWAY_2461 |
| 2462,2462,2462,2462,2462,2462,2462,2462,R-HSA-8850843,Phosphate bond hydrolysis by NTPDase proteins,REACTOME,pathway,PATHWAY_2462 |
| 2463,2463,2463,2463,2463,2463,2463,2463,R-HSA-9664565,Signaling by ERBB2 KD Mutants,REACTOME,pathway,PATHWAY_2463 |
| 2464,2464,2464,2464,2464,2464,2464,2464,R-HSA-211935,Fatty acids,REACTOME,pathway,PATHWAY_2464 |
| 2465,2465,2465,2465,2465,2465,2465,2465,R-HSA-3899300,SUMOylation of transcription cofactors,REACTOME,pathway,PATHWAY_2465 |
| 2466,2466,2466,2466,2466,2466,2466,2466,R-HSA-1855229,IP6 and IP7 transport between cytosol and nucleus,REACTOME,pathway,PATHWAY_2466 |
| 2467,2467,2467,2467,2467,2467,2467,2467,R-HSA-70221,Glycogen breakdown (glycogenolysis),REACTOME,pathway,PATHWAY_2467 |
| 2468,2468,2468,2468,2468,2468,2468,2468,R-HSA-5654732,Negative regulation of FGFR3 signaling,REACTOME,pathway,PATHWAY_2468 |
| 2469,2469,2469,2469,2469,2469,2469,2469,R-HSA-8848584,Wax and plasmalogen biosynthesis,REACTOME,pathway,PATHWAY_2469 |
| 2470,2470,2470,2470,2470,2470,2470,2470,R-HSA-68911,G2 Phase,REACTOME,pathway,PATHWAY_2470 |
| 2471,2471,2471,2471,2471,2471,2471,2471,R-HSA-190872,Transport of connexons to the plasma membrane,REACTOME,pathway,PATHWAY_2471 |
| 2472,2472,2472,2472,2472,2472,2472,2472,R-HSA-1433617,Regulation of signaling by NODAL,REACTOME,pathway,PATHWAY_2472 |
| 2473,2473,2473,2473,2473,2473,2473,2473,R-HSA-1483255,PI Metabolism,REACTOME,pathway,PATHWAY_2473 |
| 2474,2474,2474,2474,2474,2474,2474,2474,R-HSA-171319,Telomere Extension By Telomerase,REACTOME,pathway,PATHWAY_2474 |
| 2475,2475,2475,2475,2475,2475,2475,2475,R-HSA-425986,Sodium/Proton exchangers,REACTOME,pathway,PATHWAY_2475 |
| 2476,2476,2476,2476,2476,2476,2476,2476,R-HSA-5637812,Signaling by EGFRvIII in Cancer,REACTOME,pathway,PATHWAY_2476 |
| 2477,2477,2477,2477,2477,2477,2477,2477,R-HSA-390666,Serotonin receptors,REACTOME,pathway,PATHWAY_2477 |
| 2478,2478,2478,2478,2478,2478,2478,2478,R-HSA-5205685,PINK1-PRKN Mediated Mitophagy,REACTOME,pathway,PATHWAY_2478 |
| 2479,2479,2479,2479,2479,2479,2479,2479,R-HSA-2408550,Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,REACTOME,pathway,PATHWAY_2479 |
| 2480,2480,2480,2480,2480,2480,2480,2480,R-HSA-4793952,Defective MGAT2 causes CDG-2a,REACTOME,pathway,PATHWAY_2480 |
| 2481,2481,2481,2481,2481,2481,2481,2481,R-HSA-9674396,Imatinib-resistant PDGFR mutants,REACTOME,pathway,PATHWAY_2481 |
| 2482,2482,2482,2482,2482,2482,2482,2482,R-HSA-9702518,STAT5 activation downstream of FLT3 ITD mutants,REACTOME,pathway,PATHWAY_2482 |
| 2483,2483,2483,2483,2483,2483,2483,2483,R-HSA-5661270,Formation of xylulose-5-phosphate,REACTOME,pathway,PATHWAY_2483 |
| 2484,2484,2484,2484,2484,2484,2484,2484,R-HSA-442982,Ras activation upon Ca2+ influx through NMDA receptor,REACTOME,pathway,PATHWAY_2484 |
| 2485,2485,2485,2485,2485,2485,2485,2485,R-HSA-3928664,Ephrin signaling,REACTOME,pathway,PATHWAY_2485 |
| 2486,2486,2486,2486,2486,2486,2486,2486,R-HSA-210746,Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,REACTOME,pathway,PATHWAY_2486 |
| 2487,2487,2487,2487,2487,2487,2487,2487,R-HSA-983231,Factors involved in megakaryocyte development and platelet production,REACTOME,pathway,PATHWAY_2487 |
| 2488,2488,2488,2488,2488,2488,2488,2488,R-HSA-9768759,Regulation of NPAS4 gene expression,REACTOME,pathway,PATHWAY_2488 |
| 2489,2489,2489,2489,2489,2489,2489,2489,R-HSA-434316,Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,REACTOME,pathway,PATHWAY_2489 |
| 2490,2490,2490,2490,2490,2490,2490,2490,R-HSA-180336,SHC1 events in EGFR signaling,REACTOME,pathway,PATHWAY_2490 |
| 2491,2491,2491,2491,2491,2491,2491,2491,R-HSA-165158,Activation of AKT2,REACTOME,pathway,PATHWAY_2491 |
| 2492,2492,2492,2492,2492,2492,2492,2492,R-HSA-6783783,Interleukin-10 signaling,REACTOME,pathway,PATHWAY_2492 |
| 2493,2493,2493,2493,2493,2493,2493,2493,R-HSA-1296067,Potassium transport channels,REACTOME,pathway,PATHWAY_2493 |
| 2494,2494,2494,2494,2494,2494,2494,2494,R-HSA-163210,Formation of ATP by chemiosmotic coupling,REACTOME,pathway,PATHWAY_2494 |
| 2495,2495,2495,2495,2495,2495,2495,2495,R-HSA-5663084,Diseases of carbohydrate metabolism,REACTOME,pathway,PATHWAY_2495 |
| 2496,2496,2496,2496,2496,2496,2496,2496,R-HSA-2534343,Interaction With Cumulus Cells And The Zona Pellucida,REACTOME,pathway,PATHWAY_2496 |
| 2497,2497,2497,2497,2497,2497,2497,2497,R-HSA-5654726,Negative regulation of FGFR1 signaling,REACTOME,pathway,PATHWAY_2497 |
| 2498,2498,2498,2498,2498,2498,2498,2498,R-HSA-975576,N-glycan antennae elongation in the medial/trans-Golgi,REACTOME,pathway,PATHWAY_2498 |
| 2499,2499,2499,2499,2499,2499,2499,2499,R-HSA-5607763,CLEC7A (Dectin-1) induces NFAT activation,REACTOME,pathway,PATHWAY_2499 |
| 2500,2500,2500,2500,2500,2500,2500,2500,R-HSA-8869496,TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,REACTOME,pathway,PATHWAY_2500 |
| 2501,2501,2501,2501,2501,2501,2501,2501,R-HSA-422356,Regulation of insulin secretion,REACTOME,pathway,PATHWAY_2501 |
| 2502,2502,2502,2502,2502,2502,2502,2502,R-HSA-71291,Metabolism of amino acids and derivatives,REACTOME,pathway,PATHWAY_2502 |
| 2503,2503,2503,2503,2503,2503,2503,2503,R-HSA-77588,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,REACTOME,pathway,PATHWAY_2503 |
| 2504,2504,2504,2504,2504,2504,2504,2504,R-HSA-9635486,Infection with Mycobacterium tuberculosis,REACTOME,pathway,PATHWAY_2504 |
| 2505,2505,2505,2505,2505,2505,2505,2505,R-HSA-73887,Death Receptor Signaling,REACTOME,pathway,PATHWAY_2505 |
| 2506,2506,2506,2506,2506,2506,2506,2506,R-HSA-1839124,FGFR1 mutant receptor activation,REACTOME,pathway,PATHWAY_2506 |
| 2507,2507,2507,2507,2507,2507,2507,2507,R-HSA-433692,Proton-coupled monocarboxylate transport,REACTOME,pathway,PATHWAY_2507 |
| 2508,2508,2508,2508,2508,2508,2508,2508,R-HSA-112411,MAPK1 (ERK2) activation,REACTOME,pathway,PATHWAY_2508 |
| 2509,2509,2509,2509,2509,2509,2509,2509,R-HSA-9717326,crizotinib-resistant ALK mutants,REACTOME,pathway,PATHWAY_2509 |
| 2510,2510,2510,2510,2510,2510,2510,2510,R-HSA-1660662,Glycosphingolipid metabolism,REACTOME,pathway,PATHWAY_2510 |
| 2511,2511,2511,2511,2511,2511,2511,2511,R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,REACTOME,pathway,PATHWAY_2511 |
| 2512,2512,2512,2512,2512,2512,2512,2512,R-HSA-392499,Metabolism of proteins,REACTOME,pathway,PATHWAY_2512 |
| 2513,2513,2513,2513,2513,2513,2513,2513,R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,REACTOME,pathway,PATHWAY_2513 |
| 2514,2514,2514,2514,2514,2514,2514,2514,R-HSA-9669937,Drug resistance of KIT mutants,REACTOME,pathway,PATHWAY_2514 |
| 2515,2515,2515,2515,2515,2515,2515,2515,R-HSA-8856828,Clathrin-mediated endocytosis,REACTOME,pathway,PATHWAY_2515 |
| 2516,2516,2516,2516,2516,2516,2516,2516,R-HSA-5578768,Physiological factors,REACTOME,pathway,PATHWAY_2516 |
| 2517,2517,2517,2517,2517,2517,2517,2517,R-HSA-5660686,Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),REACTOME,pathway,PATHWAY_2517 |
| 2518,2518,2518,2518,2518,2518,2518,2518,R-HSA-2468052,Establishment of Sister Chromatid Cohesion,REACTOME,pathway,PATHWAY_2518 |
| 2519,2519,2519,2519,2519,2519,2519,2519,R-HSA-9027284,Erythropoietin activates RAS,REACTOME,pathway,PATHWAY_2519 |
| 2520,2520,2520,2520,2520,2520,2520,2520,R-HSA-9758274,Regulation of NF-kappa B signaling,REACTOME,pathway,PATHWAY_2520 |
| 2521,2521,2521,2521,2521,2521,2521,2521,R-HSA-9669934,Sunitinib-resistant KIT mutants,REACTOME,pathway,PATHWAY_2521 |
| 2522,2522,2522,2522,2522,2522,2522,2522,R-HSA-1980143,Signaling by NOTCH1,REACTOME,pathway,PATHWAY_2522 |
| 2523,2523,2523,2523,2523,2523,2523,2523,R-HSA-9649948,Signaling downstream of RAS mutants,REACTOME,pathway,PATHWAY_2523 |
| 2524,2524,2524,2524,2524,2524,2524,2524,R-HSA-388479,Vasopressin-like receptors,REACTOME,pathway,PATHWAY_2524 |
| 2525,2525,2525,2525,2525,2525,2525,2525,R-HSA-5619061,Defective SLC33A1 causes spastic paraplegia 42 (SPG42),REACTOME,pathway,PATHWAY_2525 |
| 2526,2526,2526,2526,2526,2526,2526,2526,R-HSA-203615,eNOS activation,REACTOME,pathway,PATHWAY_2526 |
| 2527,2527,2527,2527,2527,2527,2527,2527,R-HSA-9632974,NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ,REACTOME,pathway,PATHWAY_2527 |
| 2528,2528,2528,2528,2528,2528,2528,2528,R-HSA-9832991,Formation of the posterior neural plate,REACTOME,pathway,PATHWAY_2528 |
| 2529,2529,2529,2529,2529,2529,2529,2529,R-HSA-9915355,Beta-ketothiolase deficiency,REACTOME,pathway,PATHWAY_2529 |
| 2530,2530,2530,2530,2530,2530,2530,2530,R-HSA-8934593,Regulation of RUNX1 Expression and Activity,REACTOME,pathway,PATHWAY_2530 |
| 2531,2531,2531,2531,2531,2531,2531,2531,R-HSA-9690406,Transcriptional regulation of testis differentiation,REACTOME,pathway,PATHWAY_2531 |
| 2532,2532,2532,2532,2532,2532,2532,2532,R-HSA-8985586,SLIT2:ROBO1 increases RHOA activity,REACTOME,pathway,PATHWAY_2532 |
| 2533,2533,2533,2533,2533,2533,2533,2533,R-HSA-1839120,Signaling by FGFR1 amplification mutants,REACTOME,pathway,PATHWAY_2533 |
| 2534,2534,2534,2534,2534,2534,2534,2534,R-HSA-190241,FGFR2 ligand binding and activation,REACTOME,pathway,PATHWAY_2534 |
| 2535,2535,2535,2535,2535,2535,2535,2535,R-HSA-8956321,Nucleotide salvage,REACTOME,pathway,PATHWAY_2535 |
| 2536,2536,2536,2536,2536,2536,2536,2536,R-HSA-176412,Phosphorylation of the APC/C,REACTOME,pathway,PATHWAY_2536 |
| 2537,2537,2537,2537,2537,2537,2537,2537,R-HSA-111464,SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ,REACTOME,pathway,PATHWAY_2537 |
| 2538,2538,2538,2538,2538,2538,2538,2538,R-HSA-445144,Signal transduction by L1,REACTOME,pathway,PATHWAY_2538 |
| 2539,2539,2539,2539,2539,2539,2539,2539,R-HSA-5619096,Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1),REACTOME,pathway,PATHWAY_2539 |
| 2540,2540,2540,2540,2540,2540,2540,2540,R-HSA-191273,Cholesterol biosynthesis,REACTOME,pathway,PATHWAY_2540 |
| 2541,2541,2541,2541,2541,2541,2541,2541,R-HSA-9755779,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,REACTOME,pathway,PATHWAY_2541 |
| 2542,2542,2542,2542,2542,2542,2542,2542,R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,REACTOME,pathway,PATHWAY_2542 |
| 2543,2543,2543,2543,2543,2543,2543,2543,R-HSA-1296065,Inwardly rectifying K+ channels,REACTOME,pathway,PATHWAY_2543 |
| 2544,2544,2544,2544,2544,2544,2544,2544,R-HSA-8874081,MET activates PTK2 signaling,REACTOME,pathway,PATHWAY_2544 |
| 2545,2545,2545,2545,2545,2545,2545,2545,R-HSA-5250992,Toxicity of botulinum toxin type E (botE),REACTOME,pathway,PATHWAY_2545 |
| 2546,2546,2546,2546,2546,2546,2546,2546,R-HSA-4793953,Defective B4GALT1 causes CDG-2d,REACTOME,pathway,PATHWAY_2546 |
| 2547,2547,2547,2547,2547,2547,2547,2547,R-HSA-9661070,Defective translocation of RB1 mutants to the nucleus,REACTOME,pathway,PATHWAY_2547 |
| 2548,2548,2548,2548,2548,2548,2548,2548,R-HSA-5663220,RHO GTPases Activate Formins,REACTOME,pathway,PATHWAY_2548 |
| 2549,2549,2549,2549,2549,2549,2549,2549,R-HSA-9031525,NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ,REACTOME,pathway,PATHWAY_2549 |
| 2550,2550,2550,2550,2550,2550,2550,2550,R-HSA-1181150,Signaling by NODAL,REACTOME,pathway,PATHWAY_2550 |
| 2551,2551,2551,2551,2551,2551,2551,2551,R-HSA-9657689,Defective SERPING1 causes hereditary angioedema,REACTOME,pathway,PATHWAY_2551 |
| 2552,2552,2552,2552,2552,2552,2552,2552,R-HSA-9627069,Regulation of the apoptosome activity,REACTOME,pathway,PATHWAY_2552 |
| 2553,2553,2553,2553,2553,2553,2553,2553,R-HSA-2559580,Oxidative Stress Induced Senescence,REACTOME,pathway,PATHWAY_2553 |
| 2554,2554,2554,2554,2554,2554,2554,2554,R-HSA-8866910,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,REACTOME,pathway,PATHWAY_2554 |
| 2555,2555,2555,2555,2555,2555,2555,2555,R-HSA-3238698,WNT ligand biogenesis and trafficking,REACTOME,pathway,PATHWAY_2555 |
| 2556,2556,2556,2556,2556,2556,2556,2556,R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,REACTOME,pathway,PATHWAY_2556 |
| 2557,2557,2557,2557,2557,2557,2557,2557,R-HSA-9734767,Developmental Cell Lineages,REACTOME,pathway,PATHWAY_2557 |
| 2558,2558,2558,2558,2558,2558,2558,2558,R-HSA-2892245,"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",REACTOME,pathway,PATHWAY_2558 |
| 2559,2559,2559,2559,2559,2559,2559,2559,R-HSA-400042,"Adrenaline,noradrenaline inhibits insulin secretion",REACTOME,pathway,PATHWAY_2559 |
| 2560,2560,2560,2560,2560,2560,2560,2560,R-HSA-112122,ALKBH2 mediated reversal of alkylation damage,REACTOME,pathway,PATHWAY_2560 |
| 2561,2561,2561,2561,2561,2561,2561,2561,R-HSA-9716542,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",REACTOME,pathway,PATHWAY_2561 |
| 2562,2562,2562,2562,2562,2562,2562,2562,R-HSA-5654716,Downstream signaling of activated FGFR4,REACTOME,pathway,PATHWAY_2562 |
| 2563,2563,2563,2563,2563,2563,2563,2563,R-HSA-8853659,RET signaling,REACTOME,pathway,PATHWAY_2563 |
| 2564,2564,2564,2564,2564,2564,2564,2564,R-HSA-416482,G alpha (12/13) signalling events,REACTOME,pathway,PATHWAY_2564 |
| 2565,2565,2565,2565,2565,2565,2565,2565,R-HSA-3065678,"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",REACTOME,pathway,PATHWAY_2565 |
| 2566,2566,2566,2566,2566,2566,2566,2566,R-HSA-199920,CREB phosphorylation,REACTOME,pathway,PATHWAY_2566 |
| 2567,2567,2567,2567,2567,2567,2567,2567,R-HSA-9819196,Zygotic genome activation (ZGA),REACTOME,pathway,PATHWAY_2567 |
| 2568,2568,2568,2568,2568,2568,2568,2568,R-HSA-168302,Budding,REACTOME,pathway,PATHWAY_2568 |
| 2569,2569,2569,2569,2569,2569,2569,2569,R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,REACTOME,pathway,PATHWAY_2569 |
| 2570,2570,2570,2570,2570,2570,2570,2570,R-HSA-1606341,IRF3 mediated activation of type 1 IFN,REACTOME,pathway,PATHWAY_2570 |
| 2571,2571,2571,2571,2571,2571,2571,2571,R-HSA-399719,Trafficking of AMPA receptors,REACTOME,pathway,PATHWAY_2571 |
| 2572,2572,2572,2572,2572,2572,2572,2572,R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),REACTOME,pathway,PATHWAY_2572 |
| 2573,2573,2573,2573,2573,2573,2573,2573,R-HSA-111995,phospho-PLA2 pathway,REACTOME,pathway,PATHWAY_2573 |
| 2574,2574,2574,2574,2574,2574,2574,2574,R-HSA-8873719,RAB geranylgeranylation,REACTOME,pathway,PATHWAY_2574 |
| 2575,2575,2575,2575,2575,2575,2575,2575,R-HSA-113507,E2F-enabled inhibition of pre-replication complex formation,REACTOME,pathway,PATHWAY_2575 |
| 2576,2576,2576,2576,2576,2576,2576,2576,R-HSA-427652,Sodium-coupled phosphate cotransporters,REACTOME,pathway,PATHWAY_2576 |
| 2577,2577,2577,2577,2577,2577,2577,2577,R-HSA-2465910,MASTL Facilitates Mitotic Progression,REACTOME,pathway,PATHWAY_2577 |
| 2578,2578,2578,2578,2578,2578,2578,2578,R-HSA-9673163,Oleoyl-phe metabolism,REACTOME,pathway,PATHWAY_2578 |
| 2579,2579,2579,2579,2579,2579,2579,2579,R-HSA-9907900,Proteasome assembly,REACTOME,pathway,PATHWAY_2579 |
| 2580,2580,2580,2580,2580,2580,2580,2580,R-HSA-9037628,Rhesus blood group biosynthesis,REACTOME,pathway,PATHWAY_2580 |
| 2581,2581,2581,2581,2581,2581,2581,2581,R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,REACTOME,pathway,PATHWAY_2581 |
| 2582,2582,2582,2582,2582,2582,2582,2582,R-HSA-5627117,RHO GTPases Activate ROCKs,REACTOME,pathway,PATHWAY_2582 |
| 2583,2583,2583,2583,2583,2583,2583,2583,R-HSA-5579015,Defective CYP26B1 causes RHFCA,REACTOME,pathway,PATHWAY_2583 |
| 2584,2584,2584,2584,2584,2584,2584,2584,R-HSA-9662834,CD163 mediating an anti-inflammatory response,REACTOME,pathway,PATHWAY_2584 |
| 2585,2585,2585,2585,2585,2585,2585,2585,R-HSA-6807004,Negative regulation of MET activity,REACTOME,pathway,PATHWAY_2585 |
| 2586,2586,2586,2586,2586,2586,2586,2586,R-HSA-9660821,ADORA2B mediated anti-inflammatory cytokines production,REACTOME,pathway,PATHWAY_2586 |
| 2587,2587,2587,2587,2587,2587,2587,2587,R-HSA-9020958,Interleukin-21 signaling,REACTOME,pathway,PATHWAY_2587 |
| 2588,2588,2588,2588,2588,2588,2588,2588,R-HSA-1369007,Mitochondrial ABC transporters,REACTOME,pathway,PATHWAY_2588 |
| 2589,2589,2589,2589,2589,2589,2589,2589,R-HSA-2395516,Electron transport from NADPH to Ferredoxin,REACTOME,pathway,PATHWAY_2589 |
| 2590,2590,2590,2590,2590,2590,2590,2590,R-HSA-156581,Methylation,REACTOME,pathway,PATHWAY_2590 |
| 2591,2591,2591,2591,2591,2591,2591,2591,R-HSA-110357,Displacement of DNA glycosylase by APEX1,REACTOME,pathway,PATHWAY_2591 |
| 2592,2592,2592,2592,2592,2592,2592,2592,R-HSA-4717374,Defective DPM1 causes DPM1-CDG,REACTOME,pathway,PATHWAY_2592 |
| 2593,2593,2593,2593,2593,2593,2593,2593,R-HSA-6809371,Formation of the cornified envelope,REACTOME,pathway,PATHWAY_2593 |
| 2594,2594,2594,2594,2594,2594,2594,2594,R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",REACTOME,pathway,PATHWAY_2594 |
| 2595,2595,2595,2595,2595,2595,2595,2595,R-HSA-427389,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,REACTOME,pathway,PATHWAY_2595 |
| 2596,2596,2596,2596,2596,2596,2596,2596,R-HSA-1268020,Mitochondrial protein import,REACTOME,pathway,PATHWAY_2596 |
| 2597,2597,2597,2597,2597,2597,2597,2597,R-HSA-9730414,MITF-M-regulated melanocyte development,REACTOME,pathway,PATHWAY_2597 |
| 2598,2598,2598,2598,2598,2598,2598,2598,R-HSA-5654736,Signaling by FGFR1,REACTOME,pathway,PATHWAY_2598 |
| 2599,2599,2599,2599,2599,2599,2599,2599,R-HSA-8863678,Neurodegenerative Diseases,REACTOME,pathway,PATHWAY_2599 |
| 2600,2600,2600,2600,2600,2600,2600,2600,R-HSA-2408508,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",REACTOME,pathway,PATHWAY_2600 |
| 2601,2601,2601,2601,2601,2601,2601,2601,R-HSA-6803529,FGFR2 alternative splicing,REACTOME,pathway,PATHWAY_2601 |
| 2602,2602,2602,2602,2602,2602,2602,2602,R-HSA-2142770,Synthesis of 15-eicosatetraenoic acid derivatives,REACTOME,pathway,PATHWAY_2602 |
| 2603,2603,2603,2603,2603,2603,2603,2603,R-HSA-211945,Phase I - Functionalization of compounds,REACTOME,pathway,PATHWAY_2603 |
| 2604,2604,2604,2604,2604,2604,2604,2604,R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,REACTOME,pathway,PATHWAY_2604 |
| 2605,2605,2605,2605,2605,2605,2605,2605,R-HSA-9026762,Biosynthesis of maresin conjugates in tissue regeneration (MCTR),REACTOME,pathway,PATHWAY_2605 |
| 2606,2606,2606,2606,2606,2606,2606,2606,R-HSA-5693532,DNA Double-Strand Break Repair,REACTOME,pathway,PATHWAY_2606 |
| 2607,2607,2607,2607,2607,2607,2607,2607,R-HSA-5603041,IRAK4 deficiency (TLR2/4),REACTOME,pathway,PATHWAY_2607 |
| 2608,2608,2608,2608,2608,2608,2608,2608,R-HSA-3000157,Laminin interactions,REACTOME,pathway,PATHWAY_2608 |
| 2609,2609,2609,2609,2609,2609,2609,2609,R-HSA-72613,Eukaryotic Translation Initiation,REACTOME,pathway,PATHWAY_2609 |
| 2610,2610,2610,2610,2610,2610,2610,2610,R-HSA-9855142,Cellular responses to mechanical stimuli,REACTOME,pathway,PATHWAY_2610 |
| 2611,2611,2611,2611,2611,2611,2611,2611,R-HSA-9032759,NTRK2 activates RAC1,REACTOME,pathway,PATHWAY_2611 |
| 2612,2612,2612,2612,2612,2612,2612,2612,R-HSA-432142,Platelet sensitization by LDL,REACTOME,pathway,PATHWAY_2612 |
| 2613,2613,2613,2613,2613,2613,2613,2613,R-HSA-6804760,Regulation of TP53 Activity through Methylation,REACTOME,pathway,PATHWAY_2613 |
| 2614,2614,2614,2614,2614,2614,2614,2614,R-HSA-9918449,Defective visual phototransduction due to STRA6 loss of function,REACTOME,pathway,PATHWAY_2614 |
| 2615,2615,2615,2615,2615,2615,2615,2615,R-HSA-9682385,FLT3 signaling in disease,REACTOME,pathway,PATHWAY_2615 |
| 2616,2616,2616,2616,2616,2616,2616,2616,R-HSA-9025106,Biosynthesis of DPAn-6 SPMs,REACTOME,pathway,PATHWAY_2616 |
| 2617,2617,2617,2617,2617,2617,2617,2617,R-HSA-9608287,Defective MUTYH substrate binding,REACTOME,pathway,PATHWAY_2617 |
| 2618,2618,2618,2618,2618,2618,2618,2618,R-HSA-5619067,Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA),REACTOME,pathway,PATHWAY_2618 |
| 2619,2619,2619,2619,2619,2619,2619,2619,R-HSA-109581,Apoptosis,REACTOME,pathway,PATHWAY_2619 |
| 2620,2620,2620,2620,2620,2620,2620,2620,R-HSA-166166,MyD88-independent TLR4 cascade ,REACTOME,pathway,PATHWAY_2620 |
| 2621,2621,2621,2621,2621,2621,2621,2621,R-HSA-181429,Serotonin Neurotransmitter Release Cycle,REACTOME,pathway,PATHWAY_2621 |
| 2622,2622,2622,2622,2622,2622,2622,2622,R-HSA-8963693,Aspartate and asparagine metabolism,REACTOME,pathway,PATHWAY_2622 |
| 2623,2623,2623,2623,2623,2623,2623,2623,R-HSA-9753512,Signaling by RAS GTPase mutants,REACTOME,pathway,PATHWAY_2623 |
| 2624,2624,2624,2624,2624,2624,2624,2624,R-HSA-3560796,Defective PAPSS2 causes SEMD-PA,REACTOME,pathway,PATHWAY_2624 |
| 2625,2625,2625,2625,2625,2625,2625,2625,R-HSA-69306,DNA Replication,REACTOME,pathway,PATHWAY_2625 |
| 2626,2626,2626,2626,2626,2626,2626,2626,R-HSA-72172,mRNA Splicing,REACTOME,pathway,PATHWAY_2626 |
| 2627,2627,2627,2627,2627,2627,2627,2627,R-HSA-5358606,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),REACTOME,pathway,PATHWAY_2627 |
| 2628,2628,2628,2628,2628,2628,2628,2628,R-HSA-162906,HIV Infection,REACTOME,pathway,PATHWAY_2628 |
| 2629,2629,2629,2629,2629,2629,2629,2629,R-HSA-110381,Resolution of AP sites via the single-nucleotide replacement pathway,REACTOME,pathway,PATHWAY_2629 |
| 2630,2630,2630,2630,2630,2630,2630,2630,R-HSA-196783,Coenzyme A biosynthesis,REACTOME,pathway,PATHWAY_2630 |
| 2631,2631,2631,2631,2631,2631,2631,2631,R-HSA-9645460,Alpha-protein kinase 1 signaling pathway,REACTOME,pathway,PATHWAY_2631 |
| 2632,2632,2632,2632,2632,2632,2632,2632,R-HSA-5579007,Defective ACY1 causes encephalopathy,REACTOME,pathway,PATHWAY_2632 |
| 2633,2633,2633,2633,2633,2633,2633,2633,R-HSA-4720489,Defective ALG12 causes CDG-1g,REACTOME,pathway,PATHWAY_2633 |
| 2634,2634,2634,2634,2634,2634,2634,2634,R-HSA-5083627,Defective LARGE causes MDDGA6 and MDDGB6,REACTOME,pathway,PATHWAY_2634 |
| 2635,2635,2635,2635,2635,2635,2635,2635,R-HSA-9679509,Virion Assembly and Release,REACTOME,pathway,PATHWAY_2635 |
| 2636,2636,2636,2636,2636,2636,2636,2636,R-HSA-3359474,Defective MMACHC causes MAHCC,REACTOME,pathway,PATHWAY_2636 |
| 2637,2637,2637,2637,2637,2637,2637,2637,R-HSA-163316,Mitochondrial transcription termination,REACTOME,pathway,PATHWAY_2637 |
| 2638,2638,2638,2638,2638,2638,2638,2638,R-HSA-162599,Late Phase of HIV Life Cycle,REACTOME,pathway,PATHWAY_2638 |
| 2639,2639,2639,2639,2639,2639,2639,2639,R-HSA-167160,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,REACTOME,pathway,PATHWAY_2639 |
| 2640,2640,2640,2640,2640,2640,2640,2640,R-HSA-4791275,Signaling by WNT in cancer,REACTOME,pathway,PATHWAY_2640 |
| 2641,2641,2641,2641,2641,2641,2641,2641,R-HSA-187037,Signaling by NTRK1 (TRKA),REACTOME,pathway,PATHWAY_2641 |
| 2642,2642,2642,2642,2642,2642,2642,2642,R-HSA-167060,NGF processing,REACTOME,pathway,PATHWAY_2642 |
| 2643,2643,2643,2643,2643,2643,2643,2643,R-HSA-9006115,Signaling by NTRK2 (TRKB),REACTOME,pathway,PATHWAY_2643 |
| 2644,2644,2644,2644,2644,2644,2644,2644,R-HSA-9758920,Formation of lateral plate mesoderm,REACTOME,pathway,PATHWAY_2644 |
| 2645,2645,2645,2645,2645,2645,2645,2645,R-HSA-888590,"GABA synthesis, release, reuptake and degradation",REACTOME,pathway,PATHWAY_2645 |
| 2646,2646,2646,2646,2646,2646,2646,2646,R-HSA-166520,Signaling by NTRKs,REACTOME,pathway,PATHWAY_2646 |
| 2647,2647,2647,2647,2647,2647,2647,2647,R-HSA-5545619,XAV939 stabilizes AXIN,REACTOME,pathway,PATHWAY_2647 |
| 2648,2648,2648,2648,2648,2648,2648,2648,R-HSA-2142753,Arachidonate metabolism,REACTOME,pathway,PATHWAY_2648 |
| 2649,2649,2649,2649,2649,2649,2649,2649,R-HSA-2161541,Abacavir metabolism,REACTOME,pathway,PATHWAY_2649 |
| 2650,2650,2650,2650,2650,2650,2650,2650,R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,REACTOME,pathway,PATHWAY_2650 |
| 2651,2651,2651,2651,2651,2651,2651,2651,R-HSA-159854,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",REACTOME,pathway,PATHWAY_2651 |
| 2652,2652,2652,2652,2652,2652,2652,2652,R-HSA-68886,M Phase,REACTOME,pathway,PATHWAY_2652 |
| 2653,2653,2653,2653,2653,2653,2653,2653,R-HSA-9706374,FLT3 signaling through SRC family kinases,REACTOME,pathway,PATHWAY_2653 |
| 2654,2654,2654,2654,2654,2654,2654,2654,R-HSA-5619109,Defective SLC6A2 causes orthostatic intolerance (OI),REACTOME,pathway,PATHWAY_2654 |
| 2655,2655,2655,2655,2655,2655,2655,2655,R-HSA-2142712,Synthesis of 12-eicosatetraenoic acid derivatives,REACTOME,pathway,PATHWAY_2655 |
| 2656,2656,2656,2656,2656,2656,2656,2656,R-HSA-381753,Olfactory Signaling Pathway,REACTOME,pathway,PATHWAY_2656 |
| 2657,2657,2657,2657,2657,2657,2657,2657,R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,REACTOME,pathway,PATHWAY_2657 |
| 2658,2658,2658,2658,2658,2658,2658,2658,R-HSA-173736,Alternative complement activation,REACTOME,pathway,PATHWAY_2658 |
| 2659,2659,2659,2659,2659,2659,2659,2659,R-HSA-2206281,Mucopolysaccharidoses,REACTOME,pathway,PATHWAY_2659 |
| 2660,2660,2660,2660,2660,2660,2660,2660,R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,REACTOME,pathway,PATHWAY_2660 |
| 2661,2661,2661,2661,2661,2661,2661,2661,R-HSA-448706,Interleukin-1 processing,REACTOME,pathway,PATHWAY_2661 |
| 2662,2662,2662,2662,2662,2662,2662,2662,R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,REACTOME,pathway,PATHWAY_2662 |
| 2663,2663,2663,2663,2663,2663,2663,2663,R-HSA-141333,Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,REACTOME,pathway,PATHWAY_2663 |
| 2664,2664,2664,2664,2664,2664,2664,2664,R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,REACTOME,pathway,PATHWAY_2664 |
| 2665,2665,2665,2665,2665,2665,2665,2665,R-HSA-5619087,Defective SLC12A3 causes Gitelman syndrome (GS),REACTOME,pathway,PATHWAY_2665 |
| 2666,2666,2666,2666,2666,2666,2666,2666,R-HSA-9796292,Formation of axial mesoderm,REACTOME,pathway,PATHWAY_2666 |
| 2667,2667,2667,2667,2667,2667,2667,2667,R-HSA-187706,Signalling to p38 via RIT and RIN,REACTOME,pathway,PATHWAY_2667 |
| 2668,2668,2668,2668,2668,2668,2668,2668,R-HSA-9609646,HCMV Infection,REACTOME,pathway,PATHWAY_2668 |
| 2669,2669,2669,2669,2669,2669,2669,2669,R-HSA-196819,Vitamin B1 (thiamin) metabolism,REACTOME,pathway,PATHWAY_2669 |
| 2670,2670,2670,2670,2670,2670,2670,2670,R-HSA-8964208,Phenylalanine metabolism,REACTOME,pathway,PATHWAY_2670 |
| 2671,2671,2671,2671,2671,2671,2671,2671,R-HSA-2022870,Chondroitin sulfate biosynthesis,REACTOME,pathway,PATHWAY_2671 |
| 2672,2672,2672,2672,2672,2672,2672,2672,R-HSA-9662360,Sensory processing of sound by inner hair cells of the cochlea,REACTOME,pathway,PATHWAY_2672 |
| 2673,2673,2673,2673,2673,2673,2673,2673,R-HSA-6807505,RNA polymerase II transcribes snRNA genes,REACTOME,pathway,PATHWAY_2673 |
| 2674,2674,2674,2674,2674,2674,2674,2674,R-HSA-9843970,Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex,REACTOME,pathway,PATHWAY_2674 |
| 2675,2675,2675,2675,2675,2675,2675,2675,R-HSA-5357956,TNFR1-induced NF-kappa-B signaling pathway,REACTOME,pathway,PATHWAY_2675 |
| 2676,2676,2676,2676,2676,2676,2676,2676,R-HSA-1912408,Pre-NOTCH Transcription and Translation,REACTOME,pathway,PATHWAY_2676 |
| 2677,2677,2677,2677,2677,2677,2677,2677,R-HSA-2142789,Ubiquinol biosynthesis,REACTOME,pathway,PATHWAY_2677 |
| 2678,2678,2678,2678,2678,2678,2678,2678,R-HSA-5620924,Intraflagellar transport,REACTOME,pathway,PATHWAY_2678 |
| 2679,2679,2679,2679,2679,2679,2679,2679,R-HSA-561048,Organic anion transport,REACTOME,pathway,PATHWAY_2679 |
| 2680,2680,2680,2680,2680,2680,2680,2680,R-HSA-168316,Assembly of Viral Components at the Budding Site,REACTOME,pathway,PATHWAY_2680 |
| 2681,2681,2681,2681,2681,2681,2681,2681,R-HSA-446219,Synthesis of substrates in N-glycan biosythesis,REACTOME,pathway,PATHWAY_2681 |
| 2682,2682,2682,2682,2682,2682,2682,2682,R-HSA-912694,Regulation of IFNA/IFNB signaling,REACTOME,pathway,PATHWAY_2682 |
| 2683,2683,2683,2683,2683,2683,2683,2683,R-HSA-9723907,Loss of Function of TP53 in Cancer,REACTOME,pathway,PATHWAY_2683 |
| 2684,2684,2684,2684,2684,2684,2684,2684,R-HSA-428930,Thromboxane signalling through TP receptor,REACTOME,pathway,PATHWAY_2684 |
| 2685,2685,2685,2685,2685,2685,2685,2685,R-HSA-168874,"Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus",REACTOME,pathway,PATHWAY_2685 |
| 2686,2686,2686,2686,2686,2686,2686,2686,R-HSA-75102,C6 deamination of adenosine,REACTOME,pathway,PATHWAY_2686 |
| 2687,2687,2687,2687,2687,2687,2687,2687,R-HSA-977444,GABA B receptor activation,REACTOME,pathway,PATHWAY_2687 |
| 2688,2688,2688,2688,2688,2688,2688,2688,R-HSA-8939256,RUNX1 regulates transcription of genes involved in WNT signaling,REACTOME,pathway,PATHWAY_2688 |
| 2689,2689,2689,2689,2689,2689,2689,2689,R-HSA-3371598,Defective BTD causes biotidinase deficiency,REACTOME,pathway,PATHWAY_2689 |
| 2690,2690,2690,2690,2690,2690,2690,2690,R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",REACTOME,pathway,PATHWAY_2690 |
| 2691,2691,2691,2691,2691,2691,2691,2691,R-HSA-3642279,TGFBR2 MSI Frameshift Mutants in Cancer,REACTOME,pathway,PATHWAY_2691 |
| 2692,2692,2692,2692,2692,2692,2692,2692,R-HSA-9703465,Signaling by FLT3 fusion proteins,REACTOME,pathway,PATHWAY_2692 |
| 2693,2693,2693,2693,2693,2693,2693,2693,R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,REACTOME,pathway,PATHWAY_2693 |
| 2694,2694,2694,2694,2694,2694,2694,2694,R-HSA-9703009,tamatinib-resistant FLT3 mutants,REACTOME,pathway,PATHWAY_2694 |
| 2695,2695,2695,2695,2695,2695,2695,2695,R-HSA-9013409,RHOJ GTPase cycle,REACTOME,pathway,PATHWAY_2695 |
| 2696,2696,2696,2696,2696,2696,2696,2696,R-HSA-2892247,"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",REACTOME,pathway,PATHWAY_2696 |
| 2697,2697,2697,2697,2697,2697,2697,2697,R-HSA-9824878,"Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 ",REACTOME,pathway,PATHWAY_2697 |
| 2698,2698,2698,2698,2698,2698,2698,2698,R-HSA-380612,Metabolism of serotonin,REACTOME,pathway,PATHWAY_2698 |
| 2699,2699,2699,2699,2699,2699,2699,2699,R-HSA-192905,vRNP Assembly,REACTOME,pathway,PATHWAY_2699 |
| 2700,2700,2700,2700,2700,2700,2700,2700,R-HSA-391160,Signal regulatory protein family interactions,REACTOME,pathway,PATHWAY_2700 |
| 2701,2701,2701,2701,2701,2701,2701,2701,R-HSA-9679514,SARS-CoV-1 Genome Replication and Transcription,REACTOME,pathway,PATHWAY_2701 |
| 2702,2702,2702,2702,2702,2702,2702,2702,R-HSA-8964572,Lipid particle organization,REACTOME,pathway,PATHWAY_2702 |
| 2703,2703,2703,2703,2703,2703,2703,2703,R-HSA-9830364,Formation of the nephric duct,REACTOME,pathway,PATHWAY_2703 |
| 2704,2704,2704,2704,2704,2704,2704,2704,R-HSA-5250941,Negative epigenetic regulation of rRNA expression,REACTOME,pathway,PATHWAY_2704 |
| 2705,2705,2705,2705,2705,2705,2705,2705,R-HSA-2024101,CS/DS degradation,REACTOME,pathway,PATHWAY_2705 |
| 2706,2706,2706,2706,2706,2706,2706,2706,R-HSA-174362,Transport and synthesis of PAPS,REACTOME,pathway,PATHWAY_2706 |
| 2707,2707,2707,2707,2707,2707,2707,2707,R-HSA-913709,O-linked glycosylation of mucins,REACTOME,pathway,PATHWAY_2707 |
| 2708,2708,2708,2708,2708,2708,2708,2708,R-HSA-69002,DNA Replication Pre-Initiation,REACTOME,pathway,PATHWAY_2708 |
| 2709,2709,2709,2709,2709,2709,2709,2709,R-HSA-388396,GPCR downstream signalling,REACTOME,pathway,PATHWAY_2709 |
| 2710,2710,2710,2710,2710,2710,2710,2710,R-HSA-5683371,Defective ABCB6 causes MCOPCB7,REACTOME,pathway,PATHWAY_2710 |
| 2711,2711,2711,2711,2711,2711,2711,2711,R-HSA-389356,Co-stimulation by CD28,REACTOME,pathway,PATHWAY_2711 |
| 2712,2712,2712,2712,2712,2712,2712,2712,R-HSA-70921,Histidine catabolism,REACTOME,pathway,PATHWAY_2712 |
| 2713,2713,2713,2713,2713,2713,2713,2713,R-HSA-9818564,Epigenetic regulation of gene expression by MLL3 and MLL4 complexes,REACTOME,pathway,PATHWAY_2713 |
| 2714,2714,2714,2714,2714,2714,2714,2714,R-HSA-9658195,Leishmania infection,REACTOME,pathway,PATHWAY_2714 |
| 2715,2715,2715,2715,2715,2715,2715,2715,R-HSA-5579024,Defective MAT1A causes MATD,REACTOME,pathway,PATHWAY_2715 |
| 2716,2716,2716,2716,2716,2716,2716,2716,R-HSA-141334,PAOs oxidise polyamines to amines,REACTOME,pathway,PATHWAY_2716 |
| 2717,2717,2717,2717,2717,2717,2717,2717,R-HSA-72695,"Formation of the ternary complex, and subsequently, the 43S complex",REACTOME,pathway,PATHWAY_2717 |
| 2718,2718,2718,2718,2718,2718,2718,2718,R-HSA-69205,G1/S-Specific Transcription,REACTOME,pathway,PATHWAY_2718 |
| 2719,2719,2719,2719,2719,2719,2719,2719,R-HSA-9692916,SARS-CoV-1 activates/modulates innate immune responses,REACTOME,pathway,PATHWAY_2719 |
| 2720,2720,2720,2720,2720,2720,2720,2720,R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,REACTOME,pathway,PATHWAY_2720 |
| 2721,2721,2721,2721,2721,2721,2721,2721,R-HSA-72200,mRNA Editing: C to U Conversion,REACTOME,pathway,PATHWAY_2721 |
| 2722,2722,2722,2722,2722,2722,2722,2722,R-HSA-390918,Peroxisomal lipid metabolism,REACTOME,pathway,PATHWAY_2722 |
| 2723,2723,2723,2723,2723,2723,2723,2723,R-HSA-1482798,Acyl chain remodeling of CL,REACTOME,pathway,PATHWAY_2723 |
| 2724,2724,2724,2724,2724,2724,2724,2724,R-HSA-1296071,Potassium Channels,REACTOME,pathway,PATHWAY_2724 |
| 2725,2725,2725,2725,2725,2725,2725,2725,R-HSA-5693537,Resolution of D-Loop Structures,REACTOME,pathway,PATHWAY_2725 |
| 2726,2726,2726,2726,2726,2726,2726,2726,R-HSA-442755,Activation of NMDA receptors and postsynaptic events,REACTOME,pathway,PATHWAY_2726 |
| 2727,2727,2727,2727,2727,2727,2727,2727,R-HSA-167246,Tat-mediated elongation of the HIV-1 transcript,REACTOME,pathway,PATHWAY_2727 |
| 2728,2728,2728,2728,2728,2728,2728,2728,R-HSA-5619077,Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D),REACTOME,pathway,PATHWAY_2728 |
| 2729,2729,2729,2729,2729,2729,2729,2729,R-HSA-167172,Transcription of the HIV genome,REACTOME,pathway,PATHWAY_2729 |
| 2730,2730,2730,2730,2730,2730,2730,2730,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,REACTOME,pathway,PATHWAY_2730 |
| 2731,2731,2731,2731,2731,2731,2731,2731,R-HSA-8849468,PTK6 Regulates Proteins Involved in RNA Processing,REACTOME,pathway,PATHWAY_2731 |
| 2732,2732,2732,2732,2732,2732,2732,2732,R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",REACTOME,pathway,PATHWAY_2732 |
| 2733,2733,2733,2733,2733,2733,2733,2733,R-HSA-3270619,IRF3-mediated induction of type I IFN,REACTOME,pathway,PATHWAY_2733 |
| 2734,2734,2734,2734,2734,2734,2734,2734,R-HSA-212300,PRC2 methylates histones and DNA,REACTOME,pathway,PATHWAY_2734 |
| 2735,2735,2735,2735,2735,2735,2735,2735,R-HSA-9013026,RHOB GTPase cycle,REACTOME,pathway,PATHWAY_2735 |
| 2736,2736,2736,2736,2736,2736,2736,2736,R-HSA-5682294,Defective ABCA12 causes ARCI4B,REACTOME,pathway,PATHWAY_2736 |
| 2737,2737,2737,2737,2737,2737,2737,2737,R-HSA-3214815,HDACs deacetylate histones,REACTOME,pathway,PATHWAY_2737 |
| 2738,2738,2738,2738,2738,2738,2738,2738,R-HSA-110320,Translesion Synthesis by POLH,REACTOME,pathway,PATHWAY_2738 |
| 2739,2739,2739,2739,2739,2739,2739,2739,R-HSA-5657655,MGMT-mediated DNA damage reversal,REACTOME,pathway,PATHWAY_2739 |
| 2740,2740,2740,2740,2740,2740,2740,2740,R-HSA-5083635,Defective B3GALTL causes PpS,REACTOME,pathway,PATHWAY_2740 |
| 2741,2741,2741,2741,2741,2741,2741,2741,R-HSA-373756,SDK interactions,REACTOME,pathway,PATHWAY_2741 |
| 2742,2742,2742,2742,2742,2742,2742,2742,R-HSA-432722,Golgi Associated Vesicle Biogenesis,REACTOME,pathway,PATHWAY_2742 |
| 2743,2743,2743,2743,2743,2743,2743,2743,R-HSA-9613829,Chaperone Mediated Autophagy,REACTOME,pathway,PATHWAY_2743 |
| 2744,2744,2744,2744,2744,2744,2744,2744,R-HSA-3359471,"Defective MMAB causes MMA, cblB type",REACTOME,pathway,PATHWAY_2744 |
| 2745,2745,2745,2745,2745,2745,2745,2745,R-HSA-4420097,VEGFA-VEGFR2 Pathway,REACTOME,pathway,PATHWAY_2745 |
| 2746,2746,2746,2746,2746,2746,2746,2746,R-HSA-9768778,Regulation of NPAS4 mRNA translation,REACTOME,pathway,PATHWAY_2746 |
| 2747,2747,2747,2747,2747,2747,2747,2747,R-HSA-901042,Calnexin/calreticulin cycle,REACTOME,pathway,PATHWAY_2747 |
| 2748,2748,2748,2748,2748,2748,2748,2748,R-HSA-446203,Asparagine N-linked glycosylation,REACTOME,pathway,PATHWAY_2748 |
| 2749,2749,2749,2749,2749,2749,2749,2749,R-HSA-445095,Interaction between L1 and Ankyrins,REACTOME,pathway,PATHWAY_2749 |
| 2750,2750,2750,2750,2750,2750,2750,2750,R-HSA-9018896,Biosynthesis of E-series 18(S)-resolvins,REACTOME,pathway,PATHWAY_2750 |
|
|
